CMD, VAAST -m pvaast --enable_splice_sites y -r 0.05 --region /mnt/san/xing/brz_wgs/VAAST_JUN_3/ADHD.bed -pv_control /mnt/san/xing/brz_wgs/VAAST_JUN_3/CTL/ADHD_dominant.ctl -o /mnt/san/xing/brz_wgs/VAAST_JUN_3/Result/ADHD_DOM_5/ADHD_DOM_5 /nfs/XingLab_ISI/TS_Exome_Yale/VAAST/Data/refGene_hg19.gff3 /mnt/san/xing/brz_wgs/VAAST_JUN_3/bg_gtex.cdr -d 2000 -min_suc 50 -p 32 -o /mnt/san/xing/brz_wgs/VAAST_JUN_3/Result/ADHD_DOM_5/ADHD_DOM_5-run1 -max_time 300
Rank,Gene,FullName,Found in Pathway,mRNA,Chr,Score,PValue,LOD_Score,LOD_PValue,Strand,StandardName,Start,End,Description,Type,Synonym,pLI,ASD,ADHD,Textmining,Experiments,Knowledge,MousePheno,TissueML,GTEx,BrainSpan,#ofVar,VarType,VarScore,VarLODScore,VarPosition,nAllele,Ref,GenoType,gnomad_AF,ExAC_nonpsych_AF,PolyPhen,SIFT
1,KDM6B,Homo sapiens lysine (K)-specific demethylase 6B (KDM6B) mRNA.,Transcription Factor,NM_001080424,chr17,125.82,1e-06,1.12,4e-02,+,KDM6B,7834210,7854796,lysine demethylase 6B,protein_coding,"JMJD3,NEDCFSA",1.00,1,0,2.40:Cancer|2.23:Hematopoietic system disease|1.89:Gastrointestinal system disease|1.80:Parasitic helminthiasis infectious disease|1.80:Breast disease|1.72:Prostate disease|1.71:Lung disease|1.70:Eye disease|1.62:Kidney disease|1.59:Neurodegenerative disease|1.59:Vascular disease|1.58:Intellectual disability|1.54:Autoimmune hypersensitivity disease|1.53:Diabetes mellitus|1.53:Arthritis,NA,NA,NA,"0.73:leukocyte|0.70:spleen|0.68:placenta|0.66:autism spectrum disorder|0.62:blood|0.62:liver|0.62:ovary|0.62:brain|0.60:lung|0.60:testis|0.58:heart|0.56:regulation of DNA binding transcription factor activity|0.56:fetus|0.55:regulation of response to external stimulus|0.54:nervous system|0.54:regulation of translational initiation in response to stress|0.53:kidney|0.52:pancreas|0.50:histone modification|0.49:central nervous system|0.48:skeletal muscle|0.47:positive regulation of MAPK cascade|0.46:gastrointestinal tract|0.45:spinal cord|0.44:regulation of translation|0.43:prostate gland|0.41:negative regulation of DNA binding transcription factor activity|0.39:3'-UTR-mediated mRNA destabilization|0.37:regulation of defense response|0.37:stress-activated MAPK cascade|0.36:T-lymphocyte|0.35:lymph node|0.35:regulation of cellular amide metabolic process|0.35:intestine|0.34:macrophage|0.34:regulation of myeloid cell differentiation|0.33:lymphocyte|0.33:positive regulation of stress-activated MAPK cascade|0.33:regulation of epithelial cell differentiation|0.33:posttranscriptional regulation of gene expression|0.32:regulation of inflammatory response|0.31:uterus|0.30:umbilical vein endothelial cell|0.30:corpus striatum|0.30:small intestine|0.29:regulation of translation initiation in response to endoplasmic reticulum stress|0.29:positive regulation of tyrosine phosphorylation of STAT protein|0.29:bone marrow|0.29:peptide biosynthetic process|0.29:regulation of cell adhesion|0.28:negative regulation of protein modification process|0.28:regulation of stress-activated MAPK cascade|0.28:ERK1 and ERK2 cascade|0.28:translation|0.27:regulation of tyrosine phosphorylation of STAT protein|0.26:negative regulation of myeloid cell differentiation|0.26:regulation of hemopoiesis|0.26:negative regulation of translation|0.26:mRNA destabilization|0.25:cerebellum|0.25:regulation of translation in response to stress|0.25:regulation of multi-organism process|0.25:positive regulation of cell differentiation|0.25:amide biosynthetic process|0.24:caudate nucleus|0.24:forebrain|0.24:subthalamic nucleus|0.24:telencephalon|0.24:cerebral cortex|0.24:peptidyl-lysine modification|0.24:regulation of epithelial cell apoptotic process|0.23:mammary gland|0.23:regulation of histone modification|0.23:thyroid gland|0.23:positive regulation of cellular catabolic process|0.23:amygdala|0.22:apoptotic signaling pathway|0.22:negative regulation of response to external stimulus|0.22:regulation of ERK1 and ERK2 cascade|0.22:hippocampus|0.22:regulation of protein serine/threonine kinase activity|0.22:regulation of protein complex assembly|0.22:blood vessel|0.22:regulation of gene silencing by miRNA|0.22:JNK cascade|0.22:regulation of apoptotic signaling pathway|0.22:peptide metabolic process|0.22:positive regulation of protein kinase activity|0.21:positive regulation of catabolic process|0.21:negative regulation of hemopoiesis|0.21:regulation of translation in response to endoplasmic reticulum stress|0.21:negative regulation of intracellular signal transduction|0.21:positive regulation of programmed cell death|0.21:granulocyte|0.21:dendritic cell|0.20:positive regulation of apoptotic process|0.20:regulation of MAP kinase activity|0.20:colon|0.20:umbilical cord|0.20:positive regulation of DNA binding transcription factor activity|0.20:regulation of epithelial cell proliferation|0.20:regulation of protein localization to nucleus|0.20:negative regulation of cellular amide metabolic process|0.20:temporal lobe|0.20:positive regulation of JNK cascade|0.19:uterine endometrium|0.19:midbrain|0.19:RNA destabilization|0.19:neutrophil|0.19:regulation of intracellular protein transport|0.19:stress-activated protein kinase signaling cascade|0.19:regulation of immune response|0.19:regulation of epidermis development|0.18:large intestine|0.18:histone H3-K36 demethylation|0.18:regulation of mRNA metabolic process|0.18:positive regulation of cellular protein localization|0.18:stomach|0.18:adrenal gland|0.18:I-kappaB kinase/NF-kappaB signaling|0.18:substantia nigra|0.17:positive regulation of histone modification|0.17:regulation of smooth muscle cell proliferation|0.17:regulation of I-kappaB kinase/NF-kappaB signaling|0.17:monocyte|0.17:regulation of chromosome organization|0.17:B-lymphocyte|0.16:diencephalon|0.16:regulation of cell-cell adhesion|0.16:negative regulation of developmental process|0.16:negative regulation of cell cycle|0.16:gene silencing by miRNA|0.16:negative regulation of protein phosphorylation|0.16:regulation of epidermal cell differentiation|0.16:epidermis|0.16:tyrosine phosphorylation of STAT protein|0.15:positive regulation of peptidyl-tyrosine phosphorylation|0.15:regulation of kidney development|0.15:G-protein coupled receptor signaling pathway|0.15:positive regulation of immune response|0.15:muscle|0.15:basal ganglion|0.15:negative regulation of cell differentiation|0.15:mRNA catabolic process|0.15:regulation of JNK cascade|0.15:positive regulation of I-kappaB kinase/NF-kappaB signaling|0.15:regulation of DNA metabolic process|0.15:nuclear-transcribed mRNA catabolic process|0.15:skin|0.14:regulation of gene expression, epigenetic|0.14:negative regulation of NF-kappaB transcription factor activity|0.14:transmembrane receptor protein tyrosine kinase signaling pathway|0.14:mononuclear phagocyte|0.14:negative regulation of cell proliferation|0.14:negative regulation of immune system process|0.14:corpus callosum|0.14:positive regulation of MAP kinase activity|0.14:positive regulation of p38MAPK cascade|0.14:eosinophil|0.14:regulation of symbiosis, encompassing mutualism through parasitism|0.13:positive regulation of ERK1 and ERK2 cascade|0.13:regulation of keratinocyte differentiation|0.13:regulation of transcription from RNA polymerase II promoter in response to stress|0.13:regulation of interleukin-8 biosynthetic process|0.13:protein acylation|0.13:regulation of peptidyl-tyrosine phosphorylation|0.13:positive regulation of protein serine/threonine kinase activity|0.13:histone acetylation|0.13:histone lysine demethylation|0.13:regulation of viral process|0.13:regulation of DNA-templated transcription in response to stress|0.13:regulation of secretion|0.13:positive regulation of locomotion|0.13:positive regulation of kinase activity|0.13:internal peptidyl-lysine acetylation|0.12:regulation of chromatin organization|0.12:positive regulation of cell adhesion|0.12:positive regulation of intracellular transport|0.12:regulation of STAT cascade|0.12:regulation of JAK-STAT cascade|0.12:transmembrane receptor protein serine/threonine kinase signaling pathway|0.12:positive regulation of cellular component movement|0.12:positive regulation of protein transport|0.12:regulation of endopeptidase activity|0.12:positive regulation of mRNA catabolic process|0.12:positive regulation of cell migration|0.11:regulation of peptidase activity|0.11:positive regulation of gene silencing by miRNA|0.11:positive regulation of cell motility|0.11:internal protein amino acid acetylation|0.11:peptidyl-lysine acetylation|0.11:positive regulation of mRNA metabolic process|0.11:regulation of cytoskeleton organization|0.11:vascular endothelial cell|0.11:regulation of cytokine biosynthetic process|0.11:peripheral nervous system disease|0.11:epilepsy|0.11:regulation of protein catabolic process|0.11:serum|0.11:activation of immune response|0.11:positive regulation of protein complex assembly|0.11:posttranscriptional gene silencing by RNA|0.11:neuropathy|0.11:extrinsic apoptotic signaling pathway|0.11:positive regulation of STAT cascade|0.11:positive regulation of JAK-STAT cascade|0.11:protein acetylation|0.11:regulation of secretion by cell|0.11:positive regulation of apoptotic signaling pathway|0.11:regulation of stress-activated protein kinase signaling cascade|0.11:hypophysis|0.11:mRNA metabolic process|0.11:posttranscriptional gene silencing|0.11:hematopoietic stem cell|0.10:positive regulation of response to external stimulus|0.10:regulation of extrinsic apoptotic signaling pathway|0.10:regulation of protein import into nucleus|0.10:tonsil|0.10:positive regulation of transcription from RNA polymerase II promoter in response to stress|0.10:positive regulation of stress-activated protein kinase signaling cascade|0.10:regulation of vasculature development|0.10:trachea|0.10:gene silencing by RNA|0.10:positive regulation of intracellular protein transport|0.10:negative regulation of multi-organism process",64.36:Whole Blood|60.18:Ovary|41.75:Lung|41.28:Brain - Cerebellum|40.13:Pituitary|39.37:Testis|38.23:Spleen|36.52:Brain - Cerebellar Hemisphere|34.38:Thyroid|33.23:Uterus|32.70:Fallopian Tube|31.71:Adipose - Visceral (Omentum)|30.24:Cervix - Endocervix|28.54:Small Intestine - Terminal Ileum|28.15:Cervix - Ectocervix|27.65:Colon - Sigmoid|27.10:Prostate|27.06:Skin - Not Sun Exposed (Suprapubic)|26.93:Bladder|25.67:Vagina|25.22:Cells - EBV-transformed lymphocytes|25.20:Skin - Sun Exposed (Lower leg)|24.95:Esophagus - Gastroesophageal Junction|23.98:Breast - Mammary Tissue|22.11:Esophagus - Muscularis|21.49:Artery - Tibial|21.49:Colon - Transverse|20.20:Artery - Coronary|19.99:Adipose - Subcutaneous|19.74:Nerve - Tibial|18.82:Minor Salivary Gland|18.59:Stomach|18.12:Esophagus - Mucosa|16.82:Artery - Aorta|15.43:Kidney - Medulla|14.77:Adrenal Gland|13.49:Kidney - Cortex|13.04:Heart - Atrial Appendage|9.32:Liver|8.90:Muscle - Skeletal|8.51:Brain - Cortex|8.26:Heart - Left Ventricle|7.74:Brain - Hypothalamus|7.62:Cells - Cultured fibroblasts|7.59:Pancreas|6.80:Brain - Frontal Cortex (BA9)|5.92:Brain - Nucleus accumbens (basal ganglia)|5.61:Brain - Caudate (basal ganglia)|5.22:Brain - Anterior cingulate cortex (BA24)|5.11:Brain - Spinal cord (cervical c-1)|4.61:Brain - Hippocampus|4.61:Brain - Putamen (basal ganglia)|4.37:Brain - Amygdala|3.93:Brain - Substantia nigra,"25.43:upper (rostral) rhombic lip|22.17:temporal neocortex|21.67:lateral ganglionic eminence|20.33:parietal neocortex|19.01:primary motor-sensory cortex (samples)|16.76:cerebellum|15.91:occipital neocortex|13.88:caudal ganglionic eminence|12.81:medial ganglionic eminence|9.98:dorsal thalamus|6.49:cerebellar cortex|4.52:striatum|4.09:primary visual cortex (striate cortex, area V1/17)|3.83:ventrolateral prefrontal cortex|3.48:primary auditory cortex (core)|3.42:amygdaloid complex|3.35:posteroventral (inferior) parietal cortex|3.19:anterior (rostral) cingulate (medial prefrontal) cortex|3.12:dorsolateral prefrontal cortex|2.99:posterior (caudal) superior temporal cortex (area 22c)|2.97:primary somatosensory cortex (area S1, areas 3,1,2)|2.96:hippocampus (hippocampal formation)|2.82:primary motor cortex (area M1, area 4)|2.67:orbital frontal cortex|2.44:inferolateral temporal cortex (area TEv, area 20)|1.79:mediodorsal nucleus of thalamus",8,SNP,13.39,0|0.79;1-46|0.00,7749567,NA,C|Y,"N|4|C:G|Y:*;N|0|^:^|^:^;N|8-9|^:^|^:^;N|35|^:^|^:^;N|42|^:^|^:^;N|50|^:^|^:^;N|73-74|^:^|^:^;N|80|^:^|^:^;N|101|^:^|^:^;N|104|^:^|^:^;N|142|^:^|^:^;N|146|^:^|^:^;N|151-152|^:^|^:^;N|154,157-158|^:^|^:^;N|159|^:^|^:^;N|165-167,169-170|^:^|^:^",NA,NA,NA,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.41,"18|0.13;0-17,19-46|0.00",7749972,NA,G|V,"N|35-36|^:^|^:^;N|63,65|G:T|V:L;N|146,149|^:^|^:^;N|153|^:^|^:^;N|154|^:^|^:^;N|160|^:^|^:^;N|170|^:^|^:^",0.0041,0.0032,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,14.26,0-46|0.00,7750010,NA,G|E,"N|21,23|C:G|D:E;N|29|C:G|D:E;N|35|^:^|^:^;N|63-64|C:G|D:E;N|78|C:G|D:E;N|90|^:^|^:^;N|100-102|C:G|D:E;N|113|C:G|D:E;N|115,117|C:G|D:E;N|148|^:^|^:^;N|151-152|C:G|D:E;N|163-164,168-169|C:G|D:E;N|170|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.26,0-46|0.00,7750903,NA,T|S,"N|10|^:^|^:^;N|23|^:^|^:^;N|37|^:^|^:^;N|65|^:^|^:^;N|74|^:^|^:^;N|79|^:^|^:^;N|84|C:T|P:S;N|86|^:^|^:^;N|104,107|C:T|P:S;N|146-147|^:^|^:^;N|156|^:^|^:^;N|167|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.43,"25|0.26;0-24,26-46|0.00",7751888,NA,C|T,"N|0|^:^|^:^;N|9,11|^:^|^:^;N|26|^:^|^:^;N|35|^:^|^:^;N|44|^:^|^:^;N|63|^:^|^:^;N|69|^:^|^:^;N|74|^:^|^:^;N|78|^:^|^:^;N|88,91|C:G|T:S;N|100|^:^|^:^;N|107|^:^|^:^;N|124-125|^:^|^:^;N|139-140|^:^|^:^;N|142|^:^|^:^;N|149|^:^|^:^;N|151|^:^|^:^;N|154,156-157|^:^|^:^;N|162|^:^|^:^;N|165,167,169,171|^:^|^:^",0.0006,0.0007,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.50,0-46|0.00,7752332,NA,C|S,"N|0-1|^:^|^:^;N|8-10|^:^|^:^;N|20-21|^:^|^:^;N|25|^:^|^:^;N|37|^:^|^:^;N|50|^:^|^:^;N|69|^:^|^:^;N|79-81|^:^|^:^;N|86-87|^:^|^:^;N|92-94,96|A:C|Y:S;N|100|^:^|^:^;N|107|^:^|^:^;N|124|^:^|^:^;N|137,139-141|^:^|^:^;N|142-143|^:^|^:^;N|146,148-149|^:^|^:^;N|150-151,153|^:^|^:^;N|154-155,157-158|^:^|^:^;N|159-162|^:^|^:^;N|164,168-169|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,mnp,65.84,0-46|0.00,7750178,NA,ACCACCACCACCACCACC|LPPPPPP,"2|ACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPP:LPPPPPPP;3|ACCACCACCACC:ACCACCACCACCACCACC|LPPPP:LPPPPPP;4|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;0-1|^:^|^:^;7|ACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPP:LPPPPPPP;5-6|^:^|^:^;8-13|^:^|^:^;14-15|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;16|^:^|^:^;18|ACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPP:LPPPPPPP;19|ACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;17|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;23|ACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;22|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;20-21|^:^|^:^;29|ACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;27|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;24-26,28|^:^|^:^;31-32|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;30,33|^:^|^:^;34|^:^|^:^;39|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;35-38|^:^|^:^;40|^:^|^:^;41|^:^|^:^;45-46|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;42-44|^:^|^:^;49|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;47-48|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;51,53|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;50,52|^:^|^:^;54-55|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;56|^:^|^:^;57-59|^:^|^:^;61|ACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPP:LPPPPPPP;60|ACCACCACCACC:ACCACCACCACCACCACC|LPPPP:LPPPPPP;62|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;64|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;63,65|^:^|^:^;67|ACCACCACCACC:ACCACCACCACCACCACC|LPPPP:LPPPPPP;66,68|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;72|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;69-71|^:^|^:^;73-77|^:^|^:^;78|^:^|^:^;82|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;79-81|^:^|^:^;84|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;83,85|^:^|^:^;89|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;86-88,90-91|^:^|^:^;95-96|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;92-94|^:^|^:^;98-99|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;97|^:^|^:^;103|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;100-102|^:^|^:^;107|ACCACCACCACC:ACCACCACCACCACCACC|LPPPP:LPPPPPP;106|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;104-105|^:^|^:^;108|^:^|^:^;111|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;110|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;109|^:^|^:^;113|ACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;114|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;112|^:^|^:^;116-117|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;115|^:^|^:^;119-120|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;118|^:^|^:^;121|ACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPP:LPPPPPPP;123|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;122|^:^|^:^;127|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;124-126|^:^|^:^;128-129|^:^|^:^;131,133|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;130,132|^:^|^:^;134|ACCACCACCACCACCACC:ACCACCACCACCACCACCACCACC|LPPPPPP:LPPPPPPP;135|ACCACCACCACCACCACCACCACC:ACCACCACCACCACCACCACCACCACC|LPPPPPPP:LPPPPPPP;136|^:^|^:^;137-141|^:^|^:^;142-145|^:^|^:^;146-149|^:^|^:^;150-153|^:^|^:^;154-158|^:^|^:^;159-162|^:^|^:^;163-171|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,mnp,13.24,0-46|0.00,7751859,NA,CACCACCAC|VTTT,"1-3|CAC:CACCACCAC|VT:VTTT;0,4|^:^|^:^;5,7|CAC:CACCACCAC|VT:VTTT;6|^:^|^:^;8-9,11|^:^|^:^;14|^:^|^:^;18|CAC:CACCACCAC|VT:VTTT;19|^:^|^:^;20,23|^:^|^:^;24-26,28-29|^:^|^:^;31,33|^:^|^:^;39|CACCAC:CACCACCAC|VTT:VTTT;35-38|^:^|^:^;40|^:^|^:^;41|^:^|^:^;43-46|^:^|^:^;47,49|^:^|^:^;50-52|CAC:CACCACCAC|VT:VTTT;56|CACCAC:CACCACCAC|VTT:VTTT;54-55|^:^|^:^;57|^:^|^:^;61|CAC:CACCACCAC|VT:VTTT;60|^:^|^:^;63|CAC:CACCACCAC|VT:VTTT;64-65|^:^|^:^;67|CAC:CACCACCAC|VT:VTTT;66,68|^:^|^:^;69,71-72|^:^|^:^;74,77|^:^|^:^;78|^:^|^:^;79|^:^|^:^;84|CAC:CACCACCAC|VT:VTTT;85|^:^|^:^;88,91|CAC:CACCACCAC|VT:VTTT;87,90|^:^|^:^;93-96|^:^|^:^;98-99|^:^|^:^;103|CACCACCAC:CACCACCACCAC|VTTT:VTTTT;100-102|^:^|^:^;104,107|^:^|^:^;110-111|^:^|^:^;116|CAC:CACCACCAC|VT:VTTT;115,117|^:^|^:^;119-120|CAC:CACCACCAC|VT:VTTT;121-122|^:^|^:^;125,127|CAC:CACCACCAC|VT:VTTT;124,126|^:^|^:^;130,133|^:^|^:^;134-135|^:^|^:^;137,139-141|^:^|^:^;144|^:^|^:^;146-147,149|^:^|^:^;150-151|^:^|^:^;154,156-158|^:^|^:^;160,162|^:^|^:^;165-171|^:^|^:^",NA,NA,NA,NA
2,USP6,Homo sapiens ubiquitin specific peptidase 6 (Tre-2 oncogene) (USP6) mRNA.,,NM_004505,chr17,99.20,1e-06,0.17,3e-01,+,USP6,5116032,5175032,ubiquitin specific peptidase 6,protein_coding,"HRP1,Tre-2,TRE17,TRE2,TRESMCR,USP6-short",0.00,0,0,3.31:Pseudosarcomatous fibromatosis|2.82:Fibroosseous pseudotumor of digits|2.59:Myositis ossificans|2.41:Osteoblastoma|2.33:Ischemic fasciitis|2.23:Fibrous dysplasia|2.09:Fibroma|1.92:Cancer|1.84:Proliferative fasciitis|1.77:Ossifying fibroma|1.62:Cherubism,0.98:Carcinoma|0.54:Kidney cancer,4.00:Cancer,NA,NA,31.10:Testis|9.17:Muscle - Skeletal|3.82:Ovary|1.11:Pituitary|1.06:Thyroid|0.91:Breast - Mammary Tissue|0.86:Brain - Cerebellar Hemisphere|0.80:Prostate|0.79:Brain - Cerebellum|0.71:Kidney - Medulla|0.67:Brain - Spinal cord (cervical c-1)|0.66:Nerve - Tibial|0.65:Cervix - Endocervix|0.61:Minor Salivary Gland|0.60:Fallopian Tube|0.56:Adipose - Subcutaneous|0.56:Uterus|0.54:Spleen|0.49:Cervix - Ectocervix|0.47:Lung|0.47:Skin - Sun Exposed (Lower leg)|0.43:Brain - Hypothalamus|0.41:Small Intestine - Terminal Ileum|0.39:Brain - Cortex|0.39:Brain - Frontal Cortex (BA9)|0.38:Brain - Hippocampus|0.38:Colon - Sigmoid|0.38:Vagina|0.38:Brain - Nucleus accumbens (basal ganglia)|0.35:Brain - Caudate (basal ganglia)|0.35:Brain - Substantia nigra|0.32:Esophagus - Gastroesophageal Junction|0.31:Bladder|0.31:Esophagus - Muscularis|0.30:Brain - Anterior cingulate cortex (BA24)|0.29:Brain - Amygdala|0.28:Skin - Not Sun Exposed (Suprapubic)|0.28:Brain - Putamen (basal ganglia)|0.28:Kidney - Cortex|0.28:Colon - Transverse|0.27:Artery - Coronary|0.26:Adipose - Visceral (Omentum)|0.25:Cells - EBV-transformed lymphocytes|0.22:Artery - Aorta|0.20:Adrenal Gland|0.19:Artery - Tibial|0.19:Stomach|0.18:Cells - Cultured fibroblasts|0.18:Esophagus - Mucosa|0.15:Heart - Atrial Appendage|0.13:Pancreas|0.10:Liver|0.07:Heart - Left Ventricle|0.05:Whole Blood,"0.43:lateral ganglionic eminence|0.42:medial ganglionic eminence|0.39:temporal neocortex|0.28:occipital neocortex|0.22:parietal neocortex|0.20:upper (rostral) rhombic lip|0.19:cerebellum|0.14:primary motor-sensory cortex (samples)|0.10:caudal ganglionic eminence|0.09:striatum|0.08:cerebellar cortex|0.08:hippocampus (hippocampal formation)|0.08:primary auditory cortex (core)|0.08:anterior (rostral) cingulate (medial prefrontal) cortex|0.07:amygdaloid complex|0.07:dorsal thalamus|0.07:primary visual cortex (striate cortex, area V1/17)|0.07:dorsolateral prefrontal cortex|0.07:inferolateral temporal cortex (area TEv, area 20)|0.06:ventrolateral prefrontal cortex|0.06:posterior (caudal) superior temporal cortex (area 22c)|0.06:posteroventral (inferior) parietal cortex|0.06:orbital frontal cortex|0.05:primary somatosensory cortex (area S1, areas 3,1,2)|0.05:primary motor cortex (area M1, area 4)|0.05:mediodorsal nucleus of thalamus",8,SNP,15.59,"14|0.18;28|0.13;1-13,15-27,29-46|0.00;0|-0.12",5036249,NA,G|M,"N|0,2,4|G:T|M:I;N|50,52-53|G:T|M:I;N|100,102|G:T|M:I;N|112-113|G:T|M:I;N|138-139|G:T|M:I",0.0001,0.0021,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.52,"37|0.07;0-36,38-46|0.00",5036272,NA,A|K,N|129|A:C|K:T,0.0025,0.0026,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,23.61,0-46|0.00,5036748,NA,G|R,"N|0-1|G:T|R:L;N|4|^:^|^:^;N|7|^:^|^:^;N|10-12|^:^|^:^;N|20|G:T|R:L;N|22|^:^|^:^;N|30-31|^:^|^:^;N|35|G:T|R:L;N|37|^:^|^:^;N|40|G:T|R:L;N|41|^:^|^:^;N|43-46|^:^|^:^;N|52|^:^|^:^;N|55-56|^:^|^:^;N|57-58|^:^|^:^;N|60-62|^:^|^:^;N|65|G:T|R:L;N|63|^:^|^:^;N|75-76|G:T|R:L;N|74|^:^|^:^;N|85|G:T|R:L;N|83|^:^|^:^;N|86|G:T|R:L;N|87|^:^|^:^;N|92|^:^|^:^;N|97|^:^|^:^;N|102|G:T|R:L;N|100-101,103|^:^|^:^;N|105-106|^:^|^:^;N|109|^:^|^:^;N|113|G:T|R:L;N|112,114|^:^|^:^;N|117|^:^|^:^;N|121-122|^:^|^:^;N|124,127|^:^|^:^;N|132|^:^|^:^;N|136|^:^|^:^;N|137-139|^:^|^:^;N|144|G:T|R:L;N|142,145|^:^|^:^;N|146|G:T|R:L;N|148-149|^:^|^:^;N|150,153|^:^|^:^;N|155-158|^:^|^:^;N|159|^:^|^:^;N|166,168,170-171|^:^|^:^",3.818e-05,0.0042,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.03,0-46|0.00,5036780,NA,G|G,N|30-32|G:T|G:C;N|167|^:^|^:^,0.0013,0.0015,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.80,0-46|0.00,5036784,NA,C|P,"N|0-1|^:^|^:^;N|5,7|^:^|^:^;N|11|C:T|P:L;N|12|^:^|^:^;N|20|C:T|P:L;N|24-25,29|^:^|^:^;N|30-32|^:^|^:^;N|34|^:^|^:^;N|37|C:T|P:L;N|35,38|^:^|^:^;N|40|C:T|P:L;N|41|^:^|^:^;N|42-43,46|^:^|^:^;N|50|^:^|^:^;N|55|^:^|^:^;N|58|^:^|^:^;N|62|^:^|^:^;N|69|^:^|^:^;N|76|C:T|P:L;N|80,82|^:^|^:^;N|83|C:T|P:L;N|84-85|^:^|^:^;N|86-88|^:^|^:^;N|92-93|^:^|^:^;N|98|^:^|^:^;N|105-106|^:^|^:^;N|108|^:^|^:^;N|112|^:^|^:^;N|117|^:^|^:^;N|119|C:T|P:L;N|120|^:^|^:^;N|121-122|^:^|^:^;N|124|^:^|^:^;N|132-133|^:^|^:^;N|136|^:^|^:^;N|137-139,141|^:^|^:^;N|144|^:^|^:^;N|146,148-149|^:^|^:^;N|150-153|^:^|^:^;N|155,157-158|^:^|^:^;N|159-160|^:^|^:^;N|164,166,168,170|^:^|^:^",8.96e-05,0.0055,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.56,0-46|0.00,5036823,NA,T|L,"N|0-1|^:^|^:^;N|11|C:T|S:L;N|9-10|^:^|^:^;N|18|^:^|^:^;N|20,23|C:T|S:L;N|21|^:^|^:^;N|24-25,28|^:^|^:^;N|30,32-33|^:^|^:^;N|37|C:T|S:L;N|36,38|^:^|^:^;N|40|^:^|^:^;N|42,44-45|C:T|S:L;N|43|^:^|^:^;N|47,49|^:^|^:^;N|50|C:T|S:L;N|51|^:^|^:^;N|57-58|^:^|^:^;N|62|C:T|S:L;N|67|^:^|^:^;N|69,72|^:^|^:^;N|76-77|C:T|S:L;N|73|^:^|^:^;N|79-80,82|^:^|^:^;N|83,85|^:^|^:^;N|88|C:T|S:L;N|86-87,89-91|^:^|^:^;N|92-93|C:T|S:L;N|97-98|^:^|^:^;N|103|C:T|S:L;N|100-101|^:^|^:^;N|105,107|C:T|S:L;N|104|^:^|^:^;N|112-114|^:^|^:^;N|118,120|^:^|^:^;N|121|^:^|^:^;N|124,127|^:^|^:^;N|131-132|^:^|^:^;N|135-136|C:T|S:L;N|138|C:T|S:L;N|137,141|^:^|^:^;N|144|C:T|S:L;N|143|^:^|^:^;N|146,148-149|^:^|^:^;N|151|^:^|^:^;N|157|C:T|S:L;N|154-155,158|^:^|^:^;N|160,162|^:^|^:^;N|170|C:T|S:L;N|164-166,168-169,171|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,19.51,0-46|0.00,5072134,NA,C|R,"N|17,19|C:T|R:W;N|45|C:T|R:W;N|101|^:^|^:^;N|104,107|C:T|R:W;N|116|C:T|R:W",0.0273,0.0232,D,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,9.80,0-46|0.00,5074176,NA,AT|H,49|-:AT|-:H,NA,NA,NA,NA
3,MYH13,Homo sapiens myosin heavy chain 13 skeletal muscle (MYH13) mRNA.,Imflammation mediated by chemokine and cytokine signaling;Wnt Signaling Pathway;Neurological system process,NM_003802,chr17,94.93,1e-06,0.23,2e-01,-,MYH13,10300865,10373006,myosin heavy chain 13,protein_coding,"MyHC-eo,MyHC-IIL",0.00,0,0,2.50:Myopathy|2.19:Heart disease|2.01:Primary cutaneous amyloidosis|1.77:Coronary artery disease|1.76:Hyperthyroidism|1.70:X-linked recessive disease|1.60:Neuropathy|1.59:Hypothyroidism|1.53:Chronic obstructive pulmonary disease,1.22:Ulcerative colitis|1.22:Carcinoma|0.61:Kidney cancer|0.54:Liver cancer,NA,NA,NA,1.29:Stomach|0.43:Testis|0.30:Small Intestine - Terminal Ileum|0.20:Spleen|0.15:Colon - Transverse|0.14:Cervix - Ectocervix|0.11:Esophagus - Mucosa|0.10:Muscle - Skeletal|0.10:Vagina|0.06:Uterus|0.06:Brain - Anterior cingulate cortex (BA24)|0.06:Artery - Coronary|0.05:Cells - Cultured fibroblasts|0.05:Breast - Mammary Tissue|0.05:Lung|0.05:Bladder|0.04:Cervix - Endocervix|0.04:Brain - Frontal Cortex (BA9)|0.04:Heart - Atrial Appendage|0.03:Brain - Cortex|0.02:Minor Salivary Gland|0.02:Fallopian Tube|0.02:Brain - Hippocampus|0.02:Heart - Left Ventricle|0.02:Adipose - Visceral (Omentum)|0.01:Brain - Hypothalamus|0.01:Kidney - Medulla|0.01:Brain - Amygdala|0.01:Prostate|0.01:Esophagus - Muscularis|0.01:Esophagus - Gastroesophageal Junction|0.01:Colon - Sigmoid|0.01:Adipose - Subcutaneous|0.01:Artery - Aorta|0.01:Skin - Sun Exposed (Lower leg)|0.01:Brain - Putamen (basal ganglia)|0.01:Skin - Not Sun Exposed (Suprapubic)|0.01:Brain - Nucleus accumbens (basal ganglia)|0.00:Adrenal Gland|0.00:Whole Blood|0.00:Thyroid|0.00:Pituitary|0.00:Pancreas|0.00:Ovary|0.00:Nerve - Tibial|0.00:Liver|0.00:Kidney - Cortex|0.00:Cells - EBV-transformed lymphocytes|0.00:Brain - Substantia nigra|0.00:Brain - Spinal cord (cervical c-1)|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Brain - Caudate (basal ganglia)|0.00:Artery - Tibial,"0.01:inferolateral temporal cortex (area TEv, area 20)|0.01:primary motor-sensory cortex (samples)|0.01:amygdaloid complex|0.01:dorsolateral prefrontal cortex|0.01:hippocampus (hippocampal formation)|0.01:mediodorsal nucleus of thalamus|0.01:anterior (rostral) cingulate (medial prefrontal) cortex|0.01:posteroventral (inferior) parietal cortex|0.01:posterior (caudal) superior temporal cortex (area 22c)|0.01:primary somatosensory cortex (area S1, areas 3,1,2)|0.01:primary motor cortex (area M1, area 4)|0.01:primary auditory cortex (core)|0.00:ventrolateral prefrontal cortex|0.00:dorsal thalamus|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:striatum|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:medial ganglionic eminence|0.00:lateral ganglionic eminence|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence",9,SNP,14.31,0-46|0.00,10209778,NA,G|R,"N|2|A:G|W:R;N|8,13|A:G|W:R;N|31,33|A:G|W:R;N|64|A:G|W:R",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,13.08,0-46|0.00,10215944,NA,G|R,"N|49|A:G|C:R;N|124-125,127|A:G|C:R;N|142,145|A:G|C:R",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.66,0-46|0.00,10216063,NA,G|A,N|44-45|A:G|V:A;N|69|^:^|^:^;N|78|A:G|V:A;N|122|A:G|V:A;N|160-161|A:G|V:A;N|159|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.72,0-46|0.00,10219097,NA,C|E,N|6|A:C|D:E;N|105-106|A:C|D:E;N|142|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.14,0-46|0.00,10222367,NA,C|A,"N|57,59|C:T|A:T;N|162|^:^|^:^",0.0002,0.0002,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.48,"31|0.23;0-30,32-46|0.00",10222462,NA,G|A,N|65|^:^|^:^;N|107|^:^|^:^;N|111|A:G|V:A;N|142|^:^|^:^;N|164|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.14,0-46|0.00,10231335,NA,C|A,N|14-15|C:T|A:T;N|127|C:T|A:T,0.0060,0.0049,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,24.36,0-46|0.00,10236464,NA,C|G,"N|24,27|C:T|G:R;N|36-37,39|C:T|G:R;N|44,46|C:T|G:R;N|128|C:T|G:R;N|137,139,141|C:T|G:R;N|138|T:T|R:R",0.0157,0.0172,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,13.97,0-46|0.00,10265714,NA,T|Y,"N|1,3-4|C:T|C:Y;N|107|^:^|^:^;N|108|C:T|C:Y",NA,NA,NA,NA
4,MYBBP1A,Homo sapiens MYB binding protein (P160) 1a (MYBBP1A) transcript variant 2 mRNA.,Transcription Factor,NM_014520,chr17,92.40,1e-06,0.78,1e-01,-,MYBBP1A,4538896,4555386,MYB binding protein 1a,protein_coding,"P160,PAP2,Pol5",0.00,0,0,1.55:Cancer|1.51:Primary ciliary dyskinesia 13,0.70:Carcinoma,NA,"3.75:preweaning lethality, complete penetrance",0.99:night blindness|0.82:brain|0.79:nervous system|0.79:liver|0.78:central nervous system|0.76:pancreas|0.76:heart|0.75:testis|0.74:ovary|0.74:skeletal muscle|0.72:lung|0.67:placenta|0.63:Usher syndrome|0.62:kidney|0.62:fetus|0.58:forebrain|0.57:cerebral cortex|0.56:temporal lobe|0.54:telencephalon|0.53:spinal cord|0.53:cerebellum|0.52:hippocampus|0.52:spleen|0.52:blood|0.51:basal ganglion|0.51:corpus striatum|0.48:corpus callosum|0.48:caudate nucleus|0.45:diencephalon|0.44:leukocyte|0.44:prostate gland|0.44:intestine|0.41:subthalamic nucleus|0.40:amygdala|0.40:thalamus|0.39:large intestine|0.38:midbrain|0.38:substantia nigra|0.35:gastrointestinal tract|0.34:uterus|0.30:small intestine|0.30:mammary gland|0.27:colon|0.27:lymph node|0.25:negative regulation of telomere maintenance via telomere lengthening|0.25:negative regulation of telomere maintenance via telomerase|0.25:regulation of chromosome organization|0.24:adrenal gland|0.24:thyroid gland|0.22:negative regulation of cell cycle|0.22:positive regulation of pri-miRNA transcription by RNA polymerase II|0.22:ribosomal large subunit biogenesis|0.21:regulation of telomere maintenance|0.21:DNA replication|0.21:positive regulation of cell cycle|0.20:hypophysis|0.19:autosomal recessive disease|0.19:cerebellar disease|0.19:cerebral degeneration|0.18:negative regulation of telomere maintenance|0.17:muscle|0.16:positive regulation of cell cycle process|0.16:nervous system cancer|0.15:bone marrow|0.15:caudate putamen|0.15:regulation of translation|0.15:trachea|0.14:regulation of telomere maintenance via telomere lengthening|0.14:autism spectrum disorder|0.14:monocyte|0.14:regulation of telomere maintenance via telomerase|0.14:medulla oblongata|0.13:lymphocyte|0.13:rRNA processing|0.13:retinitis pigmentosa|0.13:protein-DNA complex assembly|0.13:fundus dystrophy|0.12:anatomical structure formation involved in morphogenesis|0.12:frontal lobe|0.12:regulation of histone modification|0.12:regulation of protein modification by small protein conjugation or removal|0.12:occipital lobe|0.12:hereditary retinal dystrophy|0.12:histone modification|0.11:retinal degeneration|0.11:regulation of cellular amide metabolic process|0.11:regulation of DNA biosynthetic process|0.11:nucleus accumbens|0.11:regulation of cell cycle arrest|0.11:positive regulation of protein modification by small protein conjugation or removal|0.11:hereditary ataxia|0.11:neuropathy|0.11:negative regulation of cell proliferation|0.11:positive regulation of cellular protein localization|0.11:regulation of pri-miRNA transcription by RNA polymerase II|0.11:regulation of DNA metabolic process|0.11:ncRNA processing|0.11:regulation of histone phosphorylation|0.11:regulation of DNA binding transcription factor activity|0.11:stomach|0.10:Alzheimer's disease|0.10:tauopathy|0.10:retinal disease|0.10:negative regulation of NF-kappaB transcription factor activity|0.10:peripheral nervous system disease|0.10:mRNA catabolic process|0.10:regulation of protein serine/threonine kinase activity,56.48:Cells - EBV-transformed lymphocytes|54.09:Fallopian Tube|50.28:Cells - Cultured fibroblasts|49.74:Skin - Not Sun Exposed (Suprapubic)|48.75:Skin - Sun Exposed (Lower leg)|46.28:Prostate|44.92:Brain - Cerebellum|44.41:Cervix - Endocervix|44.01:Nerve - Tibial|43.33:Uterus|42.20:Bladder|41.95:Breast - Mammary Tissue|41.80:Ovary|41.14:Brain - Cerebellar Hemisphere|38.71:Vagina|38.54:Spleen|36.88:Cervix - Ectocervix|36.17:Esophagus - Mucosa|35.32:Thyroid|34.79:Pituitary|33.88:Minor Salivary Gland|32.02:Artery - Coronary|31.35:Lung|30.41:Adipose - Subcutaneous|30.37:Artery - Tibial|29.54:Brain - Cortex|29.48:Small Intestine - Terminal Ileum|29.36:Artery - Aorta|28.70:Adipose - Visceral (Omentum)|28.49:Testis|27.32:Esophagus - Gastroesophageal Junction|27.11:Esophagus - Muscularis|27.07:Muscle - Skeletal|26.48:Brain - Frontal Cortex (BA9)|26.04:Colon - Sigmoid|24.86:Colon - Transverse|23.38:Pancreas|23.06:Stomach|22.78:Adrenal Gland|20.03:Kidney - Medulla|16.61:Brain - Caudate (basal ganglia)|16.26:Brain - Anterior cingulate cortex (BA24)|15.56:Brain - Nucleus accumbens (basal ganglia)|14.89:Brain - Hypothalamus|14.00:Heart - Atrial Appendage|13.81:Brain - Putamen (basal ganglia)|13.28:Brain - Spinal cord (cervical c-1)|12.56:Brain - Hippocampus|12.13:Kidney - Cortex|11.14:Liver|10.13:Brain - Amygdala|9.72:Heart - Left Ventricle|9.71:Brain - Substantia nigra|5.47:Whole Blood,"10.48:cerebellum|9.97:upper (rostral) rhombic lip|9.42:primary visual cortex (striate cortex, area V1/17)|8.86:primary motor-sensory cortex (samples)|8.83:occipital neocortex|8.76:primary somatosensory cortex (area S1, areas 3,1,2)|8.75:striatum|8.56:posteroventral (inferior) parietal cortex|8.39:parietal neocortex|8.33:ventrolateral prefrontal cortex|8.32:cerebellar cortex|8.30:primary motor cortex (area M1, area 4)|8.24:caudal ganglionic eminence|8.16:posterior (caudal) superior temporal cortex (area 22c)|8.13:lateral ganglionic eminence|8.12:primary auditory cortex (core)|7.74:anterior (rostral) cingulate (medial prefrontal) cortex|7.64:orbital frontal cortex|7.46:dorsolateral prefrontal cortex|7.45:hippocampus (hippocampal formation)|7.35:medial ganglionic eminence|7.29:amygdaloid complex|7.11:temporal neocortex|7.01:inferolateral temporal cortex (area TEv, area 20)|6.42:mediodorsal nucleus of thalamus|6.07:dorsal thalamus",10,SNP,27.54,0-46|0.00,4443075,NA,T|M,"N|10|A:T|L:M;N|24-26,28-29|A:T|L:M;N|35|^:^|^:^;N|41|A:T|L:M;N|59|A:T|L:M;N|74|^:^|^:^;N|109-111|A:T|L:M;N|124-126|A:T|L:M;N|129|A:T|L:M;N|141|^:^|^:^;N|142-143|A:T|L:M",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.02,0-46|0.00,4443688,NA,C|R,"N|20,22|C:T|R:H;N|142|^:^|^:^",0.0030,0.0028,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.24,"43|0.11;0-42,44-46|0.00",4443760,NA,G|T,N|151-152|A:G|M:T,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.55,0-46|0.00,4446227,NA,T|H,N|5-6|G:T|P:H;N|34|G:T|P:H;N|81|G:T|P:H;N|96|G:T|P:H;N|128|G:T|P:H,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.45,"34|0.30;0-33,35-46|0.00",4448104,NA,C|R,"N|0-1|^:^|^:^;N|8-10|^:^|^:^;N|24-25|^:^|^:^;N|35,37|^:^|^:^;N|42|^:^|^:^;N|69|^:^|^:^;N|73-74|^:^|^:^;N|79|^:^|^:^;N|86-87|^:^|^:^;N|93|^:^|^:^;N|100-101|^:^|^:^;N|104|^:^|^:^;N|118,120|C:T|R:Q;N|124|^:^|^:^;N|137,140-141|^:^|^:^;N|142|^:^|^:^;N|148-149|^:^|^:^;N|150-152|^:^|^:^;N|154-158|^:^|^:^;N|159,161-162|^:^|^:^;N|163-164,166-171|^:^|^:^",0.0075,0.0115,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.26,"14|0.37;0-13,15-46|0.00",4448940,NA,G|H,N|50-52|A:G|Y:H;N|73|^:^|^:^;N|101|^:^|^:^;N|107|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,17.37,0-46|0.00,4451453,NA,C|R,"N|0-2|C:T|R:H;N|83-84|C:T|R:H;N|104-105|C:T|R:H;N|107|T:T|H:H;N|146,148-149|C:T|R:H",0.0441,0.0400,D,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.05,0-46|0.00,4451576,NA,T|K,"N|11-12|C:T|R:K;N|21,23|C:T|R:K",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.45,0-46|0.00,4457510,NA,C|D,"N|8|^:^|^:^;N|100,103|C:G|D:H;N|139|^:^|^:^;N|144|C:G|D:H;N|153|^:^|^:^",0.0075,0.0065,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.89,0-46|0.00,4458515,NA,G|F,"N|16|G:T|F:L;N|27-28|G:T|F:L;N|43|^:^|^:^;N|91|^:^|^:^;N|112-113|G:T|F:L;N|153|^:^|^:^;N|159,161-162|G:T|F:L",0.0224,0.0246,D,T
5,NEURL4,Homo sapiens neuralized homolog 4 (Drosophila) (NEURL4) transcript variant 1 mRNA.,Nervous  System Development;Notch Signaling Pathway,NM_032442,chr17,55.97,1e-06,0.26,2e-01,-,NEURL4,7315628,7329335,neuralized E3 ubiquitin protein ligase 4,protein_coding,NA,1.00,0,0,2.02:Angelman syndrome|1.67:Ciliopathy|1.56:Asphyxiating thoracic dystrophy,0.93:Carcinoma,NA,7.07:decreased body length|6.89:abnormal bone structure|6.24:decreased total body fat amount|5.83:decreased bone mineral content|5.29:decreased prepulse inhibition|4.35:increased lean body mass|4.31:decreased circulating cholesterol level|4.10:increased grip strength,NA,65.41:Brain - Cerebellum|58.89:Brain - Cerebellar Hemisphere|41.80:Thyroid|41.04:Uterus|40.59:Ovary|39.73:Cervix - Endocervix|39.50:Testis|38.94:Pituitary|35.85:Fallopian Tube|35.71:Cervix - Ectocervix|34.11:Nerve - Tibial|33.78:Brain - Cortex|32.30:Prostate|31.54:Colon - Sigmoid|29.91:Bladder|28.90:Brain - Frontal Cortex (BA9)|27.62:Spleen|26.60:Vagina|26.52:Esophagus - Gastroesophageal Junction|25.95:Esophagus - Muscularis|24.99:Artery - Tibial|24.41:Skin - Sun Exposed (Lower leg)|23.87:Small Intestine - Terminal Ileum|22.84:Brain - Anterior cingulate cortex (BA24)|22.75:Colon - Transverse|22.50:Artery - Coronary|22.45:Skin - Not Sun Exposed (Suprapubic)|22.39:Lung|21.81:Artery - Aorta|21.33:Breast - Mammary Tissue|20.17:Adipose - Subcutaneous|19.63:Minor Salivary Gland|19.35:Muscle - Skeletal|18.63:Kidney - Medulla|18.57:Cells - EBV-transformed lymphocytes|18.21:Brain - Nucleus accumbens (basal ganglia)|16.98:Stomach|16.57:Kidney - Cortex|16.39:Esophagus - Mucosa|16.07:Adrenal Gland|16.02:Brain - Caudate (basal ganglia)|15.63:Adipose - Visceral (Omentum)|15.37:Brain - Hypothalamus|14.69:Brain - Amygdala|14.50:Cells - Cultured fibroblasts|13.65:Brain - Hippocampus|12.88:Brain - Spinal cord (cervical c-1)|12.81:Brain - Putamen (basal ganglia)|12.39:Heart - Atrial Appendage|11.50:Brain - Substantia nigra|10.90:Heart - Left Ventricle|9.66:Pancreas|7.64:Liver|6.00:Whole Blood,"18.35:cerebellum|17.98:upper (rostral) rhombic lip|15.14:primary visual cortex (striate cortex, area V1/17)|15.11:primary motor-sensory cortex (samples)|13.82:primary somatosensory cortex (area S1, areas 3,1,2)|13.64:posterior (caudal) superior temporal cortex (area 22c)|13.54:primary motor cortex (area M1, area 4)|13.16:cerebellar cortex|13.11:posteroventral (inferior) parietal cortex|13.05:dorsal thalamus|12.73:orbital frontal cortex|12.51:dorsolateral prefrontal cortex|12.48:inferolateral temporal cortex (area TEv, area 20)|12.45:anterior (rostral) cingulate (medial prefrontal) cortex|12.35:primary auditory cortex (core)|12.07:ventrolateral prefrontal cortex|11.97:lateral ganglionic eminence|11.74:temporal neocortex|11.43:amygdaloid complex|11.35:striatum|11.01:parietal neocortex|10.97:mediodorsal nucleus of thalamus|10.41:occipital neocortex|10.31:hippocampus (hippocampal formation)|9.31:medial ganglionic eminence|8.68:caudal ganglionic eminence",5,SNP,25.85,0-46|0.00,7220881,NA,C|R,"N|1,3-4|C:T|R:H;N|7|C:T|R:H;N|17|C:T|R:H;N|35,37|^:^|^:^;N|67|C:T|R:H;N|78|C:T|R:H;N|117|^:^|^:^;N|119-120|C:T|R:H;N|123|C:T|R:H;N|121|T:T|H:H;N|125,127|C:T|R:H;N|144|C:T|R:H",0.0360,0.0373,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,16.61,0-46|0.00,7221197,NA,C|R,"N|11-12|C:T|R:Q;N|97,99|C:T|R:Q;N|134-135|C:T|R:Q;N|147|^:^|^:^",0.0178,0.0140,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.49,"25|0.26;0-24,26-34,36-46|0.00;35|-0.03",7224433,NA,C|G,"N|37|^:^|^:^;N|88,91|C:T|G:R;N|109-110|C:T|G:R;N|122-123|C:T|G:R",0.0151,0.0128,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.72,0-46|0.00,7224736,NA,T|M,"N|104,107|G:T|L:M",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.09,0-46|0.00,7230768,NA,C|A,N|34|C:T|A:T;N|70|^:^|^:^;N|158|^:^|^:^,0.0006,0.0009,B,T
6,PFAS,Homo sapiens phosphoribosylformylglycinamidine synthase (PFAS) mRNA.,,NM_012393,chr17,52.31,1e-06,0.23,1e-01,+,PFAS,8247596,8270491,phosphoribosylformylglycinamidine synthase,protein_coding,"FGAMS,FGAR-AT,FGARAT,GATD8,PURL",0.00,0,0,3.24:Fetal alcohol spectrum disorder|2.04:Attention deficit hyperactivity disorder|1.85:Microcephaly|1.81:Rubella|1.79:Diphtheria|1.67:Allergic hypersensitivity disease|1.61:Cancer|1.58:Common cold|1.55:Diabetes mellitus|1.55:Asthma|1.54:Substance abuse|1.53:Learning disability|1.53:Tetanus|1.51:Gastrointestinal system disease,0.93:Carcinoma,NA,NA,0.84:central nervous system|0.80:testis|0.78:fetus|0.78:brain|0.77:nervous system|0.68:placenta|0.68:tRNA metabolic process|0.68:kidney|0.67:ovary|0.64:liver|0.62:corpus callosum|0.59:pancreas|0.57:ncRNA metabolic process|0.55:spleen|0.54:blood|0.54:amino acid activation|0.54:tRNA aminoacylation|0.53:translation|0.52:heart|0.51:peptide biosynthetic process|0.48:prostate gland|0.48:skeletal muscle|0.48:leukocyte|0.46:peptide metabolic process|0.46:amide biosynthetic process|0.45:thalamus|0.44:tRNA aminoacylation for protein translation|0.44:lung|0.43:caudate nucleus|0.43:spinal cord|0.43:subthalamic nucleus|0.43:temporal lobe|0.41:diencephalon|0.40:corpus striatum|0.40:cerebellum|0.37:forebrain|0.36:mitochondrial RNA metabolic process|0.35:substantia nigra|0.35:hippocampus|0.35:telencephalon|0.35:cerebral cortex|0.34:small intestine|0.33:midbrain|0.31:gastrointestinal tract|0.31:basal ganglion|0.30:regulation of cellular amide metabolic process|0.30:regulation of translation|0.27:amygdala|0.27:uterus|0.26:intestine|0.25:monocyte|0.24:cellular amino acid metabolic process|0.23:ncRNA processing|0.20:adrenal gland|0.20:colon|0.20:thyroid gland|0.19:positive regulation of transcription by RNA polymerase I|0.19:hypophysis|0.19:large intestine|0.15:lymph node|0.13:lymphocyte|0.13:muscular disease|0.13:muscle tissue disease|0.12:cerebellar disease|0.12:myopathy|0.11:regulation of transcription by RNA polymerase I|0.11:bone marrow|0.11:mammary gland|0.11:muscle|0.11:stomach|0.11:regulation of DNA biosynthetic process|0.10:positive regulation of cellular protein localization|0.10:nucleobase-containing small molecule metabolic process|0.01:autism spectrum disorder,38.56:Cells - EBV-transformed lymphocytes|22.35:Cells - Cultured fibroblasts|16.76:Ovary|15.07:Uterus|15.00:Cervix - Endocervix|13.97:Thyroid|13.88:Spleen|13.82:Testis|12.67:Brain - Cerebellum|12.40:Breast - Mammary Tissue|12.12:Nerve - Tibial|12.11:Fallopian Tube|11.93:Brain - Cerebellar Hemisphere|11.92:Bladder|11.71:Cervix - Ectocervix|10.77:Kidney - Medulla|10.61:Adipose - Subcutaneous|10.39:Adipose - Visceral (Omentum)|10.18:Prostate|10.12:Adrenal Gland|9.69:Small Intestine - Terminal Ileum|9.49:Vagina|8.98:Lung|8.72:Esophagus - Mucosa|8.52:Skin - Sun Exposed (Lower leg)|8.47:Artery - Coronary|7.97:Pituitary|7.96:Skin - Not Sun Exposed (Suprapubic)|7.95:Minor Salivary Gland|7.59:Colon - Transverse|7.41:Stomach|7.22:Colon - Sigmoid|7.19:Artery - Aorta|6.70:Esophagus - Gastroesophageal Junction|6.60:Brain - Cortex|6.59:Esophagus - Muscularis|6.58:Artery - Tibial|5.80:Brain - Frontal Cortex (BA9)|5.13:Kidney - Cortex|5.07:Pancreas|4.58:Liver|4.31:Brain - Spinal cord (cervical c-1)|3.98:Brain - Nucleus accumbens (basal ganglia)|3.74:Heart - Atrial Appendage|3.69:Brain - Anterior cingulate cortex (BA24)|3.55:Brain - Caudate (basal ganglia)|3.48:Brain - Hypothalamus|3.46:Muscle - Skeletal|3.14:Brain - Hippocampus|2.81:Brain - Substantia nigra|2.79:Brain - Amygdala|2.74:Brain - Putamen (basal ganglia)|2.65:Heart - Left Ventricle|1.45:Whole Blood,"14.45:occipital neocortex|13.50:caudal ganglionic eminence|12.25:parietal neocortex|10.68:lateral ganglionic eminence|10.60:medial ganglionic eminence|9.47:cerebellum|9.46:temporal neocortex|7.89:upper (rostral) rhombic lip|7.50:primary motor-sensory cortex (samples)|7.19:dorsal thalamus|4.85:primary visual cortex (striate cortex, area V1/17)|4.62:hippocampus (hippocampal formation)|4.48:cerebellar cortex|4.38:orbital frontal cortex|4.30:primary somatosensory cortex (area S1, areas 3,1,2)|4.24:primary motor cortex (area M1, area 4)|4.24:ventrolateral prefrontal cortex|4.17:anterior (rostral) cingulate (medial prefrontal) cortex|4.13:posterior (caudal) superior temporal cortex (area 22c)|4.10:primary auditory cortex (core)|3.93:posteroventral (inferior) parietal cortex|3.90:dorsolateral prefrontal cortex|3.71:amygdaloid complex|3.61:striatum|3.43:inferolateral temporal cortex (area TEv, area 20)|3.10:mediodorsal nucleus of thalamus",4,SNP,10.32,0-46|0.00,8166297,NA,G|A,N|124-126|A:G|T:A;N|132-133|A:G|T:A,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,28.19,0-46|0.00,8166458,NA,T|F,"N|18|A:T|Y:F;N|26|A:T|Y:F;N|35-38|A:T|Y:F;N|42-43,46|A:T|Y:F;N|54-55|A:T|Y:F;N|58|A:T|Y:F;N|70,72|A:T|Y:F;N|116|A:A|Y:Y;N|115|A:T|Y:F;N|134,136|A:T|Y:F;N|141|^:^|^:^;N|159-162|A:T|Y:F",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.85,"31|0.23;0-30,32-46|0.00",8171934,NA,G|G,N|107|^:^|^:^;N|111|A:G|S:G,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.90,0-46|0.00,8172506,NA,T|F,"N|32|G:T|C:F;N|35-36,38|G:T|C:F;N|47|G:T|C:F;N|73,75-76|G:T|C:F;N|85|G:T|C:F;N|115-116|G:T|C:F;N|142|^:^|^:^;N|147|G:T|C:F;N|159|G:T|C:F",NA,NA,NA,NA
7,NLRP1,Homo sapiens NLR family pyrin domain containing 1 (NLRP1) transcript variant 4 mRNA.,,NM_014922,chr17,46.14,1e-06,0.90,2e-02,-,NLRP1,5501396,5584509,NLR family pyrin domain containing 1,protein_coding,"AIADK,CARD7,CIDED,CLR17.1,DEFCAP,DEFCAP-L/S,MSPC,NAC,NALP1,PP1044,SLEV1,VAMAS1",0.00,0,0,2.68:Muckle-Wells syndrome|2.49:Autoimmune hypersensitivity disease|2.43:Familial cold autoinflammatory syndrome|2.41:Addison's disease|2.30:Arthritis|2.28:Inflammatory bowel disease|2.22:Blau syndrome|2.09:Neurodegenerative disease|2.09:Diabetes mellitus|1.99:Cancer|1.98:Anthrax disease|1.92:Pernicious anemia|1.92:Psoriasis|1.90:Atherosclerosis|1.84:Toxoplasmosis|1.81:Dermatitis|1.78:Lung disease|1.76:Obesity|1.76:Cerebrovascular disease|1.76:Salmonellosis|1.75:Mevalonic aciduria|1.70:Eye disease|1.68:Meningitis|1.67:Brain disease|1.66:Hematopoietic system disease|1.66:Peritonitis|1.58:Asthma|1.57:Influenza|1.54:Liver disease|1.54:Collagen disease|1.52:Brucellosis|1.51:Kidney disease|1.51:Legionnaires' disease,1.15:Carcinoma|0.61:Kidney cancer,5.00:Vitiligo,NA,0.92:negative regulation of interleukin-1 secretion|0.78:negative regulation of interleukin-1 beta secretion|0.77:blood|0.76:spleen|0.76:placenta|0.70:lung|0.69:fetus|0.69:testis|0.66:leukocyte|0.65:lymph node|0.62:lymphocyte|0.57:liver|0.56:prostate gland|0.55:B-lymphocyte|0.51:heart|0.49:kidney|0.49:pancreas|0.48:gastrointestinal tract|0.46:T-lymphocyte|0.45:natural killer cell|0.44:dendritic cell|0.43:negative regulation of interleukin-1 production|0.42:central nervous system|0.41:autism spectrum disorder|0.41:intestine|0.39:ovary|0.37:small intestine|0.35:nervous system|0.34:eosinophil|0.34:large intestine|0.34:bone marrow|0.33:skeletal muscle|0.32:uterus|0.31:cytokine-mediated signaling pathway|0.31:colon|0.31:blood plasma|0.30:brain|0.30:tonsil|0.29:monocyte|0.27:regulation of interleukin-1 beta secretion|0.27:granulocyte|0.27:regulation of DNA binding transcription factor activity|0.27:serum|0.26:thyroid gland|0.26:negative regulation of interleukin-1 beta production|0.25:blood platelet|0.24:regulation of tumor necrosis factor-mediated signaling pathway|0.23:mammary gland|0.20:adrenal gland|0.20:regulation of interleukin-1 secretion|0.20:blood vessel|0.20:neutrophil|0.20:cerebral cortex|0.19:telencephalon|0.19:mononuclear phagocyte|0.19:regulation of response to external stimulus|0.19:regulation of defense response|0.19:temporal lobe|0.18:hematopoietic stem cell|0.18:forebrain|0.18:occipital lobe|0.17:macrophage|0.17:regulation of cytokine-mediated signaling pathway|0.17:negative regulation of tumor necrosis factor-mediated signaling pathway|0.17:positive regulation of MAPK cascade|0.16:positive regulation of programmed cell death|0.16:positive regulation of apoptotic process|0.16:regulation of immune response|0.16:tumor necrosis factor-mediated signaling pathway|0.16:amygdala|0.15:medulla oblongata|0.15:negative regulation of intracellular signal transduction|0.15:regulation of secretion|0.15:regulation of response to cytokine stimulus|0.15:stomach|0.15:negative regulation of inflammatory response|0.15:frontal lobe|0.14:muscle|0.14:positive regulation of proteolysis|0.14:spinal cord|0.14:cellular response to cytokine stimulus|0.14:regulation of peptidase activity|0.14:hypophysis|0.14:corpus striatum|0.14:trachea|0.13:regulation of endopeptidase activity|0.13:I-kappaB kinase/NF-kappaB signaling|0.13:regulation of interleukin-1 production|0.13:regulation of interleukin-1 beta production|0.13:regulation of secretion by cell|0.13:regulation of cell adhesion|0.13:basal ganglion|0.13:positive regulation of cytokine production|0.13:positive regulation of DNA binding transcription factor activity|0.13:regulation of protein complex assembly|0.13:regulation of I-kappaB kinase/NF-kappaB signaling|0.13:regulation of protein serine/threonine kinase activity|0.12:positive regulation of immune response|0.12:negative regulation of response to external stimulus|0.12:negative regulation of protein modification process|0.12:regulation of cysteine-type endopeptidase activity|0.12:artery|0.12:positive regulation of endopeptidase activity|0.12:skin|0.12:positive regulation of peptidase activity|0.12:diencephalon|0.11:caudate putamen|0.11:hippocampus|0.11:regulation of peptide secretion|0.11:stress-activated MAPK cascade|0.11:regulation of protein secretion|0.11:apoptotic signaling pathway|0.11:negative regulation of DNA binding transcription factor activity|0.11:thymocyte|0.11:negative regulation of protein phosphorylation|0.11:positive regulation of protein transport|0.11:positive regulation of protein kinase activity|0.11:ERK1 and ERK2 cascade|0.11:regulation of intracellular protein transport|0.11:positive regulation of cysteine-type endopeptidase activity|0.11:negative regulation of transport|0.10:negative regulation of NF-kappaB transcription factor activity|0.10:regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.10:regulation of stress-activated MAPK cascade|0.10:substantia nigra|0.10:regulation of ERK1 and ERK2 cascade|0.10:activation of immune response,182.79:Pituitary|74.51:Spleen|71.87:Brain - Hypothalamus|62.67:Brain - Frontal Cortex (BA9)|56.94:Skin - Not Sun Exposed (Suprapubic)|53.22:Brain - Anterior cingulate cortex (BA24)|52.41:Vagina|52.22:Brain - Cortex|52.06:Skin - Sun Exposed (Lower leg)|48.79:Cervix - Ectocervix|48.65:Cervix - Endocervix|45.66:Brain - Spinal cord (cervical c-1)|44.22:Whole Blood|42.56:Lung|39.53:Adipose - Subcutaneous|39.14:Thyroid|38.77:Uterus|38.67:Brain - Nucleus accumbens (basal ganglia)|36.87:Brain - Amygdala|34.01:Brain - Hippocampus|33.44:Fallopian Tube|32.25:Artery - Aorta|31.74:Adipose - Visceral (Omentum)|30.25:Breast - Mammary Tissue|28.20:Small Intestine - Terminal Ileum|27.72:Bladder|26.68:Artery - Coronary|26.47:Cells - EBV-transformed lymphocytes|26.09:Brain - Caudate (basal ganglia)|25.84:Prostate|25.83:Brain - Substantia nigra|24.64:Ovary|23.61:Testis|21.75:Nerve - Tibial|20.25:Brain - Cerebellar Hemisphere|19.96:Brain - Putamen (basal ganglia)|18.82:Brain - Cerebellum|17.50:Esophagus - Mucosa|17.01:Artery - Tibial|16.95:Colon - Sigmoid|16.18:Cells - Cultured fibroblasts|13.47:Esophagus - Gastroesophageal Junction|12.33:Colon - Transverse|12.23:Esophagus - Muscularis|11.97:Minor Salivary Gland|10.07:Heart - Atrial Appendage|7.48:Stomach|7.07:Kidney - Cortex|5.98:Kidney - Medulla|5.95:Heart - Left Ventricle|4.82:Adrenal Gland|3.97:Muscle - Skeletal|2.64:Liver|2.10:Pancreas,"164.37:dorsal thalamus|138.45:mediodorsal nucleus of thalamus|134.46:upper (rostral) rhombic lip|130.64:amygdaloid complex|128.48:ventrolateral prefrontal cortex|126.92:posterior (caudal) superior temporal cortex (area 22c)|125.95:anterior (rostral) cingulate (medial prefrontal) cortex|123.71:primary motor-sensory cortex (samples)|123.02:hippocampus (hippocampal formation)|122.23:inferolateral temporal cortex (area TEv, area 20)|120.33:dorsolateral prefrontal cortex|112.97:posteroventral (inferior) parietal cortex|112.05:orbital frontal cortex|111.44:striatum|110.56:primary somatosensory cortex (area S1, areas 3,1,2)|109.77:primary motor cortex (area M1, area 4)|109.64:primary auditory cortex (core)|96.91:primary visual cortex (striate cortex, area V1/17)|93.19:cerebellum|76.23:lateral ganglionic eminence|75.62:caudal ganglionic eminence|74.13:medial ganglionic eminence|58.94:parietal neocortex|57.60:occipital neocortex|51.32:temporal neocortex|48.09:cerebellar cortex",5,SNP,8.76,0-46|0.00,5425076,NA,A|M,N|83-84|A:G|M:T;N|98|A:G|M:T;N|108|A:G|M:T,0.0383,0.0370,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,26.93,0-46|0.00,5437285,NA,G|T,"N|1,3-4|A:G|I:T;N|21,23|A:G|I:T;N|30|A:G|I:T;N|50-52|A:G|I:T;N|66-67|A:G|I:T;N|92-94,96|A:G|I:T;N|102|A:G|I:T;N|118,120|A:G|I:T;N|126|A:G|I:T;N|136|A:G|I:T",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.67,"44|0.60;0-43,45-46|0.00",5442790,NA,C|V,N|50|^:^|^:^;N|156-158|C:T|V:M;N|155|T:T|M:M,0.0141,0.0125,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.17,"16|0.30;0-15,17-46|0.00",5461874,NA,G|H,N|10|^:^|^:^;N|59|C:G|Q:H,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.45,0-46|0.00,5463093,NA,C|R,"N|124-126|C:T|R:Q;N|134,136|C:T|R:Q;N|167|^:^|^:^",0.0012,0.0007,B,T
8,CHRNE,Homo sapiens cholinergic receptor nicotinic epsilon (CHRNE) mRNA.,Ion channel activity;Ligand-gated ion channel activity;Neurological system process;GABA Receptor,NM_000080,chr17,30.17,1e-06,0.15,1e-01,-,CHRNE,4897771,4905019,cholinergic receptor nicotinic epsilon subunit,protein_coding,"ACHRE,CMS1D,CMS1E,CMS2A,CMS4A,CMS4B,CMS4C,FCCMS,SCCMS",0.00,0,0,2.57:Neuropathy|2.47:Ptosis|2.12:Multiple pterygium syndrome|1.91:Myopathy|1.77:Scoliosis|1.77:Erythropoietic protoporphyria|1.71:Epidermolysis bullosa simplex|1.71:Epidermolysis bullosa simplex with muscular dystrophy|1.57:Pierson syndrome,NA,5.00:Congenital myasthenic syndrome|4.00:Congenital myasthenic syndrome,NA,0.52:blood|0.47:autism spectrum disorder|0.46:testis|0.45:prostate gland|0.40:placenta|0.39:pancreas|0.39:fetus|0.38:liver|0.35:nervous system|0.35:central nervous system|0.34:brain|0.34:leukocyte|0.31:kidney|0.29:ovary|0.27:mammary gland|0.26:gastrointestinal tract|0.25:lung|0.22:heart|0.22:uterus|0.22:G-protein coupled receptor signaling pathway|0.21:intestine|0.20:blood plasma|0.20:hypophysis|0.19:thyroid gland|0.19:adrenal gland|0.18:skeletal muscle|0.18:spleen|0.16:lymphocyte|0.16:colon|0.15:retinal disease|0.15:lymph node|0.14:small intestine|0.14:positive regulation of MAPK cascade|0.14:forebrain|0.13:movement disease|0.13:peripheral nervous system disease|0.13:neuropathy|0.12:skin|0.12:regulation of ion transport|0.12:epilepsy|0.12:large intestine|0.11:telencephalon|0.11:cerebellum|0.11:cerebral cortex|0.11:bone marrow|0.11:regulation of secretion|0.11:regulation of ion transmembrane transport|0.11:hypothalamus|0.10:serum|0.10:positive regulation of protein kinase activity,78.27:Heart - Atrial Appendage|74.85:Pituitary|8.79:Testis|7.60:Skin - Sun Exposed (Lower leg)|6.30:Skin - Not Sun Exposed (Suprapubic)|4.62:Liver|4.60:Nerve - Tibial|4.44:Whole Blood|4.34:Spleen|3.85:Adipose - Visceral (Omentum)|3.62:Lung|3.47:Pancreas|3.44:Breast - Mammary Tissue|3.18:Fallopian Tube|3.00:Ovary|2.99:Thyroid|2.88:Cervix - Endocervix|2.74:Adipose - Subcutaneous|2.74:Brain - Cerebellum|2.59:Cervix - Ectocervix|2.58:Brain - Cerebellar Hemisphere|2.34:Artery - Aorta|2.30:Prostate|2.07:Minor Salivary Gland|2.05:Small Intestine - Terminal Ileum|2.04:Artery - Tibial|1.98:Uterus|1.85:Artery - Coronary|1.74:Vagina|1.48:Kidney - Cortex|1.48:Stomach|1.43:Cells - Cultured fibroblasts|1.33:Bladder|1.31:Brain - Cortex|1.23:Colon - Sigmoid|1.07:Brain - Frontal Cortex (BA9)|1.05:Esophagus - Gastroesophageal Junction|1.04:Brain - Spinal cord (cervical c-1)|1.01:Esophagus - Muscularis|0.94:Colon - Transverse|0.93:Esophagus - Mucosa|0.85:Kidney - Medulla|0.82:Adrenal Gland|0.80:Muscle - Skeletal|0.77:Brain - Anterior cingulate cortex (BA24)|0.76:Brain - Hypothalamus|0.75:Brain - Nucleus accumbens (basal ganglia)|0.69:Brain - Hippocampus|0.66:Brain - Caudate (basal ganglia)|0.62:Brain - Putamen (basal ganglia)|0.61:Brain - Substantia nigra|0.57:Brain - Amygdala|0.51:Heart - Left Ventricle|0.50:Cells - EBV-transformed lymphocytes,"5.08:amygdaloid complex|5.00:hippocampus (hippocampal formation)|4.90:striatum|4.63:cerebellar cortex|4.44:posterior (caudal) superior temporal cortex (area 22c)|4.21:primary auditory cortex (core)|4.01:dorsolateral prefrontal cortex|4.00:inferolateral temporal cortex (area TEv, area 20)|3.90:primary visual cortex (striate cortex, area V1/17)|3.87:primary motor cortex (area M1, area 4)|3.80:cerebellum|3.75:ventrolateral prefrontal cortex|3.74:primary somatosensory cortex (area S1, areas 3,1,2)|3.73:upper (rostral) rhombic lip|3.71:orbital frontal cortex|3.71:anterior (rostral) cingulate (medial prefrontal) cortex|3.66:posteroventral (inferior) parietal cortex|3.44:mediodorsal nucleus of thalamus|1.86:primary motor-sensory cortex (samples)|1.33:dorsal thalamus|1.03:parietal neocortex|0.96:lateral ganglionic eminence|0.76:occipital neocortex|0.76:medial ganglionic eminence|0.73:temporal neocortex|0.54:caudal ganglionic eminence",3,SNP,5.47,0-46|0.00,4802111,NA,C|V,"N|63-64|C:G|V:L;N|74|^:^|^:^;N|137,140|C:G|V:L;N|144|C:G|V:L;N|147|^:^|^:^;N|153|^:^|^:^",0.0075,0.0129,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,24.03,0-46|0.00,4806052,NA,C|G,"N|24-26,28-29|A:C|V:G;N|83-84|A:C|V:G;N|98|A:C|V:G;N|107|A:A|V:V;N|104-105|A:C|V:G;N|108|A:C|V:G;N|117|A:C|V:G;N|139-141|A:C|V:G;N|155|^:^|^:^;N|166|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.15,46|0.15;0-45|0.00,4806336,NA,A|V,"N|1|^:^|^:^;N|65|^:^|^:^;N|69|^:^|^:^;N|163,165-167,170|A:G|V:A;N|164|^:^|^:^",0.0004,0.0003,B,T
9,FCGBP,Homo sapiens Fc fragment of IgG binding protein (FCGBP) mRNA.,Neurological system process,NM_003890,chr19,130.09,2e-06,0.11,9e-01,-,FCGBP,39863323,39934626,Fc fragment of IgG binding protein,protein_coding,FC(GAMMA)BP,NA,0,0,1.81:Von Willebrand's disease 2|1.66:Colitis|1.65:Von Willebrand's disease 3|1.64:Von Willebrand's disease 1|1.50:Cancer,NA,NA,Infinity:abnormal eye morphology|Infinity:abnormal seminal vesicle morphology,NA,184.11:Thyroid|181.39:Colon - Transverse|118.51:Small Intestine - Terminal Ileum|52.74:Minor Salivary Gland|15.22:Artery - Aorta|13.82:Skin - Not Sun Exposed (Suprapubic)|12.47:Skin - Sun Exposed (Lower leg)|11.62:Artery - Coronary|10.86:Kidney - Medulla|9.89:Adrenal Gland|7.04:Stomach|5.76:Testis|5.57:Nerve - Tibial|5.37:Adipose - Subcutaneous|4.56:Cervix - Endocervix|4.50:Artery - Tibial|4.47:Fallopian Tube|3.91:Ovary|3.30:Pituitary|3.20:Prostate|2.94:Adipose - Visceral (Omentum)|2.68:Colon - Sigmoid|2.67:Esophagus - Mucosa|2.53:Breast - Mammary Tissue|2.47:Lung|2.30:Bladder|2.25:Pancreas|2.18:Kidney - Cortex|2.18:Vagina|2.05:Spleen|1.73:Uterus|1.57:Brain - Spinal cord (cervical c-1)|1.13:Brain - Substantia nigra|1.03:Brain - Hypothalamus|0.98:Heart - Atrial Appendage|0.88:Brain - Nucleus accumbens (basal ganglia)|0.86:Brain - Caudate (basal ganglia)|0.85:Brain - Hippocampus|0.78:Brain - Putamen (basal ganglia)|0.75:Brain - Amygdala|0.74:Cervix - Ectocervix|0.58:Esophagus - Muscularis|0.58:Brain - Cortex|0.56:Brain - Anterior cingulate cortex (BA24)|0.53:Brain - Frontal Cortex (BA9)|0.48:Liver|0.46:Brain - Cerebellum|0.43:Esophagus - Gastroesophageal Junction|0.43:Brain - Cerebellar Hemisphere|0.40:Cells - EBV-transformed lymphocytes|0.39:Whole Blood|0.32:Heart - Left Ventricle|0.26:Cells - Cultured fibroblasts|0.16:Muscle - Skeletal,"0.76:occipital neocortex|0.58:temporal neocortex|0.56:parietal neocortex|0.27:hippocampus (hippocampal formation)|0.25:cerebellum|0.18:primary motor-sensory cortex (samples)|0.18:striatum|0.18:amygdaloid complex|0.18:primary visual cortex (striate cortex, area V1/17)|0.15:anterior (rostral) cingulate (medial prefrontal) cortex|0.14:mediodorsal nucleus of thalamus|0.14:posterior (caudal) superior temporal cortex (area 22c)|0.13:dorsolateral prefrontal cortex|0.12:orbital frontal cortex|0.12:posteroventral (inferior) parietal cortex|0.11:caudal ganglionic eminence|0.11:cerebellar cortex|0.11:inferolateral temporal cortex (area TEv, area 20)|0.11:primary somatosensory cortex (area S1, areas 3,1,2)|0.11:ventrolateral prefrontal cortex|0.10:upper (rostral) rhombic lip|0.10:primary motor cortex (area M1, area 4)|0.10:primary auditory cortex (core)|0.09:lateral ganglionic eminence|0.06:medial ganglionic eminence|0.06:dorsal thalamus",11,SNP,6.17,0-46|0.00,40363221,NA,C|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|97-98|C:T|R:Q;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0002,0.0003,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.13,0-46|0.00,40373993,NA,C|G,"N|6|^:^|^:^;N|23|^:^|^:^;N|25-26|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|40|^:^|^:^;N|41|^:^|^:^;N|42-44,46|^:^|^:^;N|54|^:^|^:^;N|57|^:^|^:^;N|62|^:^|^:^;N|63|^:^|^:^;N|66,68|C:G|G:R;N|76|^:^|^:^;N|78|^:^|^:^;N|83|^:^|^:^;N|86,91|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|126|^:^|^:^;N|128-129|^:^|^:^;N|132|^:^|^:^;N|142-144|^:^|^:^;N|153|^:^|^:^;N|154,156-158|^:^|^:^",4.59e-06,NA,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,38.19,0-46|0.00,40376811,NA,C|G,"N|3-4|C:T|G:R;N|15|C:T|G:R;N|14|^:^|^:^;N|20,23|C:T|G:R;N|21|^:^|^:^;N|24-25,27-29|C:T|G:R;N|26|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37-39|C:T|G:R;N|35-36|^:^|^:^;N|40|C:T|G:R;N|41|^:^|^:^;N|58-59|C:T|G:R;N|57|^:^|^:^;N|60|^:^|^:^;N|71|C:T|G:R;N|75|^:^|^:^;N|78|^:^|^:^;N|83|^:^|^:^;N|92,95|C:T|G:R;N|98|C:T|G:R;N|97|^:^|^:^;N|101-102|^:^|^:^;N|106-107|^:^|^:^;N|108|^:^|^:^;N|113|C:T|G:R;N|127|C:T|G:R;N|129|C:T|G:R;N|128|^:^|^:^;N|132|^:^|^:^;N|134,136|C:T|G:R;N|140|C:T|G:R;N|141|^:^|^:^;N|147|C:T|G:R;N|146,149|^:^|^:^;N|153|C:T|G:R;N|152|^:^|^:^;N|157|^:^|^:^;N|159|^:^|^:^",0.0046,0.0082,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.90,0-46|0.00,40384035,NA,G|A,"N|1-2,4|A:G|V:A;N|0|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|43|^:^|^:^;N|83|^:^|^:^;N|100,102|A:G|V:A;N|108|^:^|^:^;N|112|^:^|^:^;N|115|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.85,0-46|0.00,40384134,NA,A|V,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|94,96|A:C|V:G;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^;N|146,148-149|A:C|V:G",0.0020,0.0029,D,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,50.88,0-46|0.00,40384589,NA,C|E,"N|1|C:T|E:K;N|0,2,4|^:^|^:^;N|5|^:^|^:^;N|8-11|^:^|^:^;N|20-21|^:^|^:^;N|25-26|^:^|^:^;N|31,33|C:T|E:K;N|30,32|^:^|^:^;N|34|^:^|^:^;N|38|C:T|E:K;N|35-37|^:^|^:^;N|40|^:^|^:^;N|41|^:^|^:^;N|45|C:T|E:K;N|42-44,46|^:^|^:^;N|49|^:^|^:^;N|52-53|C:T|E:K;N|50-51|^:^|^:^;N|54-55|C:T|E:K;N|57-58|^:^|^:^;N|60|C:T|E:K;N|62|^:^|^:^;N|64-65|C:T|E:K;N|63|^:^|^:^;N|67|C:T|E:K;N|69-70|^:^|^:^;N|76|C:T|E:K;N|73-75,77|^:^|^:^;N|78|^:^|^:^;N|79,82|C:T|E:K;N|80|^:^|^:^;N|83-84|^:^|^:^;N|86-87,90|C:T|E:K;N|88,91|^:^|^:^;N|92-93,95|^:^|^:^;N|100-102|^:^|^:^;N|107|C:T|E:K;N|104|^:^|^:^;N|108|^:^|^:^;N|111|C:T|E:K;N|114|C:T|E:K;N|112|^:^|^:^;N|116-117|C:T|E:K;N|115|^:^|^:^;N|118-120|C:T|E:K;N|125-126|C:T|E:K;N|124|^:^|^:^;N|128-129|^:^|^:^;N|130,132|^:^|^:^;N|137-141|^:^|^:^;N|142-145|^:^|^:^;N|146,148-149|^:^|^:^;N|150-153|^:^|^:^;N|154-158|^:^|^:^;N|159-162|^:^|^:^;N|163-171|^:^|^:^",0.0258,0,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.79,0-46|0.00,40385078,NA,T|T,"N|3|C:T|A:T;N|0-2,4|^:^|^:^;N|5-7|^:^|^:^;N|8-13|^:^|^:^;N|16|C:T|A:T;N|14-15|^:^|^:^;N|17|C:T|A:T;N|18-19|^:^|^:^;N|22|C:T|A:T;N|20-21,23|^:^|^:^;N|27|C:T|A:T;N|24-26,28-29|^:^|^:^;N|32|C:T|A:T;N|30-31,33|^:^|^:^;N|34|^:^|^:^;N|39|C:T|A:T;N|35-38|^:^|^:^;N|40|^:^|^:^;N|41|^:^|^:^;N|42-46|^:^|^:^;N|48|C:T|A:T;N|47,49|^:^|^:^;N|51-52|C:T|A:T;N|50,53|^:^|^:^;N|54-56|^:^|^:^;N|57-59|^:^|^:^;N|61|C:T|A:T;N|60,62|^:^|^:^;N|63-65|^:^|^:^;N|66|C:T|A:T;N|67-68|^:^|^:^;N|69|C:T|A:T;N|70-72|^:^|^:^;N|73-77|^:^|^:^;N|78|^:^|^:^;N|79-82|^:^|^:^;N|83-85|^:^|^:^;N|86-91|^:^|^:^;N|96|C:T|A:T;N|92-95|^:^|^:^;N|97-99|^:^|^:^;N|100-103|^:^|^:^;N|106|C:T|A:T;N|104-105,107|^:^|^:^;N|108|^:^|^:^;N|110|C:T|A:T;N|109,111|^:^|^:^;N|112-114|^:^|^:^;N|115-117|^:^|^:^;N|118,120|C:T|A:T;N|119|^:^|^:^;N|121-123|C:T|A:T;N|127|C:T|A:T;N|124-126|^:^|^:^;N|128-129|^:^|^:^;N|130-133|^:^|^:^;N|134-136|^:^|^:^;N|141|C:T|A:T;N|137-140|^:^|^:^;N|142-145|^:^|^:^;N|146-149|^:^|^:^;N|150-153|^:^|^:^;N|154-158|^:^|^:^;N|159-162|^:^|^:^;N|165,170-171|C:T|A:T;N|163-164,166-169|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.65,0-46|0.00,40396294,NA,C|R,"N|0|^:^|^:^;N|5|^:^|^:^;N|8,11|^:^|^:^;N|16|^:^|^:^;N|17,19|^:^|^:^;N|30,32|^:^|^:^;N|34|^:^|^:^;N|35-36|^:^|^:^;N|41|^:^|^:^;N|49|^:^|^:^;N|50-51|^:^|^:^;N|60|^:^|^:^;N|65|^:^|^:^;N|66-67|^:^|^:^;N|69-70,72|^:^|^:^;N|77|^:^|^:^;N|83|^:^|^:^;N|86-88,90-91|C:T|R:H;N|94,96|^:^|^:^;N|100-101,103|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|111|C:T|R:H;N|109-110|^:^|^:^;N|116|C:T|R:H;N|121,123|^:^|^:^;N|124|^:^|^:^;N|128|^:^|^:^;N|130,132|^:^|^:^;N|146,148|^:^|^:^;N|150-151,153|C:T|R:H;N|167-171|^:^|^:^",0.0034,0.0039,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.23,"43|0.11;0-42,44-46|0.00",40411646,NA,T|K,"N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|101|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^;N|144|^:^|^:^;N|151-152|G:T|Q:K;N|163,169|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.47,0-46|0.00,40433200,NA,C|V,N|18-19|C:T|V:M;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|156|^:^|^:^,0.0001,0.0002,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,7.18,0-46|0.00,40408527,NA,TCCCCGGCGGG|CPPGS,6|-:TCCCCGGCGGG|-:CPPGS;30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;83|^:^|^:^;108|^:^|^:^;115|^:^|^:^;128|^:^|^:^,NA,NA,NA,NA
10,PELP1,Homo sapiens proline glutamate and leucine rich protein 1 (PELP1) mRNA.,,NM_014389,chr17,49.30,2e-06,0.37,1e-01,-,PELP1,4669774,4704137,"proline, glutamate and leucine rich protein 1",protein_coding,"MNAR,P160",1.00,0,0,2.48:Amelogenesis imperfecta type 1G|2.20:Breast cancer|1.63:Prostate cancer|1.58:Carcinoma|1.51:Ovarian cancer,0.80:Carcinoma,NA,NA,0.90:central nervous system|0.87:brain|0.87:syndromic X-linked intellectual disability|0.84:testis|0.84:ovary|0.83:syndromic intellectual disability|0.83:nervous system|0.79:placenta|0.79:pancreas|0.78:liver|0.78:regulation of chromosome organization|0.77:heart|0.77:spinal cord|0.76:corpus callosum|0.75:fetus|0.71:forebrain|0.71:prostate gland|0.70:skeletal muscle|0.68:cerebral cortex|0.68:lung|0.67:ncRNA processing|0.66:basal ganglion|0.66:corpus striatum|0.65:telencephalon|0.61:subthalamic nucleus|0.60:kidney|0.59:diencephalon|0.59:caudate nucleus|0.58:midbrain|0.57:substantia nigra|0.57:thalamus|0.57:temporal lobe|0.52:hippocampus|0.51:cerebellum|0.51:amygdala|0.46:primary ciliary dyskinesia|0.44:spleen|0.42:regulation of histone modification|0.41:ncRNA metabolic process|0.41:intracellular estrogen receptor signaling pathway|0.41:regulation of DNA metabolic process|0.40:intellectual disability|0.39:intracellular receptor signaling pathway|0.39:uterus|0.37:autism spectrum disorder|0.37:histone modification|0.36:blood|0.35:leukocyte|0.33:ciliopathy|0.33:negative regulation of DNA binding transcription factor activity|0.33:positive regulation of protein kinase activity|0.32:histone methylation|0.31:regulation of chromatin organization|0.31:intestine|0.30:positive regulation of histone modification|0.30:positive regulation of proteolysis|0.30:hormone-mediated signaling pathway|0.28:regulation of histone methylation|0.28:regulation of DNA binding transcription factor activity|0.27:positive regulation of cellular catabolic process|0.27:gastrointestinal tract|0.27:regulation of lipid metabolic process|0.27:regulation of cellular protein catabolic process|0.27:positive regulation of catabolic process|0.26:thyroid gland|0.25:hypophysis|0.25:regulation of protein catabolic process|0.25:lymph node|0.25:small intestine|0.25:regulation of DNA repair|0.24:regulation of translation|0.24:positive regulation of protein catabolic process|0.24:intracellular steroid hormone receptor signaling pathway|0.23:large intestine|0.22:negative regulation of protein modification process|0.22:Kartagener syndrome|0.22:steroid hormone mediated signaling pathway|0.22:positive regulation of biomineral tissue development|0.22:regulation of protein ubiquitination|0.22:positive regulation of chromosome organization|0.21:DNA repair|0.21:muscle|0.21:colon|0.21:positive regulation of programmed cell death|0.21:proteasomal protein catabolic process|0.21:regulation of intracellular steroid hormone receptor signaling pathway|0.20:positive regulation of apoptotic process|0.20:positive regulation of kinase activity|0.20:regulation of protein modification by small protein conjugation or removal|0.20:adrenal gland|0.20:occipital lobe|0.20:regulation of cellular amide metabolic process|0.19:modification-dependent protein catabolic process|0.19:peptidyl-lysine modification|0.18:frontal lobe|0.18:mammary gland|0.18:positive regulation of DNA binding transcription factor activity|0.17:regulation of proteolysis involved in cellular protein catabolic process|0.17:apoptotic signaling pathway|0.17:ubiquitin-dependent protein catabolic process|0.17:positive regulation of cellular protein catabolic process|0.15:regulation of cytoskeleton organization|0.15:positive regulation of bone mineralization|0.15:positive regulation of cell migration|0.15:positive regulation of locomotion|0.15:positive regulation of cell motility|0.15:proteasome-mediated ubiquitin-dependent protein catabolic process|0.14:ubiquitin-dependent ERAD pathway|0.14:regulation of response to DNA damage stimulus|0.14:regulation of wound healing|0.14:bone marrow|0.14:regulation of proteasomal protein catabolic process|0.14:regulation of response to wounding|0.14:positive regulation of cellular component movement|0.14:peptide biosynthetic process|0.13:translation|0.13:regulation of intracellular estrogen receptor signaling pathway|0.13:regulation of lipid biosynthetic process|0.13:regulation of vesicle-mediated transport|0.13:regulation of DNA biosynthetic process|0.13:regulation of telomerase activity|0.13:double-strand break repair|0.12:signal transduction by p53 class mediator|0.12:regulation of immune response|0.12:regulation of histone H3-K27 methylation|0.12:trachea|0.12:negative regulation of transport|0.12:positive regulation of MAPK cascade|0.12:negative regulation of NF-kappaB transcription factor activity|0.12:transmembrane receptor protein serine/threonine kinase signaling pathway|0.12:rRNA metabolic process|0.12:negative regulation of DNA metabolic process|0.12:amide biosynthetic process|0.11:covalent chromatin modification|0.11:adrenergic receptor signaling pathway|0.11:stress-activated MAPK cascade|0.11:regulation of stress-activated MAPK cascade|0.11:regulation of organelle assembly|0.11:negative regulation of inflammatory response|0.11:regulation of defense response|0.11:protein methylation|0.11:protein alkylation|0.11:positive regulation of protein ubiquitination|0.11:rRNA processing|0.10:paranasal sinus disease|0.10:negative regulation of organelle organization|0.10:regulation of endocytosis|0.10:regulation of protein serine/threonine kinase activity|0.10:stomach,63.51:Testis|54.22:Brain - Cerebellum|53.43:Brain - Cerebellar Hemisphere|43.84:Ovary|43.24:Uterus|42.42:Pituitary|41.41:Cervix - Endocervix|40.30:Cervix - Ectocervix|40.03:Fallopian Tube|39.77:Cells - EBV-transformed lymphocytes|37.83:Nerve - Tibial|36.25:Prostate|36.06:Thyroid|32.22:Vagina|31.81:Artery - Tibial|31.56:Bladder|30.94:Brain - Spinal cord (cervical c-1)|30.90:Spleen|30.58:Brain - Cortex|30.38:Brain - Frontal Cortex (BA9)|30.33:Artery - Aorta|28.81:Esophagus - Gastroesophageal Junction|28.71:Skin - Sun Exposed (Lower leg)|28.45:Colon - Sigmoid|28.17:Cells - Cultured fibroblasts|28.05:Artery - Coronary|28.02:Esophagus - Muscularis|27.58:Skin - Not Sun Exposed (Suprapubic)|26.20:Small Intestine - Terminal Ileum|26.14:Muscle - Skeletal|25.90:Brain - Hypothalamus|25.89:Breast - Mammary Tissue|25.78:Lung|24.72:Brain - Nucleus accumbens (basal ganglia)|23.78:Brain - Anterior cingulate cortex (BA24)|22.73:Esophagus - Mucosa|22.56:Adipose - Subcutaneous|22.15:Brain - Substantia nigra|21.89:Brain - Caudate (basal ganglia)|21.19:Minor Salivary Gland|21.16:Colon - Transverse|20.98:Brain - Putamen (basal ganglia)|20.91:Brain - Hippocampus|20.69:Adipose - Visceral (Omentum)|20.67:Brain - Amygdala|20.05:Adrenal Gland|19.09:Kidney - Medulla|18.59:Stomach|14.27:Heart - Atrial Appendage|11.63:Heart - Left Ventricle|11.15:Kidney - Cortex|9.99:Liver|9.53:Pancreas|5.66:Whole Blood,NA,5,SNP,5.29,0-46|0.00,4576299,NA,G|P,N|10|^:^|^:^;N|42|^:^|^:^;N|65|^:^|^:^;N|87|^:^|^:^;N|104|^:^|^:^;N|108|A:G|S:P;N|142|^:^|^:^;N|169|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.14,0-46|0.00,4579700,NA,C|A,N|8|^:^|^:^;N|34|C:T|A:T,0.0016,0.0023,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,7.89,"14|0.37;0-13,15-46|0.00",4575437,NA,TCC|ED,10|^:^|^:^;50-52|-:TCC|-:ED;79|^:^|^:^;87|^:^|^:^;101|^:^|^:^;107|^:^|^:^;128|-:TCC|-:ED;132|^:^|^:^;143|^:^|^:^;147|^:^|^:^;154|-:TCC|-:ED;168|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,13.07,0-46|0.00,4575584,NA,TCT|EE,"75,77|-:TCT|-:EE;100,103|-:TCT|-:EE;104|^:^|^:^;125|^:^|^:^;146,148|^:^|^:^;160|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,mnp,20.16,0-46|0.00,4576216,NA,G|P,"86-89|G:GGGCATGGGGCCTGCTGAA|P:PS;118|A:GGGCATGGGGCCTGCTGAA|P:PS;120|G:GGGCATGGGGCCTGCTGAA|P:PS;130,132-133|G:GGGCATGGGGCCTGCTGAA|P:PS",0.0048,0.0047,NA,NA
11,ARHGEF15,Homo sapiens Rho guanine nucleotide exchange factor (GEF) 15 (ARHGEF15) transcript variant 2 mRNA.,,NM_025014,chr17,30.98,7e-06,0.98,4e-03,+,ARHGEF15,8310241,8322516,Rho guanine nucleotide exchange factor 15,protein_coding,"ARGEF15,E5,Ephexin5,Vsm-RhoGEF",0.00,0,0,2.54:Angelman syndrome|1.85:Autistic disorder|1.65:Intellectual disability,0.78:Carcinoma,NA,Infinity:abnormal brain morphology|Infinity:hydrocephaly|Infinity:enlarged heart|10.00:male infertility|4.80:improved glucose tolerance,0.63:heart|0.58:placenta|0.56:testis|0.55:fetus|0.53:liver|0.49:ovary|0.48:central nervous system|0.47:blood|0.45:autism spectrum disorder|0.44:lung|0.44:nervous system|0.43:kidney|0.43:skeletal muscle|0.42:pancreas|0.42:prostate gland|0.40:spleen|0.38:leukocyte|0.37:brain|0.32:gastrointestinal tract|0.29:intestine|0.27:lymph node|0.27:forebrain|0.26:telencephalon|0.26:uterus|0.26:basal ganglion|0.26:hippocampus|0.25:temporal lobe|0.25:amygdala|0.25:small intestine|0.25:corpus striatum|0.24:caudate nucleus|0.24:substantia nigra|0.23:large intestine|0.23:cerebral cortex|0.22:diencephalon|0.22:midbrain|0.22:corpus callosum|0.20:colon|0.20:mammary gland|0.20:spinal cord|0.19:umbilical vein endothelial cell|0.19:adrenal gland|0.19:thalamus|0.19:subthalamic nucleus|0.19:positive regulation of MAPK cascade|0.18:cerebellum|0.18:blood vessel|0.18:thyroid gland|0.17:monocyte|0.17:mononuclear phagocyte|0.15:negative regulation of locomotion|0.15:bone marrow|0.15:negative regulation of cell migration|0.15:ERK1 and ERK2 cascade|0.15:response to growth factor|0.15:regulation of angiogenesis|0.15:cellular response to growth factor stimulus|0.15:negative regulation of cell motility|0.15:regulation of vasculature development|0.15:G-protein coupled receptor signaling pathway|0.15:positive regulation of cell migration|0.14:positive regulation of cell motility|0.14:positive regulation of protein kinase activity|0.14:negative regulation of cellular component movement|0.14:positive regulation of cellular component movement|0.13:umbilical cord|0.13:positive regulation of locomotion|0.13:regulation of system process|0.13:regulation of ERK1 and ERK2 cascade|0.13:hypophysis|0.13:stomach|0.12:blood plasma|0.12:skin|0.12:muscle|0.12:vascular endothelial cell|0.12:regulation of protein serine/threonine kinase activity|0.12:regulation of response to external stimulus|0.11:regulation of endothelial cell migration|0.11:hypothalamus|0.11:regulation of cellular response to growth factor stimulus|0.11:positive regulation of protein transport|0.11:positive regulation of ERK1 and ERK2 cascade|0.11:frontal lobe|0.11:caudate putamen|0.10:positive regulation of kinase activity|0.10:lymphocyte|0.10:cell surface receptor signaling pathway involved in cell-cell signaling|0.10:regulation of epithelial cell migration|0.10:positive regulation of protein serine/threonine kinase activity,72.63:Adipose - Subcutaneous|69.27:Adipose - Visceral (Omentum)|63.57:Breast - Mammary Tissue|38.60:Lung|28.69:Uterus|26.60:Thyroid|21.88:Nerve - Tibial|20.70:Cervix - Endocervix|20.14:Fallopian Tube|19.76:Cervix - Ectocervix|19.21:Artery - Coronary|18.29:Kidney - Medulla|15.94:Esophagus - Gastroesophageal Junction|15.78:Bladder|15.71:Heart - Left Ventricle|15.34:Esophagus - Muscularis|13.85:Kidney - Cortex|13.49:Prostate|12.81:Vagina|12.64:Spleen|11.71:Skin - Sun Exposed (Lower leg)|11.10:Heart - Atrial Appendage|9.88:Colon - Sigmoid|9.47:Skin - Not Sun Exposed (Suprapubic)|8.82:Small Intestine - Terminal Ileum|8.32:Artery - Tibial|8.05:Artery - Aorta|7.41:Stomach|7.27:Minor Salivary Gland|7.15:Colon - Transverse|7.09:Pituitary|6.71:Adrenal Gland|5.94:Ovary|5.73:Esophagus - Mucosa|5.42:Muscle - Skeletal|5.08:Testis|2.84:Brain - Cortex|2.59:Brain - Substantia nigra|2.46:Pancreas|2.37:Brain - Spinal cord (cervical c-1)|2.06:Brain - Cerebellum|1.92:Brain - Frontal Cortex (BA9)|1.89:Brain - Hypothalamus|1.85:Liver|1.77:Brain - Hippocampus|1.76:Brain - Putamen (basal ganglia)|1.73:Brain - Caudate (basal ganglia)|1.44:Brain - Amygdala|1.42:Brain - Anterior cingulate cortex (BA24)|1.32:Brain - Nucleus accumbens (basal ganglia)|1.04:Brain - Cerebellar Hemisphere|0.07:Whole Blood|0.03:Cells - EBV-transformed lymphocytes|0.03:Cells - Cultured fibroblasts,"1.18:parietal neocortex|1.07:striatum|1.02:primary motor cortex (area M1, area 4)|0.99:primary visual cortex (striate cortex, area V1/17)|0.98:hippocampus (hippocampal formation)|0.98:upper (rostral) rhombic lip|0.98:mediodorsal nucleus of thalamus|0.97:temporal neocortex|0.88:primary somatosensory cortex (area S1, areas 3,1,2)|0.86:ventrolateral prefrontal cortex|0.85:lateral ganglionic eminence|0.84:posterior (caudal) superior temporal cortex (area 22c)|0.84:amygdaloid complex|0.83:cerebellar cortex|0.83:occipital neocortex|0.81:posteroventral (inferior) parietal cortex|0.80:orbital frontal cortex|0.80:anterior (rostral) cingulate (medial prefrontal) cortex|0.80:medial ganglionic eminence|0.79:primary auditory cortex (core)|0.78:caudal ganglionic eminence|0.72:inferolateral temporal cortex (area TEv, area 20)|0.72:dorsolateral prefrontal cortex|0.71:cerebellum|0.49:dorsal thalamus|0.45:primary motor-sensory cortex (samples)",2,SNP,4.28,"18|0.13;0-17,19-46|0.00",8218393,NA,A|Y,"N|63,65|A:T|Y:F;N|100-101|^:^|^:^",NA,NA,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,24.15,"46|0.57;43|0.41;37|0.07;0-30,32-36,38-42,44-45|0.00;31|-0.20",8222870,NA,C|R,"N|51|C:T|R:W;N|107|^:^|^:^;N|110-111|C:T|R:W;N|129|C:T|R:W;N|130-131|C:T|R:W;N|150|C:T|R:W;N|165,167-168,171|C:T|R:W",0.0234,0.0251,D,D
12,TRPV3,Homo sapiens transient receptor potential cation channel subfamily V member 3 (TRPV3) mRNA.,Ion channel activity;Neurological system process,NM_145068,chr17,39.49,8e-06,0.31,1e-01,-,TRPV3,3510502,3557812,transient receptor potential cation channel subfamily V member 3,protein_coding,"FNEPPK2,OLMS,VRL3",0.00,0,0,2.29:Erythromelalgia|2.22:Keratosis|2.21:Pain agnosia|2.10:Alopecia|2.09:Pain disorder|2.02:Migraine|1.99:Dermatitis|1.91:Neuropathy|1.90:Brachyolmia|1.82:Mucolipidosis|1.81:Rosacea|1.69:Adult respiratory distress syndrome|1.60:Irritable bowel syndrome|1.57:Gastrointestinal system disease|1.55:Allergic hypersensitivity disease|1.54:Arthritis,0.70:Carcinoma,4.00:Palmoplantar keratosis,NA,0.65:testis|0.52:liver|0.52:nervous system|0.48:autism spectrum disorder|0.48:central nervous system|0.45:placenta|0.45:pancreas|0.43:brain|0.42:prostate gland|0.40:fetus|0.40:lung|0.39:heart|0.37:kidney|0.37:ovary|0.32:skeletal muscle|0.30:thalamus|0.27:intestine|0.26:cerebellum|0.26:gastrointestinal tract|0.26:lymph node|0.26:spinal cord|0.24:spleen|0.24:colon|0.23:large intestine|0.23:amygdala|0.21:adrenal gland|0.21:diencephalon|0.20:cerebral cortex|0.20:mammary gland|0.20:temporal lobe|0.19:blood|0.19:uterus|0.19:small intestine|0.19:hypophysis|0.19:forebrain|0.19:telencephalon|0.18:corpus callosum|0.18:hippocampus|0.18:basal ganglion|0.18:corpus striatum|0.18:caudate nucleus|0.18:thyroid gland|0.16:substantia nigra|0.16:leukocyte|0.16:midbrain|0.15:subthalamic nucleus|0.12:stomach|0.10:retinal disease,19.74:Skin - Sun Exposed (Lower leg)|17.81:Nerve - Tibial|17.55:Skin - Not Sun Exposed (Suprapubic)|9.30:Testis|4.68:Cells - EBV-transformed lymphocytes|4.44:Brain - Spinal cord (cervical c-1)|3.68:Brain - Cortex|3.47:Brain - Nucleus accumbens (basal ganglia)|3.36:Brain - Caudate (basal ganglia)|3.16:Brain - Putamen (basal ganglia)|2.96:Brain - Frontal Cortex (BA9)|2.94:Small Intestine - Terminal Ileum|2.85:Brain - Amygdala|2.84:Brain - Hippocampus|2.75:Brain - Substantia nigra|2.36:Pituitary|2.11:Brain - Anterior cingulate cortex (BA24)|2.05:Brain - Hypothalamus|1.91:Muscle - Skeletal|1.89:Ovary|1.87:Brain - Cerebellum|1.75:Vagina|1.71:Cervix - Ectocervix|1.66:Colon - Transverse|1.43:Bladder|1.34:Adipose - Subcutaneous|1.32:Brain - Cerebellar Hemisphere|1.26:Esophagus - Gastroesophageal Junction|1.19:Adipose - Visceral (Omentum)|1.18:Cervix - Endocervix|1.13:Spleen|1.11:Breast - Mammary Tissue|1.08:Colon - Sigmoid|1.01:Esophagus - Mucosa|1.01:Heart - Atrial Appendage|0.96:Esophagus - Muscularis|0.93:Fallopian Tube|0.90:Stomach|0.79:Cells - Cultured fibroblasts|0.78:Artery - Coronary|0.75:Minor Salivary Gland|0.67:Lung|0.63:Prostate|0.58:Thyroid|0.55:Liver|0.51:Adrenal Gland|0.50:Uterus|0.42:Artery - Aorta|0.37:Pancreas|0.35:Heart - Left Ventricle|0.23:Artery - Tibial|0.22:Kidney - Cortex|0.22:Kidney - Medulla|0.11:Whole Blood,"0.90:mediodorsal nucleus of thalamus|0.64:striatum|0.62:amygdaloid complex|0.57:posterior (caudal) superior temporal cortex (area 22c)|0.54:primary somatosensory cortex (area S1, areas 3,1,2)|0.54:primary motor cortex (area M1, area 4)|0.53:hippocampus (hippocampal formation)|0.43:primary auditory cortex (core)|0.43:orbital frontal cortex|0.40:posteroventral (inferior) parietal cortex|0.38:ventrolateral prefrontal cortex|0.38:primary visual cortex (striate cortex, area V1/17)|0.37:dorsolateral prefrontal cortex|0.35:inferolateral temporal cortex (area TEv, area 20)|0.34:cerebellar cortex|0.32:anterior (rostral) cingulate (medial prefrontal) cortex|0.15:upper (rostral) rhombic lip|0.12:parietal neocortex|0.11:cerebellum|0.10:dorsal thalamus|0.10:occipital neocortex|0.09:temporal neocortex|0.09:medial ganglionic eminence|0.08:lateral ganglionic eminence|0.07:primary motor-sensory cortex (samples)|0.07:caudal ganglionic eminence",5,SNP,3.72,0-46|0.00,3431387,NA,T|M,"N|0|^:^|^:^;N|37,39|A:T|L:M;N|50-52|A:T|L:M",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.12,0-46|0.00,3433452,NA,G|R,N|31-32|A:G|W:R,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.10,0-46|0.00,3433458,NA,G|R,"N|79,82|A:G|W:R;N|93|^:^|^:^;N|105|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.80,0-46|0.00,3445867,NA,C|D,N|8|^:^|^:^;N|40|C:T|D:N;N|101|^:^|^:^,0.0081,0.0122,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,11.28,"14|0.37;0-7,9-13,15-46|0.00;8|-0.06",3446840,NA,C|V,N|34|C:T|V:M;N|50-52|C:T|V:M,0.0149,0.0252,D,D
13,P2RX5,Homo sapiens purinergic receptor P2X ligand-gated ion channel 5 (P2RX5) transcript variant 2 mRNA.,Ion channel activity;Ligand-gated ion channel activity;Neurological system process,NM_001204520,chr17,35.82,1e-05,0.56,6e-02,-,P2RX5-TAX1BP3,3662893,3696404,P2RX5-TAX1BP3 readthrough (NMD candidate),lncRNA,"P2RX5,P2X5",NA,0,0,NA,NA,NA,NA,NA,NA,NA,4,SNP,10.77,"34|0.15;0-3,5-33,35-46|0.00;4|-0.08",3582954,NA,C|E,"N|18-19|C:T|E:K;N|118,120|C:T|E:K;N|137-139|C:T|E:K",0.0106,0.0117,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.81,0-46|0.00,3583059,NA,G|Q,N|34|A:G|*:Q,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.92,"14|0.37;0-13,15-46|0.00",3591359,NA,G|R,"N|1|^:^|^:^;N|8-10|^:^|^:^;N|24|^:^|^:^;N|36,38|A:G|C:R;N|35|^:^|^:^;N|50-52|A:G|C:R;N|69|^:^|^:^;N|86-87|^:^|^:^;N|100-101|^:^|^:^;N|137,140|^:^|^:^;N|146,149|^:^|^:^;N|151,153|^:^|^:^;N|154,156|^:^|^:^;N|162|^:^|^:^;N|165,167,169-170|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.76,"42|0.11;0-41,43-46|0.00",3599205,NA,A|L,N|50|^:^|^:^;N|87|^:^|^:^;N|107|^:^|^:^;N|141|^:^|^:^;N|148|A:T|L:Q,0.0042,0.0044,D,D
14,AMAC1L3,Homo sapiens solute carrier family 35 member G6 (SLC35G6) mRNA.,,NM_001102614,chr17,16.37,1e-05,0.83,2e-03,+,SLC35G6,7481402,7483064,solute carrier family 35 member G6,protein_coding,"AMAC1L3,TMEM21B",0.00,0,0,NA,NA,NA,NA,NA,12.31:Testis|0.37:Brain - Cerebellum|0.29:Brain - Cerebellar Hemisphere|0.18:Cells - Cultured fibroblasts|0.18:Cervix - Ectocervix|0.15:Cells - EBV-transformed lymphocytes|0.14:Ovary|0.14:Thyroid|0.13:Cervix - Endocervix|0.13:Adrenal Gland|0.12:Bladder|0.11:Pituitary|0.11:Spleen|0.11:Uterus|0.11:Small Intestine - Terminal Ileum|0.11:Minor Salivary Gland|0.09:Prostate|0.09:Esophagus - Mucosa|0.09:Nerve - Tibial|0.08:Brain - Frontal Cortex (BA9)|0.08:Esophagus - Gastroesophageal Junction|0.08:Brain - Cortex|0.08:Esophagus - Muscularis|0.07:Brain - Hypothalamus|0.07:Vagina|0.07:Breast - Mammary Tissue|0.07:Brain - Anterior cingulate cortex (BA24)|0.07:Colon - Transverse|0.06:Stomach|0.06:Fallopian Tube|0.06:Adipose - Subcutaneous|0.06:Skin - Not Sun Exposed (Suprapubic)|0.06:Brain - Caudate (basal ganglia)|0.06:Lung|0.06:Brain - Spinal cord (cervical c-1)|0.06:Skin - Sun Exposed (Lower leg)|0.06:Brain - Nucleus accumbens (basal ganglia)|0.06:Artery - Coronary|0.05:Adipose - Visceral (Omentum)|0.05:Colon - Sigmoid|0.05:Muscle - Skeletal|0.05:Brain - Hippocampus|0.05:Brain - Putamen (basal ganglia)|0.04:Artery - Aorta|0.04:Liver|0.04:Pancreas|0.04:Brain - Substantia nigra|0.04:Kidney - Cortex|0.04:Brain - Amygdala|0.04:Whole Blood|0.04:Heart - Atrial Appendage|0.03:Heart - Left Ventricle|0.03:Artery - Tibial|0.03:Kidney - Medulla,"0.06:mediodorsal nucleus of thalamus|0.05:cerebellar cortex|0.05:primary motor cortex (area M1, area 4)|0.05:lateral ganglionic eminence|0.04:temporal neocortex|0.04:orbital frontal cortex|0.03:parietal neocortex|0.03:occipital neocortex|0.03:primary auditory cortex (core)|0.03:hippocampus (hippocampal formation)|0.03:anterior (rostral) cingulate (medial prefrontal) cortex|0.03:upper (rostral) rhombic lip|0.02:dorsal thalamus|0.01:inferolateral temporal cortex (area TEv, area 20)|0.01:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:ventrolateral prefrontal cortex|0.00:striatum|0.00:primary motor-sensory cortex (samples)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:medial ganglionic eminence|0.00:dorsolateral prefrontal cortex|0.00:cerebellum|0.00:caudal ganglionic eminence|0.00:amygdaloid complex",1,SNP,12.55,"43|0.55;14|0.37;0-13,15-20,22-42,44-46|0.00;21|-0.10",7385871,NA,G|A,"N|50-52|A:G|T:A;N|73,75-76|A:G|T:A;N|150|A:G|T:A",NA,NA,NA,NA
15,USP43,Homo sapiens ubiquitin specific peptidase 43 (USP43) mRNA.,,NM_153210,chr17,35.14,2e-05,0.23,2e-01,+,USP43,9643493,9729687,ubiquitin specific peptidase 43,protein_coding,NA,0.01,0,0,1.94:Machado-Joseph disease,0.90:Carcinoma,NA,4.03:increased or absent threshold for auditory brainstem response,NA,9.39:Prostate|7.39:Esophagus - Mucosa|6.79:Testis|6.34:Brain - Cortex|5.89:Brain - Frontal Cortex (BA9)|5.77:Minor Salivary Gland|5.06:Pituitary|4.31:Fallopian Tube|4.31:Kidney - Medulla|4.13:Lung|4.02:Colon - Transverse|3.84:Small Intestine - Terminal Ileum|3.82:Brain - Anterior cingulate cortex (BA24)|3.77:Vagina|3.65:Thyroid|3.61:Liver|2.92:Kidney - Cortex|2.82:Skin - Sun Exposed (Lower leg)|2.79:Skin - Not Sun Exposed (Suprapubic)|2.55:Pancreas|2.45:Breast - Mammary Tissue|2.20:Stomach|2.01:Brain - Hypothalamus|1.94:Brain - Hippocampus|1.89:Brain - Amygdala|1.30:Brain - Substantia nigra|1.27:Brain - Nucleus accumbens (basal ganglia)|1.13:Brain - Caudate (basal ganglia)|1.00:Brain - Cerebellar Hemisphere|1.00:Brain - Cerebellum|0.95:Brain - Spinal cord (cervical c-1)|0.85:Cervix - Endocervix|0.83:Cells - Cultured fibroblasts|0.80:Cervix - Ectocervix|0.80:Brain - Putamen (basal ganglia)|0.50:Spleen|0.49:Uterus|0.48:Adipose - Visceral (Omentum)|0.44:Bladder|0.34:Nerve - Tibial|0.33:Colon - Sigmoid|0.28:Adrenal Gland|0.24:Ovary|0.22:Cells - EBV-transformed lymphocytes|0.16:Artery - Coronary|0.15:Adipose - Subcutaneous|0.14:Esophagus - Gastroesophageal Junction|0.14:Esophagus - Muscularis|0.12:Whole Blood|0.10:Artery - Aorta|0.09:Artery - Tibial|0.06:Heart - Atrial Appendage|0.03:Muscle - Skeletal|0.03:Heart - Left Ventricle,"1.95:orbital frontal cortex|1.90:anterior (rostral) cingulate (medial prefrontal) cortex|1.87:mediodorsal nucleus of thalamus|1.63:ventrolateral prefrontal cortex|1.59:dorsolateral prefrontal cortex|1.49:primary somatosensory cortex (area S1, areas 3,1,2)|1.37:primary motor cortex (area M1, area 4)|1.34:inferolateral temporal cortex (area TEv, area 20)|1.34:posteroventral (inferior) parietal cortex|1.26:primary auditory cortex (core)|1.18:cerebellum|1.16:primary motor-sensory cortex (samples)|1.13:posterior (caudal) superior temporal cortex (area 22c)|0.87:primary visual cortex (striate cortex, area V1/17)|0.85:amygdaloid complex|0.74:hippocampus (hippocampal formation)|0.57:upper (rostral) rhombic lip|0.53:cerebellar cortex|0.46:dorsal thalamus|0.46:medial ganglionic eminence|0.41:lateral ganglionic eminence|0.38:striatum|0.29:occipital neocortex|0.26:caudal ganglionic eminence|0.16:temporal neocortex|0.14:parietal neocortex",5,SNP,8.61,0-46|0.00,9631303,NA,G|V,"N|100,103|A:G|M:V;N|122-123|A:G|M:V",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.78,"31|0.23;0-30,32-46|0.00",9631418,NA,C|A,N|111|C:G|A:G;N|141|^:^|^:^,0.0019,0.0014,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,12.06,0-46|0.00,9631730,NA,C|P,N|5-6|C:T|P:L;N|41|C:T|P:L;N|43|^:^|^:^;N|50|^:^|^:^;N|100|^:^|^:^,0.0020,0.0019,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.78,0-46|0.00,9631745,NA,C|P,N|34|A:C|H:P,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.86,0-46|0.00,9632146,NA,C|R,"N|97,99|C:T|R:C",0.0022,0.0024,D,T
16,ACADVL,Homo sapiens acyl-CoA dehydrogenase very long chain (ACADVL) nuclear gene encoding mitochondrial protein transcript variant 2 mRNA.,,NM_000018,chr17,24.81,2e-05,0.51,7e-02,+,ACADVL,7217125,7225267,acyl-CoA dehydrogenase very long chain,protein_coding,"ACAD6,LCACD,VLCAD",0.00,0,0,2.64:Multiple acyl-CoA dehydrogenase deficiency|2.51:Hypoglycemia|2.51:Systemic primary carnitine deficiency disease|2.49:Lipid metabolism disorder|2.22:Myopathy|2.14:3-Methylcrotonyl-CoA carboxylase deficiency|2.04:Organic acidemia|1.88:Metabolic acidosis|1.88:Obesity|1.86:Complement component 2 deficiency|1.81:Glycogen storage disease|1.75:Heart disease|1.74:Lysosomal storage disease|1.73:Biotinidase deficiency|1.71:Urea cycle disorder|1.71:Reye syndrome|1.67:Diabetes mellitus|1.66:Hyperlysinemia|1.65:Tyrosinemia|1.62:Sudden infant death syndrome|1.60:Brain disease|1.56:beta-ketothiolase deficiency|1.50:Leigh disease,0.68:Carcinoma,5.00:Very long chain acyl-CoA dehydrogenase deficiency|4.00:Cardiomyopathy,NA,0.91:liver|0.79:blood|0.79:kidney|0.78:pancreas|0.74:blood plasma|0.70:ovary|0.68:leukocyte|0.65:tear gland|0.64:placenta|0.59:heart|0.57:skeletal muscle|0.56:pancreatic islet|0.54:testis|0.49:muscle|0.48:prostate gland|0.48:lymph node|0.47:lung|0.46:amino acid metabolic disorder|0.46:central nervous system|0.46:fetus|0.44:serum|0.43:nervous system|0.42:spleen|0.41:mammary gland|0.40:neutrophil|0.40:autism spectrum disorder|0.35:brain|0.34:cardiac muscle|0.32:renal tubule|0.28:skin|0.28:mononuclear phagocyte|0.28:granulocyte|0.27:blood platelet|0.26:gastrointestinal tract|0.26:monocyte|0.25:large intestine|0.25:intestine|0.25:adrenal gland|0.25:colon|0.24:eye|0.24:uterine endometrium|0.24:forebrain|0.24:uterus|0.23:lymphocyte|0.20:erythrocyte|0.20:thyroid gland|0.19:organic acid catabolic process|0.19:carboxylic acid catabolic process|0.19:cerebral cortex|0.19:small molecule catabolic process|0.18:bone marrow|0.18:small intestine|0.18:hypophysis|0.17:bile acid metabolic process|0.16:fatty acid metabolic process|0.16:stomach|0.16:temporal lobe|0.16:blood vessel|0.15:muscle tissue disease|0.15:muscular disease|0.15:hippocampus|0.15:cerebellum|0.15:renal proximal tubule|0.14:myopathy|0.14:peripheral nervous system disease|0.14:bile duct|0.14:hepatocyte|0.13:neuropathy|0.12:negative regulation of protein modification process|0.12:monocarboxylic acid metabolic process|0.12:nephron|0.11:macrophage|0.11:telencephalon|0.11:movement disease|0.10:cerebellar disease|0.10:regulation of protein catabolic process,901.90:Adrenal Gland|722.13:Thyroid|698.60:Pituitary|616.00:Liver|595.52:Muscle - Skeletal|572.73:Kidney - Medulla|549.76:Prostate|528.61:Heart - Left Ventricle|474.82:Breast - Mammary Tissue|470.94:Adipose - Visceral (Omentum)|464.80:Cervix - Endocervix|459.90:Bladder|459.75:Fallopian Tube|451.75:Cervix - Ectocervix|449.53:Uterus|433.20:Spleen|431.58:Lung|425.93:Vagina|419.61:Ovary|411.11:Esophagus - Mucosa|405.84:Small Intestine - Terminal Ileum|405.37:Colon - Transverse|396.80:Esophagus - Gastroesophageal Junction|396.32:Stomach|392.22:Colon - Sigmoid|387.20:Heart - Atrial Appendage|372.74:Esophagus - Muscularis|367.91:Adipose - Subcutaneous|360.38:Minor Salivary Gland|358.60:Kidney - Cortex|349.77:Nerve - Tibial|348.98:Skin - Not Sun Exposed (Suprapubic)|331.95:Pancreas|330.62:Artery - Coronary|323.17:Brain - Cerebellum|290.23:Artery - Aorta|287.37:Skin - Sun Exposed (Lower leg)|278.75:Brain - Cerebellar Hemisphere|274.72:Testis|247.04:Artery - Tibial|209.13:Cells - EBV-transformed lymphocytes|202.85:Cells - Cultured fibroblasts|166.99:Brain - Cortex|141.29:Brain - Frontal Cortex (BA9)|130.69:Brain - Spinal cord (cervical c-1)|130.09:Brain - Hypothalamus|129.98:Brain - Substantia nigra|127.32:Brain - Caudate (basal ganglia)|124.25:Brain - Anterior cingulate cortex (BA24)|121.36:Brain - Nucleus accumbens (basal ganglia)|113.91:Whole Blood|111.72:Brain - Hippocampus|111.50:Brain - Putamen (basal ganglia)|106.59:Brain - Amygdala,"52.05:cerebellar cortex|45.88:mediodorsal nucleus of thalamus|34.50:primary motor cortex (area M1, area 4)|34.27:striatum|33.49:amygdaloid complex|31.99:hippocampus (hippocampal formation)|31.53:primary auditory cortex (core)|29.89:posterior (caudal) superior temporal cortex (area 22c)|27.19:primary visual cortex (striate cortex, area V1/17)|26.92:ventrolateral prefrontal cortex|26.63:inferolateral temporal cortex (area TEv, area 20)|25.51:orbital frontal cortex|25.23:anterior (rostral) cingulate (medial prefrontal) cortex|24.59:dorsolateral prefrontal cortex|22.98:cerebellum|22.64:posteroventral (inferior) parietal cortex|21.84:primary somatosensory cortex (area S1, areas 3,1,2)|19.75:occipital neocortex|19.71:primary motor-sensory cortex (samples)|19.47:upper (rostral) rhombic lip|18.25:lateral ganglionic eminence|17.59:parietal neocortex|17.37:medial ganglionic eminence|16.41:caudal ganglionic eminence|16.38:temporal neocortex|10.32:dorsal thalamus",3,SNP,3.44,"14|0.21;0-13,15-46|0.00",7123488,NA,G|R,"N|50,52-53|A:G|Q:R;N|65|^:^|^:^;N|85|^:^|^:^;N|107|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,15.84,0-46|0.00,7123506,NA,G|G,"N|0-2|A:G|D:G;N|40|A:G|D:G;N|88|^:^|^:^;N|104,107|A:G|D:G;N|108|A:G|D:G",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.15,"1|0.30;0,2-46|0.00",7128292,NA,G|R,N|5-6|A:G|Q:R;N|37|^:^|^:^,NA,NA,NA,NA
17,ZZEF1,Homo sapiens zinc finger ZZ-type with EF-hand domain 1 (ZZEF1) mRNA.,Transcription Factor,NM_015113,chr17,39.71,2e-05,0.56,2e-01,-,ZZEF1,4004445,4143030,zinc finger ZZ-type and EF-hand domain containing 1,protein_coding,ZZZ4,1.00,0,0,NA,1.27:Carcinoma|0.90:Kidney cancer,NA,10.07:increased mean corpuscular hemoglobin|8.06:decreased total body fat amount|6.95:abnormal sleep behavior|4.84:decreased circulating free fatty acid level|4.78:decreased grip strength|4.44:decreased erythrocyte cell number|4.41:absent teeth|4.07:increased lean body mass|4.02:abnormal coat/hair pigmentation,NA,37.81:Small Intestine - Terminal Ileum|30.90:Esophagus - Muscularis|27.11:Esophagus - Gastroesophageal Junction|26.86:Colon - Transverse|25.89:Thyroid|25.63:Uterus|25.62:Spleen|25.05:Brain - Cerebellum|24.90:Artery - Tibial|23.85:Colon - Sigmoid|23.82:Lung|23.31:Ovary|23.27:Artery - Aorta|23.06:Pituitary|23.00:Nerve - Tibial|22.46:Fallopian Tube|22.39:Brain - Cerebellar Hemisphere|22.21:Cervix - Endocervix|22.15:Skin - Sun Exposed (Lower leg)|21.51:Prostate|21.47:Bladder|20.72:Testis|20.58:Skin - Not Sun Exposed (Suprapubic)|20.49:Cells - EBV-transformed lymphocytes|20.34:Artery - Coronary|19.89:Adipose - Subcutaneous|19.47:Cervix - Ectocervix|19.14:Breast - Mammary Tissue|17.69:Muscle - Skeletal|17.66:Vagina|17.03:Esophagus - Mucosa|16.35:Stomach|15.95:Cells - Cultured fibroblasts|15.82:Adrenal Gland|15.30:Minor Salivary Gland|14.70:Adipose - Visceral (Omentum)|10.23:Pancreas|9.91:Brain - Cortex|9.16:Whole Blood|9.14:Heart - Atrial Appendage|8.26:Brain - Frontal Cortex (BA9)|7.99:Brain - Spinal cord (cervical c-1)|7.58:Kidney - Medulla|7.42:Heart - Left Ventricle|7.27:Brain - Hypothalamus|7.24:Kidney - Cortex|6.42:Brain - Nucleus accumbens (basal ganglia)|6.16:Brain - Caudate (basal ganglia)|6.14:Brain - Substantia nigra|6.12:Brain - Hippocampus|6.11:Liver|6.04:Brain - Anterior cingulate cortex (BA24)|5.52:Brain - Putamen (basal ganglia)|4.97:Brain - Amygdala,"8.41:temporal neocortex|6.31:parietal neocortex|6.23:upper (rostral) rhombic lip|5.95:cerebellar cortex|5.63:cerebellum|5.62:lateral ganglionic eminence|5.54:primary motor-sensory cortex (samples)|5.43:occipital neocortex|4.95:caudal ganglionic eminence|4.83:medial ganglionic eminence|4.54:primary visual cortex (striate cortex, area V1/17)|4.40:primary somatosensory cortex (area S1, areas 3,1,2)|4.40:primary motor cortex (area M1, area 4)|4.25:ventrolateral prefrontal cortex|4.21:primary auditory cortex (core)|4.18:posteroventral (inferior) parietal cortex|4.14:amygdaloid complex|4.08:posterior (caudal) superior temporal cortex (area 22c)|4.07:orbital frontal cortex|4.05:striatum|3.95:anterior (rostral) cingulate (medial prefrontal) cortex|3.89:hippocampus (hippocampal formation)|3.77:dorsolateral prefrontal cortex|3.74:mediodorsal nucleus of thalamus|3.66:dorsal thalamus|3.52:inferolateral temporal cortex (area TEv, area 20)",6,SNP,4.63,0-46|0.00,3916800,NA,T|H,N|27-28|C:T|R:H;N|157|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.32,0-46|0.00,3924566,NA,C|A,"N|2|^:^|^:^;N|34|C:T|A:T;N|40|C:T|A:T;N|51|^:^|^:^;N|87,90|^:^|^:^;N|137|^:^|^:^",0.0172,0.0303,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.34,"34|0.22;40|0.11;0-33,35-39,41-46|0.00",3947601,NA,C|G,"N|118,120|C:G|G:A;N|138,141|C:G|G:A",0.0017,0.0025,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.83,0-46|0.00,3954177,NA,C|G,N|114|C:T|G:R;N|137|^:^|^:^,4.061e-06,NA,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.56,0-46|0.00,3978574,NA,C|R,N|78|A:C|S:R,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.50,"31|0.23;0-30,32-46|0.00",4046054,NA,G|P,N|51|^:^|^:^;N|102|^:^|^:^;N|111|A:G|S:P;N|128|A:G|S:P;N|136|^:^|^:^,NA,NA,NA,NA
18,TEKT1,Homo sapiens tektin 1 (TEKT1) mRNA.,,NM_053285,chr17,29.60,2e-05,0.08,1e-01,-,TEKT1,6797993,6831734,tektin 1,protein_coding,NA,0.00,0,0,2.08:Ciliopathy|2.05:Male infertility|1.89:Infertility|1.77:Situs inversus|1.68:Juvenile myoclonic epilepsy,0.61:Carcinoma,NA,NA,0.83:axoneme assembly|0.79:testis|0.79:ciliopathy|0.75:Kartagener syndrome|0.64:paranasal sinus disease|0.62:placenta|0.61:prostate gland|0.57:fetus|0.57:ovary|0.54:primary ciliary dyskinesia|0.53:lung|0.53:liver|0.51:pancreas|0.49:kidney|0.47:autism spectrum disorder|0.44:uterus|0.42:nervous system|0.41:central nervous system|0.40:mammary gland|0.38:thyroid gland|0.38:brain|0.36:bronchiectasis|0.36:trachea|0.35:dextrocardia|0.35:hypophysis|0.34:gastrointestinal tract|0.34:spleen|0.33:adrenal gland|0.31:heart|0.29:intestine|0.29:skeletal muscle|0.28:cerebellum|0.27:lymph node|0.26:large intestine|0.25:axonemal dynein complex assembly|0.24:amygdala|0.22:colon|0.21:basal ganglion|0.20:small intestine|0.20:blood|0.19:spinal cord|0.19:microtubule bundle formation|0.19:spermatozoon|0.18:telencephalon|0.18:temporal lobe|0.18:leukocyte|0.16:stomach|0.15:substantia nigra|0.15:forebrain|0.14:midbrain|0.14:nose disease|0.14:cilium movement|0.13:corpus striatum|0.13:diencephalon|0.12:cerebral cortex|0.11:cilium organization|0.10:skin|0.10:bone marrow|0.10:cilium assembly,33.13:Testis|3.63:Fallopian Tube|1.36:Pituitary|1.29:Lung|1.28:Brain - Hypothalamus|0.94:Brain - Hippocampus|0.91:Brain - Nucleus accumbens (basal ganglia)|0.52:Brain - Caudate (basal ganglia)|0.43:Brain - Cortex|0.38:Brain - Frontal Cortex (BA9)|0.35:Brain - Substantia nigra|0.27:Brain - Spinal cord (cervical c-1)|0.27:Brain - Anterior cingulate cortex (BA24)|0.24:Brain - Amygdala|0.16:Cervix - Endocervix|0.14:Brain - Cerebellum|0.12:Ovary|0.09:Cervix - Ectocervix|0.08:Brain - Putamen (basal ganglia)|0.08:Uterus|0.08:Brain - Cerebellar Hemisphere|0.06:Liver|0.05:Prostate|0.05:Breast - Mammary Tissue|0.04:Adipose - Subcutaneous|0.04:Thyroid|0.04:Adipose - Visceral (Omentum)|0.04:Esophagus - Mucosa|0.04:Skin - Not Sun Exposed (Suprapubic)|0.04:Skin - Sun Exposed (Lower leg)|0.03:Vagina|0.03:Nerve - Tibial|0.02:Spleen|0.02:Small Intestine - Terminal Ileum|0.02:Bladder|0.02:Kidney - Cortex|0.02:Artery - Coronary|0.02:Cells - EBV-transformed lymphocytes|0.02:Adrenal Gland|0.01:Cells - Cultured fibroblasts|0.01:Esophagus - Gastroesophageal Junction|0.01:Colon - Sigmoid|0.01:Esophagus - Muscularis|0.01:Minor Salivary Gland|0.01:Colon - Transverse|0.01:Artery - Aorta|0.01:Artery - Tibial|0.01:Stomach|0.01:Kidney - Medulla|0.01:Heart - Atrial Appendage|0.01:Muscle - Skeletal|0.00:Heart - Left Ventricle|0.00:Whole Blood|0.00:Pancreas,"1.86:hippocampus (hippocampal formation)|0.57:amygdaloid complex|0.54:striatum|0.47:medial ganglionic eminence|0.45:cerebellum|0.45:upper (rostral) rhombic lip|0.39:mediodorsal nucleus of thalamus|0.38:lateral ganglionic eminence|0.38:caudal ganglionic eminence|0.23:anterior (rostral) cingulate (medial prefrontal) cortex|0.16:primary visual cortex (striate cortex, area V1/17)|0.16:dorsolateral prefrontal cortex|0.15:inferolateral temporal cortex (area TEv, area 20)|0.14:orbital frontal cortex|0.13:primary motor cortex (area M1, area 4)|0.13:posterior (caudal) superior temporal cortex (area 22c)|0.13:temporal neocortex|0.12:primary somatosensory cortex (area S1, areas 3,1,2)|0.12:occipital neocortex|0.11:ventrolateral prefrontal cortex|0.11:primary motor-sensory cortex (samples)|0.09:cerebellar cortex|0.09:primary auditory cortex (core)|0.09:posteroventral (inferior) parietal cortex|0.08:parietal neocortex|0.04:dorsal thalamus",5,SNP,7.17,"28|0.01;0-27,29-46|0.00",6716256,NA,G|T,"N|100,103|C:G|R:T;N|166|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.24,0-46|0.00,6716307,NA,C|R,N|78|C:T|R:Q;N|154|^:^|^:^;N|166|^:^|^:^,0.0021,0.0028,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.36,0-46|0.00,6718542,NA,G|S,"N|80|A:A|L:L;N|79,81-82|A:G|L:S;N|168|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.75,0-46|0.00,6719202,NA,T|I,"N|34|C:T|V:I;N|40|C:T|V:I;N|101,103|C:T|V:I",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.69,"37|0.07;0-36,38-46|0.00",6733548,NA,T|K,N|69|^:^|^:^;N|129|G:T|Q:K,NA,NA,NA,NA
19,PER1,Homo sapiens period homolog 1 (Drosophila) (PER1) mRNA.,Transcription Factor,NM_002616,chr17,32.14,3e-05,0.69,7e-02,-,PER1,8140470,8156360,period circadian regulator 1,protein_coding,"hPER,PER,RIGUI",0.88,3,0,1.66:Cancer|1.57:Breast disease|1.53:Sleep disorder,1.04:Carcinoma,NA,NA,0.81:testis|0.80:liver|0.77:placenta|0.76:kidney|0.76:ovary|0.74:pancreas|0.73:nervous system|0.73:skeletal muscle|0.71:prostate gland|0.71:central nervous system|0.70:lung|0.66:brain|0.66:heart|0.61:fetus|0.61:positive regulation of MAPK cascade|0.59:spleen|0.55:negative regulation of locomotion|0.54:negative regulation of cell migration|0.51:autism spectrum disorder|0.51:leukocyte|0.50:negative regulation of cell motility|0.50:positive regulation of stress-activated MAPK cascade|0.45:blood|0.45:negative regulation of cellular component movement|0.41:positive regulation of JNK cascade|0.39:ERK1 and ERK2 cascade|0.39:stress-activated MAPK cascade|0.39:lymph node|0.38:uterus|0.38:large intestine|0.36:cerebellum|0.35:regulation of stress-activated MAPK cascade|0.34:canonical Wnt signaling pathway|0.34:spinal cord|0.34:gastrointestinal tract|0.33:mammary gland|0.33:intestine|0.32:negative regulation of cell proliferation|0.32:regulation of epithelial cell proliferation|0.31:regulation of ERK1 and ERK2 cascade|0.31:thyroid gland|0.31:adrenal gland|0.30:negative regulation of protein modification process|0.30:colon|0.30:Wnt signaling pathway|0.29:small intestine|0.29:thalamus|0.28:hypophysis|0.28:forebrain|0.28:positive regulation of protein kinase activity|0.27:muscle|0.27:positive regulation of cell motility|0.27:positive regulation of stress-activated protein kinase signaling cascade|0.27:telencephalon|0.26:positive regulation of cell migration|0.26:JNK cascade|0.26:stress-activated protein kinase signaling cascade|0.26:protein kinase B signaling|0.26:regulation of protein catabolic process|0.25:positive regulation of cellular component movement|0.25:negative regulation of intracellular signal transduction|0.25:cerebral cortex|0.25:diencephalon|0.25:regulation of JNK cascade|0.24:negative regulation of immune system process|0.24:positive regulation of locomotion|0.24:negative regulation of hemopoiesis|0.24:cell surface receptor signaling pathway involved in cell-cell signaling|0.24:regulation of DNA binding transcription factor activity|0.23:temporal lobe|0.23:hippocampus|0.23:transmembrane receptor protein tyrosine kinase signaling pathway|0.23:regulation of stress-activated protein kinase signaling cascade|0.23:regulation of canonical Wnt signaling pathway|0.22:regulation of cell adhesion|0.22:regulation of protein serine/threonine kinase activity|0.21:regulation of protein kinase B signaling|0.21:regulation of Wnt signaling pathway|0.20:basal ganglion|0.20:regulation of striated muscle cell differentiation|0.20:umbilical vein endothelial cell|0.20:amygdala|0.20:positive regulation of kinase activity|0.19:regulation of MAP kinase activity|0.19:midbrain|0.19:regulation of epithelial cell migration|0.19:negative regulation of protein phosphorylation|0.19:lymphocyte|0.19:blood vessel|0.18:negative regulation of developmental process|0.18:substantia nigra|0.18:positive regulation of protein serine/threonine kinase activity|0.17:activation of protein kinase activity|0.17:corpus striatum|0.17:bone marrow|0.17:positive regulation of MAP kinase activity|0.17:positive regulation of DNA binding transcription factor activity|0.16:negative regulation of phosphorylation|0.16:positive regulation of striated muscle cell differentiation|0.16:regulation of cell-cell adhesion|0.16:positive regulation of protein kinase B signaling|0.16:positive regulation of catabolic process|0.16:positive regulation of cell differentiation|0.16:negative regulation of cell cycle|0.15:positive regulation of cellular catabolic process|0.15:positive regulation of protein transport|0.15:positive regulation of proteolysis|0.15:positive regulation of programmed cell death|0.15:positive regulation of cellular component biogenesis|0.15:negative regulation of cell differentiation|0.15:uterine endometrium|0.15:positive regulation of apoptotic process|0.14:corpus callosum|0.14:caudate nucleus|0.14:positive regulation of cellular protein localization|0.14:regulation of cell projection organization|0.14:umbilical cord|0.14:trachea|0.13:regulation of intracellular protein transport|0.13:regulation of cell projection assembly|0.13:regulation of hemopoiesis|0.13:stomach|0.13:negative regulation of cell adhesion|0.13:subthalamic nucleus|0.13:negative regulation of Wnt signaling pathway|0.12:serum|0.12:negative regulation of canonical Wnt signaling pathway|0.12:positive regulation of cell cycle|0.12:mononuclear phagocyte|0.12:skin|0.12:regulation of peptidase activity|0.12:regulation of ion transport|0.12:G-protein coupled receptor signaling pathway|0.12:small GTPase mediated signal transduction|0.11:regulation of secretion|0.11:regulation of muscle cell differentiation|0.11:response to growth factor|0.11:regulation of endopeptidase activity|0.11:cellular response to growth factor stimulus|0.11:Ras protein signal transduction|0.11:regulation of secretion by cell|0.11:regulation of TOR signaling|0.11:regulation of lipid metabolic process|0.11:regulation of response to external stimulus|0.10:TOR signaling|0.10:apoptotic signaling pathway,296.81:Ovary|284.93:Skin - Sun Exposed (Lower leg)|282.74:Artery - Tibial|280.10:Nerve - Tibial|277.02:Skin - Not Sun Exposed (Suprapubic)|247.28:Fallopian Tube|223.21:Adipose - Subcutaneous|189.49:Breast - Mammary Tissue|187.50:Thyroid|183.93:Esophagus - Gastroesophageal Junction|181.70:Artery - Aorta|171.52:Cervix - Ectocervix|170.11:Lung|162.60:Colon - Sigmoid|162.55:Uterus|160.57:Esophagus - Muscularis|156.28:Pituitary|155.50:Adipose - Visceral (Omentum)|152.78:Artery - Coronary|150.06:Cervix - Endocervix|149.18:Vagina|147.88:Bladder|147.23:Prostate|139.28:Muscle - Skeletal|83.69:Spleen|82.45:Stomach|82.37:Minor Salivary Gland|75.59:Colon - Transverse|75.31:Small Intestine - Terminal Ileum|68.58:Esophagus - Mucosa|67.35:Testis|67.21:Brain - Cerebellum|65.04:Heart - Atrial Appendage|62.75:Whole Blood|60.33:Adrenal Gland|51.99:Brain - Cerebellar Hemisphere|46.08:Kidney - Cortex|40.54:Liver|40.19:Heart - Left Ventricle|37.31:Kidney - Medulla|36.86:Cells - Cultured fibroblasts|36.58:Pancreas|33.94:Brain - Cortex|24.60:Brain - Frontal Cortex (BA9)|24.01:Brain - Spinal cord (cervical c-1)|21.85:Cells - EBV-transformed lymphocytes|20.60:Brain - Caudate (basal ganglia)|19.63:Brain - Nucleus accumbens (basal ganglia)|18.21:Brain - Hypothalamus|17.87:Brain - Anterior cingulate cortex (BA24)|16.22:Brain - Hippocampus|16.17:Brain - Putamen (basal ganglia)|15.19:Brain - Amygdala|14.27:Brain - Substantia nigra,"9.81:striatum|8.30:primary visual cortex (striate cortex, area V1/17)|8.23:cerebellar cortex|7.79:orbital frontal cortex|7.73:ventrolateral prefrontal cortex|7.70:upper (rostral) rhombic lip|7.55:cerebellum|7.53:primary auditory cortex (core)|7.53:primary somatosensory cortex (area S1, areas 3,1,2)|7.38:posteroventral (inferior) parietal cortex|7.35:posterior (caudal) superior temporal cortex (area 22c)|7.30:caudal ganglionic eminence|7.23:primary motor cortex (area M1, area 4)|7.18:primary motor-sensory cortex (samples)|7.18:anterior (rostral) cingulate (medial prefrontal) cortex|6.67:amygdaloid complex|6.57:lateral ganglionic eminence|6.55:temporal neocortex|6.55:hippocampus (hippocampal formation)|6.45:inferolateral temporal cortex (area TEv, area 20)|6.40:dorsolateral prefrontal cortex|6.26:medial ganglionic eminence|5.99:mediodorsal nucleus of thalamus|5.91:parietal neocortex|5.46:occipital neocortex|3.61:dorsal thalamus",4,SNP,4.97,0-46|0.00,8046664,NA,C|A,"N|35-36,38|C:T|A:T;N|76|^:^|^:^;N|86|^:^|^:^;N|107|^:^|^:^;N|115-116|C:T|A:T;N|119|C:T|A:T;N|137,139|^:^|^:^;N|146,148|^:^|^:^;N|151|^:^|^:^;N|154|^:^|^:^;N|159|^:^|^:^",0.0158,0.0170,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.08,"25|0.26;0-22,24,26-46|0.00;23|-0.02",8047081,NA,G|P,"N|9-10|^:^|^:^;N|37|^:^|^:^;N|57-58|A:G|S:P;N|73-74|^:^|^:^;N|79,81|A:G|S:P;N|88,91|A:G|S:P;N|101|^:^|^:^;N|124|^:^|^:^;N|137|^:^|^:^;N|149|^:^|^:^;N|157|^:^|^:^;N|159|^:^|^:^;N|163-164,167|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.63,"14|0.21;33|0.15;39|0.08;0-13,15-32,34-38,40-46|0.00",8052915,NA,C|V,"N|8|^:^|^:^;N|50,52-53|C:T|V:I;N|61|C:T|V:I;N|116|C:T|V:I;N|134,136|C:T|V:I;N|150|^:^|^:^",0.0043,0.0043,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.30,0-46|0.00,8053916,NA,G|P,N|109|A:G|S:P;N|155|A:G|S:P;N|163|^:^|^:^,NA,NA,NA,NA
20,C17orf74,Homo sapiens chromosome 17 open reading frame 74 (C17orf74) mRNA.,,NM_175734,chr17,24.67,3e-05,0.23,9e-02,+,SPEM2,7424874,7427568,SPEM family member 2,protein_coding,C17orf74,NA,0,0,NA,NA,NA,NA,NA,NA,NA,3,SNP,5.57,0-46|0.00,7330244,NA,G|D,"N|73,75-76|A:G|N:D;N|107|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,14.76,"25|0.19;44|0.14;0-22,24,26-43,45-46|0.00;23|-0.10",7330290,NA,C|S,"N|37|^:^|^:^;N|69,72|C:T|S:L;N|79-80,82|C:T|S:L;N|88,91|C:T|S:L;N|107|^:^|^:^;N|155-158|C:T|S:L",0.0304,0.0296,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.25,0-46|0.00,7330307,NA,C|R,"N|24,27|C:T|R:W;N|107|^:^|^:^",0.0061,0.0054,B,D
21,OR3A3,Homo sapiens olfactory receptor family 3 subfamily A member 3 (OR3A3) mRNA.,,NM_012373,chr17,19.58,6e-05,0.04,1e-01,+,OR3A3,3420424,3421805,olfactory receptor family 3 subfamily A member 3,protein_coding,"OR17-137,OR17-16,OR17-201,OR3A6,OR3A7,OR3A8P",0.42,0,0,2.65:Aicardi syndrome|1.72:Focal dermal hypoplasia,NA,NA,NA,NA,0.23:Testis|0.10:Brain - Cerebellum|0.10:Cervix - Endocervix|0.09:Brain - Cerebellar Hemisphere|0.07:Pituitary|0.06:Nerve - Tibial|0.06:Brain - Spinal cord (cervical c-1)|0.06:Brain - Caudate (basal ganglia)|0.06:Brain - Substantia nigra|0.06:Brain - Putamen (basal ganglia)|0.05:Brain - Nucleus accumbens (basal ganglia)|0.05:Cervix - Ectocervix|0.04:Brain - Cortex|0.04:Brain - Frontal Cortex (BA9)|0.03:Brain - Amygdala|0.03:Brain - Hypothalamus|0.03:Brain - Hippocampus|0.02:Kidney - Medulla|0.01:Brain - Anterior cingulate cortex (BA24)|0.00:Whole Blood|0.00:Vagina|0.00:Uterus|0.00:Thyroid|0.00:Stomach|0.00:Spleen|0.00:Small Intestine - Terminal Ileum|0.00:Skin - Sun Exposed (Lower leg)|0.00:Skin - Not Sun Exposed (Suprapubic)|0.00:Prostate|0.00:Pancreas|0.00:Ovary|0.00:Muscle - Skeletal|0.00:Minor Salivary Gland|0.00:Lung|0.00:Liver|0.00:Kidney - Cortex|0.00:Heart - Left Ventricle|0.00:Heart - Atrial Appendage|0.00:Fallopian Tube|0.00:Esophagus - Muscularis|0.00:Esophagus - Mucosa|0.00:Esophagus - Gastroesophageal Junction|0.00:Colon - Transverse|0.00:Colon - Sigmoid|0.00:Cells - EBV-transformed lymphocytes|0.00:Cells - Cultured fibroblasts|0.00:Breast - Mammary Tissue|0.00:Bladder|0.00:Artery - Tibial|0.00:Artery - Coronary|0.00:Artery - Aorta|0.00:Adrenal Gland|0.00:Adipose - Visceral (Omentum)|0.00:Adipose - Subcutaneous,"0.04:parietal neocortex|0.00:ventrolateral prefrontal cortex|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:striatum|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:medial ganglionic eminence|0.00:lateral ganglionic eminence|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:hippocampus (hippocampal formation)|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",2,SNP,5.49,0-46|0.00,3324102,NA,G|G,"N|0,2|^:^|^:^;N|9,11|^:^|^:^;N|25|^:^|^:^;N|35|^:^|^:^;N|40|^:^|^:^;N|42-44|^:^|^:^;N|63|^:^|^:^;N|66|^:^|^:^;N|70|^:^|^:^;N|76|^:^|^:^;N|78|^:^|^:^;N|96|A:G|R:G;N|107|^:^|^:^;N|132|^:^|^:^;N|140|^:^|^:^;N|151-153|A:G|R:G;N|165|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,15.86,"14|0.37;1-13,15-22,24-43,45-46|0.00;23|-0.04;44|-0.06;0|-0.23",3324720,NA,A|M,"N|1,3-4|A:G|M:V;N|50-52|A:G|M:V;N|79-81|A:G|M:V;N|155-158|A:G|M:V",0.0192,0.0246,B,D
22,MYH10,Homo sapiens myosin heavy chain 10 non-muscle (MYH10) transcript variant 2 mRNA.,Imflammation mediated by chemokine and cytokine signaling;Neurological system process,NM_005964,chr17,29.10,8e-05,0.58,8e-02,-,MYH10,8474205,8631369,myosin heavy chain 10,protein_coding,"NMMHC-IIB,NMMHCB",1.00,2,0,2.40:Myopathy|2.18:Heart disease|2.05:Vascular disease|1.94:Primary cutaneous amyloidosis|1.68:Cancer|1.67:Hyperthyroidism|1.65:X-linked recessive disease|1.60:MYH-9 related disease|1.51:Diabetes mellitus|1.51:Hypothyroidism,1.19:Carcinoma|0.65:Kidney cancer|0.54:Liver cancer,NA,"Infinity:edema|Infinity:abnormal placenta size|Infinity:hemorrhage|Infinity:abnormal skin coloration|Infinity:embryonic growth retardation|Infinity:abnormal pericardium morphology|10.00:preweaning lethality, complete penetrance|4.68:increased heart rate variability|4.67:cardiovascular system phenotype|4.04:improved glucose tolerance",0.89:corpus callosum|0.89:subthalamic nucleus|0.87:basal ganglion|0.86:central nervous system|0.86:kidney|0.85:amygdala|0.85:hippocampus|0.85:nervous system|0.84:telencephalon|0.83:caudate nucleus|0.83:corpus striatum|0.83:cerebral cortex|0.82:brain|0.79:forebrain|0.78:temporal lobe|0.77:substantia nigra|0.77:midbrain|0.75:thalamus|0.75:cerebellum|0.75:ovary|0.73:diencephalon|0.73:spinal cord|0.73:liver|0.71:fetus|0.71:lung|0.70:autism spectrum disorder|0.69:pancreas|0.69:heart|0.68:testis|0.65:placenta|0.62:neuron|0.57:skeletal muscle|0.51:spleen|0.50:prostate gland|0.46:occipital lobe|0.42:medulla oblongata|0.41:blood|0.40:leukocyte|0.37:caudate putamen|0.33:blood vessel|0.33:nephron|0.32:mammary gland|0.31:hypophysis|0.30:gastrointestinal tract|0.30:Wnt signaling pathway|0.29:cell surface receptor signaling pathway involved in cell-cell signaling|0.29:intestine|0.29:colon|0.28:artery|0.28:frontal lobe|0.28:lymph node|0.27:thyroid gland|0.26:large intestine|0.26:positive regulation of MAPK cascade|0.25:small intestine|0.25:adrenal gland|0.23:aorta|0.23:occipital pole|0.22:canonical Wnt signaling pathway|0.20:positive regulation of cellular component biogenesis|0.19:muscle|0.19:uterus|0.19:renal glomerulus|0.18:stress-activated MAPK cascade|0.18:regulation of Wnt signaling pathway|0.18:regulation of canonical Wnt signaling pathway|0.18:regulation of cytoskeleton organization|0.16:regulation of stress-activated MAPK cascade|0.15:regulation of JNK cascade|0.15:positive regulation of JNK cascade|0.15:umbilical vein endothelial cell|0.15:JNK cascade|0.14:negative regulation of protein modification process|0.14:umbilical cord|0.14:positive regulation of stress-activated MAPK cascade|0.14:bronchoalveolar lavage fluid|0.14:cerebellar cortex|0.14:atrium|0.13:regulation of mitotic cell cycle|0.13:negative regulation of intracellular signal transduction|0.13:stomach|0.12:transmembrane receptor protein serine/threonine kinase signaling pathway|0.12:cerebellar Purkinje cell|0.11:regulation of actin filament-based process|0.11:regulation of cellular response to growth factor stimulus|0.11:podocyte|0.11:bone marrow|0.11:uterine endometrium|0.11:negative regulation of locomotion|0.11:regulation of apoptotic signaling pathway|0.11:blood plasma|0.11:regulation of protein serine/threonine kinase activity|0.11:positive regulation of programmed cell death|0.10:regulation of supramolecular fiber organization|0.10:positive regulation of apoptotic process|0.10:peripheral nervous system disease|0.10:negative regulation of cell migration|0.10:positive regulation of cellular protein localization|0.10:negative regulation of organelle organization|0.10:regulation of plasma membrane bounded cell projection organization,932.73:Artery - Aorta|307.96:Artery - Coronary|220.89:Artery - Tibial|127.90:Lung|55.44:Cells - Cultured fibroblasts|54.42:Uterus|54.08:Ovary|50.02:Fallopian Tube|44.59:Cervix - Endocervix|42.91:Brain - Cerebellar Hemisphere|42.90:Brain - Frontal Cortex (BA9)|41.10:Cervix - Ectocervix|41.03:Brain - Cerebellum|36.84:Pituitary|36.32:Adipose - Visceral (Omentum)|35.60:Brain - Cortex|28.75:Breast - Mammary Tissue|28.66:Nerve - Tibial|27.94:Heart - Atrial Appendage|26.80:Thyroid|26.37:Prostate|26.07:Adipose - Subcutaneous|23.64:Kidney - Medulla|22.85:Brain - Anterior cingulate cortex (BA24)|22.75:Colon - Sigmoid|21.88:Brain - Caudate (basal ganglia)|20.92:Esophagus - Gastroesophageal Junction|20.82:Bladder|19.29:Brain - Nucleus accumbens (basal ganglia)|19.00:Vagina|18.38:Brain - Hypothalamus|18.10:Kidney - Cortex|17.44:Adrenal Gland|17.19:Testis|16.46:Esophagus - Muscularis|14.78:Brain - Putamen (basal ganglia)|14.04:Brain - Hippocampus|14.00:Skin - Sun Exposed (Lower leg)|12.58:Brain - Amygdala|11.34:Minor Salivary Gland|11.02:Skin - Not Sun Exposed (Suprapubic)|10.35:Colon - Transverse|10.33:Brain - Substantia nigra|9.11:Esophagus - Mucosa|8.68:Heart - Left Ventricle|8.24:Liver|7.89:Brain - Spinal cord (cervical c-1)|7.75:Small Intestine - Terminal Ileum|7.10:Stomach|5.75:Cells - EBV-transformed lymphocytes|4.49:Spleen|4.30:Pancreas|3.22:Muscle - Skeletal|0.67:Whole Blood,"53.27:caudal ganglionic eminence|50.15:lateral ganglionic eminence|47.82:medial ganglionic eminence|47.22:parietal neocortex|42.43:occipital neocortex|42.31:temporal neocortex|34.07:upper (rostral) rhombic lip|30.94:cerebellum|30.29:dorsal thalamus|29.47:primary motor-sensory cortex (samples)|28.84:anterior (rostral) cingulate (medial prefrontal) cortex|24.76:ventrolateral prefrontal cortex|24.57:primary motor cortex (area M1, area 4)|24.55:primary visual cortex (striate cortex, area V1/17)|24.28:orbital frontal cortex|24.11:primary somatosensory cortex (area S1, areas 3,1,2)|24.07:hippocampus (hippocampal formation)|23.97:posterior (caudal) superior temporal cortex (area 22c)|23.61:posteroventral (inferior) parietal cortex|23.32:mediodorsal nucleus of thalamus|23.09:amygdaloid complex|22.96:primary auditory cortex (core)|22.07:dorsolateral prefrontal cortex|21.84:inferolateral temporal cortex (area TEv, area 20)|20.90:striatum|18.34:cerebellar cortex",5,SNP,3.17,0-46|0.00,8402755,NA,T|T,"N|31,33|C:T|A:T",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.18,0-46|0.00,8413156,NA,C|E,N|124-126|C:T|E:K;N|158|^:^|^:^,1.243e-05,NA,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.48,0-46|0.00,8413233,NA,G|A,N|129|A:G|V:A;N|136|A:G|V:A,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.69,0-46|0.00,8445427,NA,G|P,N|134-135|G:T|P:T;N|156|^:^|^:^,NA,NA,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,5.90,"21|0.58;0-20,22-46|0.00",8397095,NA,CCT|EA,7|^:^|^:^;43|^:^|^:^;48|^:^|^:^;75|-:CCT|-:EA;109|-:CCT|-:EA;132|^:^|^:^;142|^:^|^:^,NA,NA,NA,NA
23,GSG2,Homo sapiens germ cell associated 2 (haspin) (GSG2) mRNA.,,NM_031965,chr17,22.98,9e-05,0.50,8e-02,+,HASPIN,3723903,3726699,histone H3 associated protein kinase,protein_coding,GSG2,NA,0,0,NA,NA,NA,NA,NA,NA,NA,4,SNP,5.56,0-46|0.00,3627347,NA,C|R,N|8|^:^|^:^;N|50|^:^|^:^;N|66-67|C:T|R:W;N|76|^:^|^:^;N|86|^:^|^:^,0.0015,0.0014,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.27,"18|0.13;0-17,19-46|0.00",3627528,NA,G|R,"N|63,65|A:G|H:R;N|140|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.81,0-46|0.00,3627663,NA,G|R,"N|17,19|A:G|H:R;N|37|^:^|^:^;N|107|^:^|^:^;N|142-143|A:G|H:R;N|145|^:^|^:^;N|164|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.04,"14|0.37;0-13,15-46|0.00",3628481,NA,T|S,N|50-52|C:T|P:S,NA,NA,NA,NA
24,TAX1BP3,Homo sapiens Tax1 (human T-cell leukemia virus type I) binding protein 3 (TAX1BP3) transcript variant 1 mRNA.,,NM_001204698,chr17,15.69,9e-05,1.07,1e-04,-,TAX1BP3,3662893,3668679,Tax1 binding protein 3,protein_coding,"TIP-1,TIP1",0.00,0,0,1.55:Cancer,NA,NA,"8.12:preweaning lethality, complete penetrance",0.73:leukocyte|0.73:placenta|0.72:blood plasma|0.72:blood|0.71:kidney|0.68:blood platelet|0.66:fetus|0.65:pancreas|0.65:tear gland|0.59:testis|0.58:liver|0.57:lung|0.55:heart|0.52:prostate gland|0.52:spleen|0.46:skeletal muscle|0.45:monocyte|0.44:ovary|0.44:autism spectrum disorder|0.44:granulocyte|0.44:mononuclear phagocyte|0.43:neutrophil|0.41:mammary gland|0.40:eye|0.40:brain|0.39:large intestine|0.39:renal tubule|0.36:nephron|0.36:nervous system|0.35:uterine endometrium|0.35:central nervous system|0.34:uterus|0.34:gastrointestinal tract|0.34:skin|0.32:colon|0.31:intestine|0.29:lymph node|0.28:erythrocyte|0.26:stomach|0.24:small intestine|0.24:blood vessel|0.24:muscle|0.23:umbilical vein endothelial cell|0.23:lymphocyte|0.20:umbilical cord|0.16:artery|0.16:apoptotic signaling pathway|0.16:epidermis|0.15:vascular endothelial cell|0.15:bone marrow|0.14:renal glomerulus|0.14:hypophysis|0.14:aorta|0.14:adrenal gland|0.13:urinary bladder|0.12:dendritic cell|0.12:regulation of endopeptidase activity|0.12:regulation of peptidase activity|0.12:negative regulation of protein modification process|0.12:thyroid gland|0.11:megakaryocyte|0.11:regulation of protein catabolic process|0.11:skin fibroblast|0.10:negative regulation of protein phosphorylation|0.10:negative regulation of intracellular signal transduction|0.10:basal ganglion|0.10:peripheral nervous system disease,493.56:Nerve - Tibial|404.85:Cervix - Ectocervix|379.22:Cervix - Endocervix|350.31:Esophagus - Mucosa|308.10:Vagina|277.19:Cells - Cultured fibroblasts|255.63:Artery - Aorta|241.16:Uterus|237.65:Artery - Coronary|214.66:Artery - Tibial|209.85:Bladder|202.41:Ovary|193.16:Lung|191.71:Adipose - Subcutaneous|190.22:Skin - Not Sun Exposed (Suprapubic)|184.34:Fallopian Tube|184.14:Adrenal Gland|184.03:Skin - Sun Exposed (Lower leg)|177.03:Prostate|170.33:Breast - Mammary Tissue|165.84:Minor Salivary Gland|159.11:Small Intestine - Terminal Ileum|148.81:Kidney - Medulla|148.49:Stomach|147.88:Heart - Atrial Appendage|147.46:Colon - Transverse|145.74:Adipose - Visceral (Omentum)|145.08:Esophagus - Gastroesophageal Junction|140.98:Thyroid|136.28:Esophagus - Muscularis|129.47:Colon - Sigmoid|116.98:Heart - Left Ventricle|113.94:Testis|101.37:Kidney - Cortex|90.94:Spleen|78.75:Brain - Spinal cord (cervical c-1)|62.82:Brain - Substantia nigra|57.23:Pituitary|49.74:Pancreas|45.37:Brain - Caudate (basal ganglia)|42.99:Brain - Putamen (basal ganglia)|42.51:Brain - Hippocampus|41.69:Brain - Amygdala|37.39:Brain - Cortex|35.35:Brain - Hypothalamus|32.95:Whole Blood|32.39:Brain - Frontal Cortex (BA9)|29.74:Brain - Anterior cingulate cortex (BA24)|29.48:Brain - Nucleus accumbens (basal ganglia)|27.54:Cells - EBV-transformed lymphocytes|23.27:Brain - Cerebellum|21.85:Liver|21.02:Muscle - Skeletal|18.86:Brain - Cerebellar Hemisphere,"43.12:caudal ganglionic eminence|43.04:occipital neocortex|40.00:parietal neocortex|35.77:medial ganglionic eminence|33.13:temporal neocortex|31.59:lateral ganglionic eminence|30.39:upper (rostral) rhombic lip|29.76:primary motor-sensory cortex (samples)|24.26:hippocampus (hippocampal formation)|22.75:primary auditory cortex (core)|21.41:ventrolateral prefrontal cortex|21.41:dorsolateral prefrontal cortex|21.04:striatum|20.85:primary visual cortex (striate cortex, area V1/17)|19.18:amygdaloid complex|19.13:cerebellum|19.07:posterior (caudal) superior temporal cortex (area 22c)|18.92:primary motor cortex (area M1, area 4)|18.14:orbital frontal cortex|18.06:primary somatosensory cortex (area S1, areas 3,1,2)|17.71:posteroventral (inferior) parietal cortex|16.78:dorsal thalamus|16.31:anterior (rostral) cingulate (medial prefrontal) cortex|15.59:inferolateral temporal cortex (area TEv, area 20)|12.52:mediodorsal nucleus of thalamus|10.62:cerebellar cortex",1,SNP,10.76,"46|0.90;40|0.17;0-39,41-45|0.00",3567049,NA,A|L,"N|138,141|A:G|L:P;N|165,167-168|A:G|L:P",0.0076,0.0083,B,D
25,MYH4,Homo sapiens myosin heavy chain 4 skeletal muscle (MYH4) mRNA.,,NM_017533,chr17,21.56,1e-04,0.09,1e-01,-,MYH4,10443058,10469559,myosin heavy chain 4,protein_coding,"MYH2B,MyHC-2B,MyHC-IIb",0.00,3,0,2.73:Myopathy|2.19:Heart disease|2.05:X-linked recessive disease|2.01:Primary cutaneous amyloidosis|1.79:Hypothyroidism|1.77:Coronary artery disease|1.76:Hyperthyroidism|1.73:Neuropathy|1.69:Diabetes mellitus|1.63:Chronic obstructive pulmonary disease|1.53:Obesity|1.51:Distal arthrogryposis,NA,NA,NA,NA,1.25:Muscle - Skeletal|0.21:Testis|0.03:Breast - Mammary Tissue|0.03:Uterus|0.03:Cervix - Ectocervix|0.03:Spleen|0.02:Artery - Coronary|0.02:Cervix - Endocervix|0.02:Brain - Frontal Cortex (BA9)|0.02:Minor Salivary Gland|0.02:Heart - Atrial Appendage|0.01:Bladder|0.01:Brain - Cortex|0.01:Brain - Hypothalamus|0.01:Kidney - Medulla|0.01:Cells - Cultured fibroblasts|0.01:Vagina|0.00:Small Intestine - Terminal Ileum|0.00:Heart - Left Ventricle|0.00:Brain - Anterior cingulate cortex (BA24)|0.00:Colon - Transverse|0.00:Whole Blood|0.00:Thyroid|0.00:Stomach|0.00:Skin - Sun Exposed (Lower leg)|0.00:Skin - Not Sun Exposed (Suprapubic)|0.00:Prostate|0.00:Pituitary|0.00:Pancreas|0.00:Ovary|0.00:Nerve - Tibial|0.00:Lung|0.00:Liver|0.00:Kidney - Cortex|0.00:Fallopian Tube|0.00:Esophagus - Muscularis|0.00:Esophagus - Mucosa|0.00:Esophagus - Gastroesophageal Junction|0.00:Colon - Sigmoid|0.00:Cells - EBV-transformed lymphocytes|0.00:Brain - Substantia nigra|0.00:Brain - Spinal cord (cervical c-1)|0.00:Brain - Putamen (basal ganglia)|0.00:Brain - Nucleus accumbens (basal ganglia)|0.00:Brain - Hippocampus|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Brain - Caudate (basal ganglia)|0.00:Brain - Amygdala|0.00:Artery - Tibial|0.00:Artery - Aorta|0.00:Adrenal Gland|0.00:Adipose - Visceral (Omentum)|0.00:Adipose - Subcutaneous,"0.05:primary visual cortex (striate cortex, area V1/17)|0.03:posterior (caudal) superior temporal cortex (area 22c)|0.03:posteroventral (inferior) parietal cortex|0.03:primary auditory cortex (core)|0.02:inferolateral temporal cortex (area TEv, area 20)|0.02:primary somatosensory cortex (area S1, areas 3,1,2)|0.01:parietal neocortex|0.01:orbital frontal cortex|0.01:primary motor cortex (area M1, area 4)|0.01:anterior (rostral) cingulate (medial prefrontal) cortex|0.01:dorsolateral prefrontal cortex|0.01:primary motor-sensory cortex (samples)|0.01:hippocampus (hippocampal formation)|0.00:mediodorsal nucleus of thalamus|0.00:ventrolateral prefrontal cortex|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:striatum|0.00:occipital neocortex|0.00:medial ganglionic eminence|0.00:lateral ganglionic eminence|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:amygdaloid complex",2,SNP,6.53,"38|0.09;0-37,39-46|0.00",10354727,NA,T|S,N|80-81|G:T|R:S;N|107|^:^|^:^;N|132-133|G:T|R:S;N|143|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,16.55,0-46|0.00,10366204,NA,T|Q,"N|15-16|C:T|R:Q;N|60-61|C:T|R:Q;N|78|C:T|R:Q;N|83,85|C:T|R:Q;N|122|C:T|R:Q",NA,NA,NA,NA
26,CXCL16,Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16) transcript variant 2 mRNA.,,NM_022059,chr17,15.69,2e-04,0.37,5e-02,-,CXCL16,4733533,4739928,C-X-C motif chemokine ligand 16,protein_coding,"CXCLG16,SR-PSOX,SRPSOX",0.04,0,0,2.20:Cancer|2.17:Gastrointestinal system disease|2.16:Atherosclerosis|2.05:Autoimmune hypersensitivity disease|1.96:Kidney disease|1.91:Lung disease|1.91:Arthritis|1.81:Breast disease|1.79:Prostate disease|1.78:Skin disease|1.78:Hematopoietic system disease|1.76:Coronary artery disease|1.66:Diabetes mellitus|1.60:Asthma|1.54:Allergic hypersensitivity disease|1.54:Neurodegenerative disease|1.50:Sarcoidosis,NA,NA,NA,NA,194.26:Testis|120.26:Lung|80.88:Whole Blood|64.59:Spleen|58.18:Minor Salivary Gland|37.31:Artery - Aorta|34.50:Brain - Spinal cord (cervical c-1)|32.80:Skin - Sun Exposed (Lower leg)|32.37:Small Intestine - Terminal Ileum|32.31:Skin - Not Sun Exposed (Suprapubic)|31.35:Esophagus - Mucosa|30.86:Nerve - Tibial|30.66:Adipose - Visceral (Omentum)|28.33:Kidney - Medulla|26.98:Breast - Mammary Tissue|26.74:Artery - Coronary|25.00:Prostate|24.85:Pituitary|24.52:Vagina|23.48:Adrenal Gland|23.22:Adipose - Subcutaneous|22.61:Stomach|22.32:Fallopian Tube|20.34:Thyroid|18.33:Artery - Tibial|17.05:Cervix - Endocervix|16.88:Kidney - Cortex|16.72:Bladder|16.58:Ovary|16.20:Cervix - Ectocervix|15.86:Liver|15.54:Colon - Transverse|15.11:Brain - Substantia nigra|14.47:Uterus|11.87:Esophagus - Gastroesophageal Junction|11.70:Colon - Sigmoid|11.68:Brain - Hypothalamus|10.51:Esophagus - Muscularis|10.18:Brain - Amygdala|10.16:Brain - Hippocampus|9.31:Pancreas|8.59:Brain - Anterior cingulate cortex (BA24)|7.76:Brain - Nucleus accumbens (basal ganglia)|7.42:Brain - Caudate (basal ganglia)|6.84:Brain - Cortex|6.58:Brain - Frontal Cortex (BA9)|6.47:Brain - Putamen (basal ganglia)|6.04:Heart - Atrial Appendage|5.11:Brain - Cerebellum|4.54:Brain - Cerebellar Hemisphere|3.99:Cells - Cultured fibroblasts|2.01:Heart - Left Ventricle|1.05:Muscle - Skeletal|1.04:Cells - EBV-transformed lymphocytes,"3.50:amygdaloid complex|3.29:cerebellar cortex|3.19:mediodorsal nucleus of thalamus|3.07:hippocampus (hippocampal formation)|2.46:ventrolateral prefrontal cortex|2.45:orbital frontal cortex|2.34:inferolateral temporal cortex (area TEv, area 20)|2.28:posterior (caudal) superior temporal cortex (area 22c)|2.23:primary motor cortex (area M1, area 4)|2.22:striatum|2.18:dorsolateral prefrontal cortex|2.07:primary auditory cortex (core)|1.99:anterior (rostral) cingulate (medial prefrontal) cortex|1.89:posteroventral (inferior) parietal cortex|1.76:primary somatosensory cortex (area S1, areas 3,1,2)|1.34:upper (rostral) rhombic lip|1.34:primary visual cortex (striate cortex, area V1/17)|0.80:temporal neocortex|0.79:occipital neocortex|0.70:cerebellum|0.64:parietal neocortex|0.41:primary motor-sensory cortex (samples)|0.32:medial ganglionic eminence|0.31:dorsal thalamus|0.27:lateral ganglionic eminence|0.20:caudal ganglionic eminence",3,SNP,2.41,0-46|0.00,4637929,NA,A|I,N|108|A:G|I:T,NA,NA,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.93,"14|0.37;0-13,15-46|0.00",4638530,NA,G|P,N|37|^:^|^:^;N|50-52|A:G|L:P;N|128|A:G|L:P,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.63,0-46|0.00,4642627,NA,C|R,"N|75,77|C:G|R:P;N|93|^:^|^:^;N|100,103|C:G|R:P",0.0085,0.0105,B,D
27,ITGAE,Homo sapiens integrin alpha E (antigen CD103 human mucosal lymphocyte antigen 1; alpha polypeptide) (ITGAE) mRNA.,,NM_002208,chr17,21.76,3e-04,0.23,1e-01,-,ITGAE,3714628,3803766,integrin subunit alpha E,protein_coding,"CD103,HUMINAE",0.00,0,0,2.91:Colitis|2.68:Autoimmune hypersensitivity disease|2.63:Atopic dermatitis|2.63:Allergic hypersensitivity disease|2.62:Influenza|2.51:Crohn's disease|2.51:Cancer|2.49:Hematopoietic system disease|2.40:Asthma|2.30:Kawasaki disease|2.21:Parasitic helminthiasis infectious disease|2.18:Arthritis|2.17:Lung disease|2.17:Lymphoproliferative syndrome|2.16:Psoriasis|2.08:Diabetes mellitus|1.95:Human immunodeficiency virus infectious disease|1.95:Diarrhea|1.92:Encephalitis|1.91:Neurodegenerative disease|1.89:Tuberculosis|1.83:Chediak-Higashi syndrome|1.82:Malaria|1.79:Listeriosis|1.76:Kidney disease|1.75:Vaccinia|1.75:Salmonellosis|1.69:Colonic disease|1.69:Liver disease|1.68:Ovarian disease|1.65:X-linked recessive disease|1.65:Breast disease|1.63:Eye disease|1.58:Leishmaniasis|1.55:Allergic rhinitis|1.54:Atherosclerosis|1.52:Gastroenteritis,2.70:Attention deficit hyperactivity disorder|0.93:Carcinoma,NA,7.75:decreased neutrophil cell number|5.68:decreased monocyte cell number|4.91:decreased leukocyte cell number|4.03:decreased lean body mass,0.56:liver|0.54:prostate gland|0.52:pancreas|0.50:blood|0.47:autism spectrum disorder|0.45:leukocyte|0.45:gastrointestinal tract|0.45:testis|0.44:heart|0.43:spleen|0.43:kidney|0.42:fetus|0.39:lymph node|0.39:intestine|0.37:colon|0.37:large intestine|0.35:lung|0.35:skeletal muscle|0.33:small intestine|0.33:nervous system|0.33:ovary|0.29:brain|0.28:central nervous system|0.28:placenta|0.20:adrenal gland|0.19:lymphocyte|0.18:mammary gland|0.16:thyroid gland|0.15:uterus|0.15:blood plasma|0.13:bone marrow|0.11:T-lymphocyte|0.10:stomach|0.10:hypophysis|0.10:spinal cord|0.10:peripheral nervous system disease,11.98:Spleen|11.10:Small Intestine - Terminal Ileum|10.78:Lung|10.74:Testis|10.36:Cells - Cultured fibroblasts|9.54:Vagina|9.21:Adipose - Subcutaneous|9.09:Uterus|9.07:Cervix - Endocervix|9.05:Prostate|8.85:Bladder|8.75:Nerve - Tibial|8.43:Fallopian Tube|8.28:Cervix - Ectocervix|8.13:Esophagus - Muscularis|8.10:Brain - Caudate (basal ganglia)|8.08:Adipose - Visceral (Omentum)|8.00:Colon - Sigmoid|7.95:Ovary|7.93:Breast - Mammary Tissue|7.78:Thyroid|7.63:Esophagus - Gastroesophageal Junction|7.52:Brain - Cerebellar Hemisphere|7.49:Esophagus - Mucosa|7.44:Brain - Nucleus accumbens (basal ganglia)|7.40:Artery - Coronary|7.26:Adrenal Gland|7.17:Brain - Putamen (basal ganglia)|7.11:Cells - EBV-transformed lymphocytes|7.02:Brain - Spinal cord (cervical c-1)|6.84:Colon - Transverse|6.73:Brain - Cerebellum|6.69:Artery - Aorta|6.37:Brain - Substantia nigra|6.07:Artery - Tibial|5.98:Stomach|5.94:Brain - Hypothalamus|5.86:Pituitary|5.77:Minor Salivary Gland|5.60:Brain - Frontal Cortex (BA9)|5.58:Skin - Not Sun Exposed (Suprapubic)|5.36:Kidney - Medulla|5.22:Skin - Sun Exposed (Lower leg)|5.17:Muscle - Skeletal|4.90:Brain - Amygdala|4.83:Brain - Anterior cingulate cortex (BA24)|4.81:Brain - Cortex|4.51:Brain - Hippocampus|4.31:Heart - Atrial Appendage|4.23:Kidney - Cortex|2.66:Whole Blood|2.42:Heart - Left Ventricle|1.96:Liver|1.85:Pancreas,"3.82:striatum|3.30:cerebellar cortex|2.87:medial ganglionic eminence|2.77:occipital neocortex|2.75:lateral ganglionic eminence|2.62:mediodorsal nucleus of thalamus|2.62:caudal ganglionic eminence|2.58:primary motor-sensory cortex (samples)|2.50:hippocampus (hippocampal formation)|2.44:amygdaloid complex|2.35:cerebellum|2.25:primary somatosensory cortex (area S1, areas 3,1,2)|2.23:primary auditory cortex (core)|2.23:orbital frontal cortex|2.19:ventrolateral prefrontal cortex|2.16:posterior (caudal) superior temporal cortex (area 22c)|2.14:anterior (rostral) cingulate (medial prefrontal) cortex|2.12:primary visual cortex (striate cortex, area V1/17)|2.08:primary motor cortex (area M1, area 4)|2.07:dorsolateral prefrontal cortex|2.06:inferolateral temporal cortex (area TEv, area 20)|2.01:dorsal thalamus|1.98:parietal neocortex|1.91:posteroventral (inferior) parietal cortex|1.89:upper (rostral) rhombic lip|1.55:temporal neocortex",2,SNP,17.55,0-46|0.00,3661052,NA,G|T,"N|8-10,12|A:G|M:T;N|37|A:G|M:T;N|58|^:^|^:^;N|63-64|A:G|M:T;N|84-85|A:G|M:T;N|134-135|A:G|M:T;N|146,148-149|A:G|M:T;N|160-162|A:G|M:T;N|165|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,mnp,3.16,"33|0.23;0-32,34-46|0.00",3658410,NA,C,"0-1|^:^;8,10|^:^;24-25|^:^;36-37|^:^;40|^:^;42-44,46|^:^;50-51|^:^;65|^:^;70|^:^;74|^:^;78|^:^;85|^:^;86-88|^:^;93-94|^:^;97|^:^;101|^:^;104,107|^:^;116|C:TCAGGTGGCCCCGC;125|^:^;128|-:C;130|^:^;137,139,141|^:^;143-144|^:^;146-149|^:^;150-153|^:^;154,157-158|^:^;159-160|^:^;163-165,167-168,170|^:^",NA,NA,NA,NA
28,PLD2,Homo sapiens phospholipase D2 (PLD2) transcript variant 1 mRNA.,Parkinson Disease,NM_002663,chr17,23.65,3e-04,0.63,5e-02,+,PLD2,4807152,4823432,phospholipase D2,protein_coding,PLD1C,0.00,0,0,2.00:Cancer|1.87:Neurodegenerative disease|1.69:Breast disease|1.68:Gastrointestinal system disease|1.53:Pheochromocytoma,0.76:Carcinoma,NA,NA,0.77:placenta|0.76:lung|0.75:brain|0.70:fetus|0.70:prostate gland|0.68:central nervous system|0.68:nervous system|0.66:kidney|0.64:blood|0.64:spleen|0.62:liver|0.62:testis|0.60:ovary|0.59:pancreas|0.54:leukocyte|0.53:cerebellum|0.52:heart|0.47:forebrain|0.45:positive regulation of MAPK cascade|0.44:lymph node|0.44:skeletal muscle|0.42:telencephalon|0.41:cerebral cortex|0.40:autism spectrum disorder|0.38:thyroid gland|0.38:temporal lobe|0.36:hippocampus|0.36:diencephalon|0.36:basal ganglion|0.36:gastrointestinal tract|0.34:uterus|0.31:thalamus|0.31:spinal cord|0.30:blood plasma|0.30:amygdala|0.30:corpus striatum|0.30:adrenal gland|0.30:lymphocyte|0.28:intestine|0.28:subthalamic nucleus|0.26:large intestine|0.26:positive regulation of JNK cascade|0.26:positive regulation of stress-activated MAPK cascade|0.25:mammary gland|0.25:midbrain|0.24:colon|0.24:stress-activated MAPK cascade|0.23:small intestine|0.23:hypophysis|0.22:caudate nucleus|0.22:substantia nigra|0.21:regulation of stress-activated MAPK cascade|0.21:corpus callosum|0.20:JNK cascade|0.20:regulation of cell adhesion|0.20:regulation of JNK cascade|0.19:regulation of cell-cell adhesion|0.18:blood vessel|0.18:stomach|0.18:neutrophil|0.18:skin|0.17:bone marrow|0.17:muscle|0.17:granulocyte|0.17:stress-activated protein kinase signaling cascade|0.17:frontal lobe|0.16:positive regulation of stress-activated protein kinase signaling cascade|0.16:uterine endometrium|0.16:blood platelet|0.14:umbilical vein endothelial cell|0.14:serum|0.14:regulation of stress-activated protein kinase signaling cascade|0.14:eye|0.14:tear gland|0.14:dendritic cell|0.13:negative regulation of protein modification process|0.13:epilepsy|0.12:peripheral nervous system disease|0.12:regulation of protein serine/threonine kinase activity|0.12:caudate putamen|0.12:neuropathy|0.12:umbilical cord|0.12:monocyte|0.12:regulation of MAP kinase activity|0.12:positive regulation of protein kinase activity|0.12:vascular endothelial cell|0.11:mononuclear phagocyte|0.11:T-lymphocyte|0.10:regulation of plasma membrane bounded cell projection organization|0.10:cytokine-mediated signaling pathway|0.10:medulla oblongata|0.10:trachea|0.10:regulation of cell projection organization|0.10:regulation of cell morphogenesis,94.11:Esophagus - Mucosa|75.58:Vagina|67.78:Cervix - Ectocervix|58.06:Skin - Sun Exposed (Lower leg)|52.71:Skin - Not Sun Exposed (Suprapubic)|50.46:Nerve - Tibial|50.46:Cervix - Endocervix|50.11:Ovary|45.97:Uterus|44.52:Brain - Cerebellum|41.39:Prostate|38.12:Brain - Cerebellar Hemisphere|37.38:Minor Salivary Gland|36.81:Breast - Mammary Tissue|35.82:Fallopian Tube|35.67:Lung|34.34:Adipose - Subcutaneous|30.89:Bladder|29.59:Thyroid|28.85:Artery - Aorta|27.51:Artery - Coronary|24.66:Spleen|24.41:Adipose - Visceral (Omentum)|22.19:Colon - Sigmoid|22.11:Pituitary|21.78:Artery - Tibial|21.48:Esophagus - Gastroesophageal Junction|21.04:Cells - Cultured fibroblasts|19.76:Esophagus - Muscularis|19.22:Small Intestine - Terminal Ileum|18.12:Brain - Spinal cord (cervical c-1)|17.11:Kidney - Medulla|16.87:Colon - Transverse|16.78:Brain - Cortex|16.13:Brain - Substantia nigra|16.12:Stomach|15.28:Brain - Caudate (basal ganglia)|15.15:Brain - Hypothalamus|13.76:Brain - Putamen (basal ganglia)|13.15:Brain - Nucleus accumbens (basal ganglia)|12.26:Brain - Frontal Cortex (BA9)|12.20:Adrenal Gland|12.15:Brain - Anterior cingulate cortex (BA24)|11.94:Brain - Amygdala|10.82:Kidney - Cortex|10.70:Brain - Hippocampus|10.47:Testis|9.61:Cells - EBV-transformed lymphocytes|9.43:Pancreas|9.06:Heart - Atrial Appendage|8.25:Liver|8.16:Whole Blood|5.51:Heart - Left Ventricle|3.40:Muscle - Skeletal,"6.73:occipital neocortex|5.66:parietal neocortex|5.65:cerebellar cortex|4.72:hippocampus (hippocampal formation)|3.95:lateral ganglionic eminence|3.92:temporal neocortex|3.69:amygdaloid complex|3.65:striatum|3.63:caudal ganglionic eminence|3.59:mediodorsal nucleus of thalamus|3.28:orbital frontal cortex|3.26:dorsolateral prefrontal cortex|3.15:anterior (rostral) cingulate (medial prefrontal) cortex|3.08:ventrolateral prefrontal cortex|2.77:primary motor-sensory cortex (samples)|2.64:primary auditory cortex (core)|2.62:posterior (caudal) superior temporal cortex (area 22c)|2.60:medial ganglionic eminence|2.60:primary visual cortex (striate cortex, area V1/17)|2.48:inferolateral temporal cortex (area TEv, area 20)|2.44:primary motor cortex (area M1, area 4)|2.27:primary somatosensory cortex (area S1, areas 3,1,2)|2.02:posteroventral (inferior) parietal cortex|1.60:cerebellum|1.12:upper (rostral) rhombic lip|0.61:dorsal thalamus",3,SNP,4.66,0-46|0.00,4719927,NA,C|R,"N|69|^:^|^:^;N|73,75-76|C:T|R:C;N|101|^:^|^:^;N|124|^:^|^:^;N|128|C:T|R:C;N|151|^:^|^:^;N|158|^:^|^:^;N|167|^:^|^:^",0.0011,0.0016,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.44,"14|0.37;0-13,15-46|0.00",4722825,NA,G|A,N|20|^:^|^:^;N|50-52|A:G|T:A;N|129|^:^|^:^;N|155|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,14.67,"2|0.15;43|0.11;0-1,3-42,44-46|0.00",4726143,NA,T|L,"N|11,13|G:T|R:L;N|37|^:^|^:^;N|61|G:T|R:L;N|69,71|G:T|R:L;N|151-152|G:T|R:L;N|158|^:^|^:^",NA,NA,NA,NA
29,MFSD6L,Homo sapiens major facilitator superfamily domain containing 6-like (MFSD6L) mRNA.,,NM_152599,chr17,28.91,3e-04,0.13,1e-01,-,MFSD6L,8797110,8799365,major facilitator superfamily domain containing 6 like,protein_coding,NA,0.00,0,0,2.01:Glycoproteinosis|1.60:PCWH syndrome|1.53:Tetralogy of Fallot,0.65:Carcinoma,NA,NA,NA,63.59:Testis|9.31:Minor Salivary Gland|8.80:Pituitary|7.74:Thyroid|4.56:Pancreas|3.68:Stomach|3.17:Cells - EBV-transformed lymphocytes|2.47:Kidney - Medulla|1.90:Colon - Transverse|1.19:Kidney - Cortex|1.13:Small Intestine - Terminal Ileum|0.83:Esophagus - Mucosa|0.70:Lung|0.62:Prostate|0.48:Skin - Sun Exposed (Lower leg)|0.41:Spleen|0.40:Whole Blood|0.39:Skin - Not Sun Exposed (Suprapubic)|0.32:Bladder|0.32:Breast - Mammary Tissue|0.20:Fallopian Tube|0.19:Vagina|0.17:Cervix - Ectocervix|0.17:Cervix - Endocervix|0.10:Adipose - Subcutaneous|0.10:Esophagus - Muscularis|0.09:Esophagus - Gastroesophageal Junction|0.09:Uterus|0.09:Adipose - Visceral (Omentum)|0.08:Brain - Putamen (basal ganglia)|0.08:Colon - Sigmoid|0.07:Brain - Caudate (basal ganglia)|0.06:Nerve - Tibial|0.06:Heart - Left Ventricle|0.05:Artery - Aorta|0.05:Brain - Spinal cord (cervical c-1)|0.05:Artery - Coronary|0.05:Ovary|0.04:Liver|0.04:Heart - Atrial Appendage|0.04:Brain - Hypothalamus|0.03:Brain - Substantia nigra|0.03:Brain - Amygdala|0.03:Brain - Nucleus accumbens (basal ganglia)|0.03:Brain - Cortex|0.03:Brain - Cerebellum|0.03:Adrenal Gland|0.03:Brain - Hippocampus|0.03:Brain - Frontal Cortex (BA9)|0.02:Brain - Anterior cingulate cortex (BA24)|0.02:Brain - Cerebellar Hemisphere|0.02:Artery - Tibial|0.01:Muscle - Skeletal|0.00:Cells - Cultured fibroblasts,"0.05:medial ganglionic eminence|0.04:upper (rostral) rhombic lip|0.03:dorsal thalamus|0.03:striatum|0.02:lateral ganglionic eminence|0.02:primary motor-sensory cortex (samples)|0.02:hippocampus (hippocampal formation)|0.02:mediodorsal nucleus of thalamus|0.01:primary auditory cortex (core)|0.01:occipital neocortex|0.01:caudal ganglionic eminence|0.01:posterior (caudal) superior temporal cortex (area 22c)|0.00:ventrolateral prefrontal cortex|0.00:temporal neocortex|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor cortex (area M1, area 4)|0.00:posteroventral (inferior) parietal cortex|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:dorsolateral prefrontal cortex|0.00:cerebellum|0.00:cerebellar cortex|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",3,SNP,6.81,"18|0.13;0-17,19-46|0.00",8700719,NA,C|D,N|63-64|C:T|D:N;N|104|^:^|^:^,0.0056,0.0066,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.55,0-46|0.00,8702218,NA,C|R,N|34|A:C|L:R;N|37|^:^|^:^;N|107|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,14.97,0-46|0.00,8701168,NA,A|L,"66-67|-:A|-:L;104,107|^:^|^:^;146,148-149|-:A|-:L",NA,NA,NA,NA
30,KIF1C,Homo sapiens kinesin family member 1C (KIF1C) mRNA.,,NM_006612,chr17,24.64,4e-04,0.09,1e-01,+,KIF1C,4997950,5028401,kinesin family member 1C,protein_coding,"LTXS1,SATX2,SAX2,SPAX2,SPG58",0.47,0,0,2.20:Paraplegia|1.96:Cerebellar ataxia|1.91:Cutaneous anthrax|1.52:Neurodegenerative disease,0.73:Carcinoma,4.00:Neurodegenerative disease,NA,0.80:heart|0.77:testis|0.74:liver|0.74:skeletal muscle|0.74:pancreas|0.74:lung|0.72:ovary|0.69:kidney|0.66:fetus|0.65:placenta|0.60:central nervous system|0.60:prostate gland|0.58:brain|0.52:spleen|0.50:nervous system|0.40:autism spectrum disorder|0.37:gastrointestinal tract|0.36:leukocyte|0.35:muscle|0.35:blood|0.33:intestine|0.31:cerebellum|0.30:forebrain|0.30:mammary gland|0.30:positive regulation of cell motility|0.29:large intestine|0.29:telencephalon|0.29:cerebral cortex|0.28:positive regulation of cellular component movement|0.27:regulation of cilium beat frequency|0.27:regulation of cilium movement|0.26:colon|0.25:adrenal gland|0.24:corpus callosum|0.24:small intestine|0.24:subthalamic nucleus|0.24:lymph node|0.23:diencephalon|0.23:positive regulation of locomotion|0.22:basal ganglion|0.22:thyroid gland|0.21:positive regulation of cell migration|0.21:regulation of execution phase of apoptosis|0.21:uterus|0.21:spinal cord|0.20:corpus striatum|0.20:temporal lobe|0.20:regulation of translation|0.20:posttranscriptional regulation of gene expression|0.19:caudate nucleus|0.18:stomach|0.17:amygdala|0.17:midbrain|0.17:blood vessel|0.17:hippocampus|0.16:substantia nigra|0.16:hypophysis|0.16:positive regulation of translation|0.16:positive regulation of cellular amide metabolic process|0.15:regulation of epithelial to mesenchymal transition|0.15:regulation of intracellular protein transport|0.15:regulation of cell adhesion|0.15:negative regulation of translation|0.14:skin|0.14:negative regulation of locomotion|0.14:regulation of cellular amide metabolic process|0.14:I-kappaB phosphorylation|0.14:negative regulation of cell motility|0.13:negative regulation of cell migration|0.13:thalamus|0.13:negative regulation of developmental process|0.12:negative regulation of cellular component movement|0.12:negative regulation of cellular amide metabolic process|0.12:artery|0.12:mononuclear phagocyte|0.12:regulation of Wnt signaling pathway|0.12:negative regulation of transport|0.11:positive regulation of DNA binding transcription factor activity|0.11:regulation of DNA binding transcription factor activity|0.11:blood plasma|0.11:cardiac muscle|0.11:regulation of epithelial cell migration|0.10:bone marrow|0.10:regulation of RNA splicing|0.10:regulation of ion transport,308.17:Muscle - Skeletal|252.36:Brain - Spinal cord (cervical c-1)|164.59:Brain - Substantia nigra|160.22:Artery - Tibial|151.38:Artery - Aorta|139.94:Heart - Left Ventricle|138.58:Artery - Coronary|129.26:Esophagus - Gastroesophageal Junction|122.75:Esophagus - Muscularis|119.65:Heart - Atrial Appendage|106.31:Colon - Sigmoid|105.56:Brain - Hippocampus|102.72:Brain - Putamen (basal ganglia)|97.94:Nerve - Tibial|97.55:Lung|91.96:Brain - Amygdala|84.27:Brain - Hypothalamus|83.93:Skin - Sun Exposed (Lower leg)|83.55:Thyroid|81.04:Esophagus - Mucosa|78.07:Uterus|74.41:Bladder|70.33:Adipose - Subcutaneous|70.18:Vagina|69.19:Cervix - Ectocervix|68.08:Colon - Transverse|67.22:Prostate|66.40:Skin - Not Sun Exposed (Suprapubic)|64.74:Adipose - Visceral (Omentum)|64.51:Brain - Caudate (basal ganglia)|64.12:Cells - Cultured fibroblasts|63.82:Cervix - Endocervix|59.62:Fallopian Tube|57.07:Breast - Mammary Tissue|53.84:Stomach|53.80:Small Intestine - Terminal Ileum|52.16:Brain - Frontal Cortex (BA9)|49.73:Minor Salivary Gland|47.66:Spleen|47.52:Ovary|47.40:Testis|45.46:Brain - Nucleus accumbens (basal ganglia)|45.14:Brain - Cortex|41.68:Brain - Anterior cingulate cortex (BA24)|41.47:Kidney - Medulla|38.83:Cells - EBV-transformed lymphocytes|38.48:Brain - Cerebellar Hemisphere|38.18:Brain - Cerebellum|35.71:Kidney - Cortex|31.43:Liver|27.02:Pancreas|26.09:Adrenal Gland|16.31:Pituitary|6.54:Whole Blood,"15.75:mediodorsal nucleus of thalamus|13.12:primary motor cortex (area M1, area 4)|12.36:striatum|12.07:amygdaloid complex|11.58:cerebellar cortex|11.27:hippocampus (hippocampal formation)|10.57:orbital frontal cortex|9.59:primary somatosensory cortex (area S1, areas 3,1,2)|8.63:primary auditory cortex (core)|8.60:posteroventral (inferior) parietal cortex|8.40:primary visual cortex (striate cortex, area V1/17)|8.08:posterior (caudal) superior temporal cortex (area 22c)|8.04:ventrolateral prefrontal cortex|7.25:inferolateral temporal cortex (area TEv, area 20)|6.24:dorsolateral prefrontal cortex|5.17:upper (rostral) rhombic lip|5.02:anterior (rostral) cingulate (medial prefrontal) cortex|4.93:parietal neocortex|4.63:medial ganglionic eminence|4.40:lateral ganglionic eminence|4.36:occipital neocortex|4.20:temporal neocortex|4.07:cerebellum|3.99:caudal ganglionic eminence|3.67:dorsal thalamus|3.10:primary motor-sensory cortex (samples)",4,SNP,7.42,"38|0.09;0-37,39-46|0.00",4907312,NA,C|S,N|131-132|C:T|S:L,0.0004,0.0004,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.88,0-46|0.00,4925475,NA,C|P,N|37|^:^|^:^;N|139-141|C:T|P:L,0.0029,0.0025,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.91,0-46|0.00,4925669,NA,C|R,N|122-123|C:T|R:C,6.302e-05,0.0002,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.98,0-46|0.00,4926860,NA,C|P,N|34|A:C|Q:P;N|65|^:^|^:^;N|107|^:^|^:^;N|158|^:^|^:^,NA,NA,NA,NA
31,SMTNL2,Homo sapiens smoothelin-like 2 (SMTNL2) transcript variant 1 mRNA.,Nervous  System Development;Neurological system process,NM_001114974,chr17,21.27,1e-03,0.48,9e-02,+,SMTNL2,4584007,4608319,smoothelin like 2,protein_coding,NA,0.00,0,0,1.77:Choroid plexus papilloma|1.54:Hypomyelinating leukodystrophy 2,NA,NA,NA,NA,279.02:Muscle - Skeletal|43.56:Kidney - Medulla|22.79:Kidney - Cortex|13.81:Fallopian Tube|9.66:Ovary|9.10:Adipose - Visceral (Omentum)|8.77:Esophagus - Muscularis|7.78:Heart - Left Ventricle|6.56:Lung|5.86:Nerve - Tibial|5.37:Esophagus - Gastroesophageal Junction|5.33:Cervix - Endocervix|5.26:Uterus|5.08:Heart - Atrial Appendage|4.74:Bladder|4.62:Cervix - Ectocervix|3.60:Vagina|3.21:Prostate|3.03:Breast - Mammary Tissue|2.68:Pituitary|2.67:Adipose - Subcutaneous|2.38:Esophagus - Mucosa|2.10:Testis|1.66:Thyroid|1.58:Artery - Coronary|1.35:Colon - Sigmoid|1.34:Small Intestine - Terminal Ileum|1.17:Spleen|1.01:Minor Salivary Gland|0.99:Skin - Sun Exposed (Lower leg)|0.87:Colon - Transverse|0.86:Stomach|0.85:Skin - Not Sun Exposed (Suprapubic)|0.82:Artery - Tibial|0.61:Brain - Hippocampus|0.57:Artery - Aorta|0.54:Brain - Cerebellum|0.53:Brain - Cortex|0.42:Brain - Caudate (basal ganglia)|0.39:Brain - Frontal Cortex (BA9)|0.37:Brain - Cerebellar Hemisphere|0.36:Brain - Putamen (basal ganglia)|0.33:Brain - Substantia nigra|0.31:Brain - Hypothalamus|0.30:Brain - Spinal cord (cervical c-1)|0.30:Brain - Amygdala|0.29:Brain - Anterior cingulate cortex (BA24)|0.25:Brain - Nucleus accumbens (basal ganglia)|0.25:Pancreas|0.12:Adrenal Gland|0.07:Liver|0.06:Cells - EBV-transformed lymphocytes|0.06:Whole Blood|0.04:Cells - Cultured fibroblasts,"1.82:cerebellum|1.56:upper (rostral) rhombic lip|0.93:primary motor-sensory cortex (samples)|0.77:dorsal thalamus|0.51:hippocampus (hippocampal formation)|0.48:medial ganglionic eminence|0.46:striatum|0.37:amygdaloid complex|0.32:primary auditory cortex (core)|0.30:primary visual cortex (striate cortex, area V1/17)|0.30:posterior (caudal) superior temporal cortex (area 22c)|0.28:inferolateral temporal cortex (area TEv, area 20)|0.27:anterior (rostral) cingulate (medial prefrontal) cortex|0.26:primary motor cortex (area M1, area 4)|0.26:lateral ganglionic eminence|0.26:ventrolateral prefrontal cortex|0.26:orbital frontal cortex|0.25:dorsolateral prefrontal cortex|0.25:primary somatosensory cortex (area S1, areas 3,1,2)|0.24:cerebellar cortex|0.23:temporal neocortex|0.23:occipital neocortex|0.20:posteroventral (inferior) parietal cortex|0.18:parietal neocortex|0.18:mediodorsal nucleus of thalamus|0.07:caudal ganglionic eminence",3,SNP,8.17,"43|0.11;0-42,44-46|0.00",4488144,NA,G|E,N|10|^:^|^:^;N|65|^:^|^:^;N|107|^:^|^:^;N|142|^:^|^:^;N|152-153|A:G|K:E;N|159|A:G|K:E,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.08,0-46|0.00,4495663,NA,A|D,"N|35-36|^:^|^:^;N|79-81|A:G|D:G;N|124|^:^|^:^;N|139|^:^|^:^;N|146,148-149|^:^|^:^;N|150-151|^:^|^:^;N|163,165|^:^|^:^",0.0017,0.0011,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.80,"14|0.37;0-13,15-46|0.00",4500503,NA,G|D,N|50-52|A:G|N:D,NA,NA,NA,NA
32,ZNF594,Homo sapiens zinc finger protein 594 (ZNF594) mRNA.,Transcription Factor,NM_032530,chr17,17.45,1e-03,0.39,7e-02,-,ZNF594,5174021,5191883,zinc finger protein 594,protein_coding,NA,0.00,0,0,NA,0.88:Carcinoma,NA,NA,NA,12.74:Ovary|11.12:Pituitary|10.46:Cervix - Endocervix|10.02:Thyroid|9.98:Brain - Cerebellum|9.28:Brain - Cerebellar Hemisphere|8.87:Cells - EBV-transformed lymphocytes|8.65:Uterus|8.42:Prostate|8.03:Testis|7.50:Nerve - Tibial|7.38:Fallopian Tube|7.06:Cervix - Ectocervix|6.21:Bladder|6.18:Spleen|6.12:Colon - Sigmoid|5.40:Kidney - Medulla|5.09:Vagina|4.92:Esophagus - Gastroesophageal Junction|4.85:Minor Salivary Gland|4.77:Esophagus - Muscularis|4.70:Cells - Cultured fibroblasts|4.48:Artery - Coronary|4.44:Small Intestine - Terminal Ileum|4.21:Brain - Spinal cord (cervical c-1)|4.04:Artery - Aorta|3.84:Artery - Tibial|3.77:Brain - Cortex|3.45:Colon - Transverse|3.41:Breast - Mammary Tissue|3.33:Brain - Nucleus accumbens (basal ganglia)|3.31:Brain - Frontal Cortex (BA9)|2.93:Brain - Caudate (basal ganglia)|2.91:Brain - Hypothalamus|2.89:Lung|2.68:Brain - Hippocampus|2.65:Kidney - Cortex|2.64:Adipose - Subcutaneous|2.63:Brain - Anterior cingulate cortex (BA24)|2.62:Adrenal Gland|2.56:Stomach|2.47:Adipose - Visceral (Omentum)|2.41:Muscle - Skeletal|2.39:Brain - Substantia nigra|2.24:Esophagus - Mucosa|2.21:Brain - Amygdala|2.18:Brain - Putamen (basal ganglia)|2.11:Heart - Atrial Appendage|1.87:Pancreas|1.57:Heart - Left Ventricle|1.46:Skin - Sun Exposed (Lower leg)|1.31:Liver|1.23:Skin - Not Sun Exposed (Suprapubic)|0.18:Whole Blood,"5.08:temporal neocortex|4.30:occipital neocortex|4.12:parietal neocortex|3.67:lateral ganglionic eminence|3.19:primary motor-sensory cortex (samples)|3.18:caudal ganglionic eminence|3.06:cerebellum|3.06:medial ganglionic eminence|2.82:upper (rostral) rhombic lip|2.29:striatum|2.28:amygdaloid complex|2.07:cerebellar cortex|2.01:anterior (rostral) cingulate (medial prefrontal) cortex|1.98:hippocampus (hippocampal formation)|1.93:orbital frontal cortex|1.86:dorsolateral prefrontal cortex|1.85:primary auditory cortex (core)|1.78:dorsal thalamus|1.76:primary visual cortex (striate cortex, area V1/17)|1.69:primary somatosensory cortex (area S1, areas 3,1,2)|1.68:posteroventral (inferior) parietal cortex|1.65:posterior (caudal) superior temporal cortex (area 22c)|1.62:primary motor cortex (area M1, area 4)|1.58:inferolateral temporal cortex (area TEv, area 20)|1.53:ventrolateral prefrontal cortex|1.29:mediodorsal nucleus of thalamus",3,SNP,2.05,0-46|0.00,5085637,NA,G|L,N|14-15|A:G|F:L;N|84|A:G|F:L;N|107|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.54,0-46|0.00,5086198,NA,G|R,"N|39|^:^|^:^;N|72|^:^|^:^;N|74|^:^|^:^;N|114|A:G|C:R;N|125,127|A:G|C:R",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,11.07,"14|0.37;0-7,9-13,15-46|0.00;8|-0.06",5087037,NA,ATA|II,34|-:ATA|-:II;50-52|-:ATA|-:II,NA,NA,NA,NA
33,ATP1B2,Homo sapiens ATPase Na+/K+ transporting beta 2 polypeptide (ATP1B2) mRNA.,,NM_001678,chr17,15.47,2e-03,0.30,3e-02,+,ATP1B2,7646627,7657771,ATPase Na+/K+ transporting subunit beta 2,protein_coding,AMOG,0.18,0,0,2.07:X-linked juvenile retinoschisis 1|1.75:Retinitis pigmentosa 74|1.50:Borna disease,3.00:Prostate cancer,NA,NA,0.92:nervous system|0.89:central nervous system|0.89:brain|0.83:telencephalon|0.79:cerebellum|0.77:forebrain|0.74:cerebral cortex|0.72:temporal lobe|0.69:spinal cord|0.65:hippocampus|0.63:basal ganglion|0.62:autism spectrum disorder|0.61:diencephalon|0.60:thalamus|0.57:corpus striatum|0.54:corpus callosum|0.53:frontal lobe|0.49:fetus|0.48:amygdala|0.46:substantia nigra|0.45:midbrain|0.44:caudate nucleus|0.44:blood|0.44:hypophysis|0.43:subthalamic nucleus|0.38:heart|0.37:regulation of ion transmembrane transport|0.34:regulation of ion transport|0.34:liver|0.32:ovary|0.31:spleen|0.29:occipital lobe|0.28:kidney|0.28:caudate putamen|0.27:medulla oblongata|0.27:testis|0.27:regulation of transmembrane transport|0.26:pons|0.26:prostate gland|0.25:G-protein coupled receptor signaling pathway|0.25:skeletal muscle|0.24:regulation of system process|0.24:regulation of cation transmembrane transport|0.24:adrenal gland|0.24:leukocyte|0.24:pancreas|0.23:epilepsy|0.22:lung|0.22:placenta|0.22:neuron|0.21:regulation of heart contraction|0.21:parietal lobe|0.21:cardiac conduction|0.19:regulation of metal ion transport|0.18:positive regulation of MAPK cascade|0.18:hypothalamus|0.18:occipital pole|0.18:regulation of blood circulation|0.17:regulation of heart rate|0.17:lymph node|0.17:gastrointestinal tract|0.16:nucleus accumbens|0.16:monovalent inorganic cation transport|0.16:movement disease|0.15:intestine|0.15:cerebellar cortex|0.15:blood vessel|0.14:regulation of heart rate by cardiac conduction|0.14:retina|0.14:peripheral nervous system disease|0.13:neuropathy|0.12:cerebellar Purkinje cell|0.12:regulation of atrial cardiac muscle cell membrane depolarization|0.12:ERK1 and ERK2 cascade|0.12:regulation of ERK1 and ERK2 cascade|0.12:positive regulation of cell differentiation|0.12:small intestine|0.11:erythrocyte|0.11:negative regulation of protein modification process|0.11:positive regulation of ion transport|0.11:cell surface receptor signaling pathway involved in cell-cell signaling|0.10:positive regulation of protein kinase activity|0.10:thyroid gland|0.10:regulation of nervous system development|0.10:muscle|0.10:retinal disease|0.10:atrial cardiac muscle cell action potential|0.10:atrial cardiac muscle cell to AV node cell signaling|0.10:atrial cardiac muscle cell to AV node cell communication,555.88:Brain - Cerebellum|490.26:Brain - Cerebellar Hemisphere|313.61:Brain - Cortex|293.52:Brain - Caudate (basal ganglia)|254.22:Brain - Nucleus accumbens (basal ganglia)|252.64:Brain - Anterior cingulate cortex (BA24)|241.61:Brain - Putamen (basal ganglia)|236.58:Brain - Frontal Cortex (BA9)|228.19:Brain - Amygdala|179.28:Brain - Substantia nigra|145.52:Brain - Hypothalamus|124.45:Brain - Hippocampus|71.49:Brain - Spinal cord (cervical c-1)|61.14:Pituitary|49.84:Ovary|30.84:Nerve - Tibial|30.23:Fallopian Tube|30.13:Cervix - Endocervix|22.08:Cervix - Ectocervix|21.92:Uterus|14.62:Colon - Sigmoid|14.04:Esophagus - Gastroesophageal Junction|12.66:Adrenal Gland|12.15:Testis|11.10:Prostate|11.01:Kidney - Medulla|10.96:Vagina|9.82:Esophagus - Muscularis|9.31:Kidney - Cortex|9.19:Adipose - Subcutaneous|8.76:Thyroid|8.49:Bladder|8.30:Breast - Mammary Tissue|7.27:Adipose - Visceral (Omentum)|7.10:Lung|7.08:Spleen|6.75:Artery - Coronary|5.86:Colon - Transverse|5.02:Heart - Atrial Appendage|5.01:Artery - Tibial|3.74:Heart - Left Ventricle|3.56:Skin - Sun Exposed (Lower leg)|3.43:Small Intestine - Terminal Ileum|3.37:Artery - Aorta|2.73:Minor Salivary Gland|2.62:Skin - Not Sun Exposed (Suprapubic)|2.35:Stomach|2.23:Esophagus - Mucosa|2.16:Muscle - Skeletal|1.64:Liver|1.48:Pancreas|0.62:Whole Blood|0.59:Cells - EBV-transformed lymphocytes|0.09:Cells - Cultured fibroblasts,"165.40:cerebellar cortex|113.05:amygdaloid complex|95.19:mediodorsal nucleus of thalamus|73.34:striatum|60.25:hippocampus (hippocampal formation)|55.61:inferolateral temporal cortex (area TEv, area 20)|52.35:anterior (rostral) cingulate (medial prefrontal) cortex|47.70:orbital frontal cortex|47.37:dorsolateral prefrontal cortex|47.01:ventrolateral prefrontal cortex|45.42:posterior (caudal) superior temporal cortex (area 22c)|38.90:temporal neocortex|38.44:primary somatosensory cortex (area S1, areas 3,1,2)|38.13:cerebellum|36.86:primary motor cortex (area M1, area 4)|35.89:upper (rostral) rhombic lip|34.24:posteroventral (inferior) parietal cortex|34.04:primary visual cortex (striate cortex, area V1/17)|33.28:primary auditory cortex (core)|29.78:lateral ganglionic eminence|28.57:parietal neocortex|26.55:caudal ganglionic eminence|24.57:medial ganglionic eminence|21.95:primary motor-sensory cortex (samples)|21.32:dorsal thalamus|19.70:occipital neocortex",2,SNP,8.17,"16|0.30;0-15,17-46|0.00",7557429,NA,G|E,N|59|A:G|K:E,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.91,0-46|0.00,7557465,NA,C|R,N|65|C:T|R:C,0.0002,0.0001,D,D
34,KIAA0753,Homo sapiens KIAA0753 (KIAA0753) mRNA.,,NM_014804,chr17,10.72,4e-03,0.01,1e-01,-,KIAA0753,6578147,6640730,KIAA0753,protein_coding,"MNR,OFIP",0.00,0,0,1.96:Orofaciodigital syndrome|1.69:Ciliopathy|1.68:Anxiety disorder|1.68:Microphthalmia with limb anomalies|1.52:Gastrointestinal system disease,0.80:Carcinoma|0.54:Kidney cancer,NA,"Infinity:abnormal embryo size|Infinity:embryonic lethality prior to organogenesis|10.00:preweaning lethality, complete penetrance",0.91:liver|0.91:nervous system|0.91:ovary|0.90:brain|0.89:central nervous system|0.89:pancreas|0.88:corpus callosum|0.88:testis|0.87:kidney|0.87:spinal cord|0.86:subthalamic nucleus|0.86:cerebral cortex|0.86:hippocampus|0.85:forebrain|0.85:telencephalon|0.84:caudate nucleus|0.84:basal ganglion|0.84:substantia nigra|0.83:amygdala|0.83:temporal lobe|0.83:corpus striatum|0.83:midbrain|0.83:heart|0.83:prostate gland|0.82:placenta|0.80:cerebellum|0.79:lung|0.79:diencephalon|0.74:thalamus|0.70:fetus|0.66:skeletal muscle|0.64:spleen|0.51:autism spectrum disorder|0.51:intestine|0.50:gastrointestinal tract|0.48:blood|0.45:leukocyte|0.40:colon|0.38:lymph node|0.35:hypophysis|0.34:large intestine|0.34:uterus|0.33:small intestine|0.30:adrenal gland|0.29:thyroid gland|0.29:mammary gland|0.26:retinitis pigmentosa|0.25:hereditary retinal dystrophy|0.24:fundus dystrophy|0.23:retinal degeneration|0.21:frontal lobe|0.21:bone marrow|0.21:retinal disease|0.20:caudate putamen|0.19:occipital lobe|0.19:muscle|0.15:medulla oblongata|0.14:trachea|0.13:stomach|0.13:autosomal recessive disease|0.12:cerebellar disease|0.11:lymphocyte|0.11:peripheral nervous system disease|0.11:movement disease|0.11:blood vessel|0.11:ciliopathy|0.10:neuropathy|0.10:epilepsy,26.93:Esophagus - Muscularis|24.81:Testis|23.71:Fallopian Tube|22.65:Esophagus - Gastroesophageal Junction|19.71:Uterus|19.65:Thyroid|19.43:Ovary|17.55:Cervix - Endocervix|16.37:Pituitary|14.83:Cervix - Ectocervix|14.53:Prostate|14.53:Nerve - Tibial|13.64:Cells - Cultured fibroblasts|12.34:Vagina|12.29:Colon - Sigmoid|12.20:Bladder|11.19:Spleen|10.91:Kidney - Medulla|10.48:Cells - EBV-transformed lymphocytes|10.41:Artery - Tibial|10.01:Lung|9.74:Artery - Coronary|9.41:Artery - Aorta|9.40:Esophagus - Mucosa|9.34:Brain - Cerebellar Hemisphere|9.13:Breast - Mammary Tissue|8.98:Brain - Cerebellum|8.82:Brain - Nucleus accumbens (basal ganglia)|8.77:Adipose - Subcutaneous|8.63:Brain - Cortex|8.56:Minor Salivary Gland|8.26:Brain - Frontal Cortex (BA9)|8.12:Colon - Transverse|7.97:Skin - Sun Exposed (Lower leg)|7.74:Small Intestine - Terminal Ileum|7.53:Skin - Not Sun Exposed (Suprapubic)|7.42:Adrenal Gland|7.36:Brain - Caudate (basal ganglia)|7.08:Adipose - Visceral (Omentum)|6.98:Stomach|5.65:Brain - Anterior cingulate cortex (BA24)|5.50:Brain - Hypothalamus|5.41:Brain - Putamen (basal ganglia)|5.35:Kidney - Cortex|5.15:Brain - Hippocampus|4.14:Brain - Amygdala|3.46:Heart - Atrial Appendage|3.42:Brain - Spinal cord (cervical c-1)|3.38:Pancreas|3.21:Brain - Substantia nigra|2.32:Liver|1.91:Whole Blood|1.91:Heart - Left Ventricle|1.60:Muscle - Skeletal,"8.40:temporal neocortex|7.24:parietal neocortex|7.10:primary motor-sensory cortex (samples)|6.89:lateral ganglionic eminence|6.60:cerebellum|6.56:occipital neocortex|6.02:medial ganglionic eminence|5.81:upper (rostral) rhombic lip|4.92:dorsal thalamus|4.78:primary visual cortex (striate cortex, area V1/17)|4.70:striatum|4.58:anterior (rostral) cingulate (medial prefrontal) cortex|4.51:primary somatosensory cortex (area S1, areas 3,1,2)|4.44:caudal ganglionic eminence|4.34:hippocampus (hippocampal formation)|4.29:orbital frontal cortex|4.25:primary auditory cortex (core)|4.21:posterior (caudal) superior temporal cortex (area 22c)|4.20:dorsolateral prefrontal cortex|4.16:primary motor cortex (area M1, area 4)|4.08:posteroventral (inferior) parietal cortex|4.04:amygdaloid complex|3.98:ventrolateral prefrontal cortex|3.96:inferolateral temporal cortex (area TEv, area 20)|2.57:cerebellar cortex|2.32:mediodorsal nucleus of thalamus",3,SNP,9.09,0-46|0.00,6493107,NA,T|I,"N|24-26,28-29|C:T|M:I;N|121|C:C|M:M;N|123|C:T|M:I;N|122|^:^|^:^;N|149|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.38,"41|0.01;0-40,42-46|0.00",6524225,NA,T|K,N|143-145|C:T|E:K;N|156|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.18,0-46|0.00,6531552,NA,A|H,"N|31,33|A:C|H:Q;N|84|A:C|H:Q;N|102|A:C|H:Q;N|104,106|A:C|H:Q;N|146|^:^|^:^;N|160|A:C|H:Q",0.0393,0.0458,B,T
35,GP1BA,Homo sapiens glycoprotein Ib (platelet) alpha polypeptide (GP1BA) mRNA.,,NM_000173,chr17,13.03,4e-03,0.70,8e-03,+,GP1BA,4932277,4935023,glycoprotein Ib platelet subunit alpha,protein_coding,"BDPLT1,BDPLT3,BSS,CD42B,CD42b-alpha,DBPLT3,GP1B,GPIbA,GPIbalpha,VWDP",0.01,0,0,3.54:Bernard-Soulier syndrome|3.28:platelet-type bleeding disorder 3|2.84:Thrombocytopenia|2.81:Von Willebrand's disease|2.79:Thrombosis|2.42:Glanzmann's thrombasthenia|2.29:Coronary artery disease|2.12:Acquired von Willebrand syndrome|2.10:Cerebrovascular disease|1.99:Cancer|1.96:Thrombophilia|1.91:MYH-9 related disease|1.89:Bone marrow disease|1.84:Anemia|1.80:Atherosclerosis|1.75:Autoimmune hypersensitivity disease|1.74:Hypertension|1.70:Heart disease|1.68:Kidney disease|1.65:Diabetes mellitus|1.65:Hemorrhagic disease|1.64:Thrombocytosis|1.62:Gray platelet syndrome|1.61:Qualitative platelet defect|1.60:Gastrointestinal system disease|1.59:Rigid spine muscular dystrophy 1|1.52:Chediak-Higashi syndrome|1.51:Connective tissue disease,0.65:Carcinoma,5.00:Bernard-Soulier syndrome|4.00:Bernard-Soulier syndrome,NA,0.97:hemolytic-uremic syndrome|0.94:blood coagulation|0.92:inherited blood coagulation disease|0.90:blood|0.86:wound healing|0.85:response to wounding|0.84:hemolytic anemia|0.84:normocytic anemia|0.82:platelet activation|0.81:leukocyte|0.81:blood coagulation disease|0.80:fibrinolysis|0.75:anemia|0.69:blood plasma|0.67:spleen|0.64:lymph node|0.63:blood platelet|0.61:monocyte|0.61:mononuclear phagocyte|0.56:regulation of fibrinolysis|0.48:negative regulation of blood coagulation|0.46:lymphocyte|0.43:hemostasis|0.43:negative regulation of wound healing|0.43:negative regulation of response to wounding|0.41:placenta|0.41:regulation of body fluid levels|0.39:autism spectrum disorder|0.39:testis|0.38:coagulation|0.37:prostate gland|0.36:fetus|0.35:megakaryocyte|0.35:hematopoietic stem cell|0.34:regulation of wound healing|0.33:liver|0.32:regulation of response to wounding|0.32:cell activation|0.32:regulation of response to external stimulus|0.32:granulocyte|0.31:serum|0.31:positive regulation of MAPK cascade|0.31:nervous system|0.31:brain|0.30:kidney failure|0.30:pancreas|0.29:central nervous system|0.27:T-lymphocyte|0.23:G-protein coupled receptor signaling pathway|0.23:second-messenger-mediated signaling|0.22:lung|0.22:ovary|0.22:intestine|0.21:regulation of blood coagulation|0.20:B-lymphocyte|0.19:gastrointestinal tract|0.19:bone marrow|0.19:kidney|0.19:macrophage|0.17:regulation of defense response|0.17:positive regulation of response to wounding|0.17:positive regulation of wound healing|0.16:dendritic cell|0.16:large intestine|0.16:protein complex oligomerization|0.15:regulation of MAP kinase activity|0.15:colon|0.15:skeletal muscle|0.15:negative regulation of response to external stimulus|0.15:positive regulation of proteolysis|0.14:small intestine|0.14:neutrophil|0.14:erythrocyte|0.14:positive regulation of JNK cascade|0.14:regulation of immune response|0.13:positive regulation of blood coagulation|0.13:eosinophil|0.13:positive regulation of stress-activated MAPK cascade|0.12:positive regulation of immune response|0.12:ERK1 and ERK2 cascade|0.12:positive regulation of response to external stimulus|0.12:regulation of protein complex assembly|0.12:heart|0.11:mammary gland|0.11:positive regulation of protein kinase activity|0.11:positive regulation of MAP kinase activity|0.11:positive regulation of DNA binding transcription factor activity|0.11:stress-activated MAPK cascade|0.11:thyroid gland|0.11:regulation of ERK1 and ERK2 cascade|0.11:movement disease|0.10:positive regulation of cellular protein localization|0.10:uterus|0.10:natural killer cell|0.10:positive regulation of peptidyl-tyrosine phosphorylation|0.10:regulation of inflammatory response|0.10:apoptotic signaling pathway,4.24:Skin - Sun Exposed (Lower leg)|3.96:Skin - Not Sun Exposed (Suprapubic)|3.55:Spleen|2.89:Whole Blood|2.65:Lung|2.25:Cells - EBV-transformed lymphocytes|2.05:Small Intestine - Terminal Ileum|1.63:Brain - Cerebellum|1.59:Brain - Cerebellar Hemisphere|1.48:Fallopian Tube|1.20:Cervix - Endocervix|1.19:Cervix - Ectocervix|1.18:Vagina|1.14:Testis|1.12:Nerve - Tibial|1.09:Colon - Transverse|1.08:Thyroid|1.07:Minor Salivary Gland|1.03:Uterus|0.93:Prostate|0.93:Colon - Sigmoid|0.92:Ovary|0.91:Bladder|0.87:Esophagus - Mucosa|0.86:Artery - Tibial|0.84:Esophagus - Muscularis|0.83:Esophagus - Gastroesophageal Junction|0.83:Cells - Cultured fibroblasts|0.81:Adipose - Subcutaneous|0.81:Artery - Aorta|0.76:Breast - Mammary Tissue|0.69:Liver|0.64:Artery - Coronary|0.64:Brain - Nucleus accumbens (basal ganglia)|0.62:Kidney - Medulla|0.61:Stomach|0.60:Pituitary|0.52:Muscle - Skeletal|0.51:Kidney - Cortex|0.51:Adipose - Visceral (Omentum)|0.48:Brain - Caudate (basal ganglia)|0.45:Heart - Atrial Appendage|0.40:Brain - Cortex|0.39:Brain - Frontal Cortex (BA9)|0.36:Brain - Putamen (basal ganglia)|0.35:Brain - Spinal cord (cervical c-1)|0.34:Brain - Anterior cingulate cortex (BA24)|0.34:Brain - Hippocampus|0.33:Heart - Left Ventricle|0.33:Brain - Hypothalamus|0.31:Brain - Amygdala|0.24:Brain - Substantia nigra|0.22:Pancreas|0.21:Adrenal Gland,"0.57:cerebellar cortex|0.45:striatum|0.35:upper (rostral) rhombic lip|0.33:hippocampus (hippocampal formation)|0.31:medial ganglionic eminence|0.31:cerebellum|0.31:mediodorsal nucleus of thalamus|0.31:primary visual cortex (striate cortex, area V1/17)|0.30:anterior (rostral) cingulate (medial prefrontal) cortex|0.29:amygdaloid complex|0.29:parietal neocortex|0.27:occipital neocortex|0.27:orbital frontal cortex|0.27:ventrolateral prefrontal cortex|0.25:primary motor cortex (area M1, area 4)|0.25:primary auditory cortex (core)|0.24:posterior (caudal) superior temporal cortex (area 22c)|0.24:primary motor-sensory cortex (samples)|0.24:dorsolateral prefrontal cortex|0.23:caudal ganglionic eminence|0.21:temporal neocortex|0.21:lateral ganglionic eminence|0.21:posteroventral (inferior) parietal cortex|0.20:inferolateral temporal cortex (area TEv, area 20)|0.19:primary somatosensory cortex (area S1, areas 3,1,2)|0.18:dorsal thalamus",1,del,9.79,"7|0.70;0-6,8-46|0.00",4837118,NA,AGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACCTCAGAGCCCGCCCCC|SPTTPEPTSEPAPSPTTPEPTSEPAP,"5|^:^|^:^;8,10|^:^|^:^;20|^:^|^:^;25-26|^:^|^:^;31|-:AGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACCTCAGAGCCCGCCCCC|-:SPTTPEPTSEPAPSPTTPEPTSEPAP;36-37|^:^|^:^;43|^:^|^:^;50|^:^|^:^;56|-:AGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACCTCAGAGCCCGCCCCC|-:SPTTPEPTSEPAPSPTTPEPTSEPAP;65|^:^|^:^;73-74|^:^|^:^;78|^:^|^:^;81|-:AGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACCTCAGAGCCCGCCCCC|-:SPTTPEPTSEPAPSPTTPEPTSEPAP;79-80|^:^|^:^;86-88|^:^|^:^;100-101|^:^|^:^;104,107|^:^|^:^;108|^:^|^:^;112|^:^|^:^;115,117|^:^|^:^;125|^:^|^:^;136|^:^|^:^;137,140-141|^:^|^:^;142,144|^:^|^:^;146,148-149|^:^|^:^;150-151,153|^:^|^:^;154-158|^:^|^:^;159,161|^:^|^:^;163-166,168-170|^:^|^:^",NA,NA,NA,NA
36,AIPL1,Homo sapiens aryl hydrocarbon receptor interacting protein-like 1 (AIPL1) transcript variant 1 mRNA.,Neurological system process,NM_001033055,chr17,12.14,5e-03,0.67,4e-02,-,AIPL1,6423738,6435121,aryl hydrocarbon receptor interacting protein like 1,protein_coding,"AIPL2,LCA4",0.00,0,0,3.36:Leber congenital amaurosis|2.96:Fundus dystrophy|2.73:Blindness|2.72:Retinal degeneration|2.54:Cone dystrophy|2.45:Night blindness|2.30:Keratoconus|2.15:Senior-Loken syndrome|2.07:Pseudopapilledema|2.04:Usher syndrome|1.95:Refractive error|1.91:Choroideremia|1.89:Bardet-Biedl syndrome|1.85:Ciliopathy|1.81:Enhanced S-cone syndrome|1.79:Partial central choroid dystrophy|1.60:Cataract|1.59:Nephronophthisis|1.52:Coloboma,NA,5.00:Leber congenital amaurosis|5.00:cone-rod dystrophy|4.00:Leber congenital amaurosis,NA,0.88:positive regulation of proteasomal ubiquitin-dependent protein catabolic process|0.85:positive regulation of proteasomal protein catabolic process|0.80:positive regulation of proteolysis involved in cellular protein catabolic process|0.79:positive regulation of cellular protein catabolic process|0.69:positive regulation of cellular catabolic process|0.67:positive regulation of catabolic process|0.66:positive regulation of protein catabolic process|0.63:regulation of proteasomal ubiquitin-dependent protein catabolic process|0.54:regulation of proteasomal protein catabolic process|0.53:positive regulation of proteolysis|0.51:autism spectrum disorder|0.50:proteasomal protein catabolic process|0.48:proteasome-mediated ubiquitin-dependent protein catabolic process|0.46:regulation of protein catabolic process|0.45:regulation of cellular protein catabolic process|0.45:central nervous system|0.43:brain|0.42:G-protein coupled receptor signaling pathway|0.41:regulation of proteolysis involved in cellular protein catabolic process|0.39:fetus|0.35:pancreas|0.32:nervous system|0.32:testis|0.32:ubiquitin-dependent protein catabolic process|0.31:modification-dependent protein catabolic process|0.30:liver|0.30:kidney|0.26:blood|0.26:prostate gland|0.24:leukocyte|0.23:placenta|0.23:lymph node|0.22:ovary|0.21:response to interferon-gamma|0.21:regulation of ion transport|0.20:skeletal muscle|0.19:positive regulation of MAPK cascade|0.18:caudate putamen|0.18:cerebellum|0.18:spleen|0.18:forebrain|0.17:modification-dependent macromolecule catabolic process|0.17:regulation of ion transmembrane transport|0.17:heart|0.17:gastrointestinal tract|0.16:hypothalamus|0.15:telencephalon|0.15:intestine|0.15:basal ganglion|0.15:adrenal gland|0.15:small intestine|0.14:corpus striatum|0.14:hypophysis|0.14:regulation of transmembrane transport|0.14:cerebral cortex|0.14:colon|0.14:medulla oblongata|0.13:thyroid gland|0.13:retinal disease|0.13:frontal lobe|0.13:occipital lobe|0.13:regulation of response to external stimulus|0.13:temporal lobe|0.13:mammary gland|0.12:hippocampus|0.12:regulation of purine nucleotide metabolic process|0.12:lung|0.12:regulation of nucleotide metabolic process|0.12:positive regulation of peptidyl-tyrosine phosphorylation|0.11:regulation of peptidyl-tyrosine phosphorylation|0.11:regulation of system process|0.11:large intestine|0.11:eye|0.11:regulation of metal ion transport|0.11:ERK1 and ERK2 cascade|0.11:regulation of ERK1 and ERK2 cascade|0.10:substantia nigra|0.10:movement disease|0.10:thalamus|0.10:caudate nucleus,0.76:Testis|0.12:Spleen|0.08:Brain - Cerebellum|0.08:Brain - Amygdala|0.08:Pituitary|0.08:Brain - Cerebellar Hemisphere|0.06:Brain - Frontal Cortex (BA9)|0.05:Brain - Anterior cingulate cortex (BA24)|0.05:Brain - Cortex|0.04:Brain - Hypothalamus|0.04:Brain - Hippocampus|0.03:Brain - Substantia nigra|0.03:Brain - Nucleus accumbens (basal ganglia)|0.03:Ovary|0.02:Brain - Caudate (basal ganglia)|0.02:Brain - Putamen (basal ganglia)|0.01:Esophagus - Mucosa|0.01:Skin - Not Sun Exposed (Suprapubic)|0.01:Vagina|0.01:Skin - Sun Exposed (Lower leg)|0.01:Fallopian Tube|0.01:Bladder|0.01:Cervix - Endocervix|0.01:Lung|0.01:Adrenal Gland|0.01:Esophagus - Gastroesophageal Junction|0.00:Prostate|0.00:Kidney - Medulla|0.00:Whole Blood|0.00:Uterus|0.00:Thyroid|0.00:Stomach|0.00:Small Intestine - Terminal Ileum|0.00:Pancreas|0.00:Nerve - Tibial|0.00:Muscle - Skeletal|0.00:Minor Salivary Gland|0.00:Liver|0.00:Kidney - Cortex|0.00:Heart - Left Ventricle|0.00:Heart - Atrial Appendage|0.00:Esophagus - Muscularis|0.00:Colon - Transverse|0.00:Colon - Sigmoid|0.00:Cervix - Ectocervix|0.00:Cells - EBV-transformed lymphocytes|0.00:Cells - Cultured fibroblasts|0.00:Breast - Mammary Tissue|0.00:Brain - Spinal cord (cervical c-1)|0.00:Artery - Tibial|0.00:Artery - Coronary|0.00:Artery - Aorta|0.00:Adipose - Visceral (Omentum)|0.00:Adipose - Subcutaneous,"0.81:cerebellum|0.20:occipital neocortex|0.10:upper (rostral) rhombic lip|0.09:parietal neocortex|0.07:temporal neocortex|0.05:amygdaloid complex|0.03:cerebellar cortex|0.03:mediodorsal nucleus of thalamus|0.02:inferolateral temporal cortex (area TEv, area 20)|0.02:striatum|0.02:hippocampus (hippocampal formation)|0.02:primary motor cortex (area M1, area 4)|0.02:orbital frontal cortex|0.02:lateral ganglionic eminence|0.01:caudal ganglionic eminence|0.01:medial ganglionic eminence|0.01:primary motor-sensory cortex (samples)|0.01:anterior (rostral) cingulate (medial prefrontal) cortex|0.01:posterior (caudal) superior temporal cortex (area 22c)|0.00:ventrolateral prefrontal cortex|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus",3,SNP,4.32,"9|0.29;0-8,10-46|0.00",6331702,NA,T|Y,"N|35,39|A:T|F:Y",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.44,"14|0.37;0-13,15-46|0.00",6331762,NA,G|T,N|50-52|A:G|I:T;N|73|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.32,0-46|0.00,6331817,NA,C|V,"N|31,33|C:T|V:I;N|73|^:^|^:^;N|105-106|C:T|V:I;N|107|^:^|^:^",0.0129,0.0095,B,T
37,FFAR3,Homo sapiens free fatty acid receptor 3 (FFAR3) mRNA.,,NM_005304,chr19,19.78,7e-03,0.16,2e-01,+,FFAR3,35358106,35360491,free fatty acid receptor 3,protein_coding,"FFA3R,GPR41,GPR42",NA,0,0,2.56:Obesity|2.36:Colitis|2.28:Diabetes mellitus|2.02:Irritable bowel syndrome|2.00:Asthma|2.00:Atopic dermatitis|1.94:Hyperglycemia|1.86:Allergic hypersensitivity disease|1.78:Crohn's disease|1.73:Diarrhea|1.71:Nonalcoholic fatty liver disease|1.64:Arthritis|1.60:Colonic disease|1.60:Atherosclerosis|1.58:Hypertension|1.54:Constipation,0.50:Carcinoma,NA,NA,NA,1.57:Whole Blood|1.20:Adipose - Visceral (Omentum)|0.61:Adipose - Subcutaneous|0.52:Breast - Mammary Tissue|0.45:Colon - Sigmoid|0.29:Spleen|0.20:Brain - Spinal cord (cervical c-1)|0.18:Thyroid|0.13:Colon - Transverse|0.12:Small Intestine - Terminal Ileum|0.12:Lung|0.10:Stomach|0.09:Ovary|0.09:Testis|0.09:Pituitary|0.09:Artery - Coronary|0.08:Kidney - Medulla|0.07:Fallopian Tube|0.07:Brain - Substantia nigra|0.07:Prostate|0.06:Nerve - Tibial|0.06:Artery - Aorta|0.05:Bladder|0.05:Pancreas|0.05:Esophagus - Muscularis|0.04:Brain - Hypothalamus|0.04:Brain - Caudate (basal ganglia)|0.04:Cells - EBV-transformed lymphocytes|0.04:Esophagus - Gastroesophageal Junction|0.04:Brain - Hippocampus|0.04:Brain - Putamen (basal ganglia)|0.03:Brain - Amygdala|0.03:Brain - Cortex|0.03:Brain - Nucleus accumbens (basal ganglia)|0.02:Heart - Left Ventricle|0.02:Heart - Atrial Appendage|0.01:Brain - Frontal Cortex (BA9)|0.01:Brain - Anterior cingulate cortex (BA24)|0.00:Adrenal Gland|0.00:Vagina|0.00:Uterus|0.00:Skin - Sun Exposed (Lower leg)|0.00:Skin - Not Sun Exposed (Suprapubic)|0.00:Muscle - Skeletal|0.00:Minor Salivary Gland|0.00:Liver|0.00:Kidney - Cortex|0.00:Esophagus - Mucosa|0.00:Cervix - Endocervix|0.00:Cervix - Ectocervix|0.00:Cells - Cultured fibroblasts|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Artery - Tibial,"0.03:upper (rostral) rhombic lip|0.01:lateral ganglionic eminence|0.00:ventrolateral prefrontal cortex|0.00:temporal neocortex|0.00:striatum|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:medial ganglionic eminence|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:hippocampus (hippocampal formation)|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",3,SNP,5.82,0-46|0.00,35850007,NA,T|M,"N|0|^:^|^:^;N|30,32|^:^|^:^;N|34|^:^|^:^;N|40|^:^|^:^;N|41|^:^|^:^;N|70|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|130,132|^:^|^:^;N|150,153|C:T|T:M;N|151|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.20,0-46|0.00,35850190,NA,G|G,"N|21|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|60|^:^|^:^;N|85|A:G|D:G;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^;N|142|^:^|^:^;N|163-166,169|A:G|D:G;N|167|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,10.04,"14|0.18;0-6,8-13,15-46|0.00;7|-0.02",35850264,NA,G|D,"N|31,33|A:G|N:D;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|43,46|A:G|N:D;N|50,52-53|A:G|N:D;N|57-58|A:G|N:D;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^",NA,NA,NA,NA
38,ALOX15B,Homo sapiens arachidonate 15-lipoxygenase type B (ALOX15B) transcript variant d mRNA.,,NM_001039131,chr17,11.07,8e-03,0.21,1e-01,+,ALOX15B,8039040,8049134,arachidonate 15-lipoxygenase type B,protein_coding,15-LOX-2,0.00,0,0,1.86:Prostate disease|1.84:Cancer|1.70:Atherosclerosis|1.53:Asthma|1.53:Gastrointestinal system disease,0.65:Carcinoma,NA,NA,0.56:testis|0.55:fetus|0.54:placenta|0.52:lung|0.51:liver|0.43:ovary|0.41:prostate gland|0.40:lymph node|0.39:kidney|0.38:pancreas|0.35:autism spectrum disorder|0.34:blood|0.31:brain|0.31:skin|0.30:leukocyte|0.30:mammary gland|0.24:skeletal muscle|0.24:spleen|0.24:central nervous system|0.21:nervous system|0.21:intestine|0.20:blood plasma|0.19:heart|0.19:serum|0.19:mononuclear phagocyte|0.19:monocyte|0.19:gastrointestinal tract|0.18:uterus|0.17:positive regulation of MAPK cascade|0.15:epidermis|0.15:large intestine|0.15:small intestine|0.14:lymphocyte|0.14:bone marrow|0.13:colon|0.13:regulation of response to external stimulus|0.13:eye|0.13:regulation of peptidase activity|0.13:adrenal gland|0.12:regulation of endopeptidase activity|0.12:regulation of defense response|0.11:stomach|0.11:regulation of immune response|0.11:thyroid gland|0.11:hypophysis|0.11:retinal degeneration|0.10:retinal disease,70.08:Vagina|65.91:Prostate|64.28:Esophagus - Mucosa|28.68:Lung|28.12:Skin - Sun Exposed (Lower leg)|24.77:Skin - Not Sun Exposed (Suprapubic)|7.68:Spleen|7.60:Breast - Mammary Tissue|6.70:Small Intestine - Terminal Ileum|5.62:Minor Salivary Gland|5.41:Stomach|4.93:Cervix - Ectocervix|4.76:Nerve - Tibial|4.65:Fallopian Tube|3.69:Cervix - Endocervix|3.67:Thyroid|3.26:Bladder|3.03:Cells - Cultured fibroblasts|2.95:Adrenal Gland|2.91:Colon - Transverse|2.58:Adipose - Subcutaneous|2.14:Whole Blood|1.80:Artery - Coronary|1.67:Testis|1.49:Adipose - Visceral (Omentum)|1.42:Colon - Sigmoid|1.40:Uterus|1.38:Artery - Aorta|1.16:Ovary|1.14:Brain - Cortex|1.09:Brain - Spinal cord (cervical c-1)|0.99:Brain - Frontal Cortex (BA9)|0.86:Esophagus - Muscularis|0.85:Pituitary|0.74:Esophagus - Gastroesophageal Junction|0.73:Artery - Tibial|0.55:Cells - EBV-transformed lymphocytes|0.45:Brain - Anterior cingulate cortex (BA24)|0.43:Pancreas|0.32:Brain - Hypothalamus|0.27:Muscle - Skeletal|0.26:Brain - Hippocampus|0.24:Brain - Substantia nigra|0.22:Heart - Atrial Appendage|0.19:Heart - Left Ventricle|0.14:Brain - Nucleus accumbens (basal ganglia)|0.14:Brain - Caudate (basal ganglia)|0.12:Brain - Amygdala|0.12:Liver|0.11:Brain - Putamen (basal ganglia)|0.11:Kidney - Cortex|0.10:Brain - Cerebellum|0.07:Kidney - Medulla|0.07:Brain - Cerebellar Hemisphere,"0.11:upper (rostral) rhombic lip|0.04:amygdaloid complex|0.04:anterior (rostral) cingulate (medial prefrontal) cortex|0.03:primary motor cortex (area M1, area 4)|0.03:orbital frontal cortex|0.03:striatum|0.03:hippocampus (hippocampal formation)|0.03:ventrolateral prefrontal cortex|0.02:primary auditory cortex (core)|0.02:primary somatosensory cortex (area S1, areas 3,1,2)|0.02:medial ganglionic eminence|0.02:dorsolateral prefrontal cortex|0.02:mediodorsal nucleus of thalamus|0.02:posterior (caudal) superior temporal cortex (area 22c)|0.02:posteroventral (inferior) parietal cortex|0.01:primary motor-sensory cortex (samples)|0.01:lateral ganglionic eminence|0.01:parietal neocortex|0.01:caudal ganglionic eminence|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:temporal neocortex|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:occipital neocortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex",4,SNP,3.29,0-46|0.00,7945721,NA,C|L,"N|42|^:^|^:^;N|105,107|A:C|M:L",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.94,0-46|0.00,7948239,NA,C|L,"N|9|^:^|^:^;N|37|^:^|^:^;N|69|^:^|^:^;N|73|^:^|^:^;N|97,99|C:T|L:F;N|157|^:^|^:^",0.0033,0.0033,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.77,"14|0.21;0-13,15-46|0.00",7950330,NA,G|V,"N|50,52-53|A:G|I:V",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.10,0-46|0.00,7951878,NA,A|I,N|35|^:^|^:^;N|112-113|A:G|I:V;N|138-139|A:G|I:V;N|144|A:G|I:V,0.0392,0.0493,D,T
40,C1QBP,Homo sapiens complement component 1 q subcomponent binding protein (C1QBP) nuclear gene encoding mitochondrial protein mRNA.,,NM_001212,chr17,5.94,8e-03,0.29,1e-02,-,C1QBP,5432777,5439155,complement C1q binding protein,protein_coding,"COXPD33,gC1Q-R,GC1QBP,gC1qR,HABP1,p32,SF2AP32,SF2p32",0.07,0,0,2.39:Cancer|2.22:Chromosome 1p32-p31 deletion syndrome|2.05:Neuronal ceroid lipofuscinosis|1.99:Hematopoietic system disease|1.81:Angioedema|1.78:Gastrointestinal system disease|1.74:Eye disease|1.71:Breast disease|1.70:Vascular disease|1.67:Connective tissue disease|1.63:Complement deficiency|1.58:Kidney disease|1.57:Cryoglobulinemia|1.56:Lung disease|1.56:Benign meningioma|1.56:Lipoma|1.53:Malaria|1.53:Neurodegenerative disease|1.50:Uterine disease,NA,NA,NA,0.96:mitochondrial transcription|0.83:peptide biosynthetic process|0.82:peptide metabolic process|0.81:translation|0.77:amide biosynthetic process|0.77:positive regulation of cellular component movement|0.75:positive regulation of cell motility|0.75:mitochondrial RNA metabolic process|0.74:rRNA methylation|0.74:rRNA modification|0.73:blood|0.72:regulation of translation|0.72:leukocyte|0.64:mitochondrial gene expression|0.61:positive regulation of cell migration|0.59:combined oxidative phosphorylation deficiency|0.48:placenta|0.46:brain|0.46:mononuclear phagocyte|0.45:regulation of cellular amide metabolic process|0.45:monocyte|0.44:positive regulation of blood vessel endothelial cell migration|0.43:heart|0.42:liver|0.42:pancreas|0.40:central nervous system|0.40:autism spectrum disorder|0.39:regulation of peptidyl-serine phosphorylation|0.39:fetus|0.39:ovary|0.39:nervous system|0.39:positive regulation of DNA binding transcription factor activity|0.39:positive regulation of locomotion|0.39:kidney|0.37:regulation of peptidase activity|0.36:tear gland|0.35:positive regulation of ERK1 and ERK2 cascade|0.35:testis|0.35:positive regulation of peptidyl-serine phosphorylation|0.35:erythrocyte|0.35:positive regulation of histone modification|0.32:paraplegia|0.31:spleen|0.31:lymphocyte|0.30:cellular amino acid metabolic process|0.29:lymph node|0.28:hereditary spastic paraplegia|0.28:positive regulation of humoral immune response|0.28:negative regulation of cell proliferation|0.27:positive regulation of endothelial cell chemotaxis|0.27:regulation of release of cytochrome c from mitochondria|0.26:posttranscriptional regulation of gene expression|0.26:RNA methylation|0.26:regulation of endothelial cell chemotaxis|0.26:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway|0.26:prostate gland|0.26:regulation of mitochondrion organization|0.26:regulation of cell growth|0.24:regulation of complement activation|0.24:regulation of protein activation cascade|0.24:regulation of blood vessel endothelial cell migration|0.24:skeletal muscle|0.23:mitochondrial metabolism disease|0.23:vascular endothelial growth factor receptor signaling pathway|0.23:regulation of DNA binding transcription factor activity|0.23:regulation of ERK1 and ERK2 cascade|0.23:negative regulation of growth|0.23:release of cytochrome c from mitochondria|0.23:negative regulation of cell growth|0.22:negative regulation of intrinsic apoptotic signaling pathway|0.22:regulation of response to external stimulus|0.22:gastrointestinal tract|0.22:protein deacetylation|0.22:uterus|0.22:positive regulation of chemotaxis|0.21:eye|0.21:hypertrophic cardiomyopathy|0.21:negative regulation of transcription by competitive promoter binding|0.21:regulation of growth|0.21:blood plasma|0.21:negative regulation of intracellular signal transduction|0.20:positive regulation of cell migration by vascular endothelial growth factor signaling pathway|0.20:mammary gland|0.19:protein deacylation|0.19:regulation of apoptotic signaling pathway|0.19:peptidyl-threonine phosphorylation|0.19:telencephalon|0.19:regulation of endopeptidase activity|0.19:lung|0.18:granulocyte|0.18:cerebellum|0.18:positive regulation of MAPK cascade|0.18:adrenal gland|0.17:regulation of histone modification|0.17:negative regulation of translation|0.16:ERK1 and ERK2 cascade|0.16:macromolecule deacylation|0.16:negative regulation of apoptotic signaling pathway|0.15:thyroid gland|0.15:positive regulation of peptidase activity|0.15:large intestine|0.15:positive regulation of response to external stimulus|0.14:peptidyl-threonine modification|0.14:cardiomyopathy|0.14:hippocampus|0.14:regulation of acute inflammatory response|0.13:T-lymphocyte|0.13:regulation of intrinsic apoptotic signaling pathway|0.13:response to inorganic substance|0.13:intestine|0.13:hypophysis|0.13:forebrain|0.13:temporal lobe|0.13:negative regulation of centrosome cycle|0.13:positive regulation of endothelial cell migration|0.12:regulation of protein deacetylation|0.12:regulation of MDA-5 signaling pathway|0.12:cellular response to oxidative stress|0.12:negative regulation of protein catabolic process|0.12:rRNA processing|0.12:regulation of retinoic acid receptor signaling pathway|0.12:cerebral degeneration|0.12:colon|0.12:neutrophil|0.11:vascular endothelial growth factor signaling pathway|0.11:positive regulation of proteolysis|0.11:response to hydrogen peroxide|0.11:small intestine|0.10:Leigh disease|0.10:positive regulation of epithelial cell proliferation,369.69:Cells - EBV-transformed lymphocytes|204.60:Cells - Cultured fibroblasts|136.39:Esophagus - Mucosa|130.66:Adrenal Gland|105.55:Pituitary|92.63:Bladder|92.47:Vagina|91.67:Testis|88.62:Uterus|87.94:Skin - Not Sun Exposed (Suprapubic)|87.63:Colon - Transverse|87.10:Skin - Sun Exposed (Lower leg)|85.72:Cervix - Endocervix|85.10:Muscle - Skeletal|85.03:Brain - Cerebellar Hemisphere|83.08:Breast - Mammary Tissue|83.07:Spleen|82.44:Brain - Frontal Cortex (BA9)|82.43:Cervix - Ectocervix|81.74:Fallopian Tube|79.81:Colon - Sigmoid|78.71:Adipose - Visceral (Omentum)|78.41:Kidney - Medulla|78.16:Artery - Coronary|77.43:Esophagus - Muscularis|76.40:Nerve - Tibial|76.08:Thyroid|74.97:Small Intestine - Terminal Ileum|74.26:Ovary|73.78:Adipose - Subcutaneous|73.23:Esophagus - Gastroesophageal Junction|73.11:Brain - Cerebellum|72.37:Artery - Tibial|71.51:Prostate|70.67:Artery - Aorta|69.24:Brain - Hypothalamus|68.63:Lung|66.90:Minor Salivary Gland|66.23:Brain - Anterior cingulate cortex (BA24)|65.56:Brain - Spinal cord (cervical c-1)|63.26:Brain - Cortex|62.35:Heart - Left Ventricle|61.98:Stomach|60.13:Brain - Substantia nigra|60.00:Kidney - Cortex|57.81:Brain - Nucleus accumbens (basal ganglia)|55.89:Heart - Atrial Appendage|54.93:Brain - Caudate (basal ganglia)|54.32:Brain - Hippocampus|51.94:Liver|48.30:Brain - Amygdala|46.25:Brain - Putamen (basal ganglia)|31.62:Pancreas|21.85:Whole Blood,"88.87:occipital neocortex|86.15:dorsal thalamus|81.13:primary motor-sensory cortex (samples)|73.44:parietal neocortex|70.77:hippocampus (hippocampal formation)|70.12:cerebellum|70.00:caudal ganglionic eminence|68.12:striatum|68.09:posterior (caudal) superior temporal cortex (area 22c)|67.91:medial ganglionic eminence|67.33:dorsolateral prefrontal cortex|67.00:posteroventral (inferior) parietal cortex|65.65:inferolateral temporal cortex (area TEv, area 20)|65.06:upper (rostral) rhombic lip|64.42:lateral ganglionic eminence|64.11:mediodorsal nucleus of thalamus|64.08:ventrolateral prefrontal cortex|63.85:cerebellar cortex|63.52:primary auditory cortex (core)|63.38:primary motor cortex (area M1, area 4)|62.96:primary somatosensory cortex (area S1, areas 3,1,2)|62.92:orbital frontal cortex|62.69:anterior (rostral) cingulate (medial prefrontal) cortex|62.57:primary visual cortex (striate cortex, area V1/17)|61.74:amygdaloid complex|51.12:temporal neocortex",1,SNP,4.60,"13|0.29;0-12,14-46|0.00",5338281,NA,G|T,N|30|A:G|M:T;N|42|^:^|^:^;N|48-49|A:G|M:T;N|102|A:G|M:T,NA,NA,NA,NA
41,NUMBL,Homo sapiens numb homolog (Drosophila)-like (NUMBL) mRNA.,MAPKKK cascade;Notch Signaling Pathway,NM_004756,chr19,22.22,1e-02,0.42,2e-01,-,NUMBL,40665905,40690651,NUMB like endocytic adaptor protein,protein_coding,"CAG3A,CTG3a,NBL,NUMB-R,NUMBLIKE,NUMBR,TNRC23",0.75,0,0,1.76:Cancer,0.70:Carcinoma,NA,NA,NA,92.11:Nerve - Tibial|91.30:Pituitary|80.12:Cervix - Ectocervix|76.57:Cervix - Endocervix|69.73:Uterus|67.31:Fallopian Tube|66.04:Artery - Aorta|56.90:Artery - Coronary|55.39:Ovary|55.05:Brain - Cerebellar Hemisphere|54.39:Brain - Cerebellum|52.78:Artery - Tibial|51.86:Vagina|49.26:Bladder|48.35:Prostate|44.73:Esophagus - Gastroesophageal Junction|43.01:Colon - Sigmoid|42.51:Thyroid|41.09:Adipose - Subcutaneous|39.88:Brain - Cortex|39.53:Testis|39.14:Esophagus - Muscularis|38.59:Cells - Cultured fibroblasts|37.44:Brain - Frontal Cortex (BA9)|36.09:Adipose - Visceral (Omentum)|32.47:Lung|29.05:Brain - Nucleus accumbens (basal ganglia)|28.52:Breast - Mammary Tissue|28.51:Brain - Anterior cingulate cortex (BA24)|23.48:Brain - Hypothalamus|23.20:Brain - Hippocampus|22.58:Brain - Amygdala|22.38:Skin - Sun Exposed (Lower leg)|21.32:Colon - Transverse|20.80:Brain - Caudate (basal ganglia)|20.07:Skin - Not Sun Exposed (Suprapubic)|18.42:Small Intestine - Terminal Ileum|16.43:Esophagus - Mucosa|15.97:Minor Salivary Gland|15.62:Adrenal Gland|15.39:Stomach|15.31:Brain - Putamen (basal ganglia)|15.14:Heart - Atrial Appendage|14.44:Spleen|10.98:Brain - Substantia nigra|8.53:Brain - Spinal cord (cervical c-1)|8.38:Kidney - Cortex|8.34:Kidney - Medulla|7.14:Heart - Left Ventricle|6.62:Cells - EBV-transformed lymphocytes|6.34:Liver|5.36:Muscle - Skeletal|4.57:Pancreas|3.09:Whole Blood,"22.42:primary motor-sensory cortex (samples)|19.30:posterior (caudal) superior temporal cortex (area 22c)|18.69:primary visual cortex (striate cortex, area V1/17)|18.27:ventrolateral prefrontal cortex|18.03:inferolateral temporal cortex (area TEv, area 20)|17.32:anterior (rostral) cingulate (medial prefrontal) cortex|16.32:parietal neocortex|16.14:amygdaloid complex|16.11:primary auditory cortex (core)|15.78:orbital frontal cortex|15.73:cerebellum|15.39:posteroventral (inferior) parietal cortex|15.35:dorsolateral prefrontal cortex|14.91:cerebellar cortex|14.90:hippocampus (hippocampal formation)|14.72:upper (rostral) rhombic lip|14.62:primary motor cortex (area M1, area 4)|14.52:dorsal thalamus|13.74:primary somatosensory cortex (area S1, areas 3,1,2)|13.56:temporal neocortex|13.47:occipital neocortex|13.22:caudal ganglionic eminence|12.31:mediodorsal nucleus of thalamus|11.73:lateral ganglionic eminence|10.33:medial ganglionic eminence|10.26:striatum",3,SNP,3.21,0-46|0.00,41173733,3,A|F,B|14-15|A:C|F:L;N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|50|^:^|^:^;N|83|^:^|^:^;N|101|^:^|^:^;N|108|^:^|^:^;B|124-126|A:C|F:L;N|128|^:^|^:^;N|155|^:^|^:^,0.0047,0.0092,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.71,"18|0.13;0-17,19-46|0.00",41173819,NA,G|P,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|63-64|A:G|S:P;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,13.24,"14|0.37;0-13,15-42,44-46|0.00;43|-0.07",41173866,NA,TGCTGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ,"2|^:^|^:^;11|^:^|^:^;23|^:^|^:^;25-26|^:^|^:^;30-31|^:^|^:^;34|^:^|^:^;37|^:^|^:^;41|^:^|^:^;50-52|TGCTGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ:QQQQQQQQ;60-61|^:^|^:^;63,65|^:^|^:^;70-72|^:^|^:^;76-77|TGCTGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ:QQQQQQQQ;74|TGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQ:QQQQQQQQ;73,75|^:^|^:^;78|^:^|^:^;83-84|^:^|^:^;94|^:^|^:^;104-105,107|^:^|^:^;108|^:^|^:^;122-123|^:^|^:^;124-125|^:^|^:^;128|^:^|^:^;130|^:^|^:^;140-141|TGCTGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ:QQQQQQQQ;137,139|^:^|^:^;142|^:^|^:^;147|TGCTGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ:QQQQQQQQ;149|^:^|^:^;151-152|TGCTGCTGTTGCTGCTGCTGCTGC:TGCTGTTGCTGCTGCTGCTGC|QQQQQQQQQ:QQQQQQQQ;153|^:^|^:^;163,165,167-168,170|^:^|^:^",NA,NA,NA,NA
42,WDR16,Homo sapiens WD repeat domain 16 (WDR16) transcript variant 2 mRNA.,,NM_001080556,chr17,6.10,1e-02,0.57,2e-02,+,CFAP52,9576642,9643447,cilia and flagella associated protein 52,protein_coding,"WDR16,WDRPUH",NA,0,0,NA,NA,NA,NA,NA,21.32:Testis|4.37:Fallopian Tube|3.94:Pituitary|2.15:Brain - Frontal Cortex (BA9)|1.85:Brain - Cortex|1.56:Lung|1.37:Brain - Hypothalamus|1.37:Brain - Anterior cingulate cortex (BA24)|1.32:Brain - Hippocampus|1.05:Brain - Nucleus accumbens (basal ganglia)|0.78:Brain - Caudate (basal ganglia)|0.70:Brain - Amygdala|0.54:Cervix - Endocervix|0.48:Brain - Spinal cord (cervical c-1)|0.45:Prostate|0.44:Brain - Substantia nigra|0.42:Thyroid|0.34:Kidney - Medulla|0.27:Ovary|0.27:Cervix - Ectocervix|0.25:Brain - Putamen (basal ganglia)|0.22:Uterus|0.20:Nerve - Tibial|0.19:Vagina|0.18:Kidney - Cortex|0.15:Adrenal Gland|0.15:Artery - Coronary|0.15:Breast - Mammary Tissue|0.14:Brain - Cerebellar Hemisphere|0.14:Bladder|0.14:Colon - Transverse|0.14:Brain - Cerebellum|0.13:Esophagus - Mucosa|0.13:Cells - Cultured fibroblasts|0.12:Minor Salivary Gland|0.12:Artery - Tibial|0.11:Artery - Aorta|0.11:Small Intestine - Terminal Ileum|0.11:Esophagus - Gastroesophageal Junction|0.10:Esophagus - Muscularis|0.09:Colon - Sigmoid|0.09:Liver|0.08:Adipose - Subcutaneous|0.07:Adipose - Visceral (Omentum)|0.07:Stomach|0.07:Pancreas|0.06:Skin - Not Sun Exposed (Suprapubic)|0.06:Skin - Sun Exposed (Lower leg)|0.04:Heart - Atrial Appendage|0.03:Muscle - Skeletal|0.02:Heart - Left Ventricle|0.02:Spleen|0.00:Whole Blood|0.00:Cells - EBV-transformed lymphocytes,NA,1,SNP,3.47,46|0.57;0-45|0.00,9497560,NA,C|A,"N|165,167-168,171|C:T|A:V",0.0049,0.0053,D,T
43,DVL2,Homo sapiens dishevelled dsh homolog 2 (Drosophila) (DVL2) mRNA.,Nervous  System Development;Wnt Signaling Pathway;Alzheimer Disease Presenilin Pathway,NM_004422,chr17,9.59,2e-02,0.15,8e-02,-,DVL2,7225341,7234544,dishevelled segment polarity protein 2,protein_coding,NA,0.01,0,0,2.24:Cancer|2.08:Neural tube defect|2.01:Gastrointestinal system disease|1.77:Breast disease|1.64:Lung disease|1.64:Ciliopathy|1.59:Anencephaly|1.52:Kidney disease|1.50:Prostate disease,0.70:Carcinoma,NA,NA,"0.98:regulation of tumor necrosis factor-mediated signaling pathway|0.96:positive regulation of ubiquitin-protein transferase activity|0.92:regulation of protein catabolic process|0.90:positive regulation of cell motility|0.89:positive regulation of cell migration|0.89:positive regulation of cellular component movement|0.89:positive regulation of locomotion|0.88:canonical Wnt signaling pathway|0.88:protein deubiquitination|0.86:cytokine-mediated signaling pathway|0.85:negative regulation of protein modification process|0.84:positive regulation of protein catabolic process|0.84:tumor necrosis factor-mediated signaling pathway|0.84:positive regulation of proteasomal ubiquitin-dependent protein catabolic process|0.84:regulation of response to cytokine stimulus|0.81:peptidyl-lysine modification|0.80:positive regulation of catabolic process|0.80:regulation of cytokine-mediated signaling pathway|0.78:protein modification by small protein removal|0.77:proteasomal protein catabolic process|0.75:Wnt signaling pathway|0.75:positive regulation of proteasomal protein catabolic process|0.75:regulation of cellular protein catabolic process|0.73:placenta|0.73:nervous system|0.72:negative regulation of DNA binding transcription factor activity|0.71:negative regulation of inflammatory response|0.70:apoptotic signaling pathway|0.70:cell surface receptor signaling pathway involved in cell-cell signaling|0.69:fetus|0.69:positive regulation of cellular catabolic process|0.69:testis|0.68:brain|0.67:positive regulation of cellular protein catabolic process|0.66:ovary|0.66:central nervous system|0.66:heart|0.66:regulation of proteasomal protein catabolic process|0.66:kidney|0.64:positive regulation of proteolysis involved in cellular protein catabolic process|0.64:regulation of Wnt signaling pathway|0.64:regulation of proteolysis involved in cellular protein catabolic process|0.63:regulation of canonical Wnt signaling pathway|0.63:positive regulation of proteolysis|0.62:ubiquitin-dependent protein catabolic process|0.61:proteasome-mediated ubiquitin-dependent protein catabolic process|0.60:modification-dependent protein catabolic process|0.60:prostate gland|0.59:skeletal muscle|0.59:histone H4-K12 acetylation|0.58:negative regulation of NF-kappaB transcription factor activity|0.58:positive regulation of protein modification by small protein conjugation or removal|0.57:pancreas|0.54:lung|0.54:positive regulation of protein ubiquitination|0.53:liver|0.53:regulation of protein modification by small protein conjugation or removal|0.51:Notch signaling pathway|0.51:autism spectrum disorder|0.50:regulation of proteasomal ubiquitin-dependent protein catabolic process|0.50:intrinsic apoptotic signaling pathway|0.50:positive regulation of JNK cascade|0.50:ERK1 and ERK2 cascade|0.49:negative regulation of protein phosphorylation|0.46:forebrain|0.46:regulation of protein localization to nucleus|0.45:spleen|0.44:positive regulation of Wnt signaling pathway|0.42:telencephalon|0.42:cerebral cortex|0.41:temporal lobe|0.41:regulation of ERK1 and ERK2 cascade|0.40:JNK cascade|0.40:negative regulation of cell migration|0.40:regulation of JNK cascade|0.40:regulation of ubiquitin-protein transferase activity|0.39:histone modification|0.38:histone acetylation|0.38:regulation of mRNA metabolic process|0.38:negative regulation of cell proliferation|0.38:basal ganglion|0.38:regulation of protein ubiquitination|0.37:internal peptidyl-lysine acetylation|0.37:negative regulation of locomotion|0.37:peptidyl-lysine acetylation|0.37:regulation of DNA binding transcription factor activity|0.37:stress-activated protein kinase signaling cascade|0.36:activation of immune response|0.36:positive regulation of protein localization to nucleus|0.35:cerebellum|0.35:amygdala|0.35:positive regulation of stress-activated protein kinase signaling cascade|0.34:negative regulation of phosphorylation|0.34:stress-activated MAPK cascade|0.34:negative regulation of protein kinase activity|0.34:spinal cord|0.33:regulation of inflammatory response|0.33:protein acylation|0.33:activation of innate immune response|0.33:negative regulation of cell motility|0.33:regulation of mRNA processing|0.33:negative regulation of proteolysis|0.33:internal protein amino acid acetylation|0.32:positive regulation of stress-activated MAPK cascade|0.32:histone H4 acetylation|0.32:regulation of defense response|0.31:regulation of stress-activated MAPK cascade|0.31:negative regulation of intracellular signal transduction|0.31:positive regulation of immune response|0.30:positive regulation of canonical Wnt signaling pathway|0.30:mammary gland|0.30:hippocampus|0.30:leukocyte|0.30:positive regulation of cellular protein localization|0.29:gastrointestinal tract|0.29:regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|0.29:TOR signaling|0.29:blood|0.29:intracellular receptor signaling pathway|0.28:regulation of histone modification|0.28:regulation of TOR signaling|0.28:corpus callosum|0.28:positive regulation of innate immune response|0.28:corpus striatum|0.27:regulation of immune response|0.27:substantia nigra|0.27:negative regulation of Wnt signaling pathway|0.27:intestine|0.26:protein acetylation|0.26:negative regulation of cellular component movement|0.26:positive regulation of MAPK cascade|0.26:large intestine|0.25:muscle|0.25:small intestine|0.25:regulation of protein maturation|0.25:histone H3 acetylation|0.25:midbrain|0.25:regulation of intracellular protein transport|0.24:colon|0.24:uterus|0.24:histone H4-K5 acetylation|0.24:histone H4-K8 acetylation|0.23:transmembrane receptor protein serine/threonine kinase signaling pathway|0.23:negative regulation of canonical Wnt signaling pathway|0.23:positive regulation of intracellular transport|0.23:signal transduction by p53 class mediator|0.23:regulation of innate immune response|0.23:subthalamic nucleus|0.23:regulation of stress-activated protein kinase signaling cascade|0.22:regulation of mitochondrion organization|0.22:positive regulation of protein transport|0.22:positive regulation of defense response|0.22:intrinsic apoptotic signaling pathway in response to DNA damage|0.22:regulation of protein processing|0.21:diencephalon|0.21:caudate nucleus|0.20:positive regulation of intracellular protein transport|0.20:regulation of response to external stimulus|0.20:regulation of apoptotic signaling pathway|0.20:negative regulation of hemopoiesis|0.20:regulation of epithelial cell proliferation|0.19:protein polyubiquitination|0.19:extrinsic apoptotic signaling pathway|0.19:hypophysis|0.19:immune response-activating signal transduction|0.19:immune response-regulating signaling pathway|0.19:lymph node|0.18:thalamus|0.18:regulation of epithelial cell migration|0.18:DNA damage checkpoint|0.18:pattern recognition receptor signaling pathway|0.18:innate immune response-activating signal transduction|0.17:caudate putamen|0.17:negative regulation of cell cycle|0.17:G2 DNA damage checkpoint|0.17:DNA repair|0.17:lymphocyte|0.17:regulation of cell projection organization|0.16:regulation of peptidase activity|0.16:protein K48-linked deubiquitination|0.16:regulation of cellular response to growth factor stimulus|0.16:negative regulation of kinase activity|0.16:gastrointestinal system cancer|0.16:positive regulation of protein kinase B signaling|0.16:positive regulation of mitochondrion organization|0.16:protein kinase B signaling|0.16:protein maturation|0.16:negative regulation of response to external stimulus|0.16:transmembrane receptor protein tyrosine kinase signaling pathway|0.15:regulation of alternative mRNA splicing, via spliceosome|0.15:thyroid gland|0.15:adrenal gland|0.15:glycoprotein metabolic process|0.15:pathway-restricted SMAD protein phosphorylation|0.15:regulation of mRNA splicing, via spliceosome|0.15:positive regulation of programmed cell death|0.15:regulation of protein kinase B signaling|0.15:negative regulation of epithelial cell migration|0.14:protein glycosylation|0.14:stomach|0.14:response to tumor necrosis factor|0.14:regulation of protein import into nucleus|0.14:positive regulation of apoptotic process|0.14:bone marrow|0.14:bone development disease|0.14:cellular response to cytokine stimulus|0.13:negative regulation of defense response|0.13:retinal disease|0.13:negative regulation of protein modification by small protein conjugation or removal|0.13:positive regulation of protein import into nucleus|0.13:epidermal growth factor receptor signaling pathway|0.13:regulation of pathway-restricted SMAD protein phosphorylation|0.13:regulation of protein import|0.13:regulation of endopeptidase activity|0.12:cellular modified amino acid metabolic process|0.12:negative regulation of protein maturation|0.12:negative regulation of protein processing|0.12:protein processing|0.12:negative regulation of histone modification|0.12:negative regulation of protein catabolic process|0.12:negative regulation of immune system process|0.12:regulation of autophagy|0.12:regulation of protein sumoylation|0.12:signal transduction in response to DNA damage|0.12:activation of protein kinase activity|0.11:large intestine cancer|0.11:intestinal cancer|0.11:colorectal cancer|0.11:positive regulation of nucleocytoplasmic transport|0.11:regulation of DNA metabolic process|0.11:glycoprotein biosynthetic process|0.11:I-kappaB kinase/NF-kappaB signaling|0.11:regulation of RNA splicing|0.11:positive regulation of cell cycle|0.11:positive regulation of protein import|0.11:regulation of DNA repair|0.11:regulation of protein serine/threonine kinase activity|0.11:regulation of chromatin organization|0.11:regulation of cellular amide metabolic process|0.11:regulation of I-kappaB kinase/NF-kappaB signaling|0.11:regulation of intrinsic apoptotic signaling pathway|0.10:regulation of translation|0.10:regulation of epidermal growth factor-activated receptor activity|0.10:regulation of signaling receptor activity|0.10:DNA integrity checkpoint|0.10:cellular response to tumor necrosis factor",73.46:Ovary|72.11:Cervix - Ectocervix|70.36:Cervix - Endocervix|66.95:Uterus|54.10:Fallopian Tube|51.51:Vagina|50.40:Pituitary|49.92:Prostate|49.15:Nerve - Tibial|48.18:Brain - Cerebellum|47.07:Skin - Sun Exposed (Lower leg)|46.22:Thyroid|43.56:Skin - Not Sun Exposed (Suprapubic)|43.29:Artery - Tibial|40.35:Colon - Sigmoid|40.10:Brain - Cerebellar Hemisphere|39.88:Bladder|38.58:Testis|38.36:Esophagus - Gastroesophageal Junction|36.97:Esophagus - Muscularis|36.51:Cells - Cultured fibroblasts|35.65:Artery - Aorta|34.34:Cells - EBV-transformed lymphocytes|32.66:Esophagus - Mucosa|31.76:Breast - Mammary Tissue|31.54:Adipose - Subcutaneous|31.20:Artery - Coronary|30.95:Lung|30.65:Adrenal Gland|28.23:Minor Salivary Gland|27.50:Small Intestine - Terminal Ileum|27.11:Spleen|25.45:Colon - Transverse|22.42:Adipose - Visceral (Omentum)|18.68:Brain - Cortex|18.67:Kidney - Medulla|17.03:Brain - Spinal cord (cervical c-1)|16.08:Stomach|15.92:Kidney - Cortex|13.06:Brain - Frontal Cortex (BA9)|13.00:Brain - Nucleus accumbens (basal ganglia)|12.37:Heart - Atrial Appendage|11.60:Muscle - Skeletal|11.40:Brain - Caudate (basal ganglia)|11.40:Brain - Hypothalamus|9.93:Brain - Anterior cingulate cortex (BA24)|9.85:Brain - Putamen (basal ganglia)|9.52:Brain - Substantia nigra|9.45:Brain - Hippocampus|8.58:Brain - Amygdala|8.27:Pancreas|7.45:Liver|7.34:Heart - Left Ventricle|7.03:Whole Blood,"23.10:caudal ganglionic eminence|21.80:occipital neocortex|18.84:lateral ganglionic eminence|18.39:parietal neocortex|18.13:medial ganglionic eminence|15.01:temporal neocortex|11.72:upper (rostral) rhombic lip|10.93:cerebellum|8.15:primary motor-sensory cortex (samples)|7.68:dorsal thalamus|7.50:cerebellar cortex|6.21:ventrolateral prefrontal cortex|6.08:hippocampus (hippocampal formation)|5.82:orbital frontal cortex|5.82:primary visual cortex (striate cortex, area V1/17)|5.81:striatum|5.63:primary somatosensory cortex (area S1, areas 3,1,2)|5.63:amygdaloid complex|5.63:dorsolateral prefrontal cortex|5.21:primary motor cortex (area M1, area 4)|5.00:anterior (rostral) cingulate (medial prefrontal) cortex|4.87:primary auditory cortex (core)|4.82:posterior (caudal) superior temporal cortex (area 22c)|4.49:posteroventral (inferior) parietal cortex|4.36:inferolateral temporal cortex (area TEv, area 20)|3.93:mediodorsal nucleus of thalamus",2,SNP,5.45,"2|0.15;0-1,3-46|0.00",7129898,NA,G|T,N|11-12|A:G|I:T;N|91|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.47,0-46|0.00,7137503,NA,A|Y,N|37|^:^|^:^;N|47-48|A:G|Y:H;N|107|^:^|^:^;N|160|^:^|^:^;N|163|^:^|^:^,4.061e-06,NA,D,D
44,SAT2,Homo sapiens spermidine/spermine N1-acetyltransferase family member 2 (SAT2) mRNA.,,NM_133491,chr17,6.71,2e-02,0.11,2e-02,-,SLC38A2,46358188,46372774,solute carrier family 38 member 2,protein_coding,"ATA2,PRO1068,SAT2,SNAT2",0.97,0,0,2.12:Placental insufficiency|1.74:Obesity|1.73:ADULT syndrome|1.65:Hartnup disease|1.63:Cancer|1.63:Diabetes mellitus,NA,NA,"10.00:preweaning lethality, incomplete penetrance|5.66:decreased caudal vertebrae number|5.25:abnormal femur morphology",NA,562.78:Cells - Cultured fibroblasts|279.46:Skin - Not Sun Exposed (Suprapubic)|271.02:Skin - Sun Exposed (Lower leg)|248.26:Fallopian Tube|233.00:Uterus|224.56:Artery - Coronary|223.17:Lung|218.53:Nerve - Tibial|204.56:Ovary|190.79:Cervix - Ectocervix|185.75:Vagina|179.97:Artery - Tibial|172.65:Cervix - Endocervix|159.49:Adipose - Subcutaneous|158.78:Adipose - Visceral (Omentum)|153.99:Artery - Aorta|146.43:Esophagus - Mucosa|144.63:Thyroid|129.50:Breast - Mammary Tissue|126.86:Adrenal Gland|125.00:Bladder|121.57:Minor Salivary Gland|110.39:Esophagus - Gastroesophageal Junction|108.78:Colon - Sigmoid|108.65:Prostate|96.66:Esophagus - Muscularis|94.22:Liver|93.18:Small Intestine - Terminal Ileum|86.04:Cells - EBV-transformed lymphocytes|85.40:Spleen|84.99:Colon - Transverse|79.34:Stomach|75.00:Muscle - Skeletal|65.59:Brain - Cerebellar Hemisphere|55.64:Brain - Cerebellum|51.08:Heart - Atrial Appendage|44.93:Pituitary|44.39:Brain - Spinal cord (cervical c-1)|40.38:Kidney - Medulla|38.19:Pancreas|34.98:Heart - Left Ventricle|34.78:Testis|34.20:Kidney - Cortex|30.70:Brain - Frontal Cortex (BA9)|28.64:Brain - Hypothalamus|24.98:Brain - Substantia nigra|23.30:Brain - Cortex|23.27:Whole Blood|22.73:Brain - Hippocampus|22.14:Brain - Caudate (basal ganglia)|20.77:Brain - Putamen (basal ganglia)|19.32:Brain - Amygdala|18.78:Brain - Anterior cingulate cortex (BA24)|15.95:Brain - Nucleus accumbens (basal ganglia),"34.54:medial ganglionic eminence|31.16:caudal ganglionic eminence|28.26:occipital neocortex|26.90:dorsal thalamus|26.57:lateral ganglionic eminence|26.23:parietal neocortex|21.16:temporal neocortex|20.91:upper (rostral) rhombic lip|20.79:posteroventral (inferior) parietal cortex|19.37:primary visual cortex (striate cortex, area V1/17)|19.36:cerebellar cortex|18.20:primary motor-sensory cortex (samples)|18.20:anterior (rostral) cingulate (medial prefrontal) cortex|18.00:primary auditory cortex (core)|17.99:hippocampus (hippocampal formation)|17.83:ventrolateral prefrontal cortex|17.27:amygdaloid complex|16.84:posterior (caudal) superior temporal cortex (area 22c)|16.74:orbital frontal cortex|16.57:primary somatosensory cortex (area S1, areas 3,1,2)|16.53:primary motor cortex (area M1, area 4)|16.49:dorsolateral prefrontal cortex|16.13:striatum|15.50:inferolateral temporal cortex (area TEv, area 20)|12.89:mediodorsal nucleus of thalamus|12.53:cerebellum",1,SNP,6.20,"42|0.11;0-41,43-46|0.00",7530072,NA,T|E,"N|104|^:^|^:^;N|148|A:T|V:E;N|164,166,168|^:^|^:^",NA,NA,NA,NA
45,SPNS2,Homo sapiens spinster homolog 2 (Drosophila) (SPNS2) mRNA.,,NM_001124758,chr17,7.31,2e-02,0.30,6e-02,+,SPNS2,4498881,4539035,sphingolipid transporter 2,protein_coding,"DFNB115,SLC62A2",0.00,0,0,2.05:Lymphopenia|1.67:Multiple sclerosis|1.53:Cancer,NA,4.00:Nonsyndromic deafness,"16.46:absent pinna reflex|11.34:abnormal cornea morphology|10.90:decreased B cell number|10.84:corneal opacity|10.58:corneal vascularization|10.11:increased granulocyte number|10.00:abnormal eye pigmentation|8.91:increased effector memory CD8-positive, alpha-beta T cell number|8.54:decreased CD4-positive, alpha beta T cell number|8.54:decreased T cell number|8.03:decreased CD8-positive, alpha-beta T cell number|7.01:increased monocyte cell number|5.60:increased effector memory CD4-positive, alpha-beta T cell number|5.59:increased mean corpuscular volume|5.52:abnormal eye size|5.26:decreased leukocyte cell number|5.01:narrow eye opening|5.01:trunk curl|4.86:abnormal eyelid aperture|4.75:abnormal eye morphology|4.70:increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|4.69:abnormal iris morphology|4.31:decreased mature B cell number|4.30:increased hemoglobin content|4.17:abnormal rib morphology|4.14:increased circulating sodium level|4.07:increased NK cell number",0.84:brain|0.83:central nervous system|0.83:nervous system|0.82:testis|0.81:liver|0.80:kidney|0.77:placenta|0.76:pancreas|0.76:cerebellum|0.74:ovary|0.74:lung|0.73:fetus|0.71:heart|0.71:forebrain|0.70:telencephalon|0.70:skeletal muscle|0.70:prostate gland|0.69:cerebral cortex|0.68:temporal lobe|0.67:amygdala|0.66:basal ganglion|0.65:hippocampus|0.63:corpus callosum|0.63:corpus striatum|0.62:diencephalon|0.62:midbrain|0.62:substantia nigra|0.62:caudate nucleus|0.61:spinal cord|0.59:spleen|0.55:intestine|0.54:gastrointestinal tract|0.53:thalamus|0.52:subthalamic nucleus|0.51:small intestine|0.49:mammary gland|0.48:autism spectrum disorder|0.46:uterus|0.46:large intestine|0.45:colon|0.34:lymph node|0.34:blood|0.32:leukocyte|0.28:thyroid gland|0.27:hypophysis|0.26:caudate putamen|0.26:adrenal gland|0.25:frontal lobe|0.24:occipital lobe|0.21:stomach|0.19:medulla oblongata|0.16:bone marrow|0.14:trachea|0.13:pons|0.13:blood vessel|0.12:skin|0.11:blood plasma|0.11:negative regulation of protein modification process|0.10:artery|0.10:peripheral nervous system disease|0.10:lymphocyte,98.87:Esophagus - Mucosa|80.97:Lung|62.50:Skin - Sun Exposed (Lower leg)|54.48:Brain - Spinal cord (cervical c-1)|49.35:Vagina|49.06:Skin - Not Sun Exposed (Suprapubic)|47.92:Kidney - Medulla|47.55:Adipose - Subcutaneous|43.21:Brain - Cortex|40.38:Kidney - Cortex|40.13:Breast - Mammary Tissue|36.67:Brain - Frontal Cortex (BA9)|35.05:Cervix - Ectocervix|33.08:Brain - Hippocampus|32.35:Spleen|31.85:Adipose - Visceral (Omentum)|31.59:Minor Salivary Gland|29.13:Nerve - Tibial|28.43:Brain - Nucleus accumbens (basal ganglia)|28.29:Fallopian Tube|28.06:Brain - Caudate (basal ganglia)|27.83:Brain - Substantia nigra|27.10:Thyroid|26.16:Brain - Hypothalamus|25.96:Small Intestine - Terminal Ileum|25.95:Brain - Putamen (basal ganglia)|25.49:Uterus|24.47:Brain - Anterior cingulate cortex (BA24)|24.18:Brain - Cerebellum|23.33:Brain - Amygdala|21.94:Cervix - Endocervix|21.86:Artery - Coronary|20.94:Stomach|20.89:Esophagus - Gastroesophageal Junction|20.50:Esophagus - Muscularis|20.20:Bladder|16.19:Prostate|13.76:Colon - Sigmoid|12.81:Brain - Cerebellar Hemisphere|12.73:Colon - Transverse|11.99:Artery - Aorta|10.97:Artery - Tibial|10.58:Pancreas|10.07:Heart - Atrial Appendage|8.65:Heart - Left Ventricle|5.59:Adrenal Gland|5.54:Pituitary|5.23:Testis|4.74:Muscle - Skeletal|4.59:Liver|4.35:Ovary|2.07:Whole Blood|0.52:Cells - EBV-transformed lymphocytes|0.42:Cells - Cultured fibroblasts,"13.37:cerebellum|12.99:cerebellar cortex|11.89:striatum|11.23:primary visual cortex (striate cortex, area V1/17)|10.30:primary somatosensory cortex (area S1, areas 3,1,2)|10.27:upper (rostral) rhombic lip|9.90:primary motor cortex (area M1, area 4)|9.30:ventrolateral prefrontal cortex|9.03:hippocampus (hippocampal formation)|8.83:amygdaloid complex|8.78:posterior (caudal) superior temporal cortex (area 22c)|8.54:mediodorsal nucleus of thalamus|8.45:primary auditory cortex (core)|8.35:orbital frontal cortex|8.27:posteroventral (inferior) parietal cortex|7.81:dorsolateral prefrontal cortex|7.35:inferolateral temporal cortex (area TEv, area 20)|7.20:anterior (rostral) cingulate (medial prefrontal) cortex|6.01:primary motor-sensory cortex (samples)|5.75:occipital neocortex|5.48:parietal neocortex|4.99:dorsal thalamus|4.82:temporal neocortex|4.71:lateral ganglionic eminence|3.82:medial ganglionic eminence|3.02:caudal ganglionic eminence",1,SNP,5.92,"34|0.30;0-33,35-46|0.00",4436614,NA,C|R,"N|118,120|C:T|R:C;N|167|^:^|^:^",0.0001,0.0001,P,D
46,SBSN,Homo sapiens suprabasin (SBSN) transcript variant 2 mRNA.,,NM_001166034,chr19,24.35,2e-02,0.77,8e-02,-,SBSN,35523367,35528371,suprabasin,protein_coding,UNQ698,0.04,0,0,1.66:Fuchs' endothelial dystrophy,NA,NA,NA,NA,2749.25:Skin - Sun Exposed (Lower leg)|2558.19:Skin - Not Sun Exposed (Suprapubic)|876.37:Vagina|855.56:Esophagus - Mucosa|22.29:Cells - Cultured fibroblasts|6.96:Brain - Nucleus accumbens (basal ganglia)|2.65:Brain - Caudate (basal ganglia)|1.48:Brain - Putamen (basal ganglia)|1.15:Minor Salivary Gland|1.08:Testis|1.05:Adipose - Subcutaneous|1.01:Adipose - Visceral (Omentum)|0.97:Nerve - Tibial|0.95:Esophagus - Gastroesophageal Junction|0.95:Artery - Tibial|0.91:Artery - Aorta|0.86:Esophagus - Muscularis|0.78:Ovary|0.77:Artery - Coronary|0.74:Breast - Mammary Tissue|0.72:Uterus|0.72:Thyroid|0.71:Brain - Cerebellum|0.70:Lung|0.69:Brain - Cortex|0.68:Colon - Sigmoid|0.65:Cervix - Endocervix|0.64:Cells - EBV-transformed lymphocytes|0.63:Small Intestine - Terminal Ileum|0.58:Prostate|0.58:Cervix - Ectocervix|0.57:Muscle - Skeletal|0.54:Heart - Atrial Appendage|0.53:Pituitary|0.52:Stomach|0.52:Brain - Frontal Cortex (BA9)|0.49:Spleen|0.48:Bladder|0.47:Brain - Cerebellar Hemisphere|0.46:Brain - Spinal cord (cervical c-1)|0.44:Colon - Transverse|0.43:Brain - Hypothalamus|0.43:Fallopian Tube|0.42:Brain - Hippocampus|0.40:Adrenal Gland|0.39:Whole Blood|0.38:Brain - Anterior cingulate cortex (BA24)|0.38:Liver|0.35:Pancreas|0.34:Heart - Left Ventricle|0.33:Brain - Substantia nigra|0.30:Brain - Amygdala|0.16:Kidney - Cortex|0.03:Kidney - Medulla,"0.06:striatum|0.05:cerebellum|0.03:upper (rostral) rhombic lip|0.02:primary visual cortex (striate cortex, area V1/17)|0.02:anterior (rostral) cingulate (medial prefrontal) cortex|0.02:primary somatosensory cortex (area S1, areas 3,1,2)|0.02:orbital frontal cortex|0.02:inferolateral temporal cortex (area TEv, area 20)|0.02:primary motor cortex (area M1, area 4)|0.02:primary motor-sensory cortex (samples)|0.02:posteroventral (inferior) parietal cortex|0.02:amygdaloid complex|0.02:medial ganglionic eminence|0.01:caudal ganglionic eminence|0.01:lateral ganglionic eminence|0.01:hippocampus (hippocampal formation)|0.01:dorsolateral prefrontal cortex|0.00:cerebellar cortex|0.00:ventrolateral prefrontal cortex|0.00:temporal neocortex|0.00:primary auditory cortex (core)|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:parietal neocortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:dorsal thalamus",3,SNP,4.90,"4|0.70;0-3,5-46|0.00",36017650,NA,G|L,"N|13|^:^|^:^;N|19|A:G|F:L;N|25|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37,39|^:^|^:^;N|41|^:^|^:^;N|43|^:^|^:^;N|56|^:^|^:^;N|58|^:^|^:^;N|65|^:^|^:^;N|67|^:^|^:^;N|83|^:^|^:^;N|88|^:^|^:^;N|108|^:^|^:^;N|119|^:^|^:^;N|126|^:^|^:^;N|128|^:^|^:^;N|147|^:^|^:^;N|152|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.52,0-46|0.00,36017929,NA,C|A,N|20|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|155|A:C|S:A,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,14.38,"39|0.08;31|-0.00;0-30,32-38,40-46|0.00",36018642,NA,GCCTGCCCTGCAGCATGGTGGACTCCCTGGCCAAACCTCCCAGCCTCATTTCCA|AGNEAGRFGQGVHHAAGQA,"8-10,12|^:^|^:^;14|^:^|^:^;27|^:^|^:^;30|^:^|^:^;34|^:^|^:^;35|^:^|^:^;40|^:^|^:^;41|^:^|^:^;43,45-46|^:^|^:^;50,52-53|^:^|^:^;54-55|^:^|^:^;58|^:^|^:^;63-64|^:^|^:^;71|^:^|^:^;73,76|^:^|^:^;83|^:^|^:^;87|^:^|^:^;92,94,96|^:^|^:^;107|^:^|^:^;108|^:^|^:^;111|-:GCCTGCCCTGCAGCATGGTGGACTCCCTGGCCAAACCTCCCAGCCTCATTTCCA|-:AGNEAGRFGQGVHHAAGQA;110|^:^|^:^;113|^:^|^:^;117|^:^|^:^;127|^:^|^:^;128|^:^|^:^;134,136|-:GCCTGCCCTGCAGCATGGTGGACTCCCTGGCCAAACCTCCCAGCCTCATTTCCA|-:AGNEAGRFGQGVHHAAGQA;146-148|^:^|^:^;151-152|^:^|^:^;155|^:^|^:^;159,162|^:^|^:^;163|^:^|^:^",NA,NA,NA,NA
47,FBL,Homo sapiens fibrillarin (FBL) mRNA.,,NM_001436,chr19,5.69,3e-02,0.29,5e-02,-,FBL,39834458,39846395,fibrillarin,protein_coding,"FIB,FLRN,Nop1,RNU3IP1",0.98,0,0,3.18:Liver cirrhosis|2.97:Hepatitis C|2.84:Hepatitis B|2.77:Nonalcoholic fatty liver disease|2.74:Hepatitis|2.52:Portal hypertension|2.48:Esophageal varix|2.45:Cancer|2.36:Varicose veins|2.33:Diabetes mellitus|2.26:Autoimmune hypersensitivity disease|2.20:Hypertension|2.17:Thrombosis|2.16:Connective tissue disease|2.12:Hepatic encephalopathy|2.11:Human immunodeficiency virus infectious disease|2.07:Alcohol use disorder|2.06:Heart disease|2.04:Lung disease|2.04:Cerebrovascular disease|2.01:Coronary artery disease|1.99:Kidney disease|1.97:Obesity|1.93:Myopathy|1.87:Cholangitis|1.86:Thrombocytopenia|1.85:Disseminated intravascular coagulation|1.85:Wilson disease|1.80:Anemia|1.73:Neurodegenerative disease|1.70:Hypersplenism|1.67:Skin disease|1.67:Cholestasis|1.64:Eye disease|1.64:Peripheral vascular disease|1.62:Lipid metabolism disorder|1.62:Intestinal disease|1.61:Breast disease|1.58:Hemochromatosis|1.56:Acute cystitis,0.65:Carcinoma,NA,NA,"0.98:ncRNA metabolic process|0.94:positive regulation of DNA metabolic process|0.94:activation of cysteine-type endopeptidase activity involved in apoptotic process|0.92:posttranscriptional regulation of gene expression|0.92:regulation of cysteine-type endopeptidase activity|0.89:regulation of histone methylation|0.89:positive regulation of peptidase activity|0.88:regulation of DNA metabolic process|0.87:regulation of histone modification|0.87:positive regulation of cysteine-type endopeptidase activity|0.85:positive regulation of endopeptidase activity|0.85:regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.83:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.82:rRNA metabolic process|0.80:regulation of translation|0.79:regulation of peptidase activity|0.79:positive regulation of histone modification|0.78:positive regulation of proteolysis|0.78:positive regulation of chromosome organization|0.77:blood|0.76:ncRNA processing|0.75:regulation of telomere maintenance|0.74:regulation of transcription by RNA polymerase I|0.74:negative regulation of protein modification process|0.73:RNA splicing|0.73:regulation of endopeptidase activity|0.71:mRNA splicing, via spliceosome|0.71:RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|0.71:leukocyte|0.70:RNA splicing, via transesterification reactions|0.69:negative regulation of histone methylation|0.67:regulation of protein serine/threonine kinase activity|0.66:ribonucleoprotein complex biogenesis|0.66:regulation of chromosome organization|0.64:complement activation|0.64:placenta|0.64:spliceosomal snRNP assembly|0.61:regulation of protein modification by small protein conjugation or removal|0.61:liver|0.60:regulation of signal transduction by p53 class mediator|0.58:nucleosome assembly|0.58:positive regulation of programmed cell death|0.57:positive regulation of telomere maintenance|0.57:positive regulation of apoptotic process|0.56:positive regulation of ERK1 and ERK2 cascade|0.54:signal transduction by p53 class mediator|0.54:positive regulation of immune response|0.54:DNA repair|0.54:testis|0.54:regulation of DNA biosynthetic process|0.53:regulation of telomere maintenance via telomere lengthening|0.53:ovary|0.52:translation|0.52:gastrointestinal tract|0.51:peptide biosynthetic process|0.50:regulation of apoptotic signaling pathway|0.50:regulation of cellular amide metabolic process|0.50:negative regulation of proteolysis|0.50:lymphocyte|0.50:apoptotic signaling pathway|0.49:spleen|0.48:intestine|0.48:regulation of immune response|0.47:regulation of pri-miRNA transcription by RNA polymerase II|0.46:positive regulation of pri-miRNA transcription by RNA polymerase II|0.45:skeletal muscle|0.45:mRNA metabolic process|0.44:positive regulation of protein modification by small protein conjugation or removal|0.44:bone marrow disease|0.44:regulation of multi-organism process|0.43:ERK1 and ERK2 cascade|0.43:central nervous system|0.42:positive regulation of DNA biosynthetic process|0.42:brain|0.42:lymph node|0.42:regulation of histone H3-K4 methylation|0.42:immune response-activating signal transduction|0.42:histone modification|0.42:pancreas|0.41:fetus|0.41:nervous system|0.41:immune response-regulating signaling pathway|0.41:activation of immune response|0.41:regulation of telomere maintenance via telomerase|0.41:positive regulation of protein kinase activity|0.41:regulation of ubiquitin-protein transferase activity|0.41:mRNA processing|0.40:protein alkylation|0.40:protein methylation|0.40:regulation of ERK1 and ERK2 cascade|0.40:prostate gland|0.39:positive regulation of MAPK cascade|0.38:amide biosynthetic process|0.38:negative regulation of telomere maintenance via telomere lengthening|0.38:large intestine|0.38:kidney|0.38:telomere maintenance|0.37:colon|0.36:negative regulation of histone acetylation|0.36:rRNA processing|0.36:small intestine|0.35:negative regulation of telomere maintenance via telomerase|0.34:nucleosome organization|0.33:regulation of complement activation|0.33:regulation of protein activation cascade|0.33:lung|0.30:positive regulation of nucleocytoplasmic transport|0.30:regulation of DNA binding transcription factor activity|0.30:negative regulation of histone modification|0.30:peptide metabolic process|0.29:pri-miRNA transcription by RNA polymerase II|0.29:negative regulation of telomere maintenance|0.28:negative regulation of DNA binding transcription factor activity|0.28:regulation of defense response|0.28:mononuclear phagocyte|0.27:autism spectrum disorder|0.27:monocyte|0.27:regulation of protein ubiquitination|0.27:negative regulation of translation|0.26:pure red-cell aplasia|0.26:Diamond-Blackfan anemia|0.26:positive regulation of cytokine production|0.25:ribosome biogenesis|0.25:heart|0.24:negative regulation of protein catabolic process|0.24:regulation of DNA-dependent DNA replication|0.23:thyroid gland|0.23:regulation of RNA splicing|0.23:mammary gland|0.23:positive regulation of cellular protein localization|0.23:negative regulation of protein phosphorylation|0.22:positive regulation of protein transport|0.21:ribonucleoprotein complex assembly|0.21:T-lymphocyte|0.21:regulation of innate immune response|0.21:regulation of immune effector process|0.21:negative regulation of proteolysis involved in cellular protein catabolic process|0.20:intrinsic apoptotic signaling pathway|0.20:regulation of chromatin organization|0.20:uterus|0.20:histone H3 acetylation|0.20:regulation of response to external stimulus|0.20:regulation of mRNA metabolic process|0.19:transcription by RNA polymerase I|0.19:regulation of histone H3-K9 methylation|0.19:intracellular receptor signaling pathway|0.19:negative regulation of protein acetylation|0.19:negative regulation of viral process|0.19:peptidyl-lysine modification|0.19:ribonucleoprotein complex subunit organization|0.18:positive regulation of protein serine/threonine kinase activity|0.18:negative regulation of MAPK cascade|0.18:positive regulation of DNA replication|0.18:negative regulation of chromosome organization|0.18:regulation of peptidyl-serine phosphorylation|0.18:positive regulation of telomerase RNA localization to Cajal body|0.18:positive regulation of telomerase activity|0.17:negative regulation of mRNA processing|0.17:regulation of viral genome replication|0.17:negative regulation of viral life cycle|0.17:histone H3-K4 methylation|0.17:negative regulation of peptidyl-lysine acetylation|0.17:positive regulation of DNA binding transcription factor activity|0.17:negative regulation of cellular protein catabolic process|0.17:regulation of telomerase RNA localization to Cajal body|0.17:positive regulation of cell differentiation|0.17:negative regulation of immune system process|0.17:negative regulation of peptidase activity|0.16:regulation of telomerase activity|0.16:adrenal gland|0.16:positive regulation of innate immune response|0.16:androgen receptor signaling pathway|0.16:dyskeratosis congenita|0.16:regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|0.16:congenital hypoplastic anemia|0.16:regulation of histone H3-K9 trimethylation|0.15:negative regulation of multi-organism process|0.15:regulation of viral process|0.15:positive regulation of transcription by RNA polymerase I|0.15:regulation of nucleocytoplasmic transport|0.15:positive regulation of chromatin organization|0.15:positive regulation of histone acetylation|0.14:positive regulation of response to external stimulus|0.14:granulocyte|0.14:negative regulation of organelle organization|0.14:base-excision repair|0.14:regulation of intrinsic apoptotic signaling pathway|0.14:protein activation cascade|0.14:negative regulation of protein modification by small protein conjugation or removal|0.14:positive regulation of cellular component movement|0.13:negative regulation of protein kinase activity|0.13:blood plasma|0.13:positive regulation of defense response|0.13:positive regulation of peptidyl-lysine acetylation|0.13:chromatin assembly|0.13:negative regulation of protein ubiquitination|0.13:histone H3-K9 methylation|0.13:negative regulation of endopeptidase activity|0.13:negative regulation of developmental process|0.13:regulation of intracellular protein transport|0.13:negative regulation of intracellular signal transduction|0.13:negative regulation of viral genome replication|0.13:tear gland|0.13:positive regulation of cell motility|0.12:eye|0.12:protein localization to chromosome|0.12:regulation of proteolysis involved in cellular protein catabolic process|0.12:aplastic anemia|0.12:thymocyte|0.12:erythrocyte|0.12:gene silencing by miRNA|0.12:negative regulation of mRNA metabolic process|0.12:bone marrow|0.12:positive regulation of translation|0.11:ncRNA transcription|0.11:positive regulation of cell cycle process|0.11:cerebellum|0.11:protein deubiquitination|0.11:negative regulation of DNA biosynthetic process|0.11:positive regulation of telomere maintenance via telomere lengthening|0.11:protein sumoylation|0.11:cerebral degeneration|0.11:regulation of histone acetylation|0.11:activation of innate immune response|0.11:positive regulation of chemotaxis|0.11:mammary epithelium|0.11:protein modification by small protein removal|0.11:regulation of protein catabolic process|0.11:hypophysis|0.10:muscle|0.10:regulation of RNA stability|0.10:regulation of protein sumoylation|0.10:positive regulation of cellular amide metabolic process|0.10:positive regulation of leukocyte activation|0.10:regulation of protein acetylation|0.10:negative regulation of cellular amide metabolic process|0.10:chromatin assembly or disassembly|0.10:RNA methylation|0.10:regulation of inflammatory response|0.10:regulation of transcription of nucleolar large rRNA by RNA polymerase I|0.10:regulation of protein localization to chromosome, telomeric region|0.10:cellular response to external stimulus|0.10:positive regulation of histone H4 acetylation|0.10:negative regulation of apoptotic signaling pathway|0.10:protein localization to chromosome, telomeric region",409.04:Cells - EBV-transformed lymphocytes|380.03:Ovary|271.53:Cervix - Ectocervix|258.69:Cervix - Endocervix|248.62:Uterus|248.08:Cells - Cultured fibroblasts|245.17:Skin - Sun Exposed (Lower leg)|244.82:Skin - Not Sun Exposed (Suprapubic)|211.10:Vagina|196.77:Fallopian Tube|188.70:Breast - Mammary Tissue|184.42:Esophagus - Mucosa|163.96:Testis|162.37:Nerve - Tibial|156.49:Adipose - Subcutaneous|153.42:Bladder|152.52:Spleen|150.10:Prostate|142.56:Thyroid|133.56:Adipose - Visceral (Omentum)|129.99:Artery - Tibial|125.63:Small Intestine - Terminal Ileum|125.03:Artery - Aorta|119.62:Lung|117.66:Artery - Coronary|115.43:Minor Salivary Gland|111.17:Colon - Sigmoid|110.50:Colon - Transverse|109.79:Esophagus - Gastroesophageal Junction|100.67:Esophagus - Muscularis|94.91:Pituitary|93.43:Stomach|93.05:Kidney - Medulla|82.95:Adrenal Gland|77.76:Brain - Cerebellar Hemisphere|74.74:Pancreas|69.66:Brain - Cerebellum|61.91:Muscle - Skeletal|59.58:Brain - Spinal cord (cervical c-1)|59.43:Whole Blood|47.66:Kidney - Cortex|46.71:Brain - Nucleus accumbens (basal ganglia)|44.02:Heart - Atrial Appendage|42.70:Brain - Substantia nigra|40.54:Brain - Amygdala|38.99:Brain - Caudate (basal ganglia)|38.89:Brain - Frontal Cortex (BA9)|38.60:Brain - Putamen (basal ganglia)|37.88:Brain - Hypothalamus|36.25:Brain - Cortex|36.04:Liver|34.89:Brain - Hippocampus|34.82:Brain - Anterior cingulate cortex (BA24)|28.31:Heart - Left Ventricle,"257.86:occipital neocortex|237.38:caudal ganglionic eminence|211.93:parietal neocortex|185.61:medial ganglionic eminence|175.91:temporal neocortex|165.93:lateral ganglionic eminence|155.86:primary motor-sensory cortex (samples)|124.67:cerebellum|103.09:upper (rostral) rhombic lip|88.62:dorsal thalamus|61.08:striatum|56.62:ventrolateral prefrontal cortex|56.05:hippocampus (hippocampal formation)|47.75:amygdaloid complex|46.81:dorsolateral prefrontal cortex|45.38:cerebellar cortex|43.56:posterior (caudal) superior temporal cortex (area 22c)|43.33:posteroventral (inferior) parietal cortex|41.93:primary motor cortex (area M1, area 4)|41.68:primary auditory cortex (core)|40.61:primary somatosensory cortex (area S1, areas 3,1,2)|40.29:orbital frontal cortex|40.26:inferolateral temporal cortex (area TEv, area 20)|37.29:anterior (rostral) cingulate (medial prefrontal) cortex|35.83:primary visual cortex (striate cortex, area V1/17)|33.36:mediodorsal nucleus of thalamus",2,SNP,2.19,0-46|0.00,40330874,2,G|S,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|74|A:A|L:L;B|75-77|A:G|L:S;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.02,"13|0.29;0-12,14-46|0.00",40331367,NA,C|R,N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|48-49|C:T|R:H;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^,0.0013,0.0015,P,T
48,ARRB2,Homo sapiens arrestin beta 2 (ARRB2) transcript variant 2 mRNA.,Imflammation mediated by chemokine and cytokine signaling;Wnt Signaling Pathway;Neurological system process,NM_004313,chr17,3.55,3e-02,0.19,3e-02,+,ARRB2,4710619,4721500,arrestin beta 2,protein_coding,"ARB2,ARR2,BARR2",0.77,0,0,2.33:Pain agnosia|1.96:Schizophrenia|1.93:Cancer|1.87:Constipation|1.83:Diabetes mellitus|1.77:Neurodegenerative disease|1.73:Substance dependence|1.71:Mood disorder|1.71:Hypertension|1.66:Asthma|1.59:Obesity|1.59:Placenta praevia|1.58:Lung disease|1.57:Prostate disease|1.56:Substance abuse|1.55:Kidney disease|1.54:WHIM syndrome|1.53:Heart disease,NA,NA,16.07:increased circulating alkaline phosphatase level|8.15:increased circulating HDL cholesterol level|5.52:increased grip strength|5.07:increased circulating phosphate level|4.98:decreased total body fat amount|4.51:increased circulating cholesterol level|4.16:thrombocytopenia,1.00:cAMP catabolic process|1.00:cyclic nucleotide catabolic process|0.97:translation|0.97:peptide biosynthetic process|0.96:regulation of translation|0.96:neutrophil|0.95:granulocyte|0.93:regulation of cellular amide metabolic process|0.91:regulation of immune response|0.91:posttranscriptional regulation of gene expression|0.91:blood|0.90:leukocyte|0.89:spleen|0.88:amide biosynthetic process|0.84:mononuclear phagocyte|0.83:monocyte|0.81:lymph node|0.81:peptide metabolic process|0.78:lymphocyte|0.78:regulation of interleukin-5 production|0.74:negative regulation of protein modification process|0.74:positive regulation of immune response|0.74:immune response-activating signal transduction|0.72:immune response-regulating signaling pathway|0.71:central nervous system|0.70:dendritic cell|0.69:placenta|0.68:blood plasma|0.68:activation of immune response|0.67:nervous system|0.66:liver|0.66:blood platelet|0.65:T-lymphocyte|0.63:brain|0.61:lung|0.61:macrophage|0.60:B-lymphocyte|0.59:hematopoietic stem cell|0.59:regulation of ubiquitin-protein transferase activity|0.57:regulation of cysteine-type endopeptidase activity|0.57:G-protein coupled receptor signaling pathway|0.57:regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.55:cAMP metabolic process|0.55:kidney|0.55:positive regulation of endopeptidase activity|0.54:apoptotic signaling pathway|0.54:fetus|0.54:bone development disease|0.53:positive regulation of peptidase activity|0.53:positive regulation of proteolysis|0.52:positive regulation of interleukin-2 production|0.52:cellular response to external stimulus|0.51:eosinophil|0.51:dysostosis|0.50:regulation of translational initiation by eIF2 alpha phosphorylation|0.50:pancreas|0.50:ovary|0.50:immune response-regulating cell surface receptor signaling pathway|0.50:testis|0.49:colon|0.49:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.48:heart|0.47:autism spectrum disorder|0.47:regulation of translation in response to stress|0.47:positive regulation of cysteine-type endopeptidase activity|0.47:ribonucleotide catabolic process|0.46:regulation of interleukin-2 production|0.46:G-protein coupled receptor internalization|0.45:positive regulation of cardiac muscle tissue development|0.45:activation of MAPK activity|0.44:erythrocyte|0.43:stress-activated MAPK cascade|0.43:regulation of apoptotic signaling pathway|0.42:large intestine|0.42:prostate gland|0.41:regulation of peptidase activity|0.40:regulation of MAP kinase activity|0.40:positive regulation of small GTPase mediated signal transduction|0.40:cyclic nucleotide metabolic process|0.40:gastrointestinal tract|0.39:JNK cascade|0.39:small intestine|0.38:regulation of endopeptidase activity|0.38:immune response-activating cell surface receptor signaling pathway|0.37:intrinsic apoptotic signaling pathway|0.37:intestine|0.36:regulation of translational initiation in response to stress|0.36:T cell receptor signaling pathway|0.36:negative regulation of cell cycle|0.36:natural killer cell|0.35:regulation of I-kappaB kinase/NF-kappaB signaling|0.34:I-kappaB kinase/NF-kappaB signaling|0.34:bone marrow|0.33:Treacher Collins syndrome|0.33:regulation of mitotic cell cycle|0.33:antigen receptor-mediated signaling pathway|0.33:regulation of protein serine/threonine kinase activity|0.32:positive regulation of histone acetylation|0.31:positive regulation of cytokine production|0.31:positive regulation of striated muscle tissue development|0.31:positive regulation of muscle organ development|0.31:positive regulation of peptidyl-lysine acetylation|0.30:negative regulation of I-kappaB kinase/NF-kappaB signaling|0.30:regulation of cardiac muscle tissue development|0.30:positive regulation of protein acetylation|0.30:cellular response to mechanical stimulus|0.30:cerebellum|0.30:tonsil|0.30:negative regulation of MAP kinase activity|0.29:response to mechanical stimulus|0.29:forebrain|0.29:positive regulation of muscle tissue development|0.29:regulation of histone modification|0.28:negative regulation of intracellular signal transduction|0.28:negative regulation of cellular amide metabolic process|0.28:negative regulation of translation|0.28:proteasomal protein catabolic process|0.28:regulation of lipid kinase activity|0.27:temporal lobe|0.27:mammary gland|0.27:cerebral cortex|0.27:activation of cysteine-type endopeptidase activity involved in apoptotic process|0.26:telencephalon|0.26:spinal cord|0.26:skeletal muscle|0.25:cellular response to abiotic stimulus|0.25:uterus|0.25:positive regulation of Ras protein signal transduction|0.24:negative regulation of NF-kappaB transcription factor activity|0.24:regulation of translation in response to endoplasmic reticulum stress|0.23:hypophysis|0.23:positive regulation of histone modification|0.23:purine ribonucleotide catabolic process|0.23:cellular response to inorganic substance|0.23:positive regulation of MAP kinase activity|0.23:negative regulation of protein ubiquitination|0.22:positive regulation of histone H4 acetylation|0.22:adrenal gland|0.22:regulation of defense response|0.21:positive regulation of apoptotic signaling pathway|0.21:megakaryocyte|0.21:eiF2alpha phosphorylation in response to endoplasmic reticulum stress|0.20:phosphatidylinositol-mediated signaling|0.20:inositol lipid-mediated signaling|0.20:regulation of cell cycle phase transition|0.20:cellular response to metal ion|0.20:negative regulation of protein serine/threonine kinase activity|0.19:prostate carcinoma|0.19:signal transduction by p53 class mediator|0.19:JUN phosphorylation|0.19:congestive heart failure|0.19:thyroid gland|0.19:gastrointestinal system cancer|0.19:gene silencing by miRNA|0.19:acute leukemia|0.19:negative regulation of cell cycle process|0.19:serum|0.18:response to metal ion|0.18:positive regulation of gene silencing by miRNA|0.18:cellular response to amino acid starvation|0.18:stress-activated protein kinase signaling cascade|0.18:hippocampus|0.18:caudate putamen|0.18:regulation of protein acetylation|0.18:corpus striatum|0.18:basal ganglion|0.17:response to inorganic substance|0.17:negative regulation of MAPK cascade|0.17:positive regulation of programmed cell death|0.17:regulation of JNK cascade|0.17:cellular response to nutrient levels|0.16:negative regulation of protein phosphorylation|0.16:cellular response to oxidative stress|0.16:positive regulation of apoptotic process|0.16:regulation of mitotic cell cycle phase transition|0.16:thymocyte|0.16:blood vessel|0.16:diencephalon|0.15:microglia|0.15:Langerhans cell|0.15:response to temperature stimulus|0.15:basophil|0.15:negative regulation of telomere maintenance via telomerase|0.15:regulation of gene silencing by miRNA|0.15:negative regulation of protein catabolic process|0.15:regulation of stress-activated MAPK cascade|0.15:caudate nucleus|0.15:prostate cancer|0.15:cellular response to extracellular stimulus|0.15:response to extracellular stimulus|0.15:regulation of peptidyl-lysine acetylation|0.14:frontal lobe|0.14:peripheral blood cell|0.14:positive regulation of JUN kinase activity|0.14:positive regulation of cell cycle|0.14:amygdala|0.14:response to tumor necrosis factor|0.14:negative regulation of protein kinase activity|0.14:negative regulation of kinase activity|0.14:auditory system disease|0.14:regulation of intrinsic apoptotic signaling pathway|0.14:regulation of muscle organ development|0.14:ubiquitin-dependent protein catabolic process|0.14:negative regulation of phosphorylation|0.14:activation of protein kinase activity|0.13:stomach|0.13:negative regulation of telomere maintenance via telomere lengthening|0.13:positive regulation of JNK cascade|0.13:negative regulation of cyclin-dependent protein kinase activity|0.13:positive regulation of protein serine/threonine kinase activity|0.13:negative regulation of organelle organization|0.13:thalamus|0.13:regulation of striated muscle tissue development|0.13:modification-dependent macromolecule catabolic process|0.12:response to nutrient levels|0.12:regulation of lymphocyte activation|0.12:regulation of protein ubiquitination|0.12:occipital lobe|0.12:negative regulation of immune system process|0.12:negative regulation of telomere maintenance|0.12:cellular response to organic cyclic compound|0.12:regulation of cellular protein catabolic process|0.12:overnutrition|0.12:regulation of translation initiation in response to endoplasmic reticulum stress|0.12:regulation of histone acetylation|0.12:leukemia|0.11:purine nucleotide catabolic process|0.11:response to oxidative stress|0.11:tear gland|0.11:regulation of chromosome organization|0.11:positive regulation of stress-activated MAPK cascade|0.11:cellular response to tumor necrosis factor|0.11:regulation of telomere maintenance|0.11:cecum|0.11:corpus callosum|0.11:regulation of protein modification by small protein conjugation or removal|0.11:reproductive organ cancer|0.11:midbrain|0.11:plasma membrane to endosome transport|0.10:pons|0.10:regulation of interferon-gamma production|0.10:hereditary spastic paraplegia|0.10:regulation of actin filament polymerization|0.10:regulation of DNA biosynthetic process|0.10:prostate disease,703.14:Whole Blood|206.60:Spleen|139.25:Lung|101.94:Brain - Cerebellar Hemisphere|100.28:Brain - Cerebellum|55.66:Small Intestine - Terminal Ileum|53.26:Adipose - Visceral (Omentum)|51.99:Nerve - Tibial|51.97:Brain - Frontal Cortex (BA9)|49.55:Brain - Cortex|47.98:Adipose - Subcutaneous|41.93:Brain - Spinal cord (cervical c-1)|40.95:Brain - Anterior cingulate cortex (BA24)|40.25:Brain - Hippocampus|40.03:Artery - Coronary|39.14:Brain - Hypothalamus|38.98:Adrenal Gland|38.01:Cells - EBV-transformed lymphocytes|37.87:Artery - Aorta|37.06:Fallopian Tube|34.51:Pituitary|33.02:Uterus|32.96:Brain - Amygdala|31.77:Breast - Mammary Tissue|31.69:Colon - Sigmoid|31.24:Cervix - Endocervix|30.82:Stomach|29.51:Colon - Transverse|29.29:Brain - Substantia nigra|28.67:Bladder|27.91:Esophagus - Gastroesophageal Junction|27.12:Ovary|26.61:Esophagus - Muscularis|26.02:Prostate|25.42:Vagina|25.01:Cervix - Ectocervix|24.71:Brain - Nucleus accumbens (basal ganglia)|24.62:Thyroid|22.13:Minor Salivary Gland|20.88:Brain - Caudate (basal ganglia)|20.03:Artery - Tibial|17.70:Kidney - Medulla|17.23:Brain - Putamen (basal ganglia)|17.21:Skin - Sun Exposed (Lower leg)|16.34:Skin - Not Sun Exposed (Suprapubic)|16.00:Liver|15.86:Kidney - Cortex|14.25:Esophagus - Mucosa|12.80:Heart - Atrial Appendage|11.56:Testis|11.50:Cells - Cultured fibroblasts|10.04:Heart - Left Ventricle|8.29:Pancreas|6.40:Muscle - Skeletal,"35.95:cerebellar cortex|35.48:upper (rostral) rhombic lip|34.82:cerebellum|33.52:occipital neocortex|32.90:primary motor-sensory cortex (samples)|31.44:caudal ganglionic eminence|31.12:posterior (caudal) superior temporal cortex (area 22c)|31.11:parietal neocortex|30.70:hippocampus (hippocampal formation)|29.71:amygdaloid complex|29.36:primary visual cortex (striate cortex, area V1/17)|28.19:inferolateral temporal cortex (area TEv, area 20)|28.16:ventrolateral prefrontal cortex|27.92:anterior (rostral) cingulate (medial prefrontal) cortex|27.63:dorsolateral prefrontal cortex|27.08:lateral ganglionic eminence|26.97:dorsal thalamus|26.91:primary motor cortex (area M1, area 4)|26.79:posteroventral (inferior) parietal cortex|26.49:primary auditory cortex (core)|26.46:primary somatosensory cortex (area S1, areas 3,1,2)|26.40:medial ganglionic eminence|25.88:orbital frontal cortex|25.42:temporal neocortex|24.01:mediodorsal nucleus of thalamus|21.12:striatum",1,SNP,2.70,0|0.19;1-46|0.00,4621581,NA,A|N,"N|2,4|A:G|N:S;N|35|^:^|^:^;N|50|^:^|^:^;N|167|^:^|^:^",6.571e-05,0.0001,B,T
49,COX7A1,Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1) nuclear gene encoding mitochondrial protein mRNA.,,NM_001864,chr19,9.50,3e-02,0.09,7e-02,-,COX7A1,36150922,36152447,cytochrome c oxidase subunit 7A1,protein_coding,"COX7A,COX7AH,COX7AM",0.00,0,0,2.12:Obesity|1.82:Diabetes mellitus,NA,NA,NA,0.80:heart|0.78:skeletal muscle|0.60:nervous system|0.58:central nervous system|0.54:brain|0.48:kidney|0.47:fetus|0.46:ovary|0.44:pancreas|0.43:blood vessel|0.42:liver|0.42:muscle|0.41:autism spectrum disorder|0.39:prostate gland|0.39:cardiac muscle|0.37:lung|0.36:placenta|0.36:artery|0.34:lymph node|0.32:aorta|0.29:colon|0.27:large intestine|0.27:blood|0.27:testis|0.27:gastrointestinal tract|0.26:renal glomerulus|0.25:uterus|0.24:intestine|0.24:blood plasma|0.23:mammary gland|0.23:umbilical vein endothelial cell|0.22:hypophysis|0.22:nephron|0.21:neuron|0.21:vascular endothelial cell|0.20:spleen|0.20:small intestine|0.19:thyroid gland|0.19:adrenal gland|0.19:eye|0.18:telencephalon|0.18:amygdala|0.18:stomach|0.18:skin|0.17:forebrain|0.17:basal ganglion|0.17:cerebral cortex|0.17:cerebellum|0.16:smooth muscle|0.16:leukocyte|0.16:serum|0.15:umbilical cord|0.15:corpus striatum|0.14:regulation of response to external stimulus|0.14:midbrain|0.14:parenchyma|0.14:heart ventricle|0.14:bone marrow|0.14:thalamus|0.14:substantia nigra|0.14:temporal lobe|0.13:podocyte|0.13:atrium|0.12:hippocampus|0.12:cardiomyopathy|0.12:diencephalon|0.12:spinal cord|0.12:caudate nucleus|0.12:regulation of ion transmembrane transport|0.11:regulation of transmembrane transport|0.11:regulation of system process|0.11:ERK1 and ERK2 cascade|0.11:regulation of ion transport|0.11:positive regulation of MAPK cascade|0.10:peripheral nervous system disease|0.10:regulation of ERK1 and ERK2 cascade|0.10:positive regulation of cell differentiation|0.10:neuropathy,704.83:Muscle - Skeletal|584.26:Heart - Left Ventricle|508.08:Heart - Atrial Appendage|182.09:Artery - Tibial|166.95:Esophagus - Muscularis|162.62:Artery - Aorta|161.52:Esophagus - Gastroesophageal Junction|144.17:Artery - Coronary|119.77:Colon - Sigmoid|109.40:Pituitary|107.60:Adipose - Subcutaneous|91.70:Adipose - Visceral (Omentum)|79.59:Breast - Mammary Tissue|78.45:Bladder|76.72:Cervix - Ectocervix|74.80:Uterus|68.49:Cervix - Endocervix|68.05:Fallopian Tube|63.83:Lung|60.97:Kidney - Medulla|59.91:Nerve - Tibial|58.54:Thyroid|56.55:Prostate|56.46:Adrenal Gland|55.67:Brain - Frontal Cortex (BA9)|53.46:Vagina|49.41:Ovary|46.51:Brain - Cortex|44.30:Colon - Transverse|36.98:Brain - Cerebellar Hemisphere|35.23:Minor Salivary Gland|32.77:Brain - Cerebellum|29.73:Brain - Amygdala|28.11:Kidney - Cortex|27.62:Cells - Cultured fibroblasts|27.20:Brain - Caudate (basal ganglia)|27.15:Spleen|26.94:Brain - Anterior cingulate cortex (BA24)|26.45:Skin - Sun Exposed (Lower leg)|23.62:Brain - Putamen (basal ganglia)|20.11:Brain - Nucleus accumbens (basal ganglia)|19.79:Brain - Hypothalamus|19.00:Skin - Not Sun Exposed (Suprapubic)|18.34:Brain - Hippocampus|17.35:Small Intestine - Terminal Ileum|17.14:Brain - Substantia nigra|15.79:Esophagus - Mucosa|13.80:Brain - Spinal cord (cervical c-1)|12.86:Stomach|12.32:Testis|8.17:Pancreas|3.14:Liver|0.50:Whole Blood|0.40:Cells - EBV-transformed lymphocytes,"30.85:primary visual cortex (striate cortex, area V1/17)|27.13:posterior (caudal) superior temporal cortex (area 22c)|24.37:primary auditory cortex (core)|24.26:primary somatosensory cortex (area S1, areas 3,1,2)|23.74:posteroventral (inferior) parietal cortex|22.06:inferolateral temporal cortex (area TEv, area 20)|19.00:primary motor cortex (area M1, area 4)|17.25:amygdaloid complex|16.59:ventrolateral prefrontal cortex|14.18:cerebellar cortex|13.35:orbital frontal cortex|11.30:dorsolateral prefrontal cortex|10.90:hippocampus (hippocampal formation)|9.96:mediodorsal nucleus of thalamus|8.27:striatum|7.21:anterior (rostral) cingulate (medial prefrontal) cortex|6.70:upper (rostral) rhombic lip|5.58:cerebellum|2.58:dorsal thalamus|1.93:primary motor-sensory cortex (samples)|1.18:occipital neocortex|1.14:parietal neocortex|1.04:temporal neocortex|0.89:medial ganglionic eminence|0.83:caudal ganglionic eminence|0.71:lateral ganglionic eminence",1,SNP,9.07,"38|0.09;0-37,39-46|0.00",36643294,NA,C,N|132-133|C:T,2.481e-05,0,NA,NA
50,ZNF302,Homo sapiens zinc finger protein 302 (ZNF302) transcript variant 1 mRNA.,Transcription Factor,NM_001012320,chr19,16.98,4e-02,0.60,6e-02,+,ZNF302,34677639,34686397,zinc finger protein 302,protein_coding,"HSD16,MST154,MSTP154,ZNF135L,ZNF140L,ZNF327",0.01,0,0,2.02:Hypospadias|1.89:Ectodermal dysplasia,NA,NA,NA,NA,73.63:Brain - Cerebellar Hemisphere|63.18:Brain - Cerebellum|54.55:Ovary|49.63:Fallopian Tube|48.77:Thyroid|47.77:Uterus|44.45:Cervix - Endocervix|42.63:Nerve - Tibial|39.28:Colon - Sigmoid|38.64:Cervix - Ectocervix|37.71:Pituitary|36.80:Prostate|35.92:Bladder|34.87:Testis|34.37:Esophagus - Gastroesophageal Junction|34.25:Esophagus - Muscularis|33.17:Brain - Spinal cord (cervical c-1)|32.22:Spleen|30.99:Artery - Coronary|30.77:Artery - Aorta|28.81:Artery - Tibial|28.66:Brain - Frontal Cortex (BA9)|28.60:Lung|27.68:Vagina|27.09:Kidney - Medulla|26.75:Small Intestine - Terminal Ileum|26.73:Breast - Mammary Tissue|25.50:Brain - Cortex|24.95:Cells - Cultured fibroblasts|24.65:Adrenal Gland|24.20:Colon - Transverse|24.16:Muscle - Skeletal|23.87:Adipose - Subcutaneous|22.81:Brain - Nucleus accumbens (basal ganglia)|22.78:Brain - Caudate (basal ganglia)|22.62:Cells - EBV-transformed lymphocytes|21.97:Brain - Substantia nigra|21.84:Minor Salivary Gland|21.37:Brain - Anterior cingulate cortex (BA24)|21.07:Adipose - Visceral (Omentum)|20.63:Brain - Hypothalamus|19.41:Brain - Hippocampus|19.14:Brain - Putamen (basal ganglia)|18.79:Brain - Amygdala|18.12:Stomach|18.11:Heart - Atrial Appendage|16.19:Pancreas|15.59:Heart - Left Ventricle|15.24:Skin - Not Sun Exposed (Suprapubic)|15.09:Skin - Sun Exposed (Lower leg)|13.31:Esophagus - Mucosa|13.02:Kidney - Cortex|12.34:Liver|1.20:Whole Blood,"12.41:primary motor-sensory cortex (samples)|9.82:cerebellar cortex|8.27:inferolateral temporal cortex (area TEv, area 20)|8.08:occipital neocortex|8.01:lateral ganglionic eminence|7.82:medial ganglionic eminence|7.80:caudal ganglionic eminence|7.50:temporal neocortex|7.44:dorsal thalamus|7.43:striatum|7.32:primary auditory cortex (core)|7.31:posterior (caudal) superior temporal cortex (area 22c)|7.24:parietal neocortex|7.02:primary visual cortex (striate cortex, area V1/17)|6.95:orbital frontal cortex|6.89:primary somatosensory cortex (area S1, areas 3,1,2)|6.76:amygdaloid complex|6.67:posteroventral (inferior) parietal cortex|6.64:ventrolateral prefrontal cortex|6.63:dorsolateral prefrontal cortex|6.62:hippocampus (hippocampal formation)|6.29:cerebellum|6.26:primary motor cortex (area M1, area 4)|6.08:anterior (rostral) cingulate (medial prefrontal) cortex|4.96:upper (rostral) rhombic lip|4.87:mediodorsal nucleus of thalamus",2,SNP,4.19,0-46|0.00,35175877,62,G|R,"B|11-12|A:G|H:R;B|18-19|A:G|H:R;B|59|A:G|H:R;B|69,72|A:G|H:R;B|73,75,77|A:G|H:R;B|78|A:A|H:H;B|80-81|A:G|H:R;B|115-116|A:G|H:R;B|122-123|A:G|H:R;B|132-133|A:G|H:R;B|138,141|A:G|H:R;B|159,161-162|A:G|H:R",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,9.80,"44|0.60;0-43,45-46|0.00",35175332,NA,AA|SK,30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;83|^:^|^:^;108|^:^|^:^;128|^:^|^:^;155-158|-:AA|-:SK,NA,NA,NA,NA
52,GRAMD1A,Homo sapiens GRAM domain containing 1A (GRAMD1A) transcript variant 1 mRNA.,,NM_020895,chr19,14.21,5e-02,0.32,1e-01,+,GRAMD1A,34994727,35026471,GRAM domain containing 1A,protein_coding,KIAA1533,0.57,0,0,1.55:Dravet syndrome,NA,NA,NA,NA,140.19:Whole Blood|108.70:Lung|99.61:Ovary|99.26:Fallopian Tube|89.06:Cervix - Endocervix|87.49:Uterus|85.52:Cervix - Ectocervix|79.99:Spleen|74.59:Nerve - Tibial|67.40:Prostate|65.11:Bladder|64.53:Cells - EBV-transformed lymphocytes|60.64:Artery - Coronary|60.26:Adipose - Visceral (Omentum)|59.93:Artery - Aorta|59.75:Breast - Mammary Tissue|59.53:Thyroid|58.22:Adipose - Subcutaneous|57.53:Artery - Tibial|56.75:Pituitary|52.90:Esophagus - Gastroesophageal Junction|52.02:Colon - Sigmoid|51.34:Adrenal Gland|50.40:Esophagus - Muscularis|48.58:Brain - Cerebellum|46.65:Pancreas|45.59:Vagina|45.09:Brain - Cerebellar Hemisphere|44.95:Minor Salivary Gland|43.12:Small Intestine - Terminal Ileum|42.75:Testis|42.50:Stomach|37.79:Cells - Cultured fibroblasts|33.66:Muscle - Skeletal|31.47:Colon - Transverse|30.08:Kidney - Medulla|28.43:Brain - Cortex|26.34:Skin - Sun Exposed (Lower leg)|25.86:Kidney - Cortex|24.95:Brain - Frontal Cortex (BA9)|24.44:Heart - Atrial Appendage|24.43:Brain - Hypothalamus|23.89:Brain - Spinal cord (cervical c-1)|21.50:Skin - Not Sun Exposed (Suprapubic)|19.69:Brain - Anterior cingulate cortex (BA24)|19.14:Brain - Substantia nigra|17.78:Brain - Nucleus accumbens (basal ganglia)|17.52:Brain - Hippocampus|15.91:Brain - Amygdala|15.87:Brain - Caudate (basal ganglia)|15.29:Esophagus - Mucosa|14.83:Heart - Left Ventricle|14.09:Brain - Putamen (basal ganglia)|10.37:Liver,"50.38:upper (rostral) rhombic lip|43.41:cerebellum|41.08:dorsal thalamus|34.99:caudal ganglionic eminence|32.97:primary motor-sensory cortex (samples)|32.16:lateral ganglionic eminence|31.27:medial ganglionic eminence|31.21:temporal neocortex|29.44:parietal neocortex|27.62:occipital neocortex|23.26:mediodorsal nucleus of thalamus|20.64:hippocampus (hippocampal formation)|20.55:primary visual cortex (striate cortex, area V1/17)|19.72:orbital frontal cortex|19.39:cerebellar cortex|18.63:anterior (rostral) cingulate (medial prefrontal) cortex|18.59:ventrolateral prefrontal cortex|18.24:striatum|18.15:amygdaloid complex|17.77:dorsolateral prefrontal cortex|17.35:posteroventral (inferior) parietal cortex|16.93:primary somatosensory cortex (area S1, areas 3,1,2)|16.29:primary motor cortex (area M1, area 4)|15.91:primary auditory cortex (core)|15.80:inferolateral temporal cortex (area TEv, area 20)|14.97:posterior (caudal) superior temporal cortex (area 22c)",4,SNP,0.15,"38|0.09;0-37,39-46|0.00",35504510,5,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|132-133|A:G|H:R;N|170|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.86,"31|0.23;0-30,32-46|0.00",35504539,NA,C|R,N|5|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|111|C:T|R:C;N|128|^:^|^:^;N|141|^:^|^:^,0.0008,0.0010,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.17,0-46|0.00,35510304,29,C|R,"B|15|C:T|R:W;B|16|T:T|W:W;B|27|C:T|R:W;N|30|^:^|^:^;N|34|^:^|^:^;B|35-36,38|C:T|R:W;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;B|127|C:T|R:W;N|128|^:^|^:^;B|140-141|C:T|R:W;N|149|^:^|^:^;N|157|^:^|^:^",0.0195,0.0157,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.28,0-46|0.00,35516959,NA,T|F,N|15-16|G:T|V:F;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|153|^:^|^:^;N|159|^:^|^:^,NA,NA,NA,NA
53,GLP2R,Homo sapiens glucagon-like peptide 2 receptor (GLP2R) mRNA.,G-protein coupled receptor;Neurological system process,NM_004246,chr17,2.90,6e-02,0.23,5e-02,+,GLP2R,9825508,9894163,glucagon like peptide 2 receptor,protein_coding,NA,0.00,0,0,2.83:Short bowel syndrome|1.76:Diabetes mellitus|1.60:Obesity|1.52:Inflammatory bowel disease,0.84:Carcinoma,NA,NA,0.54:brain|0.52:central nervous system|0.51:autism spectrum disorder|0.50:nervous system|0.43:liver|0.41:kidney|0.38:testis|0.32:pancreas|0.29:intestine|0.28:fetus|0.27:gastrointestinal tract|0.27:forebrain|0.26:large intestine|0.26:ovary|0.26:prostate gland|0.26:colon|0.25:cerebellum|0.24:temporal lobe|0.23:cerebral cortex|0.23:telencephalon|0.22:placenta|0.22:small intestine|0.22:hippocampus|0.21:heart|0.21:basal ganglion|0.20:lung|0.20:hypophysis|0.18:blood|0.18:spinal cord|0.18:corpus striatum|0.18:spleen|0.17:caudate nucleus|0.17:lymph node|0.16:diencephalon|0.15:leukocyte|0.14:adrenal gland|0.14:frontal lobe|0.14:midbrain|0.14:thalamus|0.14:substantia nigra|0.14:skeletal muscle|0.14:amygdala|0.14:hypothalamus|0.14:uterus|0.13:G-protein coupled receptor signaling pathway|0.13:mammary gland|0.11:thyroid gland|0.11:retinal disease|0.10:positive regulation of MAPK cascade|0.10:stomach,17.19:Colon - Sigmoid|12.67:Bladder|10.52:Colon - Transverse|8.83:Small Intestine - Terminal Ileum|8.80:Esophagus - Gastroesophageal Junction|7.61:Adipose - Visceral (Omentum)|6.91:Esophagus - Muscularis|5.41:Cervix - Endocervix|4.13:Cervix - Ectocervix|2.77:Fallopian Tube|2.12:Artery - Coronary|1.99:Stomach|1.81:Uterus|1.53:Brain - Anterior cingulate cortex (BA24)|1.19:Adipose - Subcutaneous|1.07:Vagina|1.06:Brain - Frontal Cortex (BA9)|0.88:Brain - Cortex|0.83:Lung|0.79:Breast - Mammary Tissue|0.65:Pancreas|0.61:Brain - Nucleus accumbens (basal ganglia)|0.49:Liver|0.45:Testis|0.42:Ovary|0.33:Heart - Atrial Appendage|0.21:Adrenal Gland|0.21:Kidney - Medulla|0.20:Thyroid|0.18:Brain - Spinal cord (cervical c-1)|0.15:Artery - Tibial|0.15:Brain - Substantia nigra|0.15:Brain - Hypothalamus|0.14:Esophagus - Mucosa|0.13:Brain - Amygdala|0.12:Prostate|0.11:Nerve - Tibial|0.10:Brain - Hippocampus|0.09:Artery - Aorta|0.08:Brain - Caudate (basal ganglia)|0.08:Skin - Sun Exposed (Lower leg)|0.06:Brain - Putamen (basal ganglia)|0.06:Skin - Not Sun Exposed (Suprapubic)|0.05:Minor Salivary Gland|0.05:Spleen|0.05:Heart - Left Ventricle|0.04:Pituitary|0.04:Brain - Cerebellum|0.03:Muscle - Skeletal|0.03:Brain - Cerebellar Hemisphere|0.03:Cells - Cultured fibroblasts|0.01:Kidney - Cortex|0.00:Whole Blood|0.00:Cells - EBV-transformed lymphocytes,"0.10:primary somatosensory cortex (area S1, areas 3,1,2)|0.09:primary motor cortex (area M1, area 4)|0.09:inferolateral temporal cortex (area TEv, area 20)|0.07:posterior (caudal) superior temporal cortex (area 22c)|0.05:primary auditory cortex (core)|0.05:anterior (rostral) cingulate (medial prefrontal) cortex|0.05:primary visual cortex (striate cortex, area V1/17)|0.05:posteroventral (inferior) parietal cortex|0.04:orbital frontal cortex|0.03:amygdaloid complex|0.02:ventrolateral prefrontal cortex|0.02:dorsolateral prefrontal cortex|0.01:mediodorsal nucleus of thalamus|0.01:striatum|0.01:hippocampus (hippocampal formation)|0.01:cerebellar cortex|0.01:upper (rostral) rhombic lip|0.01:medial ganglionic eminence|0.00:temporal neocortex|0.00:primary motor-sensory cortex (samples)|0.00:parietal neocortex|0.00:occipital neocortex|0.00:lateral ganglionic eminence|0.00:dorsal thalamus|0.00:cerebellum|0.00:caudal ganglionic eminence",1,SNP,1.85,"31|0.23;0-30,32-46|0.00",9729503,NA,G|R,N|104|^:^|^:^;N|111|C:G|S:R;N|144|^:^|^:^,NA,NA,NA,NA
54,PIK3R5,Homo sapiens phosphoinositide-3-kinase regulatory subunit 5 (PIK3R5) transcript variant 2 mRNA.,EGF receptor signaling pathway;PDGF Signaling Pathway,NM_014308,chr17,3.12,7e-02,0.09,7e-02,-,PIK3R5,8878916,8965712,phosphoinositide-3-kinase regulatory subunit 5,protein_coding,"F730038I15Rik,FOAP-2,p101,P101-PI3K",0.82,0,0,1.95:Cancer|1.67:Hematopoietic system disease|1.60:Gastrointestinal system disease|1.57:Breast disease,0.86:Carcinoma,4.00:Neurodegenerative disease,NA,0.99:G-protein coupled receptor signaling pathway|0.98:positive regulation of MAPK cascade|0.97:phosphatidylinositol 3-kinase signaling|0.96:positive regulation of protein kinase B signaling|0.94:phosphatidylinositol-mediated signaling|0.94:inositol lipid-mediated signaling|0.92:protein kinase B signaling|0.91:leukocyte|0.91:positive regulation of MAP kinase activity|0.90:mononuclear phagocyte|0.90:blood|0.90:monocyte|0.87:positive regulation of protein kinase activity|0.87:positive regulation of protein serine/threonine kinase activity|0.86:positive regulation of kinase activity|0.86:regulation of MAP kinase activity|0.85:regulation of protein kinase B signaling|0.84:granulocyte|0.81:regulation of protein serine/threonine kinase activity|0.78:lymphocyte|0.76:natural killer cell|0.73:B-lymphocyte|0.71:neutrophil|0.71:spleen|0.70:dendritic cell|0.70:eosinophil|0.66:T-lymphocyte|0.58:lymph node|0.52:macrophage|0.52:blood plasma|0.50:hematopoietic stem cell|0.46:regulation of immune response|0.45:central nervous system|0.45:serum|0.45:nervous system|0.45:regulation of defense response|0.43:autism spectrum disorder|0.43:regulation of response to external stimulus|0.42:brain|0.41:lung|0.38:positive regulation of immune response|0.35:fetus|0.33:blood platelet|0.31:immune response-regulating signaling pathway|0.30:placenta|0.30:activation of immune response|0.29:immune response-activating signal transduction|0.29:bone marrow|0.28:cytokine-mediated signaling pathway|0.27:gastrointestinal tract|0.26:liver|0.26:intestine|0.25:regulation of innate immune response|0.25:positive regulation of ERK1 and ERK2 cascade|0.24:heart|0.24:testis|0.23:large intestine|0.23:positive regulation of defense response|0.22:kidney|0.22:spinal cord|0.21:positive regulation of innate immune response|0.21:regulation of ERK1 and ERK2 cascade|0.21:hypophysis|0.20:ERK1 and ERK2 cascade|0.20:colon|0.19:pancreas|0.18:positive regulation of cytokine production|0.18:regulation of DNA binding transcription factor activity|0.18:tonsil|0.18:regulation of cell adhesion|0.18:ovary|0.17:small intestine|0.17:uterus|0.17:prostate gland|0.16:activation of protein kinase activity|0.16:second-messenger-mediated signaling|0.16:regulation of cell activation|0.16:skeletal muscle|0.16:regulation of ion transport|0.16:mammary gland|0.15:regulation of peptidase activity|0.15:positive regulation of programmed cell death|0.15:positive regulation of apoptotic process|0.15:thalamus|0.14:immune response-regulating cell surface receptor signaling pathway|0.14:positive regulation of response to external stimulus|0.14:hypersensitivity reaction disease|0.14:positive regulation of JAK-STAT cascade|0.14:positive regulation of STAT cascade|0.14:caudate putamen|0.14:frontal lobe|0.14:regulation of secretion|0.14:positive regulation of cell migration|0.14:positive regulation of cell motility|0.14:Langerhans cell|0.14:regulation of endopeptidase activity|0.14:positive regulation of cellular component movement|0.14:regulation of leukocyte activation|0.13:adrenal gland|0.13:forebrain|0.13:regulation of chemotaxis|0.13:immune response-activating cell surface receptor signaling pathway|0.13:thyroid gland|0.13:cerebral cortex|0.13:activation of innate immune response|0.13:regulation of cell-cell adhesion|0.13:skin|0.13:stress-activated MAPK cascade|0.13:JAK-STAT cascade|0.13:megakaryocyte|0.13:positive regulation of protein transport|0.13:innate immune response|0.13:positive regulation of locomotion|0.12:diencephalon|0.12:primary immunodeficiency disease|0.12:regulation of peptidyl-tyrosine phosphorylation|0.12:regulation of secretion by cell|0.12:regulation of multi-organism process|0.12:occipital lobe|0.12:pattern recognition receptor signaling pathway|0.12:innate immune response-activating signal transduction|0.12:negative regulation of intracellular signal transduction|0.12:positive regulation of stress-activated MAPK cascade|0.12:STAT cascade|0.12:regulation of cysteine-type endopeptidase activity|0.12:basal ganglion|0.12:blood vessel|0.12:negative regulation of immune system process|0.12:negative regulation of transport|0.11:positive regulation of tyrosine phosphorylation of STAT protein|0.11:response to bacterium|0.11:cerebral degeneration|0.11:telencephalon|0.11:regulation of lymphocyte activation|0.11:regulation of STAT cascade|0.11:regulation of JAK-STAT cascade|0.11:medulla oblongata|0.11:vermiform appendix|0.11:cecum|0.11:retinal disease|0.11:regulation of stress-activated MAPK cascade|0.11:corpus striatum|0.11:midbrain|0.11:positive regulation of DNA binding transcription factor activity|0.11:amygdala|0.11:negative regulation of protein modification process|0.11:cerebellum|0.11:temporal lobe|0.10:positive regulation of secretion|0.10:trachea|0.10:caudate nucleus|0.10:negative regulation of proteolysis|0.10:regulation of tyrosine phosphorylation of STAT protein|0.10:positive regulation of JNK cascade|0.10:substantia nigra|0.10:calcium-mediated signaling,59.93:Whole Blood|40.76:Spleen|34.67:Cells - EBV-transformed lymphocytes|26.46:Lung|10.37:Small Intestine - Terminal Ileum|7.84:Adipose - Subcutaneous|7.32:Adipose - Visceral (Omentum)|6.03:Artery - Coronary|5.75:Testis|5.51:Nerve - Tibial|5.16:Adrenal Gland|4.98:Artery - Aorta|4.61:Bladder|3.98:Fallopian Tube|3.79:Colon - Transverse|3.59:Breast - Mammary Tissue|3.08:Cervix - Endocervix|2.76:Minor Salivary Gland|2.52:Esophagus - Muscularis|2.48:Thyroid|2.45:Colon - Sigmoid|2.43:Esophagus - Gastroesophageal Junction|2.42:Stomach|2.36:Vagina|2.33:Cervix - Ectocervix|2.31:Prostate|2.28:Brain - Spinal cord (cervical c-1)|2.14:Uterus|1.97:Artery - Tibial|1.88:Skin - Sun Exposed (Lower leg)|1.85:Skin - Not Sun Exposed (Suprapubic)|1.78:Esophagus - Mucosa|1.39:Heart - Atrial Appendage|1.34:Brain - Substantia nigra|1.33:Liver|1.24:Pituitary|1.21:Ovary|1.11:Kidney - Medulla|1.04:Brain - Hypothalamus|0.94:Kidney - Cortex|0.80:Brain - Hippocampus|0.74:Brain - Amygdala|0.71:Heart - Left Ventricle|0.71:Pancreas|0.66:Brain - Caudate (basal ganglia)|0.58:Brain - Nucleus accumbens (basal ganglia)|0.51:Brain - Putamen (basal ganglia)|0.50:Brain - Cortex|0.47:Brain - Anterior cingulate cortex (BA24)|0.41:Brain - Frontal Cortex (BA9)|0.37:Muscle - Skeletal|0.27:Brain - Cerebellum|0.26:Brain - Cerebellar Hemisphere|0.02:Cells - Cultured fibroblasts,"0.36:striatum|0.29:upper (rostral) rhombic lip|0.27:mediodorsal nucleus of thalamus|0.23:amygdaloid complex|0.21:hippocampus (hippocampal formation)|0.19:posterior (caudal) superior temporal cortex (area 22c)|0.18:inferolateral temporal cortex (area TEv, area 20)|0.17:cerebellum|0.17:primary motor cortex (area M1, area 4)|0.17:ventrolateral prefrontal cortex|0.17:primary visual cortex (striate cortex, area V1/17)|0.17:dorsolateral prefrontal cortex|0.16:parietal neocortex|0.15:primary somatosensory cortex (area S1, areas 3,1,2)|0.15:primary auditory cortex (core)|0.14:cerebellar cortex|0.13:anterior (rostral) cingulate (medial prefrontal) cortex|0.13:posteroventral (inferior) parietal cortex|0.11:orbital frontal cortex|0.11:medial ganglionic eminence|0.10:dorsal thalamus|0.10:temporal neocortex|0.08:lateral ganglionic eminence|0.07:occipital neocortex|0.05:caudal ganglionic eminence|0.05:primary motor-sensory cortex (samples)",1,SNP,2.69,"38|0.09;0-37,39-46|0.00",8791494,NA,T|N,N|2|^:^|^:^;N|50|^:^|^:^;N|131-132|C:T|S:N;N|170|^:^|^:^,NA,NA,NA,NA
55,ZNF30,Homo sapiens zinc finger protein 30 (ZNF30) transcript variant 3 mRNA.,Transcription Factor,NM_194325,chr19,19.11,7e-02,0.60,9e-02,+,ZNF30,34923795,34945172,zinc finger protein 30,protein_coding,KOX28,0.00,0,0,2.18:Neurogenic arthrogryposis multiplex congenita|1.89:Ectodermal dysplasia|1.78:Hypospadias,0.50:Carcinoma,NA,NA,NA,23.84:Brain - Cerebellar Hemisphere|20.29:Brain - Cerebellum|7.57:Nerve - Tibial|6.40:Prostate|6.37:Pituitary|6.02:Testis|5.96:Spleen|5.85:Uterus|5.76:Fallopian Tube|5.60:Cervix - Endocervix|5.26:Brain - Nucleus accumbens (basal ganglia)|5.13:Brain - Caudate (basal ganglia)|4.91:Brain - Cortex|4.91:Brain - Frontal Cortex (BA9)|4.56:Brain - Spinal cord (cervical c-1)|4.52:Bladder|4.49:Thyroid|4.47:Vagina|4.47:Cervix - Ectocervix|4.47:Lung|4.42:Colon - Sigmoid|4.31:Ovary|4.20:Breast - Mammary Tissue|4.19:Brain - Putamen (basal ganglia)|4.14:Brain - Hypothalamus|4.08:Adrenal Gland|4.00:Artery - Coronary|3.89:Adipose - Subcutaneous|3.67:Small Intestine - Terminal Ileum|3.67:Brain - Anterior cingulate cortex (BA24)|3.66:Esophagus - Gastroesophageal Junction|3.55:Esophagus - Muscularis|3.49:Cells - Cultured fibroblasts|3.46:Artery - Aorta|3.42:Kidney - Medulla|3.36:Brain - Hippocampus|3.31:Cells - EBV-transformed lymphocytes|3.22:Brain - Substantia nigra|3.14:Adipose - Visceral (Omentum)|3.12:Minor Salivary Gland|3.01:Colon - Transverse|3.00:Brain - Amygdala|2.96:Skin - Not Sun Exposed (Suprapubic)|2.95:Skin - Sun Exposed (Lower leg)|2.85:Artery - Tibial|2.84:Stomach|2.49:Esophagus - Mucosa|2.38:Pancreas|2.29:Liver|2.22:Kidney - Cortex|1.84:Heart - Atrial Appendage|1.60:Muscle - Skeletal|1.56:Heart - Left Ventricle|0.36:Whole Blood,"3.69:cerebellar cortex|3.31:primary motor-sensory cortex (samples)|3.05:cerebellum|2.95:parietal neocortex|2.83:dorsal thalamus|2.83:temporal neocortex|2.77:anterior (rostral) cingulate (medial prefrontal) cortex|2.69:occipital neocortex|2.48:primary visual cortex (striate cortex, area V1/17)|2.46:orbital frontal cortex|2.37:upper (rostral) rhombic lip|2.33:primary auditory cortex (core)|2.25:primary somatosensory cortex (area S1, areas 3,1,2)|2.22:ventrolateral prefrontal cortex|2.22:posteroventral (inferior) parietal cortex|2.16:primary motor cortex (area M1, area 4)|2.16:dorsolateral prefrontal cortex|2.11:hippocampus (hippocampal formation)|2.10:amygdaloid complex|2.08:lateral ganglionic eminence|2.03:mediodorsal nucleus of thalamus|2.02:inferolateral temporal cortex (area TEv, area 20)|2.02:posterior (caudal) superior temporal cortex (area 22c)|1.96:striatum|1.86:medial ganglionic eminence|1.52:caudal ganglionic eminence",3,SNP,5.79,0-46|0.00,35434582,21,G|G,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|64|G:T|G:W;B|66,68|G:T|G:W;B|69-71|G:T|G:W;N|83|^:^|^:^;B|101-102|G:T|G:W;N|108|^:^|^:^;N|128|^:^|^:^;B|134,136|G:T|G:W;B|142-143|G:T|G:W;N|168|^:^|^:^",0.0208,0.0189,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.80,"36|0.60;0-35,37-46|0.00",35435632,3,C|R,"N|8|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;B|124,126|C:T|R:W;N|128|^:^|^:^",0.0019,0.0018,D,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.32,0-46|0.00,35435644,NA,G|G,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|92-94,96|G:T|G:C;N|108|^:^|^:^;N|128|^:^|^:^;N|147|^:^|^:^",4.069e-06,NA,D,D
56,CAMTA2,Homo sapiens calmodulin binding transcription activator 2 (CAMTA2) transcript variant 3 mRNA.,Transcription Factor;Calcium-mediated Signaling;NF-KappaB Cascade,NM_001171168,chr17,3.68,7e-02,0.30,7e-02,-,CAMTA2,4967993,4988281,calmodulin binding transcription activator 2,protein_coding,NA,1.00,0,0,1.79:Retinitis pigmentosa 22,0.92:Carcinoma,NA,"10.00:preweaning lethality, complete penetrance",NA,157.35:Brain - Cerebellum|149.74:Brain - Cerebellar Hemisphere|90.99:Brain - Cortex|85.35:Brain - Frontal Cortex (BA9)|75.52:Pituitary|66.47:Uterus|62.26:Lung|62.01:Testis|60.91:Artery - Aorta|60.55:Esophagus - Gastroesophageal Junction|58.73:Thyroid|58.26:Spleen|57.97:Esophagus - Muscularis|57.82:Brain - Anterior cingulate cortex (BA24)|57.04:Cervix - Endocervix|56.84:Artery - Tibial|56.62:Colon - Sigmoid|55.05:Nerve - Tibial|53.49:Artery - Coronary|50.84:Ovary|50.83:Bladder|50.75:Cervix - Ectocervix|50.31:Skin - Sun Exposed (Lower leg)|50.08:Fallopian Tube|49.69:Prostate|46.57:Brain - Hippocampus|46.55:Small Intestine - Terminal Ileum|45.05:Breast - Mammary Tissue|44.89:Skin - Not Sun Exposed (Suprapubic)|44.47:Vagina|44.45:Muscle - Skeletal|43.99:Adipose - Subcutaneous|41.93:Colon - Transverse|40.68:Cells - Cultured fibroblasts|40.57:Brain - Nucleus accumbens (basal ganglia)|40.29:Adipose - Visceral (Omentum)|39.25:Brain - Caudate (basal ganglia)|37.54:Brain - Amygdala|36.59:Whole Blood|34.83:Stomach|33.24:Minor Salivary Gland|33.19:Cells - EBV-transformed lymphocytes|32.35:Adrenal Gland|31.62:Brain - Hypothalamus|31.61:Esophagus - Mucosa|29.76:Brain - Putamen (basal ganglia)|26.13:Kidney - Medulla|24.34:Brain - Spinal cord (cervical c-1)|22.71:Kidney - Cortex|22.37:Heart - Atrial Appendage|19.32:Brain - Substantia nigra|17.38:Heart - Left Ventricle|17.00:Pancreas|13.41:Liver,"34.91:cerebellar cortex|26.23:primary somatosensory cortex (area S1, areas 3,1,2)|24.93:primary motor cortex (area M1, area 4)|24.85:mediodorsal nucleus of thalamus|22.39:posterior (caudal) superior temporal cortex (area 22c)|21.54:posteroventral (inferior) parietal cortex|21.29:primary auditory cortex (core)|20.63:inferolateral temporal cortex (area TEv, area 20)|20.29:ventrolateral prefrontal cortex|19.86:orbital frontal cortex|17.72:primary visual cortex (striate cortex, area V1/17)|16.96:dorsolateral prefrontal cortex|16.94:anterior (rostral) cingulate (medial prefrontal) cortex|16.64:hippocampus (hippocampal formation)|16.20:amygdaloid complex|15.36:striatum|11.77:cerebellum|11.69:upper (rostral) rhombic lip|8.44:primary motor-sensory cortex (samples)|8.20:dorsal thalamus|7.64:temporal neocortex|6.26:parietal neocortex|5.14:lateral ganglionic eminence|4.74:occipital neocortex|4.23:medial ganglionic eminence|2.90:caudal ganglionic eminence",1,SNP,2.30,"16|0.30;0-15,17-46|0.00",4875636,NA,G|A,N|59|C:G|G:A,NA,NA,NA,NA
57,CHD3,Homo sapiens chromodomain helicase DNA binding protein 3 (CHD3) transcript variant 2 mRNA.,,NM_001005271,chr17,5.95,8e-02,0.30,1e-01,+,CHD3,7884764,7912755,chromodomain helicase DNA binding protein 3,protein_coding,"Mi-2a,Mi2-ALPHA,SNIBCPS,ZFH",1.00,1,0,2.11:CHARGE syndrome|1.88:Dermatomyositis|1.86:Cancer|1.83:Congenital myasthenic syndrome 1A|1.63:Intellectual disability|1.54:Breast disease|1.54:Hematopoietic system disease,1.10:Carcinoma|0.84:Kidney cancer,4.00:Intellectual disability,8.24:abnormal behavior|7.80:hyperactivity|5.73:decreased bone mineral content|5.73:increased bone mineral content|4.31:abnormal behavioral response to light,"0.99:regulation of chromosome organization|0.99:regulation of chromatin organization|0.99:positive regulation of chromosome organization|0.98:regulation of histone modification|0.96:positive regulation of chromatin organization|0.96:regulation of DNA-templated transcription, initiation|0.95:positive regulation of ubiquitin-protein transferase activity|0.88:positive regulation of histone modification|0.88:nervous system|0.84:brain|0.84:regulation of transcription initiation from RNA polymerase II promoter|0.81:gene silencing|0.81:central nervous system|0.80:regulation of gene expression, epigenetic|0.80:histone modification|0.79:positive regulation of protein modification by small protein conjugation or removal|0.77:lung|0.75:spleen|0.74:intracellular receptor signaling pathway|0.72:regulation of I-kappaB kinase/NF-kappaB signaling|0.71:leukocyte|0.70:ovary|0.70:spinal cord|0.67:corpus callosum|0.67:blood|0.66:regulation of protein sumoylation|0.66:Huntington's disease|0.65:corpus striatum|0.64:fetus|0.64:pancreas|0.64:caudate nucleus|0.64:regulation of defense response|0.64:placenta|0.64:positive regulation of I-kappaB kinase/NF-kappaB signaling|0.64:negative regulation of histone modification|0.64:cerebellum|0.63:kidney|0.63:autism spectrum disorder|0.63:gene silencing by miRNA|0.61:I-kappaB kinase/NF-kappaB signaling|0.61:apoptotic signaling pathway|0.61:testis|0.61:regulation of protein acetylation|0.60:telencephalon|0.60:prostate gland|0.59:posttranscriptional gene silencing by RNA|0.59:negative regulation of protein modification process|0.59:negative regulation of chromatin organization|0.58:cerebral cortex|0.58:temporal lobe|0.57:liver|0.57:forebrain|0.57:stress-activated protein kinase signaling cascade|0.57:hippocampus|0.56:basal ganglion|0.56:occipital lobe|0.56:posttranscriptional gene silencing|0.56:amygdala|0.56:negative regulation of protein acetylation|0.55:positive regulation of protein ubiquitination|0.55:regulation of response to DNA damage stimulus|0.54:negative regulation of cellular amide metabolic process|0.54:diencephalon|0.54:subthalamic nucleus|0.53:regulation of autophagy|0.53:positive regulation of cellular protein catabolic process|0.53:negative regulation of locomotion|0.53:frontal lobe|0.53:positive regulation of DNA metabolic process|0.52:positive regulation of stress fiber assembly|0.52:substantia nigra|0.50:midbrain|0.50:skeletal muscle|0.50:negative regulation of chromosome organization|0.50:regulation of peptidase activity|0.50:regulation of immune response|0.50:regulation of stress-activated MAPK cascade|0.49:positive regulation of histone H3-K4 methylation|0.49:positive regulation of proteolysis involved in cellular protein catabolic process|0.49:regulation of protein modification by small protein conjugation or removal|0.48:negative regulation of translation|0.48:regulation of DNA metabolic process|0.48:regulation of telomere maintenance|0.48:regulation of response to cytokine stimulus|0.47:stress-activated MAPK cascade|0.47:negative regulation of organelle organization|0.47:caudate putamen|0.46:heart|0.46:regulation of DNA repair|0.46:regulation of ubiquitin-protein transferase activity|0.46:regulation of platelet-derived growth factor receptor signaling pathway|0.45:positive regulation of apoptotic process|0.45:heme biosynthetic process|0.45:production of small RNA involved in gene silencing by RNA|0.45:thalamus|0.44:intestine|0.43:Wnt signaling pathway|0.43:negative regulation of epithelial cell migration|0.42:regulation of endopeptidase activity|0.42:regulation of cysteine-type endopeptidase activity involved in apoptotic process|0.41:regulation of peptidyl-lysine acetylation|0.41:lymph node|0.41:positive regulation of programmed cell death|0.40:production of miRNAs involved in gene silencing by miRNA|0.40:regulation of histone acetylation|0.40:protein sumoylation|0.39:regulation of endocytosis|0.39:gastrointestinal tract|0.39:regulation of cytokinesis|0.39:posttranscriptional regulation of gene expression|0.39:positive regulation of defense response|0.39:large intestine|0.38:positive regulation of autophagy of mitochondrion|0.38:regulation of stress-activated protein kinase signaling cascade|0.37:negative regulation of protein complex assembly|0.37:gene silencing by RNA|0.37:regulation of epithelial cell migration|0.36:regulation of cellular amide metabolic process|0.36:regulation of chromatin assembly or disassembly|0.36:neuron|0.36:regulation of interferon-alpha production|0.36:positive regulation of protein catabolic process|0.36:regulation of protein complex assembly|0.36:cell surface receptor signaling pathway involved in cell-cell signaling|0.36:movement disease|0.35:intrinsic apoptotic signaling pathway|0.34:intracellular steroid hormone receptor signaling pathway|0.34:thyroid gland|0.34:regulation of cysteine-type endopeptidase activity|0.34:steroid hormone mediated signaling pathway|0.34:regulation of translation|0.33:telomere maintenance|0.33:hormone-mediated signaling pathway|0.33:regulation of JNK cascade|0.33:medulla oblongata|0.33:adrenal gland|0.32:regulation of histone ubiquitination|0.31:regulation of proteolysis involved in cellular protein catabolic process|0.31:regulation of protein ubiquitination|0.31:lymphocyte|0.31:cardiac left ventricle morphogenesis|0.30:regulation of gene silencing|0.30:response to redox state|0.30:colon|0.30:regulation of intracellular protein transport|0.29:positive regulation of proteolysis|0.28:JNK cascade|0.28:occipital pole|0.28:platelet-derived growth factor receptor signaling pathway|0.28:positive regulation of mitochondrion organization|0.28:negative regulation of peptidase activity|0.28:regulation of cytokine-mediated signaling pathway|0.28:positive regulation of actin filament bundle assembly|0.28:uterus|0.27:regulation of DNA biosynthetic process|0.27:positive regulation of transcription from RNA polymerase II promoter in response to stress|0.27:negative regulation of endopeptidase activity|0.27:hypophysis|0.27:mammary gland|0.26:chromatin silencing|0.26:regulation of cell division|0.26:positive regulation of histone H3-K9 methylation|0.26:negative regulation of cell migration|0.26:regulation of protein catabolic process|0.25:bone marrow|0.24:positive regulation of telomere maintenance|0.24:regulation of macroautophagy|0.24:regulation of nucleocytoplasmic transport|0.24:histone deacetylation|0.24:small intestine|0.24:regulation of telomere maintenance via telomerase|0.24:negative regulation of stress-activated MAPK cascade|0.24:regulation of receptor-mediated endocytosis|0.24:porphyrin-containing compound metabolic process|0.23:T-lymphocyte|0.23:dsRNA fragmentation|0.23:negative regulation of viral process|0.23:heme metabolic process|0.22:cellular response to organic cyclic compound|0.22:positive regulation of catabolic process|0.22:regulation of mitochondrion organization|0.22:trachea|0.22:regulation of cellular protein catabolic process|0.22:positive regulation of cellular catabolic process|0.22:regulation of multi-organism process|0.21:tetrapyrrole metabolic process|0.21:negative regulation of cell motility|0.21:negative regulation of stress-activated protein kinase signaling cascade|0.20:regulation of cell morphogenesis|0.20:regulation of transposition|0.20:negative regulation of transposition|0.20:regulation of mitotic cell cycle|0.20:negative regulation of immune system process|0.20:positive regulation of autophagy|0.20:response to dsRNA|0.20:protein polyubiquitination|0.20:regulation of telomere maintenance via telomere lengthening|0.19:stomach|0.19:positive regulation of chromatin silencing|0.19:regulation of apoptotic signaling pathway|0.19:regulation of morphogenesis of an epithelium|0.19:type I interferon signaling pathway|0.18:negative regulation of proteolysis|0.18:regulation of cytoskeleton organization|0.18:cellular response to dsRNA|0.18:negative regulation of cytokine production|0.18:regulation of interferon-beta production|0.18:histone methylation|0.17:regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|0.17:chromatin assembly|0.17:peripheral nervous system disease|0.17:neuropathy|0.17:negative regulation of viral life cycle|0.17:negative regulation of cellular component movement|0.17:negative regulation of multi-organism process|0.16:blood vessel|0.16:negative regulation of protein modification by small protein conjugation or removal|0.16:negative regulation of cell proliferation|0.16:chromatin remodeling|0.16:protein acetylation|0.16:negative regulation of gene expression, epigenetic|0.16:artery|0.16:aorta|0.15:regulation of chromatin silencing|0.15:positive regulation of response to DNA damage stimulus|0.15:negative regulation of DNA binding transcription factor activity|0.15:regulation of Wnt signaling pathway|0.15:regulation of histone phosphorylation|0.15:primary miRNA processing|0.15:tetrapyrrole biosynthetic process|0.15:positive regulation of epithelial cell proliferation|0.15:positive regulation of supramolecular fiber organization|0.14:negative regulation of histone acetylation|0.14:regulation of double-strand break repair|0.14:basal ganglia disease|0.14:regulation of response to endoplasmic reticulum stress|0.14:regulation of immune effector process|0.14:regulation of organelle assembly|0.14:methylation-dependent chromatin silencing|0.14:negative regulation of lipid transport|0.14:regulation of DNA-templated transcription in response to stress|0.14:regulation of autophagosome assembly|0.14:muscle|0.13:positive regulation of endothelial cell proliferation|0.13:positive regulation of apoptotic signaling pathway|0.13:epilepsy|0.13:monocyte|0.13:regulation of histone methylation|0.13:regulation of cell cycle phase transition|0.13:auditory system disease|0.13:regulation of innate immune response|0.13:positive regulation of cell differentiation|0.13:negative regulation of JNK cascade|0.13:positive regulation of cytoskeleton organization|0.12:retinal disease|0.12:negative regulation of intracellular signal transduction|0.12:regulation of actomyosin structure organization|0.12:negative regulation of apoptotic signaling pathway|0.12:positive regulation of protein transport|0.12:intracellular estrogen receptor signaling pathway|0.12:transforming growth factor beta receptor signaling pathway|0.11:regulation of ERAD pathway|0.11:negative regulation of protein sumoylation|0.11:regulation of angiogenesis|0.11:blood platelet|0.11:regulation of stress fiber assembly|0.11:regulation of vesicle-mediated transport|0.11:regulation of fatty acid biosynthetic process|0.11:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|0.11:peptidyl-lysine modification|0.11:positive regulation of cell cycle|0.11:positive regulation of histone methylation|0.11:regulation of cellular response to growth factor stimulus|0.11:Charcot-Marie-Tooth disease|0.11:regulation of gene silencing by miRNA|0.11:Golgi vesicle transport|0.11:negative regulation of phosphorylation|0.10:regulation of autophagy of mitochondrion|0.10:regulation of intrinsic apoptotic signaling pathway|0.10:negative regulation of lipid localization|0.10:B-lymphocyte|0.10:positive regulation of cellular protein localization|0.10:regulation of vasculature development|0.10:regulation of production of miRNAs involved in gene silencing by miRNA|0.10:cerebellar Purkinje cell",180.93:Cervix - Ectocervix|166.68:Cervix - Endocervix|155.47:Uterus|146.49:Prostate|122.60:Fallopian Tube|121.55:Ovary|109.25:Colon - Sigmoid|102.57:Thyroid|100.41:Pituitary|91.94:Nerve - Tibial|83.76:Vagina|81.77:Bladder|73.66:Cells - Cultured fibroblasts|68.23:Lung|67.15:Esophagus - Muscularis|65.01:Esophagus - Gastroesophageal Junction|64.78:Brain - Cortex|63.93:Artery - Aorta|61.25:Brain - Frontal Cortex (BA9)|59.51:Brain - Anterior cingulate cortex (BA24)|59.02:Colon - Transverse|58.17:Cells - EBV-transformed lymphocytes|56.31:Spleen|55.97:Small Intestine - Terminal Ileum|55.79:Brain - Nucleus accumbens (basal ganglia)|55.37:Kidney - Medulla|53.76:Breast - Mammary Tissue|53.65:Minor Salivary Gland|52.91:Esophagus - Mucosa|51.80:Testis|50.83:Brain - Cerebellum|49.03:Brain - Cerebellar Hemisphere|48.56:Skin - Not Sun Exposed (Suprapubic)|47.11:Adrenal Gland|46.03:Adipose - Visceral (Omentum)|44.12:Skin - Sun Exposed (Lower leg)|42.09:Stomach|41.30:Artery - Coronary|40.54:Adipose - Subcutaneous|38.94:Artery - Tibial|38.64:Brain - Hypothalamus|36.91:Brain - Amygdala|34.52:Brain - Hippocampus|31.92:Kidney - Cortex|29.11:Whole Blood|28.06:Brain - Caudate (basal ganglia)|25.26:Brain - Putamen (basal ganglia)|23.04:Pancreas|18.69:Heart - Atrial Appendage|15.16:Brain - Substantia nigra|12.47:Brain - Spinal cord (cervical c-1)|7.08:Heart - Left Ventricle|4.35:Muscle - Skeletal|3.95:Liver,"126.54:temporal neocortex|107.78:parietal neocortex|100.29:primary motor-sensory cortex (samples)|76.46:lateral ganglionic eminence|75.78:upper (rostral) rhombic lip|74.78:occipital neocortex|60.41:cerebellum|59.22:medial ganglionic eminence|53.71:caudal ganglionic eminence|47.77:anterior (rostral) cingulate (medial prefrontal) cortex|47.59:primary visual cortex (striate cortex, area V1/17)|44.89:inferolateral temporal cortex (area TEv, area 20)|43.26:amygdaloid complex|42.34:dorsal thalamus|41.66:hippocampus (hippocampal formation)|41.45:primary auditory cortex (core)|39.01:ventrolateral prefrontal cortex|38.89:posteroventral (inferior) parietal cortex|38.52:striatum|37.35:dorsolateral prefrontal cortex|36.90:orbital frontal cortex|36.88:posterior (caudal) superior temporal cortex (area 22c)|32.35:primary somatosensory cortex (area S1, areas 3,1,2)|32.03:primary motor cortex (area M1, area 4)|24.15:mediodorsal nucleus of thalamus|19.95:cerebellar cortex",1,ins,4.56,"34|0.30;0-33,35-46|0.00",7788364,NA,-|-,"32|-:CCA|-:P;118,120|-:CCA|-:P;130,133|-:CCA|-:P",0.0084,0,NA,NA
58,PSMD8,Homo sapiens proteasome (prosome macropain) 26S subunit non-ATPase 8 (PSMD8) mRNA.,,NM_002812,chr19,5.00,8e-02,0.30,7e-02,+,PSMD8,38374550,38383824,"proteasome 26S subunit, non-ATPase 8",protein_coding,"HEL-S-91n,HIP6,HYPF,Nin1p,p31,Rpn12,S14",0.18,0,0,1.76:Autosomal dominant nonsyndromic deafness 40,NA,NA,NA,"0.92:modulation by host of symbiont transcription|0.92:modulation of transcription in other organism involved in symbiotic interaction|0.92:modulation by host of viral transcription|0.89:positive regulation of peptidase activity|0.89:regulation of DNA binding transcription factor activity|0.88:positive regulation of proteolysis|0.86:positive regulation of endopeptidase activity|0.85:regulation of peptidase activity|0.84:regulation of ER-associated ubiquitin-dependent protein catabolic process|0.82:positive regulation of protein ubiquitination|0.82:regulation of endopeptidase activity|0.77:regulation of protein catabolic process|0.77:blood|0.75:regulation of ERAD pathway|0.72:regulation of proteolysis involved in cellular protein catabolic process|0.72:protein modification by small protein removal|0.71:negative regulation of DNA binding transcription factor activity|0.71:leukocyte|0.70:autism spectrum disorder|0.69:positive regulation of proteasomal ubiquitin-dependent protein catabolic process|0.69:regulation of proteasomal protein catabolic process|0.69:proteasomal protein catabolic process|0.68:regulation of cellular protein catabolic process|0.68:positive regulation of DNA binding transcription factor activity|0.65:positive regulation of protein modification by small protein conjugation or removal|0.62:erythrocyte|0.59:negative regulation of ERAD pathway|0.58:placenta|0.55:positive regulation of protein catabolic process|0.50:brain|0.49:nervous system|0.49:central nervous system|0.47:testis|0.47:fetus|0.46:positive regulation of protein transport|0.45:positive regulation of NF-kappaB transcription factor activity|0.45:heart|0.44:positive regulation of proteasomal protein catabolic process|0.44:regulation of protein ubiquitination|0.43:regulation of proteasomal ubiquitin-dependent protein catabolic process|0.43:liver|0.43:positive regulation of ubiquitin-protein transferase activity|0.41:tear gland|0.41:proteasome-mediated ubiquitin-dependent protein catabolic process|0.40:blood plasma|0.40:regulation of intracellular protein transport|0.40:ovary|0.39:negative regulation of NF-kappaB transcription factor activity|0.39:lymph node|0.38:pancreas|0.38:regulation of protein modification by small protein conjugation or removal|0.37:spleen|0.36:positive regulation of cellular protein localization|0.36:mononuclear phagocyte|0.35:nucleoside phosphate biosynthetic process|0.35:protein deubiquitination|0.34:positive regulation of intracellular transport|0.33:monocyte|0.33:regulation of symbiosis, encompassing mutualism through parasitism|0.33:kidney|0.33:positive regulation of proteolysis involved in cellular protein catabolic process|0.33:positive regulation of intracellular protein transport|0.32:prostate gland|0.32:positive regulation of DNA replication|0.32:negative regulation of MAPK cascade|0.32:DNA recombination|0.32:lymphocyte|0.32:granulocyte|0.31:lung|0.31:double-strand break repair via homologous recombination|0.31:eye|0.31:recombinational repair|0.30:skeletal muscle|0.30:positive regulation of protein kinase activity|0.29:neutrophil|0.29:regulation of viral process|0.29:ubiquitin-dependent protein catabolic process|0.26:nucleotide biosynthetic process|0.25:modification-dependent protein catabolic process|0.25:positive regulation of cyclin-dependent protein kinase activity|0.23:positive regulation of cyclin-dependent protein serine/threonine kinase activity|0.22:regulation of lipid metabolic process|0.21:regulation of apoptotic signaling pathway|0.21:negative regulation of peptidase activity|0.21:negative regulation of proteolysis|0.21:positive regulation of cellular protein catabolic process|0.21:purine-containing compound biosynthetic process|0.21:regulation of multi-organism process|0.20:regulation of mitochondrion organization|0.20:negative regulation of endopeptidase activity|0.20:positive regulation of mitochondrion organization|0.20:regulation of protein serine/threonine kinase activity|0.20:purine nucleotide biosynthetic process|0.20:adrenal gland|0.20:positive regulation of protein serine/threonine kinase activity|0.20:negative regulation of apoptotic signaling pathway|0.20:mammary gland|0.18:gastrointestinal tract|0.18:myocardial infarction|0.17:intestine|0.17:coronary artery disease|0.17:regulation of ion transport|0.16:apoptotic signaling pathway|0.16:uterus|0.16:nucleoside triphosphate biosynthetic process|0.16:negative regulation of intracellular signal transduction|0.16:regulation of ERK1 and ERK2 cascade|0.16:regulation of viral transcription|0.16:atherosclerosis|0.16:arteriosclerotic cardiovascular disease|0.15:purine ribonucleotide biosynthetic process|0.15:negative regulation of protein catabolic process|0.15:coronary artery anomaly|0.15:large intestine|0.15:protein K63-linked ubiquitination|0.15:negative regulation of protein phosphorylation|0.15:muscle|0.15:ERK1 and ERK2 cascade|0.15:forebrain|0.15:spermatozoon|0.15:colon|0.14:arteriosclerosis|0.14:peptide biosynthetic process|0.14:bone marrow cancer|0.14:regulation of DNA replication|0.14:hypersensitivity reaction disease|0.14:translation|0.14:muscular disease|0.14:muscle tissue disease|0.14:double-strand break repair|0.14:mineral metabolism disease|0.13:thyroid gland|0.13:negative regulation of proteolysis involved in cellular protein catabolic process|0.13:cerebellum|0.13:myopathy|0.13:autosomal recessive disease|0.13:ribonucleotide biosynthetic process|0.13:small intestine|0.13:telencephalon|0.13:positive regulation of lymphocyte apoptotic process|0.13:negative regulation of protein modification process|0.12:positive regulation of nucleotide metabolic process|0.12:positive regulation of purine nucleotide metabolic process|0.12:hypersensitivity reaction type IV disease|0.12:cerebral cortex|0.12:N-terminal protein amino acid acetylation|0.11:cardiomyopathy|0.11:sensorineural hearing loss|0.11:hypophysis|0.11:hematologic cancer|0.11:regulation of protein targeting|0.11:non-Hodgkin lymphoma|0.10:temporal lobe|0.10:myeloid neoplasm|0.10:immune system cancer|0.10:positive regulation of T cell apoptotic process",194.71:Cells - Cultured fibroblasts|193.18:Muscle - Skeletal|159.07:Testis|131.41:Adipose - Subcutaneous|128.69:Cells - EBV-transformed lymphocytes|119.73:Skin - Sun Exposed (Lower leg)|112.20:Skin - Not Sun Exposed (Suprapubic)|109.29:Artery - Aorta|105.65:Adipose - Visceral (Omentum)|104.26:Artery - Tibial|103.10:Breast - Mammary Tissue|103.03:Heart - Atrial Appendage|94.51:Artery - Coronary|94.33:Heart - Left Ventricle|92.77:Cervix - Ectocervix|92.05:Nerve - Tibial|91.95:Esophagus - Mucosa|91.13:Cervix - Endocervix|90.68:Uterus|89.88:Fallopian Tube|89.46:Lung|88.09:Esophagus - Muscularis|84.84:Esophagus - Gastroesophageal Junction|84.63:Vagina|83.89:Prostate|83.41:Pituitary|82.18:Thyroid|79.51:Bladder|76.66:Colon - Sigmoid|76.59:Brain - Cerebellar Hemisphere|75.72:Adrenal Gland|75.48:Brain - Cerebellum|72.41:Brain - Frontal Cortex (BA9)|69.74:Minor Salivary Gland|68.05:Ovary|67.93:Spleen|67.92:Brain - Cortex|65.94:Small Intestine - Terminal Ileum|64.85:Colon - Transverse|62.47:Kidney - Medulla|59.48:Stomach|51.12:Brain - Hypothalamus|50.65:Brain - Spinal cord (cervical c-1)|50.01:Brain - Anterior cingulate cortex (BA24)|49.95:Kidney - Cortex|48.34:Brain - Nucleus accumbens (basal ganglia)|42.00:Whole Blood|40.47:Brain - Caudate (basal ganglia)|39.10:Brain - Amygdala|38.87:Brain - Substantia nigra|36.46:Brain - Putamen (basal ganglia)|36.24:Brain - Hippocampus|35.96:Liver|31.44:Pancreas,"82.14:mediodorsal nucleus of thalamus|77.02:caudal ganglionic eminence|74.30:dorsal thalamus|73.93:occipital neocortex|73.64:inferolateral temporal cortex (area TEv, area 20)|73.03:cerebellum|72.61:upper (rostral) rhombic lip|72.60:cerebellar cortex|72.13:dorsolateral prefrontal cortex|71.95:posterior (caudal) superior temporal cortex (area 22c)|71.39:amygdaloid complex|70.83:hippocampus (hippocampal formation)|69.43:ventrolateral prefrontal cortex|69.02:primary somatosensory cortex (area S1, areas 3,1,2)|68.57:orbital frontal cortex|68.03:anterior (rostral) cingulate (medial prefrontal) cortex|67.34:parietal neocortex|66.71:medial ganglionic eminence|65.93:lateral ganglionic eminence|65.63:posteroventral (inferior) parietal cortex|65.39:primary visual cortex (striate cortex, area V1/17)|63.90:primary auditory cortex (core)|63.00:primary motor-sensory cortex (samples)|62.95:striatum|62.18:primary motor cortex (area M1, area 4)|50.74:temporal neocortex",1,SNP,3.47,0-46|0.00,38871600,NA,G|S,"N|4|^:^|^:^;N|21|^:^|^:^;N|28|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|39|G:T|S:I;N|41|^:^|^:^;N|43|^:^|^:^;N|47|^:^|^:^;N|52|^:^|^:^;N|54-56|^:^|^:^;N|67|^:^|^:^;N|79|^:^|^:^;N|83,85|^:^|^:^;N|86,90|^:^|^:^;N|98|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|116|^:^|^:^;N|118-119|^:^|^:^;N|122|^:^|^:^;N|126|^:^|^:^;N|128|^:^|^:^;N|133|^:^|^:^;N|135-136|^:^|^:^;N|161|^:^|^:^",8.042e-05,NA,D,T
59,WSCD1,Homo sapiens WSC domain containing 1 (WSCD1) mRNA.,,NM_015253,chr17,5.16,8e-02,0.11,1e-01,+,WSCD1,6069106,6124427,WSC domain containing 1,protein_coding,NA,0.00,0,0,NA,0.92:Carcinoma,NA,NA,NA,29.46:Brain - Cerebellum|29.04:Brain - Cerebellar Hemisphere|14.28:Brain - Spinal cord (cervical c-1)|11.14:Spleen|10.79:Testis|10.09:Brain - Hypothalamus|9.92:Brain - Substantia nigra|8.25:Brain - Amygdala|8.15:Brain - Hippocampus|7.85:Brain - Anterior cingulate cortex (BA24)|6.73:Brain - Cortex|6.59:Brain - Frontal Cortex (BA9)|5.91:Brain - Nucleus accumbens (basal ganglia)|5.84:Artery - Tibial|5.43:Brain - Caudate (basal ganglia)|5.31:Brain - Putamen (basal ganglia)|4.79:Pituitary|4.26:Colon - Transverse|4.23:Artery - Aorta|4.21:Kidney - Medulla|4.05:Small Intestine - Terminal Ileum|3.06:Muscle - Skeletal|2.41:Adipose - Subcutaneous|2.19:Adrenal Gland|2.01:Breast - Mammary Tissue|1.91:Uterus|1.82:Fallopian Tube|1.80:Artery - Coronary|1.51:Lung|1.48:Cervix - Endocervix|1.41:Adipose - Visceral (Omentum)|1.34:Esophagus - Gastroesophageal Junction|1.25:Thyroid|1.24:Cervix - Ectocervix|1.12:Kidney - Cortex|1.11:Esophagus - Muscularis|1.11:Nerve - Tibial|1.09:Skin - Sun Exposed (Lower leg)|1.08:Stomach|1.06:Colon - Sigmoid|0.95:Vagina|0.81:Heart - Left Ventricle|0.76:Heart - Atrial Appendage|0.73:Bladder|0.73:Skin - Not Sun Exposed (Suprapubic)|0.68:Prostate|0.62:Pancreas|0.50:Minor Salivary Gland|0.47:Ovary|0.36:Esophagus - Mucosa|0.25:Liver|0.16:Cells - Cultured fibroblasts|0.03:Whole Blood|0.02:Cells - EBV-transformed lymphocytes,"35.81:caudal ganglionic eminence|26.86:occipital neocortex|25.67:temporal neocortex|23.52:upper (rostral) rhombic lip|23.43:parietal neocortex|22.80:lateral ganglionic eminence|22.41:cerebellar cortex|22.30:cerebellum|20.56:dorsal thalamus|15.43:amygdaloid complex|15.32:medial ganglionic eminence|12.16:hippocampus (hippocampal formation)|11.19:mediodorsal nucleus of thalamus|8.49:striatum|8.00:anterior (rostral) cingulate (medial prefrontal) cortex|7.73:inferolateral temporal cortex (area TEv, area 20)|7.33:orbital frontal cortex|7.11:posterior (caudal) superior temporal cortex (area 22c)|6.79:dorsolateral prefrontal cortex|6.50:primary auditory cortex (core)|6.04:posteroventral (inferior) parietal cortex|6.02:primary visual cortex (striate cortex, area V1/17)|5.95:ventrolateral prefrontal cortex|5.26:primary motor cortex (area M1, area 4)|5.19:primary motor-sensory cortex (samples)|4.44:primary somatosensory cortex (area S1, areas 3,1,2)",1,SNP,4.67,"43|0.11;0-42,44-46|0.00",6023862,NA,G|D,N|151-152|A:G|N:D;N|166|^:^|^:^,NA,NA,NA,NA
60,CHST8,Homo sapiens carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 (CHST8) transcript variant 3 mRNA.,,NM_022467,chr19,10.36,8e-02,0.21,2e-01,+,CHST8,33621953,33773509,carbohydrate sulfotransferase 8,protein_coding,"GalNAc4ST,GALNAC4ST1,PSS3",0.00,0,0,2.63:Peeling skin syndrome|1.74:Periarthritis|1.65:Clubfoot,1.92:Schizophrenia|0.86:Carcinoma,NA,Infinity:abnormal eye morphology|Infinity:abnormal seminal vesicle morphology|4.94:abnormal vibrissa morphology|4.03:hypoactivity,0.85:central nervous system|0.81:nervous system|0.80:brain|0.63:pancreas|0.63:temporal lobe|0.61:cerebellum|0.59:diencephalon|0.58:liver|0.55:testis|0.54:forebrain|0.53:cerebral cortex|0.53:lymph node|0.51:autism spectrum disorder|0.51:kidney|0.50:prostate gland|0.49:corpus striatum|0.48:heart|0.47:caudate putamen|0.47:fetus|0.44:midbrain|0.43:telencephalon|0.43:hippocampus|0.43:spinal cord|0.42:ovary|0.42:placenta|0.41:hypophysis|0.41:occipital lobe|0.41:caudate nucleus|0.38:basal ganglion|0.36:frontal lobe|0.35:gastrointestinal tract|0.35:blood|0.33:leukocyte|0.33:mammary gland|0.32:substantia nigra|0.31:spleen|0.30:thalamus|0.30:corpus callosum|0.29:nucleus accumbens|0.29:adrenal gland|0.29:amygdala|0.28:skeletal muscle|0.28:uterus|0.26:intestine|0.24:subthalamic nucleus|0.24:medulla oblongata|0.22:colon|0.22:large intestine|0.21:lung|0.19:small intestine|0.19:thyroid gland|0.15:positive regulation of MAPK cascade|0.14:hypothalamus|0.14:stomach|0.13:parietal lobe|0.12:epilepsy|0.12:regulation of ion transmembrane transport|0.12:negative regulation of cell proliferation|0.11:movement disease|0.11:peripheral nervous system disease|0.11:regulation of ion transport|0.11:regulation of transmembrane transport|0.11:G-protein coupled receptor signaling pathway|0.11:neuropathy|0.11:bone marrow|0.10:positive regulation of cell differentiation,90.92:Pituitary|24.64:Brain - Cerebellum|24.16:Brain - Cerebellar Hemisphere|11.22:Brain - Spinal cord (cervical c-1)|10.25:Brain - Hypothalamus|8.37:Brain - Hippocampus|8.33:Brain - Anterior cingulate cortex (BA24)|7.56:Brain - Frontal Cortex (BA9)|6.50:Brain - Cortex|4.56:Brain - Substantia nigra|3.28:Brain - Amygdala|3.13:Testis|2.65:Brain - Nucleus accumbens (basal ganglia)|1.65:Fallopian Tube|1.52:Ovary|1.52:Cervix - Endocervix|1.51:Spleen|1.10:Cervix - Ectocervix|1.05:Brain - Caudate (basal ganglia)|1.05:Breast - Mammary Tissue|1.05:Brain - Putamen (basal ganglia)|0.92:Prostate|0.90:Thyroid|0.87:Artery - Coronary|0.86:Nerve - Tibial|0.84:Uterus|0.65:Artery - Tibial|0.63:Adipose - Visceral (Omentum)|0.61:Vagina|0.49:Esophagus - Gastroesophageal Junction|0.45:Adipose - Subcutaneous|0.43:Colon - Sigmoid|0.43:Bladder|0.37:Esophagus - Muscularis|0.32:Skin - Not Sun Exposed (Suprapubic)|0.32:Pancreas|0.32:Skin - Sun Exposed (Lower leg)|0.31:Artery - Aorta|0.31:Small Intestine - Terminal Ileum|0.30:Stomach|0.30:Lung|0.28:Colon - Transverse|0.26:Heart - Atrial Appendage|0.25:Esophagus - Mucosa|0.25:Minor Salivary Gland|0.12:Whole Blood|0.12:Heart - Left Ventricle|0.08:Adrenal Gland|0.08:Muscle - Skeletal|0.06:Liver|0.06:Kidney - Cortex|0.06:Kidney - Medulla|0.04:Cells - Cultured fibroblasts|0.02:Cells - EBV-transformed lymphocytes,"8.88:occipital neocortex|8.43:temporal neocortex|7.30:hippocampus (hippocampal formation)|6.41:cerebellar cortex|6.24:parietal neocortex|6.12:upper (rostral) rhombic lip|5.37:posterior (caudal) superior temporal cortex (area 22c)|5.23:cerebellum|4.61:primary visual cortex (striate cortex, area V1/17)|4.48:ventrolateral prefrontal cortex|4.47:inferolateral temporal cortex (area TEv, area 20)|4.34:posteroventral (inferior) parietal cortex|4.25:primary motor-sensory cortex (samples)|4.19:primary auditory cortex (core)|4.11:anterior (rostral) cingulate (medial prefrontal) cortex|3.94:primary motor cortex (area M1, area 4)|3.83:primary somatosensory cortex (area S1, areas 3,1,2)|3.73:amygdaloid complex|3.59:dorsolateral prefrontal cortex|3.31:mediodorsal nucleus of thalamus|3.18:orbital frontal cortex|2.54:lateral ganglionic eminence|2.28:dorsal thalamus|2.23:caudal ganglionic eminence|1.79:striatum|1.38:medial ganglionic eminence",3,SNP,4.55,0-46|0.00,34262922,1,C|R,"B|30|^:^|^:^;B|34|^:^|^:^;B|41|^:^|^:^;N|58|C:T|R:W;B|83|^:^|^:^;N|97,99|C:T|R:W;B|108|^:^|^:^;B|128|^:^|^:^",0.0040,0.0043,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.86,0-46|0.00,34262952,NA,C|R,N|21-22|C:T|R:C;N|24|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|72|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0006,0.0009,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.13,"14|0.21;0-13,15-46|0.00",34263192,1,T|Y,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|50,52-53|C:T|H:Y;N|58|^:^|^:^;N|83|^:^|^:^;N|104,107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|142|^:^|^:^",NA,NA,NA,NA
61,BLVRB,Homo sapiens biliverdin reductase B (flavin reductase (NADPH)) (BLVRB) mRNA.,,NM_000713,chr19,7.03,1e-01,0.12,2e-01,-,BLVRB,40447768,40465745,biliverdin reductase B,protein_coding,"BVRB,FLR,HEL-S-10,SDR43U1",0.00,0,0,1.88:Cancer|1.75:Liver disease,NA,NA,5.23:increased blood urea nitrogen level|4.55:increased or absent threshold for auditory brainstem response,NA,175.76:Whole Blood|142.61:Spleen|125.22:Esophagus - Mucosa|97.18:Lung|94.29:Adipose - Visceral (Omentum)|92.35:Vagina|91.73:Artery - Aorta|89.36:Liver|85.11:Stomach|84.57:Breast - Mammary Tissue|83.06:Nerve - Tibial|82.88:Cervix - Ectocervix|82.67:Adipose - Subcutaneous|81.26:Artery - Coronary|79.22:Bladder|79.07:Esophagus - Gastroesophageal Junction|75.29:Esophagus - Muscularis|75.23:Cervix - Endocervix|74.41:Muscle - Skeletal|73.99:Fallopian Tube|73.74:Prostate|73.55:Thyroid|71.89:Ovary|71.54:Artery - Tibial|69.33:Skin - Sun Exposed (Lower leg)|69.31:Skin - Not Sun Exposed (Suprapubic)|68.50:Colon - Sigmoid|67.86:Uterus|66.94:Minor Salivary Gland|58.75:Colon - Transverse|55.91:Adrenal Gland|54.30:Small Intestine - Terminal Ileum|53.70:Cells - Cultured fibroblasts|47.67:Kidney - Medulla|46.84:Kidney - Cortex|46.14:Heart - Atrial Appendage|42.50:Heart - Left Ventricle|38.48:Cells - EBV-transformed lymphocytes|29.62:Brain - Nucleus accumbens (basal ganglia)|27.57:Brain - Frontal Cortex (BA9)|27.55:Brain - Spinal cord (cervical c-1)|25.55:Pancreas|25.43:Brain - Caudate (basal ganglia)|25.09:Brain - Anterior cingulate cortex (BA24)|24.40:Brain - Substantia nigra|24.17:Brain - Cortex|23.88:Pituitary|22.44:Brain - Hypothalamus|21.19:Brain - Putamen (basal ganglia)|20.97:Brain - Amygdala|16.70:Brain - Hippocampus|14.41:Brain - Cerebellum|13.66:Brain - Cerebellar Hemisphere|11.45:Testis,"22.12:mediodorsal nucleus of thalamus|16.91:hippocampus (hippocampal formation)|16.84:posterior (caudal) superior temporal cortex (area 22c)|16.44:amygdaloid complex|16.27:primary visual cortex (striate cortex, area V1/17)|15.47:anterior (rostral) cingulate (medial prefrontal) cortex|15.41:orbital frontal cortex|15.29:primary somatosensory cortex (area S1, areas 3,1,2)|15.22:primary motor cortex (area M1, area 4)|15.15:inferolateral temporal cortex (area TEv, area 20)|14.14:dorsolateral prefrontal cortex|13.64:cerebellar cortex|12.94:primary auditory cortex (core)|12.56:ventrolateral prefrontal cortex|12.29:cerebellum|12.27:striatum|11.65:posteroventral (inferior) parietal cortex|10.06:upper (rostral) rhombic lip|9.48:occipital neocortex|9.25:parietal neocortex|8.28:primary motor-sensory cortex (samples)|6.64:temporal neocortex|6.30:medial ganglionic eminence|6.25:caudal ganglionic eminence|5.63:lateral ganglionic eminence|5.15:dorsal thalamus",3,SNP,2.50,0-46|0.00,40957316,2,G|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;B|94,96|C:G|G:R;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.41,"2|0.14;0-1,3-18,20-46|0.00;19|-0.03",40964064,6,G|S,"B|11-12|A:G|L:S;N|10|^:^|^:^;N|20|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|50|^:^|^:^;N|65|^:^|^:^;B|66-67|A:G|L:S;N|69|^:^|^:^;N|74|^:^|^:^;N|78|^:^|^:^;N|83|^:^|^:^;N|88|^:^|^:^;N|93|^:^|^:^;N|97|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|143|^:^|^:^;N|147,149|^:^|^:^;N|154-155|^:^|^:^;N|162|^:^|^:^;N|163,169|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.70,0-46|0.00,40964395,7,C|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|130-132|C:T|R:Q;N|141|^:^|^:^;N|146,148-149|^:^|^:^",0.0039,0.0045,B,T
62,ZNF574,Homo sapiens zinc finger protein 574 (ZNF574) mRNA.,Transcription Factor,NM_022752,chr19,8.53,1e-01,0.30,1e-01,+,ZNF574,42068477,42081567,zinc finger protein 574,protein_coding,FP972,0.91,0,0,1.53:Benign recurrent intrahepatic cholestasis,0.90:Carcinoma,NA,NA,NA,50.33:Testis|17.26:Uterus|16.56:Brain - Cerebellum|16.30:Brain - Cerebellar Hemisphere|15.18:Ovary|15.06:Skin - Sun Exposed (Lower leg)|14.47:Cervix - Endocervix|14.25:Fallopian Tube|13.27:Skin - Not Sun Exposed (Suprapubic)|12.93:Cells - EBV-transformed lymphocytes|12.68:Nerve - Tibial|12.45:Colon - Sigmoid|12.08:Esophagus - Gastroesophageal Junction|12.06:Cervix - Ectocervix|11.70:Bladder|11.39:Esophagus - Muscularis|11.24:Artery - Tibial|11.22:Cells - Cultured fibroblasts|11.03:Prostate|10.66:Spleen|10.61:Vagina|10.41:Adipose - Subcutaneous|10.39:Breast - Mammary Tissue|10.25:Esophagus - Mucosa|10.06:Artery - Aorta|9.90:Thyroid|9.15:Pituitary|8.97:Artery - Coronary|8.76:Small Intestine - Terminal Ileum|8.66:Minor Salivary Gland|8.56:Colon - Transverse|7.51:Lung|7.34:Adipose - Visceral (Omentum)|7.22:Brain - Cortex|6.37:Stomach|6.34:Brain - Frontal Cortex (BA9)|5.64:Adrenal Gland|5.63:Kidney - Medulla|4.92:Muscle - Skeletal|4.51:Brain - Nucleus accumbens (basal ganglia)|4.50:Brain - Hypothalamus|4.43:Brain - Anterior cingulate cortex (BA24)|4.14:Brain - Caudate (basal ganglia)|3.67:Brain - Spinal cord (cervical c-1)|3.50:Whole Blood|3.35:Brain - Putamen (basal ganglia)|3.35:Kidney - Cortex|3.30:Brain - Hippocampus|3.29:Brain - Amygdala|3.25:Heart - Atrial Appendage|3.13:Heart - Left Ventricle|3.09:Pancreas|3.07:Brain - Substantia nigra|2.81:Liver,"11.28:cerebellum|11.24:upper (rostral) rhombic lip|10.04:caudal ganglionic eminence|9.95:primary motor-sensory cortex (samples)|8.43:parietal neocortex|8.26:lateral ganglionic eminence|8.19:medial ganglionic eminence|7.97:occipital neocortex|7.81:dorsal thalamus|7.74:cerebellar cortex|6.50:temporal neocortex|6.21:primary visual cortex (striate cortex, area V1/17)|6.17:hippocampus (hippocampal formation)|5.85:dorsolateral prefrontal cortex|5.52:ventrolateral prefrontal cortex|5.27:posterior (caudal) superior temporal cortex (area 22c)|5.14:anterior (rostral) cingulate (medial prefrontal) cortex|4.75:primary motor cortex (area M1, area 4)|4.70:primary somatosensory cortex (area S1, areas 3,1,2)|4.59:posteroventral (inferior) parietal cortex|4.54:orbital frontal cortex|4.48:amygdaloid complex|4.42:striatum|4.35:inferolateral temporal cortex (area TEv, area 20)|3.99:primary auditory cortex (core)|3.97:mediodorsal nucleus of thalamus",1,SNP,7.15,"16|0.30;0-15,17-46|0.00",42585315,NA,C|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|59|C:T|R:W;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0001,0.0001,B,D
63,ACTN4,Homo sapiens actinin alpha 4 (ACTN4) mRNA.,Nervous  System Development;Neurological system process,NM_004924,chr19,10.35,1e-01,0.37,2e-01,+,ACTN4,38647649,38731589,actinin alpha 4,protein_coding,"ACTININ-4,FSGS,FSGS1",1.00,3,0,2.96:Proteinuria|2.78:Nephritis|2.36:Kidney failure|2.33:Frasier syndrome|2.25:Denys-Drash syndrome|2.15:Pierson syndrome|2.14:Alport syndrome|2.10:Galloway-Mowat syndrome|2.09:Cancer|2.01:nail-patella syndrome|1.75:Pseudohermaphroditism|1.75:Hypertension|1.73:Gastrointestinal system disease|1.70:Diabetes mellitus|1.59:Gonadoblastoma|1.58:Lung disease|1.56:Breast disease|1.51:Autoimmune hypersensitivity disease|1.50:Ovarian disease,0.84:Carcinoma,NA,"10.00:preweaning lethality, incomplete penetrance|5.72:abnormal retina morphology",0.88:ovary|0.88:kidney|0.87:leukocyte|0.86:blood|0.81:testis|0.79:spleen|0.77:prostate gland|0.77:liver|0.76:heart|0.74:placenta|0.72:pancreas|0.67:fetus|0.66:blood plasma|0.63:brain|0.61:central nervous system|0.60:autism spectrum disorder|0.59:monocyte|0.59:mononuclear phagocyte|0.58:tear gland|0.58:nervous system|0.55:uterus|0.55:cell-cell adhesion|0.55:skeletal muscle|0.54:lymph node|0.51:colon|0.49:blood platelet|0.49:lung|0.46:mammary gland|0.46:gastrointestinal tract|0.46:large intestine|0.45:intestine|0.44:cerebellum|0.44:amygdala|0.43:hippocampus|0.43:thalamus|0.42:uterine endometrium|0.40:bronchoalveolar lavage fluid|0.37:epidermis|0.37:eye|0.36:lymphocyte|0.36:small intestine|0.35:midbrain|0.35:telencephalon|0.33:muscle|0.33:substantia nigra|0.32:granulocyte|0.31:hypophysis|0.31:forebrain|0.31:cerebral cortex|0.30:Roundabout signaling pathway|0.30:neutrophil|0.29:caudate nucleus|0.28:adrenal gland|0.28:skin|0.27:thyroid gland|0.26:keratinocyte|0.26:erythrocyte|0.25:umbilical vein endothelial cell|0.25:regulation of actin filament-based process|0.25:blood vessel|0.25:basal ganglion|0.24:subthalamic nucleus|0.23:temporal lobe|0.22:serum|0.22:corpus callosum|0.22:stomach|0.22:spinal cord|0.22:bone marrow|0.20:mammary epithelium|0.20:renal glomerulus|0.19:bone development disease|0.19:corpus striatum|0.19:umbilical cord|0.19:T-lymphocyte|0.19:actin filament-based process|0.18:nephron|0.17:trachea|0.15:epilepsy|0.15:osteochondrodysplasia|0.15:regulation of cytoskeleton organization|0.15:positive regulation of I-kappaB kinase/NF-kappaB signaling|0.14:regulation of I-kappaB kinase/NF-kappaB signaling|0.14:vascular endothelial cell|0.14:regulation of nucleocytoplasmic transport|0.13:dysostosis|0.13:transmembrane receptor protein tyrosine kinase signaling pathway|0.13:peripheral nervous system disease|0.13:I-kappaB kinase/NF-kappaB signaling|0.13:neuropathy|0.13:response to growth factor|0.13:artery|0.13:smooth muscle|0.13:motor neuron disease|0.13:diencephalon|0.13:adolescence-adult electroclinical syndrome|0.13:epilepsy with generalized tonic-clonic seizures|0.13:regulation of supramolecular fiber organization|0.12:hematopoietic stem cell|0.12:idiopathic generalized epilepsy|0.12:negative regulation of STAT cascade|0.12:negative regulation of JAK-STAT cascade|0.12:autosomal recessive disease|0.12:regulation of MAP kinase activity|0.12:regulation of intracellular protein transport|0.12:positive regulation of cellular component biogenesis|0.12:cellular response to growth factor stimulus|0.11:cranial nerve disease|0.11:regulation of cellular response to growth factor stimulus|0.11:electroclinical syndrome|0.11:regulation of actin cytoskeleton organization|0.10:cerebellar disease|0.10:macrophage|0.10:podocyte|0.10:urinary bladder|0.10:regulation of protein import into nucleus,950.19:Artery - Tibial|777.30:Artery - Aorta|552.68:Uterus|481.06:Artery - Coronary|373.83:Fallopian Tube|338.62:Vagina|335.36:Lung|327.40:Esophagus - Mucosa|324.75:Nerve - Tibial|306.46:Cells - Cultured fibroblasts|304.49:Cervix - Ectocervix|296.68:Skin - Sun Exposed (Lower leg)|291.93:Adipose - Subcutaneous|273.59:Cervix - Endocervix|268.59:Esophagus - Gastroesophageal Junction|267.77:Esophagus - Muscularis|267.42:Breast - Mammary Tissue|266.59:Skin - Not Sun Exposed (Suprapubic)|251.42:Bladder|238.30:Adipose - Visceral (Omentum)|224.00:Colon - Transverse|222.88:Adrenal Gland|222.58:Thyroid|214.92:Small Intestine - Terminal Ileum|214.17:Minor Salivary Gland|201.04:Ovary|191.73:Prostate|188.87:Spleen|188.80:Colon - Sigmoid|157.87:Kidney - Medulla|147.54:Cells - EBV-transformed lymphocytes|142.08:Stomach|140.61:Kidney - Cortex|131.10:Pituitary|114.92:Brain - Spinal cord (cervical c-1)|85.65:Brain - Cortex|79.43:Brain - Cerebellum|78.42:Whole Blood|77.15:Brain - Frontal Cortex (BA9)|73.52:Heart - Atrial Appendage|72.23:Brain - Cerebellar Hemisphere|62.26:Pancreas|56.19:Brain - Caudate (basal ganglia)|55.71:Brain - Substantia nigra|53.34:Brain - Putamen (basal ganglia)|51.84:Testis|51.75:Liver|47.07:Brain - Nucleus accumbens (basal ganglia)|46.40:Brain - Hypothalamus|46.19:Heart - Left Ventricle|44.15:Brain - Anterior cingulate cortex (BA24)|44.13:Brain - Hippocampus|38.26:Brain - Amygdala|34.30:Muscle - Skeletal,"25.66:primary motor cortex (area M1, area 4)|25.29:primary auditory cortex (core)|24.49:primary visual cortex (striate cortex, area V1/17)|23.93:primary somatosensory cortex (area S1, areas 3,1,2)|23.31:caudal ganglionic eminence|23.27:amygdaloid complex|22.79:cerebellar cortex|22.75:parietal neocortex|22.58:posterior (caudal) superior temporal cortex (area 22c)|22.34:striatum|21.56:occipital neocortex|21.44:ventrolateral prefrontal cortex|21.42:hippocampus (hippocampal formation)|21.13:orbital frontal cortex|20.98:cerebellum|20.59:mediodorsal nucleus of thalamus|20.29:posteroventral (inferior) parietal cortex|20.23:lateral ganglionic eminence|20.01:anterior (rostral) cingulate (medial prefrontal) cortex|19.85:dorsolateral prefrontal cortex|19.35:temporal neocortex|18.53:upper (rostral) rhombic lip|18.13:inferolateral temporal cortex (area TEv, area 20)|16.89:medial ganglionic eminence|16.60:primary motor-sensory cortex (samples)|11.28:dorsal thalamus",2,SNP,4.38,0-46|0.00,39208597,NA,C|Q,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|54,56|C:G|Q:E;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|137|^:^|^:^",0.0007,0.0007,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.26,0-46|0.00,39208652,NA,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|86-89|A:G|Q:R;N|93|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
64,FBXO17,Homo sapiens F-box protein 17 (FBXO17) transcript variant 1 mRNA.,,NM_148169,chr19,6.14,1e-01,0.37,9e-02,-,FBXO17,38941401,38975742,F-box protein 17,protein_coding,"FBG4,Fbx17,FBX26,FBXO26",0.00,0,0,NA,NA,NA,NA,0.79:testis|0.79:liver|0.77:placenta|0.75:fetus|0.72:ovary|0.70:pancreas|0.62:prostate gland|0.61:kidney|0.57:heart|0.56:nervous system|0.55:brain|0.53:central nervous system|0.49:skeletal muscle|0.48:lung|0.47:autism spectrum disorder|0.44:gastrointestinal tract|0.43:lymph node|0.41:intestine|0.39:hypophysis|0.38:colon|0.37:large intestine|0.31:telencephalon|0.29:adrenal gland|0.29:small intestine|0.28:cerebral cortex|0.28:spleen|0.28:thalamus|0.27:cerebellum|0.27:forebrain|0.26:temporal lobe|0.24:hippocampus|0.24:basal ganglion|0.23:mammary gland|0.23:blood|0.23:frontal lobe|0.22:thyroid gland|0.21:substantia nigra|0.21:uterus|0.21:caudate nucleus|0.20:amygdala|0.19:occipital lobe|0.19:midbrain|0.19:spinal cord|0.18:muscle|0.18:corpus striatum|0.17:stomach|0.17:leukocyte|0.16:diencephalon|0.15:caudate putamen|0.14:corpus callosum|0.13:skin|0.12:medulla oblongata|0.12:blood vessel|0.10:peripheral nervous system disease|0.10:negative regulation of protein modification process|0.10:artery|0.10:neuropathy,45.04:Ovary|41.26:Cervix - Ectocervix|39.72:Uterus|38.13:Cervix - Endocervix|30.86:Fallopian Tube|30.40:Nerve - Tibial|28.77:Brain - Cerebellum|28.42:Brain - Cerebellar Hemisphere|26.73:Liver|25.93:Artery - Tibial|24.69:Kidney - Cortex|23.51:Artery - Aorta|23.43:Adipose - Subcutaneous|22.55:Vagina|22.43:Prostate|21.41:Bladder|19.90:Colon - Sigmoid|19.52:Cells - Cultured fibroblasts|19.33:Kidney - Medulla|18.75:Esophagus - Gastroesophageal Junction|18.31:Artery - Coronary|18.11:Breast - Mammary Tissue|17.28:Esophagus - Muscularis|17.16:Adipose - Visceral (Omentum)|14.63:Skin - Sun Exposed (Lower leg)|13.35:Skin - Not Sun Exposed (Suprapubic)|12.12:Lung|10.23:Pituitary|8.09:Colon - Transverse|7.09:Brain - Cortex|6.97:Thyroid|6.76:Brain - Nucleus accumbens (basal ganglia)|6.72:Brain - Frontal Cortex (BA9)|6.68:Heart - Atrial Appendage|6.51:Minor Salivary Gland|5.91:Brain - Caudate (basal ganglia)|5.89:Esophagus - Mucosa|5.89:Testis|5.78:Brain - Anterior cingulate cortex (BA24)|5.46:Stomach|5.15:Brain - Amygdala|4.78:Brain - Hypothalamus|4.69:Small Intestine - Terminal Ileum|4.65:Brain - Putamen (basal ganglia)|4.45:Pancreas|3.88:Spleen|3.72:Adrenal Gland|3.66:Brain - Hippocampus|3.38:Brain - Substantia nigra|2.95:Brain - Spinal cord (cervical c-1)|1.38:Cells - EBV-transformed lymphocytes|1.34:Heart - Left Ventricle|1.20:Muscle - Skeletal|0.04:Whole Blood,"9.45:caudal ganglionic eminence|7.52:medial ganglionic eminence|6.70:lateral ganglionic eminence|6.55:cerebellar cortex|6.47:occipital neocortex|5.32:parietal neocortex|5.07:amygdaloid complex|4.80:primary motor cortex (area M1, area 4)|4.56:orbital frontal cortex|4.56:ventrolateral prefrontal cortex|4.46:mediodorsal nucleus of thalamus|4.46:dorsolateral prefrontal cortex|4.45:primary visual cortex (striate cortex, area V1/17)|4.37:striatum|4.32:anterior (rostral) cingulate (medial prefrontal) cortex|4.29:posterior (caudal) superior temporal cortex (area 22c)|4.29:primary somatosensory cortex (area S1, areas 3,1,2)|4.24:primary auditory cortex (core)|4.24:hippocampus (hippocampal formation)|4.08:primary motor-sensory cortex (samples)|4.04:inferolateral temporal cortex (area TEv, area 20)|3.94:posteroventral (inferior) parietal cortex|3.84:temporal neocortex|3.61:cerebellum|3.54:upper (rostral) rhombic lip|3.18:dorsal thalamus",2,SNP,3.07,0-46|0.00,39440710,NA,T|S,N|9|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|65|^:^|^:^;N|78|G:T|R:S;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|153|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.35,"14|0.37;0-13,15-46|0.00",39440782,NA,G|L,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|50-52|G:T|L:M;N|83|^:^|^:^;N|91|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|142|^:^|^:^;N|149|^:^|^:^;N|153|^:^|^:^,NA,NA,D,T
65,IL28A,Homo sapiens interleukin 28A (interferon lambda 2) (IL28A) mRNA.,,NM_172138,chr19,8.57,1e-01,0.53,1e-01,+,IFNL2,39268396,39270188,interferon lambda 2,protein_coding,"IL-28A,IL28A",0.00,0,0,2.54:Hepatitis C|2.27:Hepatitis|2.18:Microphthalmia with limb anomalies|2.12:Influenza|1.97:Liver cirrhosis|1.83:Hepatitis B|1.82:Asthma|1.77:Cancer|1.75:Autoimmune hypersensitivity disease|1.75:Bronchiolitis|1.56:Atopic dermatitis|1.55:Psoriasis|1.54:Allergic hypersensitivity disease|1.50:Pneumonia,NA,NA,NA,NA,0.50:Testis|0.10:Pancreas|0.10:Skin - Sun Exposed (Lower leg)|0.10:Skin - Not Sun Exposed (Suprapubic)|0.00:Whole Blood|0.00:Vagina|0.00:Uterus|0.00:Thyroid|0.00:Stomach|0.00:Spleen|0.00:Small Intestine - Terminal Ileum|0.00:Prostate|0.00:Pituitary|0.00:Ovary|0.00:Nerve - Tibial|0.00:Muscle - Skeletal|0.00:Minor Salivary Gland|0.00:Lung|0.00:Liver|0.00:Kidney - Medulla|0.00:Kidney - Cortex|0.00:Heart - Left Ventricle|0.00:Heart - Atrial Appendage|0.00:Fallopian Tube|0.00:Esophagus - Muscularis|0.00:Esophagus - Mucosa|0.00:Esophagus - Gastroesophageal Junction|0.00:Colon - Transverse|0.00:Colon - Sigmoid|0.00:Cervix - Endocervix|0.00:Cervix - Ectocervix|0.00:Cells - EBV-transformed lymphocytes|0.00:Cells - Cultured fibroblasts|0.00:Breast - Mammary Tissue|0.00:Brain - Substantia nigra|0.00:Brain - Spinal cord (cervical c-1)|0.00:Brain - Putamen (basal ganglia)|0.00:Brain - Nucleus accumbens (basal ganglia)|0.00:Brain - Hypothalamus|0.00:Brain - Hippocampus|0.00:Brain - Frontal Cortex (BA9)|0.00:Brain - Cortex|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Brain - Caudate (basal ganglia)|0.00:Brain - Anterior cingulate cortex (BA24)|0.00:Brain - Amygdala|0.00:Bladder|0.00:Artery - Tibial|0.00:Artery - Coronary|0.00:Artery - Aorta|0.00:Adrenal Gland|0.00:Adipose - Visceral (Omentum)|0.00:Adipose - Subcutaneous,NA,1,SNP,6.14,"29|0.53;0-28,30-46|0.00",39759425,NA,G|G,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|A:G|D:G;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^,NA,NA,NA,NA
66,ZNF850,Homo sapiens zinc finger protein 850 (ZNF850) mRNA.,,NM_001193552,chr19,15.35,1e-01,0.30,3e-01,-,ZNF850,36743478,36772814,zinc finger protein 850,protein_coding,ZNF850P,0.19,0,0,NA,NA,NA,NA,NA,2.93:Cells - EBV-transformed lymphocytes|2.85:Testis|1.85:Uterus|1.69:Ovary|1.57:Cervix - Ectocervix|1.55:Cervix - Endocervix|1.55:Nerve - Tibial|1.51:Fallopian Tube|1.36:Adipose - Subcutaneous|1.25:Spleen|1.18:Breast - Mammary Tissue|1.14:Lung|1.13:Vagina|1.09:Prostate|1.07:Brain - Cerebellar Hemisphere|1.07:Thyroid|1.05:Adipose - Visceral (Omentum)|1.05:Artery - Coronary|1.03:Brain - Cerebellum|1.02:Artery - Tibial|0.97:Bladder|0.97:Artery - Aorta|0.97:Adrenal Gland|0.97:Skin - Sun Exposed (Lower leg)|0.95:Pituitary|0.94:Skin - Not Sun Exposed (Suprapubic)|0.93:Small Intestine - Terminal Ileum|0.88:Colon - Sigmoid|0.85:Esophagus - Gastroesophageal Junction|0.83:Cells - Cultured fibroblasts|0.83:Kidney - Medulla|0.82:Esophagus - Muscularis|0.72:Stomach|0.70:Colon - Transverse|0.70:Minor Salivary Gland|0.60:Heart - Atrial Appendage|0.50:Esophagus - Mucosa|0.47:Brain - Spinal cord (cervical c-1)|0.44:Heart - Left Ventricle|0.42:Pancreas|0.37:Liver|0.32:Kidney - Cortex|0.29:Brain - Hypothalamus|0.28:Brain - Substantia nigra|0.26:Brain - Hippocampus|0.26:Brain - Caudate (basal ganglia)|0.23:Brain - Cortex|0.23:Brain - Amygdala|0.23:Brain - Frontal Cortex (BA9)|0.23:Brain - Nucleus accumbens (basal ganglia)|0.22:Brain - Putamen (basal ganglia)|0.20:Muscle - Skeletal|0.19:Brain - Anterior cingulate cortex (BA24)|0.14:Whole Blood,NA,5,SNP,3.25,"16|0.30;0-15,17-46|0.00",37238758,1,C|E,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|59|C:T|E:K;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0015,0.0032,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.50,0-46|0.00,37239529,NA,G|P,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|45|^:^|^:^;N|74|C:C|A:A;N|75-77|C:G|A:P;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.32,0-46|0.00,37239816,1,G|S,N|30|^:^|^:^;N|34|^:^|^:^;B|40|G:T|S:Y;N|41|^:^|^:^;N|83|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0024,0.0078,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.04,0-46|0.00,37240020,NA,C|G,"N|9|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|60,62|C:G|G:A;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|155|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,4.77,0-46|0.00,37241322,NA,T|H,"N|7|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|35-36,38|C:T|R:H;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|125-126|C:T|R:H;N|128|^:^|^:^",NA,NA,NA,NA
68,PRX,Homo sapiens periaxin (PRX) transcript variant 2 mRNA.,,NM_181882,chr19,22.27,1e-01,0.60,2e-01,-,PRDX6,173477335,173488815,peroxiredoxin 6,protein_coding,"1-Cys,aiPLA2,AOP2,HEL-S-128m,NSGPx,p29,PRX",0.01,0,0,2.02:Cancer|2.02:Neurodegenerative disease|1.97:Vascular disease|1.80:Gastrointestinal system disease|1.71:Eye disease|1.70:Lung disease|1.65:Endocrine system disease|1.61:Diabetes mellitus|1.51:Hematopoietic system disease,NA,NA,NA,1.00:detoxification|1.00:cellular detoxification|1.00:cellular oxidant detoxification|0.98:response to toxic substance|0.89:liver|0.81:blood|0.78:testis|0.78:ovary|0.77:leukocyte|0.75:pancreas|0.74:prostate gland|0.70:heart|0.69:placenta|0.69:kidney|0.53:tear gland|0.53:blood plasma|0.52:skeletal muscle|0.52:postreplication repair|0.51:apoptotic signaling pathway|0.50:translesion synthesis|0.48:fetus|0.48:lung|0.46:spleen|0.42:erythrocyte|0.40:autism spectrum disorder|0.39:DNA synthesis involved in DNA repair|0.39:extrinsic apoptotic signaling pathway|0.33:central nervous system|0.32:regulation of apoptotic signaling pathway|0.30:muscle|0.30:eye|0.29:colon|0.28:intestine|0.28:lymph node|0.28:small intestine|0.27:large intestine|0.26:nervous system|0.25:brain|0.24:gastrointestinal tract|0.24:regulation of purine nucleotide metabolic process|0.24:monocyte|0.23:regulation of nucleotide metabolic process|0.23:negative regulation of intracellular signal transduction|0.22:adrenal gland|0.21:uterus|0.20:nucleotide-excision repair|0.19:DNA repair|0.19:intrinsic apoptotic signaling pathway|0.18:negative regulation of apoptotic signaling pathway|0.18:blood platelet|0.17:response to inorganic substance|0.17:response to radiation|0.17:purine ribonucleotide metabolic process|0.15:regulation of cellular amide metabolic process|0.15:cell type cancer|0.15:ribonucleotide metabolic process|0.15:thyroid gland|0.15:mammary gland|0.14:mononuclear phagocyte|0.14:regulation of extrinsic apoptotic signaling pathway|0.14:regulation of ion transport|0.13:regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|0.13:peripheral nervous system disease|0.13:neuropathy|0.13:purine-containing compound metabolic process|0.13:protein polymerization|0.13:pancreatic islet|0.13:lymphocyte|0.13:purine nucleotide metabolic process|0.13:regulation of cellular response to growth factor stimulus|0.12:positive regulation of cytokine production|0.12:granulocyte|0.12:transmembrane receptor protein serine/threonine kinase signaling pathway|0.12:regulation of intrinsic apoptotic signaling pathway|0.12:transforming growth factor beta receptor signaling pathway|0.12:cardiac muscle|0.12:response to UV|0.12:response to light stimulus|0.12:gastrointestinal system cancer|0.11:positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|0.11:nucleobase-containing small molecule metabolic process|0.11:negative regulation of protein modification process|0.11:endocrine gland cancer|0.11:positive regulation of cellular response to transforming growth factor beta stimulus|0.11:positive regulation of transforming growth factor beta receptor signaling pathway|0.11:nucleoside phosphate metabolic process|0.11:hypophysis|0.11:negative regulation of extrinsic apoptotic signaling pathway|0.10:skin|0.10:movement disease|0.10:response to reactive oxygen species|0.10:hepatobiliary disease|0.10:carbohydrate metabolic disorder|0.10:DNA biosynthetic process|0.10:benign neoplasm,443.76:Adipose - Visceral (Omentum)|429.30:Muscle - Skeletal|384.46:Esophagus - Gastroesophageal Junction|370.05:Fallopian Tube|359.65:Esophagus - Muscularis|354.41:Adipose - Subcutaneous|333.70:Cells - Cultured fibroblasts|313.11:Breast - Mammary Tissue|308.59:Nerve - Tibial|255.47:Heart - Atrial Appendage|252.91:Uterus|244.62:Lung|239.76:Artery - Coronary|232.29:Cervix - Ectocervix|227.70:Vagina|227.62:Adrenal Gland|223.67:Testis|223.56:Ovary|221.41:Cervix - Endocervix|220.99:Thyroid|219.27:Artery - Tibial|215.10:Prostate|214.39:Artery - Aorta|204.53:Liver|199.08:Bladder|195.48:Skin - Sun Exposed (Lower leg)|195.21:Colon - Transverse|190.79:Esophagus - Mucosa|182.67:Colon - Sigmoid|175.98:Stomach|173.98:Skin - Not Sun Exposed (Suprapubic)|161.22:Heart - Left Ventricle|161.11:Kidney - Medulla|137.00:Spleen|134.63:Brain - Caudate (basal ganglia)|133.28:Kidney - Cortex|126.65:Cells - EBV-transformed lymphocytes|118.74:Brain - Substantia nigra|118.60:Pituitary|116.19:Brain - Cortex|115.71:Whole Blood|114.94:Brain - Putamen (basal ganglia)|114.43:Minor Salivary Gland|112.11:Brain - Frontal Cortex (BA9)|101.99:Brain - Hypothalamus|100.00:Brain - Nucleus accumbens (basal ganglia)|98.16:Brain - Amygdala|95.12:Small Intestine - Terminal Ileum|91.56:Brain - Spinal cord (cervical c-1)|91.55:Brain - Anterior cingulate cortex (BA24)|88.03:Brain - Hippocampus|81.53:Pancreas|71.24:Brain - Cerebellum|66.97:Brain - Cerebellar Hemisphere,"40.82:occipital neocortex|39.52:medial ganglionic eminence|39.39:hippocampus (hippocampal formation)|33.49:amygdaloid complex|33.03:caudal ganglionic eminence|32.17:striatum|30.56:parietal neocortex|29.88:orbital frontal cortex|29.02:mediodorsal nucleus of thalamus|27.80:inferolateral temporal cortex (area TEv, area 20)|27.28:dorsolateral prefrontal cortex|26.45:lateral ganglionic eminence|25.31:anterior (rostral) cingulate (medial prefrontal) cortex|24.26:posterior (caudal) superior temporal cortex (area 22c)|23.94:posteroventral (inferior) parietal cortex|23.87:primary somatosensory cortex (area S1, areas 3,1,2)|23.33:ventrolateral prefrontal cortex|22.80:temporal neocortex|22.74:cerebellar cortex|22.39:primary motor cortex (area M1, area 4)|22.08:primary auditory cortex (core)|20.29:primary visual cortex (striate cortex, area V1/17)|19.06:dorsal thalamus|18.24:upper (rostral) rhombic lip|16.42:cerebellum|15.65:primary motor-sensory cortex (samples)",3,SNP,3.44,0-46|0.00,40901528,NA,C|V,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|64|C:T|V:M;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,9.747e-05,0.0001,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.68,0-46|0.00,40902005,NA,C|E,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|54,56|C:T|E:K;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^",0.0014,0.0013,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,9.80,0-46|0.00,40900486,NA,C|G,"30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;43|^:^|^:^;65|^:^|^:^;66,68|-:C|-:G;83|^:^|^:^;104|^:^|^:^;108|^:^|^:^;128|^:^|^:^;141|^:^|^:^;142|^:^|^:^;147-149|^:^|^:^;151|^:^|^:^;162|^:^|^:^;166|^:^|^:^",NA,NA,NA,NA
70,LIN37,Homo sapiens lin-37 homolog (C. elegans) (LIN37) mRNA.,,NM_019104,chr19,4.74,2e-01,0.13,2e-01,+,LIN37,35748576,35754519,lin-37 DREAM MuvB core complex component,protein_coding,"F25965,lin-37,ZK418.4",0.36,0,0,1.81:Retinoblastoma|1.68:Hemoglobin E disease,NA,NA,NA,NA,26.97:Brain - Cerebellum|26.97:Brain - Cerebellar Hemisphere|23.48:Ovary|20.20:Pituitary|19.37:Testis|19.37:Uterus|18.36:Cervix - Ectocervix|18.16:Cervix - Endocervix|18.10:Fallopian Tube|15.00:Artery - Tibial|14.79:Artery - Aorta|14.74:Nerve - Tibial|14.44:Artery - Coronary|14.40:Spleen|14.28:Esophagus - Gastroesophageal Junction|14.25:Thyroid|13.63:Colon - Sigmoid|13.13:Prostate|12.74:Esophagus - Muscularis|12.20:Bladder|12.12:Breast - Mammary Tissue|11.87:Adipose - Visceral (Omentum)|11.54:Adipose - Subcutaneous|11.38:Vagina|11.20:Brain - Cortex|11.11:Lung|10.90:Cells - Cultured fibroblasts|10.57:Brain - Frontal Cortex (BA9)|10.38:Small Intestine - Terminal Ileum|10.12:Kidney - Medulla|9.79:Adrenal Gland|9.26:Skin - Sun Exposed (Lower leg)|9.24:Whole Blood|9.17:Brain - Nucleus accumbens (basal ganglia)|9.09:Brain - Hypothalamus|9.08:Colon - Transverse|8.87:Skin - Not Sun Exposed (Suprapubic)|8.64:Brain - Anterior cingulate cortex (BA24)|8.06:Brain - Caudate (basal ganglia)|7.76:Cells - EBV-transformed lymphocytes|7.55:Brain - Spinal cord (cervical c-1)|7.29:Brain - Putamen (basal ganglia)|7.26:Brain - Hippocampus|7.16:Minor Salivary Gland|7.16:Brain - Amygdala|7.08:Stomach|7.07:Esophagus - Mucosa|6.29:Kidney - Cortex|5.98:Brain - Substantia nigra|5.65:Muscle - Skeletal|5.44:Heart - Atrial Appendage|5.32:Liver|4.20:Heart - Left Ventricle|3.60:Pancreas,"23.45:cerebellum|22.72:upper (rostral) rhombic lip|16.71:dorsal thalamus|16.31:primary motor-sensory cortex (samples)|14.31:cerebellar cortex|14.07:striatum|13.49:posterior (caudal) superior temporal cortex (area 22c)|13.23:mediodorsal nucleus of thalamus|13.08:amygdaloid complex|13.02:primary auditory cortex (core)|12.99:ventrolateral prefrontal cortex|12.80:caudal ganglionic eminence|12.79:orbital frontal cortex|12.61:primary somatosensory cortex (area S1, areas 3,1,2)|12.57:inferolateral temporal cortex (area TEv, area 20)|12.46:primary visual cortex (striate cortex, area V1/17)|12.04:lateral ganglionic eminence|11.97:dorsolateral prefrontal cortex|11.90:anterior (rostral) cingulate (medial prefrontal) cortex|11.31:primary motor cortex (area M1, area 4)|11.27:posteroventral (inferior) parietal cortex|11.17:hippocampus (hippocampal formation)|10.86:medial ganglionic eminence|9.81:temporal neocortex|9.76:parietal neocortex|8.28:occipital neocortex",2,SNP,2.23,"28|0.13;0-27,29-46|0.00",36243111,NA,T|D,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|100,102|G:T|E:D;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.80,0-46|0.00,36244099,2,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;B|65|A:G|H:R;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|157|^:^|^:^;N|162|^:^|^:^,NA,NA,NA,NA
71,CLC,Homo sapiens Charcot-Leyden crystal protein (CLC) mRNA.,,NM_001828,chr19,1.05,2e-01,0.08,2e-01,-,CLCF1,67364168,67374177,cardiotrophin like cytokine factor 1,protein_coding,"BSF-3,BSF3,CISS2,CLC,NNT-1,NNT1,NR6",0.86,0,0,3.28:cold-induced sweating syndrome|1.95:Focal segmental glomerulosclerosis|1.74:Scoliosis|1.65:Proteinuria,NA,5.00:cold-induced sweating syndrome,"Infinity:abnormal embryo size|10.00:preweaning lethality, complete penetrance|4.55:increased bone mineral density",0.79:prostate gland|0.76:placenta|0.74:liver|0.71:pancreas|0.69:ovary|0.63:fetus|0.60:lymph node|0.60:kidney|0.58:lung|0.53:testis|0.51:mammary gland|0.50:nervous system|0.50:heart|0.50:spleen|0.48:brain|0.47:central nervous system|0.46:gastrointestinal tract|0.44:intestine|0.42:uterus|0.42:hypophysis|0.40:autism spectrum disorder|0.37:large intestine|0.37:colon|0.37:skeletal muscle|0.35:regulation of kidney development|0.34:small intestine|0.33:blood|0.31:positive regulation of MAPK cascade|0.30:cerebellum|0.30:thyroid gland|0.29:cerebral cortex|0.29:leukocyte|0.28:adrenal gland|0.28:lymphocyte|0.25:skin|0.25:stomach|0.23:regulation of peptidyl-tyrosine phosphorylation|0.22:spinal cord|0.21:positive regulation of tyrosine phosphorylation of STAT protein|0.20:positive regulation of peptidyl-tyrosine phosphorylation|0.20:substantia nigra|0.19:cytokine-mediated signaling pathway|0.19:diencephalon|0.19:blood vessel|0.19:occipital lobe|0.19:medulla oblongata|0.18:bone marrow|0.17:positive regulation of protein kinase activity|0.17:nephron|0.17:regulation of protein serine/threonine kinase activity|0.17:uterine endometrium|0.17:regulation of tyrosine phosphorylation of STAT protein|0.16:dendritic cell|0.15:trachea|0.15:positive regulation of cellular component biogenesis|0.15:umbilical vein endothelial cell|0.15:caudate nucleus|0.15:telencephalon|0.15:transmembrane receptor protein tyrosine kinase signaling pathway|0.14:G-protein coupled receptor signaling pathway|0.14:basal ganglion|0.14:thalamus|0.14:mammary epithelium|0.14:T-lymphocyte|0.14:positive regulation of cell differentiation|0.14:tyrosine phosphorylation of STAT protein|0.14:renal tubule|0.14:positive regulation of locomotion|0.13:regulation of MAP kinase activity|0.13:positive regulation of cellular protein localization|0.13:midbrain|0.13:B-lymphocyte|0.13:frontal lobe|0.13:regulation of hormone secretion|0.12:positive regulation of protein serine/threonine kinase activity|0.12:muscle|0.12:tonsil|0.12:temporal lobe|0.12:positive regulation of cell motility|0.12:positive regulation of cellular component movement|0.12:apoptotic signaling pathway|0.12:positive regulation of cell migration|0.12:forebrain|0.12:positive regulation of protein transport|0.11:negative regulation of protein modification process|0.11:peptidyl-tyrosine modification|0.11:subthalamic nucleus|0.11:regulation of DNA binding transcription factor activity|0.11:umbilical cord|0.11:positive regulation of MAP kinase activity|0.11:artery|0.11:stress-activated MAPK cascade|0.11:urinary bladder|0.11:regulation of protein complex assembly|0.11:positive regulation of kinase activity|0.11:regulation of intracellular protein transport|0.11:vascular endothelial cell|0.11:ERK1 and ERK2 cascade|0.11:eye|0.11:regulation of secretion|0.10:macrophage|0.10:epidermis|0.10:positive regulation of programmed cell death|0.10:positive regulation of apoptotic process|0.10:regulation of secretion by cell|0.10:regulation of peptidase activity|0.10:regulation of ERK1 and ERK2 cascade|0.10:regulation of cell adhesion,36.84:Uterus|30.03:Cells - Cultured fibroblasts|26.98:Cervix - Endocervix|25.33:Fallopian Tube|22.67:Cervix - Ectocervix|20.55:Kidney - Medulla|20.28:Nerve - Tibial|19.83:Artery - Aorta|18.60:Adipose - Visceral (Omentum)|18.10:Thyroid|14.98:Colon - Sigmoid|14.44:Lung|14.32:Esophagus - Gastroesophageal Junction|13.92:Esophagus - Muscularis|13.47:Artery - Tibial|13.19:Vagina|13.19:Kidney - Cortex|12.99:Spleen|12.62:Artery - Coronary|12.45:Ovary|12.01:Minor Salivary Gland|11.36:Prostate|10.98:Small Intestine - Terminal Ileum|10.20:Bladder|8.81:Breast - Mammary Tissue|8.64:Adipose - Subcutaneous|8.10:Stomach|8.07:Colon - Transverse|5.60:Heart - Atrial Appendage|5.51:Pituitary|4.71:Esophagus - Mucosa|4.70:Testis|4.59:Cells - EBV-transformed lymphocytes|3.86:Skin - Sun Exposed (Lower leg)|3.71:Pancreas|3.50:Adrenal Gland|3.43:Skin - Not Sun Exposed (Suprapubic)|2.08:Whole Blood|1.54:Heart - Left Ventricle|1.19:Liver|0.88:Brain - Cerebellum|0.87:Muscle - Skeletal|0.75:Brain - Hypothalamus|0.70:Brain - Cortex|0.66:Brain - Spinal cord (cervical c-1)|0.64:Brain - Caudate (basal ganglia)|0.61:Brain - Nucleus accumbens (basal ganglia)|0.58:Brain - Cerebellar Hemisphere|0.53:Brain - Substantia nigra|0.52:Brain - Frontal Cortex (BA9)|0.50:Brain - Putamen (basal ganglia)|0.49:Brain - Hippocampus|0.46:Brain - Anterior cingulate cortex (BA24)|0.45:Brain - Amygdala,"0.47:primary visual cortex (striate cortex, area V1/17)|0.40:hippocampus (hippocampal formation)|0.30:posterior (caudal) superior temporal cortex (area 22c)|0.29:occipital neocortex|0.28:upper (rostral) rhombic lip|0.26:primary motor-sensory cortex (samples)|0.25:cerebellum|0.25:posteroventral (inferior) parietal cortex|0.23:primary auditory cortex (core)|0.23:inferolateral temporal cortex (area TEv, area 20)|0.21:anterior (rostral) cingulate (medial prefrontal) cortex|0.21:cerebellar cortex|0.21:dorsolateral prefrontal cortex|0.20:primary somatosensory cortex (area S1, areas 3,1,2)|0.20:primary motor cortex (area M1, area 4)|0.20:ventrolateral prefrontal cortex|0.19:amygdaloid complex|0.18:striatum|0.18:orbital frontal cortex|0.17:parietal neocortex|0.16:mediodorsal nucleus of thalamus|0.15:temporal neocortex|0.11:lateral ganglionic eminence|0.11:medial ganglionic eminence|0.10:dorsal thalamus|0.01:caudal ganglionic eminence",2,SNP,0.68,0-46|0.00,40224985,NA,T|M,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|97-98|G:T|L:M;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.68,"39|0.08;0-38,40-46|0.00",40225120,NA,G|L,"N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|134,136|C:G|V:L",NA,NA,NA,NA
72,FAM98C,Homo sapiens family with sequence similarity 98 member C (FAM98C) mRNA.,,NM_174905,chr19,11.55,2e-01,0.13,3e-01,+,FAM98C,38403124,38409088,family with sequence similarity 98 member C,protein_coding,NA,0.00,3,0,1.77:Meckel syndrome|1.68:Joubert syndrome|1.65:Synpolydactyly,NA,NA,NA,NA,47.79:Brain - Cerebellar Hemisphere|43.86:Brain - Cerebellum|36.52:Skin - Not Sun Exposed (Suprapubic)|35.64:Skin - Sun Exposed (Lower leg)|31.67:Nerve - Tibial|30.49:Cervix - Endocervix|29.97:Brain - Frontal Cortex (BA9)|29.28:Cervix - Ectocervix|27.09:Brain - Cortex|26.78:Fallopian Tube|26.22:Vagina|25.48:Ovary|25.18:Prostate|25.12:Thyroid|24.53:Brain - Anterior cingulate cortex (BA24)|24.24:Uterus|24.18:Small Intestine - Terminal Ileum|24.11:Artery - Aorta|23.03:Esophagus - Mucosa|22.84:Artery - Tibial|22.30:Brain - Nucleus accumbens (basal ganglia)|22.26:Bladder|21.83:Brain - Spinal cord (cervical c-1)|21.53:Pituitary|20.99:Spleen|20.74:Minor Salivary Gland|19.98:Colon - Transverse|19.90:Breast - Mammary Tissue|19.44:Colon - Sigmoid|19.31:Brain - Amygdala|19.30:Artery - Coronary|18.94:Testis|18.88:Brain - Hypothalamus|18.84:Brain - Caudate (basal ganglia)|18.80:Brain - Hippocampus|17.65:Lung|17.53:Esophagus - Gastroesophageal Junction|17.32:Adipose - Subcutaneous|17.29:Esophagus - Muscularis|16.99:Stomach|16.99:Brain - Putamen (basal ganglia)|16.03:Cells - EBV-transformed lymphocytes|14.75:Brain - Substantia nigra|14.32:Kidney - Medulla|13.82:Whole Blood|13.10:Cells - Cultured fibroblasts|12.78:Adrenal Gland|12.46:Adipose - Visceral (Omentum)|11.55:Pancreas|10.66:Kidney - Cortex|8.91:Heart - Atrial Appendage|8.27:Liver|6.52:Heart - Left Ventricle|2.02:Muscle - Skeletal,"18.14:cerebellar cortex|13.14:posterior (caudal) superior temporal cortex (area 22c)|12.93:striatum|12.66:inferolateral temporal cortex (area TEv, area 20)|12.62:ventrolateral prefrontal cortex|12.41:dorsolateral prefrontal cortex|12.39:primary motor cortex (area M1, area 4)|11.94:cerebellum|11.45:anterior (rostral) cingulate (medial prefrontal) cortex|11.34:orbital frontal cortex|11.05:primary visual cortex (striate cortex, area V1/17)|10.91:primary somatosensory cortex (area S1, areas 3,1,2)|10.90:posteroventral (inferior) parietal cortex|10.75:amygdaloid complex|10.68:hippocampus (hippocampal formation)|10.37:mediodorsal nucleus of thalamus|9.93:upper (rostral) rhombic lip|9.72:primary auditory cortex (core)|6.36:dorsal thalamus|5.75:primary motor-sensory cortex (samples)|4.57:lateral ganglionic eminence|4.40:parietal neocortex|4.28:medial ganglionic eminence|4.06:occipital neocortex|3.64:temporal neocortex|3.52:caudal ganglionic eminence",3,SNP,1.00,0-46|0.00,38896204,18,T|C,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|57,59|G:T|G:C;B|70-71|G:T|G:C;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|143|^:^|^:^;N|149|^:^|^:^;B|159,161-162|G:T|G:C",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.94,"28|0.13;0-27,29-46|0.00",38897674,NA,C|T,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|100,102|A:C|N:T;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,mnp,8.33,0-46|0.00,38899502,NA,AAG|K,"0,2,4|^:^|^:^;11-12|AAG:AAGAAG|K:K;9-10|^:^|^:^;18|^:^|^:^;30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;42|^:^|^:^;51-53|AAG:AAGAAG|K:K;50|^:^|^:^;59|-:AAG|-:K;57-58|^:^|^:^;60-61|^:^|^:^;63-64|AAG:AAGAAG|K:K;69,71|AAG:AAGAAG|K:K;70|^:^|^:^;83|^:^|^:^;91|AAG:AAGAAG|K:K;86-87|^:^|^:^;96|^:^|^:^;100,103|^:^|^:^;108|^:^|^:^;121|^:^|^:^;126|^:^|^:^;128|^:^|^:^;131|AAG:AAGAAG|K:K;130,132|^:^|^:^;134|^:^|^:^;142|^:^|^:^;149|^:^|^:^;150-151|^:^|^:^;161|^:^|^:^;170-171|^:^|^:^",NA,NA,NA,NA
73,B3GNT8,Homo sapiens UDP-GlcNAc:betaGal beta-13-N-acetylglucosaminyltransferase 8 (B3GNT8) mRNA.,,NM_198540,chr19,10.07,2e-01,0.41,2e-01,-,B3GNTL1,82942149,83051845,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1",protein_coding,"3-Gn-T8,B3GNT8,beta-1,beta3Gn-T8,beta3GnTL1,BGnT-8",0.00,0,0,1.74:Mixed receptive-expressive language disorder,NA,NA,NA,NA,6.28:Whole Blood|5.31:Cervix - Endocervix|5.22:Ovary|5.01:Fallopian Tube|4.88:Cervix - Ectocervix|4.74:Testis|4.61:Cells - EBV-transformed lymphocytes|4.58:Uterus|4.54:Cells - Cultured fibroblasts|4.28:Spleen|3.93:Lung|3.77:Pituitary|3.75:Brain - Cerebellum|3.67:Nerve - Tibial|3.62:Bladder|3.61:Brain - Cerebellar Hemisphere|3.42:Skin - Not Sun Exposed (Suprapubic)|3.41:Skin - Sun Exposed (Lower leg)|3.17:Thyroid|3.13:Prostate|2.99:Vagina|2.88:Breast - Mammary Tissue|2.77:Adipose - Visceral (Omentum)|2.70:Brain - Frontal Cortex (BA9)|2.69:Adipose - Subcutaneous|2.67:Artery - Coronary|2.51:Brain - Nucleus accumbens (basal ganglia)|2.42:Brain - Cortex|2.23:Small Intestine - Terminal Ileum|2.22:Brain - Caudate (basal ganglia)|2.18:Artery - Aorta|2.17:Adrenal Gland|2.01:Colon - Sigmoid|2.00:Minor Salivary Gland|1.95:Brain - Spinal cord (cervical c-1)|1.88:Esophagus - Mucosa|1.87:Brain - Hypothalamus|1.84:Esophagus - Gastroesophageal Junction|1.83:Esophagus - Muscularis|1.83:Brain - Anterior cingulate cortex (BA24)|1.81:Artery - Tibial|1.67:Colon - Transverse|1.65:Brain - Putamen (basal ganglia)|1.63:Heart - Atrial Appendage|1.63:Brain - Hippocampus|1.51:Stomach|1.47:Muscle - Skeletal|1.41:Brain - Amygdala|1.27:Brain - Substantia nigra|1.12:Heart - Left Ventricle|1.06:Kidney - Medulla|0.88:Kidney - Cortex|0.85:Pancreas|0.84:Liver,"6.09:mediodorsal nucleus of thalamus|4.76:cerebellum|3.86:cerebellar cortex|3.16:primary visual cortex (striate cortex, area V1/17)|3.11:primary somatosensory cortex (area S1, areas 3,1,2)|3.05:anterior (rostral) cingulate (medial prefrontal) cortex|2.84:posterior (caudal) superior temporal cortex (area 22c)|2.74:striatum|2.69:upper (rostral) rhombic lip|2.69:dorsal thalamus|2.68:hippocampus (hippocampal formation)|2.64:orbital frontal cortex|2.58:ventrolateral prefrontal cortex|2.58:dorsolateral prefrontal cortex|2.57:primary motor cortex (area M1, area 4)|2.56:primary motor-sensory cortex (samples)|2.53:inferolateral temporal cortex (area TEv, area 20)|2.41:posteroventral (inferior) parietal cortex|2.38:primary auditory cortex (core)|2.26:temporal neocortex|2.17:occipital neocortex|2.13:parietal neocortex|2.06:amygdaloid complex|1.95:lateral ganglionic eminence|1.75:medial ganglionic eminence|1.57:caudal ganglionic eminence",2,SNP,3.39,"16|0.30;0-15,17-46|0.00",41931716,NA,G|A,N|8|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|59|A:G|V:A;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|148|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,6.81,"43|0.11;0-42,44-46|0.00",41932038,NA,C|D,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|152-153|C:T|D:N,NA,NA,D,D
74,EID2,Homo sapiens EP300 interacting inhibitor of differentiation 2 (EID2) mRNA.,,NM_153232,chr19,0.87,2e-01,0.09,2e-01,-,EID2,39538707,39540161,EP300 interacting inhibitor of differentiation 2,protein_coding,"CRI2,EID-2",0.75,0,0,1.84:Campylobacteriosis|1.59:Cutaneous diphtheria|1.55:Salmonellosis,NA,NA,4.98:increased bone mineral content|4.84:abnormal bone structure|4.79:decreased heart weight|4.51:cataract|4.09:increased total body fat amount,NA,36.00:Brain - Frontal Cortex (BA9)|31.04:Brain - Cerebellar Hemisphere|26.71:Brain - Cerebellum|25.95:Adrenal Gland|25.63:Brain - Cortex|24.68:Pituitary|23.22:Cells - Cultured fibroblasts|22.94:Brain - Hypothalamus|21.36:Brain - Anterior cingulate cortex (BA24)|20.97:Testis|20.32:Uterus|20.26:Brain - Nucleus accumbens (basal ganglia)|19.40:Esophagus - Muscularis|18.57:Esophagus - Gastroesophageal Junction|18.39:Fallopian Tube|18.16:Thyroid|17.57:Cervix - Endocervix|17.07:Artery - Aorta|16.42:Spleen|16.39:Lung|16.29:Artery - Coronary|16.10:Colon - Sigmoid|15.97:Nerve - Tibial|15.76:Brain - Caudate (basal ganglia)|15.75:Ovary|15.52:Adipose - Subcutaneous|15.40:Bladder|15.23:Small Intestine - Terminal Ileum|15.03:Breast - Mammary Tissue|14.98:Prostate|14.73:Artery - Tibial|14.54:Brain - Hippocampus|14.44:Cervix - Ectocervix|14.39:Brain - Spinal cord (cervical c-1)|14.27:Adipose - Visceral (Omentum)|13.87:Brain - Substantia nigra|13.80:Brain - Amygdala|13.78:Esophagus - Mucosa|13.63:Kidney - Medulla|13.14:Brain - Putamen (basal ganglia)|12.70:Vagina|12.14:Skin - Sun Exposed (Lower leg)|11.99:Skin - Not Sun Exposed (Suprapubic)|11.96:Colon - Transverse|11.77:Minor Salivary Gland|11.46:Cells - EBV-transformed lymphocytes|10.66:Stomach|8.56:Kidney - Cortex|8.23:Muscle - Skeletal|7.55:Heart - Atrial Appendage|6.91:Heart - Left Ventricle|6.89:Liver|5.10:Pancreas|2.90:Whole Blood,"21.29:dorsal thalamus|18.36:upper (rostral) rhombic lip|17.42:primary motor-sensory cortex (samples)|15.49:inferolateral temporal cortex (area TEv, area 20)|15.38:posteroventral (inferior) parietal cortex|15.20:hippocampus (hippocampal formation)|14.94:ventrolateral prefrontal cortex|14.90:cerebellum|14.43:anterior (rostral) cingulate (medial prefrontal) cortex|14.41:primary somatosensory cortex (area S1, areas 3,1,2)|14.38:primary visual cortex (striate cortex, area V1/17)|14.07:posterior (caudal) superior temporal cortex (area 22c)|14.02:striatum|14.01:orbital frontal cortex|13.99:amygdaloid complex|13.90:parietal neocortex|13.89:dorsolateral prefrontal cortex|13.88:primary auditory cortex (core)|13.87:mediodorsal nucleus of thalamus|13.82:occipital neocortex|13.65:lateral ganglionic eminence|13.56:medial ganglionic eminence|13.44:primary motor cortex (area M1, area 4)|12.97:caudal ganglionic eminence|11.78:cerebellar cortex|8.52:temporal neocortex",1,SNP,0.24,0-46|0.00,40030625,2,C|R,"B|6|C:T|R:Q;N|30|^:^|^:^;N|34|^:^|^:^;N|35|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;B|91|C:T|R:Q;N|86,88|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|153|^:^|^:^;N|156|^:^|^:^;N|165,170|^:^|^:^",0.0018,0.0025,B,D
75,LSR,Homo sapiens lipolysis stimulated lipoprotein receptor (LSR) transcript variant 3 mRNA.,,NM_205835,chr19,12.83,2e-01,0.30,2e-01,+,LSR,35248656,35267964,lipolysis stimulated lipoprotein receptor,protein_coding,"ILDR3,LISCH7",0.00,0,0,2.73:Cancer|2.66:Hematopoietic system disease|2.60:Autoimmune hypersensitivity disease|2.56:Gastrointestinal system disease|2.52:Influenza|2.41:Allergic hypersensitivity disease|2.40:Acquired immunodeficiency syndrome|2.38:Lung disease|2.35:Hypotrichosis 1|2.27:Arthritis|2.23:Vascular disease|2.19:Breast disease|2.18:Primary immunodeficiency disease|2.15:Diabetes mellitus|2.13:Atopic dermatitis|2.13:Neurodegenerative disease|2.10:Malaria|2.10:Asthma|2.04:Tuberculosis|2.02:Eye disease|2.00:Kidney disease|1.96:Vaccinia|1.93:Lymphatic system disease|1.90:Tetanus|1.87:Prostate disease|1.86:Brain disease|1.83:X-linked recessive disease|1.82:Ovarian disease|1.82:Pancreas disease|1.80:Hepatitis B|1.78:Heart disease|1.74:Parasitic helminthiasis infectious disease|1.72:Obesity|1.71:Psoriasis|1.65:Uterine disease|1.63:Smallpox|1.60:Radiculopathy|1.58:Yellow fever|1.54:Listeriosis|1.53:Salmonellosis|1.52:Meningitis|1.51:Neuropathy,0.70:Carcinoma,NA,NA,NA,72.59:Minor Salivary Gland|72.24:Liver|71.08:Stomach|62.27:Colon - Transverse|60.97:Small Intestine - Terminal Ileum|60.50:Skin - Not Sun Exposed (Suprapubic)|60.33:Esophagus - Mucosa|58.44:Skin - Sun Exposed (Lower leg)|57.53:Thyroid|51.31:Pancreas|46.22:Testis|41.11:Vagina|39.04:Prostate|39.03:Lung|38.34:Pituitary|35.01:Breast - Mammary Tissue|30.99:Adrenal Gland|29.45:Kidney - Medulla|27.50:Fallopian Tube|27.24:Cells - EBV-transformed lymphocytes|24.32:Cervix - Endocervix|23.61:Uterus|22.75:Cervix - Ectocervix|22.68:Spleen|19.70:Nerve - Tibial|19.52:Kidney - Cortex|18.44:Adipose - Visceral (Omentum)|17.67:Adipose - Subcutaneous|14.62:Bladder|12.19:Artery - Aorta|10.78:Artery - Coronary|10.26:Ovary|8.19:Brain - Spinal cord (cervical c-1)|7.35:Brain - Substantia nigra|7.13:Esophagus - Muscularis|7.02:Esophagus - Gastroesophageal Junction|6.98:Artery - Tibial|6.45:Brain - Cortex|6.19:Brain - Hypothalamus|6.03:Brain - Putamen (basal ganglia)|5.90:Brain - Hippocampus|5.57:Colon - Sigmoid|5.42:Brain - Caudate (basal ganglia)|5.22:Brain - Cerebellum|5.14:Brain - Frontal Cortex (BA9)|4.63:Brain - Amygdala|4.17:Brain - Anterior cingulate cortex (BA24)|3.99:Brain - Nucleus accumbens (basal ganglia)|3.84:Brain - Cerebellar Hemisphere|3.26:Heart - Atrial Appendage|3.04:Whole Blood|2.75:Heart - Left Ventricle|2.36:Cells - Cultured fibroblasts|2.22:Muscle - Skeletal,"4.10:mediodorsal nucleus of thalamus|3.94:cerebellar cortex|3.81:primary motor cortex (area M1, area 4)|3.74:hippocampus (hippocampal formation)|3.31:primary visual cortex (striate cortex, area V1/17)|3.28:posterior (caudal) superior temporal cortex (area 22c)|3.27:primary somatosensory cortex (area S1, areas 3,1,2)|3.10:dorsolateral prefrontal cortex|3.07:ventrolateral prefrontal cortex|3.05:upper (rostral) rhombic lip|2.97:amygdaloid complex|2.83:anterior (rostral) cingulate (medial prefrontal) cortex|2.77:striatum|2.70:orbital frontal cortex|2.70:posteroventral (inferior) parietal cortex|2.63:primary auditory cortex (core)|2.27:inferolateral temporal cortex (area TEv, area 20)|2.22:occipital neocortex|1.99:parietal neocortex|1.73:dorsal thalamus|1.65:primary motor-sensory cortex (samples)|1.16:caudal ganglionic eminence|1.10:cerebellum|0.85:medial ganglionic eminence|0.84:temporal neocortex|0.81:lateral ganglionic eminence",2,SNP,4.90,"16|0.30;0-15,17-46|0.00",35757349,NA,C|P,"N|8,10|^:^|^:^;N|25|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|59|C:T|P:L;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|139|^:^|^:^",0.0002,0.0002,D,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.54,0-46|0.00,35758192,NA,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|58|^:^|^:^;N|66-67|G:T|R:L;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|136|^:^|^:^;N|137|^:^|^:^,8.048e-06,0,D,D
79,MLL4,Homo sapiens myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4) mRNA.,,NM_014727,chr19,29.76,2e-01,0.60,3e-01,+,KMT2D,49018975,49060884,lysine methyltransferase 2D,protein_coding,"AAD10,ALR,CAGL114,KABUK1,KMS,MLL2,MLL4,TNRC21",1.00,0,0,3.33:Kabuki syndrome|2.74:Cancer|2.64:Hematopoietic system disease|2.31:Intellectual disability|2.13:Gastrointestinal system disease|2.09:Breast disease|2.08:Kleefstra syndrome|2.04:Congenital heart disease|1.99:Multiple endocrine neoplasia type 1|1.98:CHARGE syndrome|1.96:Central nervous system disease|1.93:Bladder disease|1.92:Lung disease|1.90:Prostate disease|1.86:Sotos syndrome|1.84:Rubinstein-Taybi syndrome|1.79:KBG syndrome|1.76:Kidney disease|1.74:Weaver syndrome|1.72:Eye disease|1.70:Benign neoplasm|1.70:Ovarian disease|1.65:Uterine disease|1.59:Connective tissue disease|1.59:Cleft lip|1.58:Microcephaly|1.56:Cleft palate|1.56:Autistic disorder,1.60:Carcinoma|1.32:DOID:10747|1.32:Immune system cancer|1.00:Kidney cancer|0.88:Breast cancer|0.76:Large intestine cancer|0.65:DOID:3858|0.65:Liver cancer|0.61:Endometrial cancer|0.54:Pancreatic cancer|0.50:Lung cancer,5.00:Coloboma|5.00:Kabuki syndrome|4.00:Intellectual disability,NA,0.99:histone H3-K36 demethylation|0.97:histone modification|0.96:histone H3-K4 methylation|0.92:histone lysine methylation|0.85:histone methylation|0.81:histone lysine demethylation|0.77:protein alkylation|0.77:protein methylation|0.74:blood|0.73:positive regulation of transcription by RNA polymerase III|0.73:covalent chromatin modification|0.73:histone H4-K5 acetylation|0.73:histone H4-K8 acetylation|0.71:subthalamic nucleus|0.71:peptidyl-lysine modification|0.68:diencephalon|0.68:corpus callosum|0.65:leukocyte|0.65:caudate nucleus|0.64:placenta|0.64:hippocampus|0.64:nervous system|0.64:thalamus|0.63:peptidyl-lysine methylation|0.63:corpus striatum|0.63:testis|0.63:amygdala|0.62:midbrain|0.62:substantia nigra|0.62:brain|0.62:forebrain|0.61:cerebral cortex|0.61:temporal lobe|0.61:telencephalon|0.61:central nervous system|0.61:skeletal muscle|0.60:liver|0.60:transcription by RNA polymerase III|0.59:basal ganglion|0.58:spleen|0.58:ovary|0.57:fetus|0.56:pancreas|0.55:heart|0.55:lung|0.51:autism spectrum disorder|0.51:histone acetylation|0.47:kidney|0.47:cerebellum|0.46:histone H4-K16 acetylation|0.46:histone demethylation|0.45:spinal cord|0.41:prostate gland|0.38:regulation of chromosome organization|0.29:lymph node|0.28:histone H4 acetylation|0.27:uterus|0.27:regulation of transcription by RNA polymerase III|0.26:positive regulation of transcription initiation from RNA polymerase II promoter|0.24:lymphocyte|0.22:peptidyl-lysine acetylation|0.22:internal peptidyl-lysine acetylation|0.22:protein acylation|0.21:gastrointestinal tract|0.20:internal protein amino acid acetylation|0.20:regulation of chromatin organization|0.19:intestine|0.18:mammary gland|0.18:stress-activated MAPK cascade|0.18:negative regulation of DNA binding transcription factor activity|0.17:protein acetylation|0.17:regulation of DNA binding transcription factor activity|0.16:bone marrow|0.16:regulation of stress-activated MAPK cascade|0.16:small intestine|0.16:ubiquitin-dependent protein catabolic process|0.16:muscle|0.16:negative regulation of protein modification process|0.16:modification-dependent protein catabolic process|0.15:adrenal gland|0.15:negative regulation of protein phosphorylation|0.15:regulation of DNA metabolic process|0.15:hypophysis|0.14:large intestine|0.14:colon|0.13:regulation of protein serine/threonine kinase activity|0.13:epilepsy|0.13:serum|0.12:negative regulation of DNA metabolic process|0.12:frontal lobe|0.11:histone H3-K9 demethylation|0.11:JNK cascade|0.11:regulation of JNK cascade|0.11:occipital lobe|0.11:positive regulation of protein kinase activity|0.11:movement disease|0.11:negative regulation of cyclin-dependent protein kinase activity|0.10:macromolecule methylation|0.10:blood vessel,29.97:Uterus|29.91:Thyroid|27.40:Brain - Cerebellum|25.38:Ovary|24.73:Nerve - Tibial|23.49:Skin - Sun Exposed (Lower leg)|23.43:Lung|23.22:Cervix - Endocervix|22.50:Brain - Cerebellar Hemisphere|22.40:Spleen|21.98:Fallopian Tube|21.85:Pituitary|21.79:Skin - Not Sun Exposed (Suprapubic)|21.58:Testis|20.73:Cells - EBV-transformed lymphocytes|18.80:Cells - Cultured fibroblasts|18.44:Artery - Tibial|18.25:Bladder|18.19:Cervix - Ectocervix|18.19:Prostate|17.92:Small Intestine - Terminal Ileum|17.72:Artery - Coronary|17.33:Vagina|17.13:Breast - Mammary Tissue|17.02:Esophagus - Gastroesophageal Junction|16.88:Artery - Aorta|16.72:Adipose - Subcutaneous|16.61:Colon - Sigmoid|16.49:Esophagus - Muscularis|16.25:Minor Salivary Gland|15.75:Esophagus - Mucosa|13.75:Stomach|13.59:Adipose - Visceral (Omentum)|13.32:Muscle - Skeletal|13.00:Adrenal Gland|12.84:Colon - Transverse|9.14:Brain - Cortex|9.02:Pancreas|8.57:Kidney - Medulla|8.41:Whole Blood|7.30:Heart - Atrial Appendage|7.18:Brain - Frontal Cortex (BA9)|6.48:Kidney - Cortex|6.38:Brain - Spinal cord (cervical c-1)|6.12:Brain - Nucleus accumbens (basal ganglia)|6.04:Heart - Left Ventricle|5.51:Brain - Hypothalamus|5.50:Brain - Caudate (basal ganglia)|5.37:Brain - Anterior cingulate cortex (BA24)|5.28:Liver|5.17:Brain - Hippocampus|4.36:Brain - Substantia nigra|4.20:Brain - Putamen (basal ganglia)|4.16:Brain - Amygdala,NA,3,SNP,5.65,0-46|0.00,36210896,NA,C|P,"N|14-15|A:C|H:P;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|69,71|A:C|H:P;N|83|^:^|^:^;N|91|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|130-132|A:C|H:P",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,16.27,0-46|0.00,36211375,NA,AAG|K,"5-6|-:AAG|-:K;20|^:^|^:^;30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;73,77|-:AAG|-:K;74|^:^|^:^;83|^:^|^:^;97,99|-:AAG|-:K;108|^:^|^:^;114|-:AAG|-:K;128|^:^|^:^;149|^:^|^:^;155|^:^|^:^;164,167-168|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,ins,4.35,"36|0.60;0-35,37-46|0.00",36212516,NA,-|-,"124,126|-:ACAGCCACAGCT|-:TATA",0.0012,0.0010,NA,NA
80,IGFLR1,Homo sapiens IGF-like family receptor 1 (IGFLR1) mRNA.,,NM_024660,chr19,7.88,2e-01,0.30,2e-01,-,IGFLR1,35738801,35742452,IGF like family receptor 1,protein_coding,TMEM149,0.00,0,0,NA,NA,NA,Infinity:hydrometra|Infinity:small superior vagus ganglion,NA,52.02:Whole Blood|45.68:Cells - EBV-transformed lymphocytes|44.76:Spleen|24.30:Liver|20.52:Lung|15.42:Small Intestine - Terminal Ileum|14.76:Kidney - Medulla|13.94:Nerve - Tibial|13.77:Testis|13.59:Cervix - Endocervix|13.09:Fallopian Tube|12.14:Thyroid|11.31:Kidney - Cortex|11.18:Adrenal Gland|10.91:Prostate|10.76:Adipose - Subcutaneous|10.39:Adipose - Visceral (Omentum)|10.33:Bladder|9.41:Breast - Mammary Tissue|9.23:Artery - Coronary|9.05:Pituitary|8.43:Minor Salivary Gland|8.17:Artery - Aorta|8.00:Brain - Spinal cord (cervical c-1)|7.83:Colon - Transverse|7.75:Ovary|7.25:Uterus|7.17:Stomach|6.80:Brain - Cerebellum|6.71:Cervix - Ectocervix|6.52:Esophagus - Muscularis|6.27:Brain - Cerebellar Hemisphere|6.24:Vagina|6.11:Esophagus - Gastroesophageal Junction|6.09:Colon - Sigmoid|6.00:Skin - Sun Exposed (Lower leg)|5.99:Skin - Not Sun Exposed (Suprapubic)|5.81:Artery - Tibial|5.37:Brain - Substantia nigra|5.04:Esophagus - Mucosa|4.35:Pancreas|4.20:Brain - Hypothalamus|3.93:Cells - Cultured fibroblasts|3.64:Brain - Cortex|3.59:Brain - Amygdala|3.29:Brain - Caudate (basal ganglia)|3.20:Brain - Hippocampus|3.18:Brain - Frontal Cortex (BA9)|3.08:Brain - Nucleus accumbens (basal ganglia)|3.07:Brain - Putamen (basal ganglia)|2.99:Brain - Anterior cingulate cortex (BA24)|2.86:Heart - Atrial Appendage|2.71:Muscle - Skeletal|2.25:Heart - Left Ventricle,"3.47:caudal ganglionic eminence|2.58:medial ganglionic eminence|2.53:occipital neocortex|2.32:lateral ganglionic eminence|1.85:amygdaloid complex|1.62:hippocampus (hippocampal formation)|1.62:cerebellar cortex|1.59:parietal neocortex|1.26:mediodorsal nucleus of thalamus|1.21:striatum|1.16:upper (rostral) rhombic lip|1.08:orbital frontal cortex|1.03:primary somatosensory cortex (area S1, areas 3,1,2)|0.97:ventrolateral prefrontal cortex|0.95:primary visual cortex (striate cortex, area V1/17)|0.93:primary motor cortex (area M1, area 4)|0.90:dorsolateral prefrontal cortex|0.90:anterior (rostral) cingulate (medial prefrontal) cortex|0.90:posterior (caudal) superior temporal cortex (area 22c)|0.84:primary auditory cortex (core)|0.84:temporal neocortex|0.81:cerebellum|0.79:dorsal thalamus|0.77:inferolateral temporal cortex (area TEv, area 20)|0.58:posteroventral (inferior) parietal cortex|0.55:primary motor-sensory cortex (samples)",1,del,6.29,0-46|0.00,36230500,NA,AG|L,30|^:^|^:^;34|^:^|^:^;41|^:^|^:^;79|^:^|^:^;83|^:^|^:^;97-98|-:AG|-:L;108|^:^|^:^;128|^:^|^:^,NA,NA,NA,NA
81,ZNF573,Homo sapiens zinc finger protein 573 (ZNF573) transcript variant 1 mRNA.,Transcription Factor,NM_001172691,chr19,4.78,2e-01,0.23,2e-01,-,ZNF573,37738302,37779590,zinc finger protein 573,protein_coding,NA,0.00,0,0,1.82:Endocervical adenocarcinoma|1.64:Hypogonadotropism,0.90:Carcinoma|0.54:Kidney cancer,NA,NA,NA,5.11:Testis|1.97:Nerve - Tibial|1.87:Ovary|1.79:Uterus|1.78:Thyroid|1.59:Cells - EBV-transformed lymphocytes|1.54:Cervix - Endocervix|1.50:Cells - Cultured fibroblasts|1.50:Artery - Tibial|1.41:Vagina|1.41:Cervix - Ectocervix|1.41:Skin - Sun Exposed (Lower leg)|1.38:Brain - Cerebellum|1.32:Skin - Not Sun Exposed (Suprapubic)|1.31:Artery - Aorta|1.25:Pituitary|1.24:Artery - Coronary|1.23:Bladder|1.21:Minor Salivary Gland|1.15:Fallopian Tube|1.11:Adipose - Subcutaneous|1.10:Breast - Mammary Tissue|1.08:Brain - Cerebellar Hemisphere|1.05:Esophagus - Gastroesophageal Junction|1.02:Lung|1.01:Esophagus - Muscularis|0.96:Colon - Sigmoid|0.93:Prostate|0.88:Small Intestine - Terminal Ileum|0.86:Adrenal Gland|0.82:Adipose - Visceral (Omentum)|0.74:Esophagus - Mucosa|0.69:Brain - Spinal cord (cervical c-1)|0.67:Stomach|0.65:Colon - Transverse|0.64:Spleen|0.55:Pancreas|0.54:Heart - Atrial Appendage|0.49:Muscle - Skeletal|0.45:Brain - Hypothalamus|0.44:Brain - Nucleus accumbens (basal ganglia)|0.44:Kidney - Medulla|0.44:Brain - Cortex|0.43:Brain - Frontal Cortex (BA9)|0.40:Kidney - Cortex|0.38:Heart - Left Ventricle|0.36:Brain - Substantia nigra|0.36:Brain - Caudate (basal ganglia)|0.35:Brain - Anterior cingulate cortex (BA24)|0.35:Brain - Hippocampus|0.32:Brain - Amygdala|0.28:Brain - Putamen (basal ganglia)|0.24:Liver|0.09:Whole Blood,"2.52:lateral ganglionic eminence|2.46:primary motor-sensory cortex (samples)|2.44:temporal neocortex|2.37:medial ganglionic eminence|2.29:cerebellum|2.07:occipital neocortex|2.04:parietal neocortex|1.85:caudal ganglionic eminence|1.80:cerebellar cortex|1.62:striatum|1.62:primary auditory cortex (core)|1.61:anterior (rostral) cingulate (medial prefrontal) cortex|1.58:dorsolateral prefrontal cortex|1.55:posteroventral (inferior) parietal cortex|1.54:amygdaloid complex|1.54:hippocampus (hippocampal formation)|1.53:upper (rostral) rhombic lip|1.51:dorsal thalamus|1.50:orbital frontal cortex|1.48:primary somatosensory cortex (area S1, areas 3,1,2)|1.48:inferolateral temporal cortex (area TEv, area 20)|1.46:ventrolateral prefrontal cortex|1.42:posterior (caudal) superior temporal cortex (area 22c)|1.36:primary motor cortex (area M1, area 4)|1.34:primary visual cortex (striate cortex, area V1/17)|1.23:mediodorsal nucleus of thalamus",2,SNP,0.89,0-46|0.00,38230877,1,G|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|42,44,46|A:G|C:R;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.36,"33|0.23;0-32,34-46|0.00",38231008,NA,T|Y,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|116|C:T|C:Y;N|128|^:^|^:^,NA,NA,NA,NA
82,CYP2A13,Homo sapiens cytochrome P450 family 2 subfamily A polypeptide 13 (CYP2A13) mRNA.,,NM_000766,chr19,15.49,2e-01,0.15,4e-01,+,CYP2A13,41088451,41096195,cytochrome P450 family 2 subfamily A member 13,protein_coding,"CPAD,CYP2A,CYPIIA13",0.00,0,0,2.00:Cancer|1.94:Lung disease|1.58:Nicotine dependence|1.54:Liver disease,0.95:Carcinoma,NA,NA,0.52:liver|0.51:autism spectrum disorder|0.48:testis|0.47:prostate gland|0.37:placenta|0.35:ovary|0.35:fetus|0.34:central nervous system|0.34:kidney|0.34:pancreas|0.33:nervous system|0.30:brain|0.27:gastrointestinal tract|0.26:lung|0.26:intestine|0.25:blood|0.24:heart|0.24:uterus|0.23:mammary gland|0.23:spleen|0.23:skeletal muscle|0.22:leukocyte|0.20:small intestine|0.19:large intestine|0.19:lymph node|0.18:colon|0.18:adrenal gland|0.17:thyroid gland|0.15:retinal disease|0.15:positive regulation of MAPK cascade|0.14:retinal degeneration|0.12:fundus dystrophy|0.11:hereditary retinal dystrophy|0.11:retinitis pigmentosa|0.11:hypothalamus|0.11:G-protein coupled receptor signaling pathway|0.11:regulation of secretion|0.11:blood plasma|0.10:forebrain|0.10:peripheral nervous system disease,0.54:Testis|0.48:Liver|0.16:Cervix - Ectocervix|0.14:Vagina|0.08:Minor Salivary Gland|0.06:Brain - Substantia nigra|0.06:Brain - Spinal cord (cervical c-1)|0.06:Cervix - Endocervix|0.05:Brain - Hypothalamus|0.04:Lung|0.03:Brain - Hippocampus|0.03:Bladder|0.03:Ovary|0.03:Uterus|0.02:Brain - Nucleus accumbens (basal ganglia)|0.01:Brain - Caudate (basal ganglia)|0.01:Brain - Putamen (basal ganglia)|0.00:Whole Blood|0.00:Thyroid|0.00:Stomach|0.00:Spleen|0.00:Small Intestine - Terminal Ileum|0.00:Skin - Sun Exposed (Lower leg)|0.00:Skin - Not Sun Exposed (Suprapubic)|0.00:Prostate|0.00:Pituitary|0.00:Pancreas|0.00:Nerve - Tibial|0.00:Muscle - Skeletal|0.00:Kidney - Medulla|0.00:Kidney - Cortex|0.00:Heart - Left Ventricle|0.00:Heart - Atrial Appendage|0.00:Fallopian Tube|0.00:Esophagus - Muscularis|0.00:Esophagus - Mucosa|0.00:Esophagus - Gastroesophageal Junction|0.00:Colon - Transverse|0.00:Colon - Sigmoid|0.00:Cells - EBV-transformed lymphocytes|0.00:Cells - Cultured fibroblasts|0.00:Breast - Mammary Tissue|0.00:Brain - Frontal Cortex (BA9)|0.00:Brain - Cortex|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Brain - Anterior cingulate cortex (BA24)|0.00:Brain - Amygdala|0.00:Artery - Tibial|0.00:Artery - Coronary|0.00:Artery - Aorta|0.00:Adrenal Gland|0.00:Adipose - Visceral (Omentum)|0.00:Adipose - Subcutaneous,"0.13:upper (rostral) rhombic lip|0.06:dorsal thalamus|0.05:mediodorsal nucleus of thalamus|0.05:striatum|0.03:amygdaloid complex|0.02:lateral ganglionic eminence|0.02:medial ganglionic eminence|0.01:caudal ganglionic eminence|0.00:hippocampus (hippocampal formation)|0.00:ventrolateral prefrontal cortex|0.00:temporal neocortex|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:dorsolateral prefrontal cortex|0.00:cerebellum|0.00:cerebellar cortex|0.00:anterior (rostral) cingulate (medial prefrontal) cortex",4,SNP,2.32,0-46|0.00,41594450,33,G|R,"B|0-2,4|A:G|Q:R;B|5-6|A:G|Q:R;N|30|^:^|^:^;N|34|^:^|^:^;B|40|A:G|Q:R;N|41|^:^|^:^;B|64|A:G|Q:R;N|83|^:^|^:^;B|100,102|A:G|Q:R;N|108|^:^|^:^;N|128|^:^|^:^;B|143-145|A:G|Q:R",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.50,0-46|0.00,41594954,12,C|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|150-151,153|C:T|R:*;N|156,158|^:^|^:^",0.0057,0.0056,NA,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.78,"2|0.15;0-1,3-46|0.00",41595950,1,A,"B|11-12|A:G;N|30|^:^;N|34|^:^;N|41|^:^;N|43|^:^;N|57|^:^;N|69|^:^;N|74|^:^;N|83|^:^;N|88|^:^;N|93|^:^;N|101|^:^;N|104|^:^;N|108|^:^;N|128|^:^;N|137|^:^;N|146-147|^:^;N|151|^:^;N|154,158|^:^;N|165,168|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.14,0-46|0.00,41600925,NA,C|P,N|8|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|75-77|C:T|P:L;N|74|T:T|L:L;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,0.0003,0.0002,D,D
83,PSG1,Homo sapiens pregnancy specific beta-1-glycoprotein 1 (PSG1) transcript variant 1 mRNA.,,NM_006905,chr19,5.76,2e-01,0.30,3e-01,-,PSG8,42752686,42765692,pregnancy specific beta-1-glycoprotein 8,protein_coding,PSG1,0.00,0,0,1.52:Takayasu's arteritis,1.07:Carcinoma|0.54:Kidney cancer,NA,NA,NA,0.38:Testis|0.04:Pituitary|0.02:Minor Salivary Gland|0.02:Adipose - Visceral (Omentum)|0.02:Adipose - Subcutaneous|0.02:Breast - Mammary Tissue|0.00:Whole Blood|0.00:Vagina|0.00:Uterus|0.00:Thyroid|0.00:Stomach|0.00:Spleen|0.00:Small Intestine - Terminal Ileum|0.00:Skin - Sun Exposed (Lower leg)|0.00:Skin - Not Sun Exposed (Suprapubic)|0.00:Prostate|0.00:Pancreas|0.00:Ovary|0.00:Nerve - Tibial|0.00:Muscle - Skeletal|0.00:Lung|0.00:Liver|0.00:Kidney - Medulla|0.00:Kidney - Cortex|0.00:Heart - Left Ventricle|0.00:Heart - Atrial Appendage|0.00:Fallopian Tube|0.00:Esophagus - Muscularis|0.00:Esophagus - Mucosa|0.00:Esophagus - Gastroesophageal Junction|0.00:Colon - Transverse|0.00:Colon - Sigmoid|0.00:Cervix - Endocervix|0.00:Cervix - Ectocervix|0.00:Cells - EBV-transformed lymphocytes|0.00:Cells - Cultured fibroblasts|0.00:Brain - Substantia nigra|0.00:Brain - Spinal cord (cervical c-1)|0.00:Brain - Putamen (basal ganglia)|0.00:Brain - Nucleus accumbens (basal ganglia)|0.00:Brain - Hypothalamus|0.00:Brain - Hippocampus|0.00:Brain - Frontal Cortex (BA9)|0.00:Brain - Cortex|0.00:Brain - Cerebellum|0.00:Brain - Cerebellar Hemisphere|0.00:Brain - Caudate (basal ganglia)|0.00:Brain - Anterior cingulate cortex (BA24)|0.00:Brain - Amygdala|0.00:Bladder|0.00:Artery - Tibial|0.00:Artery - Coronary|0.00:Artery - Aorta|0.00:Adrenal Gland,"0.00:ventrolateral prefrontal cortex|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:striatum|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:medial ganglionic eminence|0.00:lateral ganglionic eminence|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:hippocampus (hippocampal formation)|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",2,SNP,2.91,"34|0.30;0-33,35-46|0.00",43372429,NA,G|A,"N|24|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|104|^:^|^:^;N|108|^:^|^:^;N|112|^:^|^:^;N|118,120|A:G|V:A;N|128|^:^|^:^;N|132|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.45,0-46|0.00,43373033,NA,C|R,N|0-2|C:T|R:Q;N|4|T:T|Q:Q;N|24|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|132|^:^|^:^,0.0058,0.0061,B,T
84,ZNF526,Homo sapiens zinc finger protein 526 (ZNF526) mRNA.,Transcription Factor,NM_133444,chr19,5.32,2e-01,0.58,8e-02,+,ZNF526,42220312,42228201,zinc finger protein 526,protein_coding,NA,0.07,0,0,2.38:Prostate small cell carcinoma|1.87:Pleomorphic carcinoma|1.66:Seckel syndrome|1.64:Treacher Collins syndrome|1.53:Bardet-Biedl syndrome,0.65:Carcinoma,NA,NA,NA,12.15:Cells - Cultured fibroblasts|11.37:Cells - EBV-transformed lymphocytes|9.22:Uterus|8.59:Cervix - Ectocervix|8.59:Cervix - Endocervix|8.51:Ovary|8.12:Nerve - Tibial|8.03:Testis|7.57:Skin - Sun Exposed (Lower leg)|7.08:Fallopian Tube|6.93:Vagina|6.79:Prostate|6.72:Bladder|6.38:Artery - Aorta|6.28:Brain - Cerebellar Hemisphere|6.27:Artery - Tibial|6.25:Adipose - Subcutaneous|6.18:Thyroid|6.10:Colon - Sigmoid|5.97:Pituitary|5.95:Brain - Cerebellum|5.91:Breast - Mammary Tissue|5.87:Esophagus - Gastroesophageal Junction|5.77:Skin - Not Sun Exposed (Suprapubic)|5.70:Esophagus - Muscularis|5.68:Artery - Coronary|5.65:Lung|5.56:Spleen|5.44:Minor Salivary Gland|4.95:Small Intestine - Terminal Ileum|4.75:Adipose - Visceral (Omentum)|4.71:Colon - Transverse|4.59:Esophagus - Mucosa|3.85:Stomach|3.65:Adrenal Gland|3.42:Muscle - Skeletal|2.81:Kidney - Medulla|2.79:Whole Blood|2.76:Brain - Cortex|2.54:Brain - Frontal Cortex (BA9)|2.25:Pancreas|2.21:Kidney - Cortex|2.18:Heart - Atrial Appendage|1.96:Brain - Spinal cord (cervical c-1)|1.90:Liver|1.84:Brain - Nucleus accumbens (basal ganglia)|1.83:Brain - Caudate (basal ganglia)|1.74:Heart - Left Ventricle|1.72:Brain - Anterior cingulate cortex (BA24)|1.62:Brain - Hypothalamus|1.50:Brain - Putamen (basal ganglia)|1.45:Brain - Hippocampus|1.33:Brain - Amygdala|1.29:Brain - Substantia nigra,"4.02:cerebellum|3.80:caudal ganglionic eminence|3.70:occipital neocortex|3.60:upper (rostral) rhombic lip|3.59:parietal neocortex|3.37:lateral ganglionic eminence|3.30:temporal neocortex|2.97:medial ganglionic eminence|2.63:primary motor-sensory cortex (samples)|2.60:dorsal thalamus|2.29:cerebellar cortex|2.12:primary visual cortex (striate cortex, area V1/17)|2.04:primary auditory cortex (core)|1.91:ventrolateral prefrontal cortex|1.86:anterior (rostral) cingulate (medial prefrontal) cortex|1.76:dorsolateral prefrontal cortex|1.74:primary somatosensory cortex (area S1, areas 3,1,2)|1.69:posteroventral (inferior) parietal cortex|1.69:posterior (caudal) superior temporal cortex (area 22c)|1.67:striatum|1.64:hippocampus (hippocampal formation)|1.63:amygdaloid complex|1.63:primary motor cortex (area M1, area 4)|1.60:mediodorsal nucleus of thalamus|1.60:orbital frontal cortex|1.60:inferolateral temporal cortex (area TEv, area 20)",2,SNP,0.67,0-46|0.00,42729121,11,C|P,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|65|C:T|P:L;N|83|^:^|^:^;N|108|^:^|^:^;B|116|C:T|P:L;N|128|^:^|^:^;N|137|^:^|^:^,0.0079,0.0068,B,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.32,"43|0.58;0-42,44-46|0.00",42729610,1,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|150|A:G|Q:R,NA,NA,NA,NA
85,C19orf54,Homo sapiens chromosome 19 open reading frame 54 (C19orf54) mRNA.,,NM_198476,chr19,2.54,2e-01,0.13,2e-01,-,,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,NA,NA,1,SNP,1.65,0-46|0.00,41251098,1,C|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;B|124-125,127|C:T|R:Q;N|128|^:^|^:^",0.0010,0.0005,D,T
87,WDR87,Homo sapiens WD repeat domain 87 (WDR87) mRNA.,,NM_031951,chr19,28.93,3e-01,0.42,5e-01,-,WDR87,37884577,37906617,WD repeat domain 87,protein_coding,NYD-SP11,NA,0,0,1.75:Cerebrotendinous xanthomatosis|1.51:Galactosemia,1.13:Carcinoma|0.61:Endometrial cancer,NA,NA,NA,29.37:Testis|0.70:Thyroid|0.11:Brain - Cerebellum|0.09:Brain - Cerebellar Hemisphere|0.07:Skin - Sun Exposed (Lower leg)|0.07:Brain - Hypothalamus|0.06:Brain - Spinal cord (cervical c-1)|0.06:Brain - Nucleus accumbens (basal ganglia)|0.05:Skin - Not Sun Exposed (Suprapubic)|0.05:Brain - Caudate (basal ganglia)|0.04:Brain - Cortex|0.04:Pituitary|0.04:Small Intestine - Terminal Ileum|0.04:Brain - Anterior cingulate cortex (BA24)|0.04:Brain - Frontal Cortex (BA9)|0.03:Brain - Amygdala|0.03:Brain - Substantia nigra|0.03:Cervix - Ectocervix|0.03:Brain - Putamen (basal ganglia)|0.03:Brain - Hippocampus|0.02:Spleen|0.02:Cervix - Endocervix|0.02:Vagina|0.02:Kidney - Medulla|0.02:Esophagus - Mucosa|0.02:Nerve - Tibial|0.02:Prostate|0.01:Lung|0.01:Colon - Transverse|0.01:Breast - Mammary Tissue|0.01:Bladder|0.01:Uterus|0.01:Cells - EBV-transformed lymphocytes|0.01:Ovary|0.01:Colon - Sigmoid|0.01:Minor Salivary Gland|0.01:Kidney - Cortex|0.01:Esophagus - Gastroesophageal Junction|0.01:Esophagus - Muscularis|0.01:Fallopian Tube|0.01:Artery - Aorta|0.01:Artery - Tibial|0.01:Adrenal Gland|0.01:Pancreas|0.01:Artery - Coronary|0.01:Muscle - Skeletal|0.00:Stomach|0.00:Adipose - Subcutaneous|0.00:Heart - Atrial Appendage|0.00:Cells - Cultured fibroblasts|0.00:Adipose - Visceral (Omentum)|0.00:Heart - Left Ventricle|0.00:Whole Blood|0.00:Liver,"0.05:upper (rostral) rhombic lip|0.03:cerebellum|0.02:amygdaloid complex|0.02:temporal neocortex|0.02:medial ganglionic eminence|0.02:anterior (rostral) cingulate (medial prefrontal) cortex|0.02:ventrolateral prefrontal cortex|0.02:mediodorsal nucleus of thalamus|0.02:posteroventral (inferior) parietal cortex|0.01:orbital frontal cortex|0.01:primary auditory cortex (core)|0.01:primary motor cortex (area M1, area 4)|0.01:lateral ganglionic eminence|0.01:inferolateral temporal cortex (area TEv, area 20)|0.01:striatum|0.01:hippocampus (hippocampal formation)|0.01:posterior (caudal) superior temporal cortex (area 22c)|0.01:primary somatosensory cortex (area S1, areas 3,1,2)|0.01:primary visual cortex (striate cortex, area V1/17)|0.01:caudal ganglionic eminence|0.01:dorsolateral prefrontal cortex|0.01:dorsal thalamus|0.01:cerebellar cortex|0.01:parietal neocortex|0.00:primary motor-sensory cortex (samples)|0.00:occipital neocortex",3,SNP,14.96,0-46|0.00,38376594,NA,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|74|A:A|*:*;N|75-77|A:G|*:R;N|83|^:^|^:^;N|108|^:^|^:^;N|129|A:G|*:R;N|128|^:^|^:^,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,9.79,0-46|0.00,38378514,NA,T|K,"N|6|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|163-167,169|A:T|*:K",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.64,0-46|0.00,38383545,NA,G|S,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|64|A:G|F:S;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^,NA,NA,NA,NA
88,NPHS1,Homo sapiens nephrosis 1 congenital Finnish type (nephrin) (NPHS1) mRNA.,,NM_004646,chr19,10.00,3e-01,0.49,2e-01,-,NPHS1,35825372,35851993,"NPHS1 adhesion molecule, nephrin",protein_coding,"CNF,nephrin,NPHN",0.00,0,0,3.77:Proteinuria|3.23:Nephritis|3.04:Kidney failure|2.64:Diabetes mellitus|2.56:Pierson syndrome|2.55:Renal fibrosis|2.54:Nephroblastoma|2.53:Hypertension|2.47:Frasier syndrome|2.47:Denys-Drash syndrome|2.40:Alport syndrome|2.31:Hyperglycemia|2.18:Kidney hypertrophy|2.14:Lupus erythematosus|2.11:Urinary tract obstruction|2.05:nail-patella syndrome|2.01:Cystic kidney disease|1.96:Acute cystitis|1.96:Galloway-Mowat syndrome|1.88:Pseudohermaphroditism|1.84:Pyelonephritis|1.83:CAKUT|1.82:Obesity|1.77:hemolytic-uremic syndrome|1.76:Nephronophthisis|1.66:Renal hypoplasia|1.66:Neurofibroma|1.65:Connective tissue disease|1.63:Paraplegia|1.59:Renal agenesis|1.54:Lipid metabolism disorder|1.53:Eye disease|1.52:Gonadoblastoma|1.51:WAGR syndrome,1.09:Carcinoma|0.61:Skin cancer|0.61:Kidney cancer|0.50:Melanoma,5.00:Familial nephrotic syndrome,NA,0.49:autism spectrum disorder|0.39:kidney|0.39:prostate gland|0.38:testis|0.38:pancreas|0.35:liver|0.34:fetus|0.33:placenta|0.33:G-protein coupled receptor signaling pathway|0.32:nervous system|0.31:lymph node|0.28:central nervous system|0.27:brain|0.26:blood|0.23:ovary|0.21:hypophysis|0.21:mammary gland|0.21:positive regulation of MAPK cascade|0.20:gastrointestinal tract|0.19:uterus|0.19:leukocyte|0.18:adrenal gland|0.18:lung|0.17:heart|0.17:intestine|0.17:spleen|0.17:regulation of response to external stimulus|0.16:temporal lobe|0.16:thyroid gland|0.14:cerebellum|0.14:hypothalamus|0.14:mononuclear phagocyte|0.14:monocyte|0.14:large intestine|0.14:telencephalon|0.14:small intestine|0.13:forebrain|0.13:retinal disease|0.13:skeletal muscle|0.13:occipital lobe|0.12:corpus striatum|0.12:eye|0.12:nucleoside phosphate metabolic process|0.12:nucleotide metabolic process|0.11:positive regulation of protein kinase activity|0.11:nucleobase-containing small molecule metabolic process|0.11:regulation of secretion|0.11:retinal degeneration|0.11:caudate putamen|0.11:basal ganglion|0.11:purine nucleotide metabolic process|0.11:blood plasma|0.11:midbrain|0.11:second-messenger-mediated signaling|0.10:purine ribonucleotide metabolic process|0.10:colon|0.10:peripheral nervous system disease|0.10:ribonucleotide metabolic process|0.10:positive regulation of kinase activity|0.10:fundus dystrophy|0.10:purine-containing compound metabolic process|0.10:neuropathy,36.78:Kidney - Cortex|15.89:Pancreas|3.13:Kidney - Medulla|2.34:Testis|0.72:Brain - Cerebellum|0.64:Brain - Cerebellar Hemisphere|0.37:Brain - Cortex|0.36:Brain - Frontal Cortex (BA9)|0.35:Pituitary|0.34:Brain - Anterior cingulate cortex (BA24)|0.32:Stomach|0.29:Brain - Caudate (basal ganglia)|0.22:Adipose - Visceral (Omentum)|0.21:Brain - Putamen (basal ganglia)|0.20:Brain - Nucleus accumbens (basal ganglia)|0.14:Brain - Hippocampus|0.13:Brain - Spinal cord (cervical c-1)|0.12:Brain - Amygdala|0.09:Brain - Hypothalamus|0.08:Brain - Substantia nigra|0.07:Small Intestine - Terminal Ileum|0.05:Spleen|0.03:Cervix - Endocervix|0.03:Colon - Transverse|0.02:Uterus|0.02:Skin - Sun Exposed (Lower leg)|0.02:Skin - Not Sun Exposed (Suprapubic)|0.02:Ovary|0.02:Lung|0.02:Minor Salivary Gland|0.02:Colon - Sigmoid|0.02:Prostate|0.02:Thyroid|0.02:Fallopian Tube|0.02:Cells - EBV-transformed lymphocytes|0.01:Artery - Coronary|0.01:Nerve - Tibial|0.01:Esophagus - Mucosa|0.01:Vagina|0.01:Esophagus - Gastroesophageal Junction|0.01:Cervix - Ectocervix|0.01:Esophagus - Muscularis|0.01:Artery - Aorta|0.01:Adrenal Gland|0.01:Breast - Mammary Tissue|0.01:Artery - Tibial|0.01:Adipose - Subcutaneous|0.01:Whole Blood|0.01:Bladder|0.01:Cells - Cultured fibroblasts|0.01:Heart - Atrial Appendage|0.01:Liver|0.01:Muscle - Skeletal|0.01:Heart - Left Ventricle,"0.20:cerebellum|0.13:primary motor cortex (area M1, area 4)|0.10:striatum|0.09:upper (rostral) rhombic lip|0.08:inferolateral temporal cortex (area TEv, area 20)|0.08:posterior (caudal) superior temporal cortex (area 22c)|0.08:anterior (rostral) cingulate (medial prefrontal) cortex|0.07:primary somatosensory cortex (area S1, areas 3,1,2)|0.07:amygdaloid complex|0.07:dorsolateral prefrontal cortex|0.06:ventrolateral prefrontal cortex|0.06:posteroventral (inferior) parietal cortex|0.06:temporal neocortex|0.05:primary auditory cortex (core)|0.05:orbital frontal cortex|0.03:cerebellar cortex|0.03:hippocampus (hippocampal formation)|0.03:primary visual cortex (striate cortex, area V1/17)|0.03:dorsal thalamus|0.02:primary motor-sensory cortex (samples)|0.02:lateral ganglionic eminence|0.02:mediodorsal nucleus of thalamus|0.02:occipital neocortex|0.02:parietal neocortex|0.01:medial ganglionic eminence|0.01:caudal ganglionic eminence",3,SNP,3.79,"40|0.19;0-39,41-46|0.00",36326621,NA,G|T,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|138,141|C:G|R:T;N|158|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.90,0-46|0.00,36339295,7,A|L,"N|30|^:^|^:^;N|34|^:^|^:^;N|37|^:^|^:^;N|41|^:^|^:^;N|50|^:^|^:^;N|74|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;B|121,123|A:G|L:P;N|128|^:^|^:^;N|152|^:^|^:^",0.0080,0.0109,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,2.14,0-46|0.00,36340187,17,G|P,"B|10|C:G|R:P;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|74|C:C|R:R;B|75-77|C:G|R:P;N|83|^:^|^:^;B|93-95|C:G|R:P;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|147-148|^:^|^:^;B|159,161-162|C:G|R:P;N|160|^:^|^:^;N|171|^:^|^:^",NA,NA,NA,NA
89,GPI,Homo sapiens glucose-6-phosphate isomerase (GPI) transcript variant 2 mRNA.,,NM_000175,chr19,2.17,3e-01,0.13,2e-01,+,GNPDA1,142000671,142013027,glucosamine-6-phosphate deaminase 1,protein_coding,"GNP1,GNPDA,GNPI,GPI,HLN",0.00,0,0,1.69:Griscelli syndrome type 3|1.54:Cancer,NA,NA,"Infinity:small kidney|Infinity:abnormal uterus morphology|Infinity:small superior vagus ganglion|Infinity:embryonic growth retardation|Infinity:abnormal embryo size|Infinity:embryonic lethality prior to tooth bud stage|Infinity:embryonic lethality prior to organogenesis|10.00:preweaning lethality, complete penetrance",NA,46.44:Cells - Cultured fibroblasts|43.45:Cervix - Endocervix|40.10:Uterus|39.46:Cervix - Ectocervix|39.29:Ovary|38.77:Adrenal Gland|33.87:Bladder|33.21:Thyroid|30.49:Fallopian Tube|30.30:Spleen|28.13:Pituitary|27.69:Testis|26.00:Prostate|25.58:Colon - Sigmoid|25.55:Nerve - Tibial|24.69:Kidney - Cortex|24.63:Brain - Frontal Cortex (BA9)|23.77:Artery - Aorta|23.34:Brain - Cerebellar Hemisphere|23.02:Vagina|22.90:Adipose - Subcutaneous|22.89:Cells - EBV-transformed lymphocytes|22.50:Kidney - Medulla|22.25:Artery - Coronary|22.15:Lung|21.83:Esophagus - Gastroesophageal Junction|21.73:Breast - Mammary Tissue|21.60:Small Intestine - Terminal Ileum|21.56:Adipose - Visceral (Omentum)|20.68:Brain - Nucleus accumbens (basal ganglia)|20.28:Brain - Cerebellum|20.06:Esophagus - Muscularis|19.88:Artery - Tibial|19.19:Brain - Cortex|17.79:Skin - Sun Exposed (Lower leg)|17.61:Brain - Hypothalamus|17.44:Brain - Caudate (basal ganglia)|17.39:Colon - Transverse|16.76:Brain - Anterior cingulate cortex (BA24)|15.92:Skin - Not Sun Exposed (Suprapubic)|15.28:Minor Salivary Gland|13.87:Muscle - Skeletal|13.81:Brain - Spinal cord (cervical c-1)|13.69:Esophagus - Mucosa|13.58:Brain - Putamen (basal ganglia)|13.39:Brain - Substantia nigra|12.29:Brain - Amygdala|11.73:Stomach|11.59:Brain - Hippocampus|8.90:Heart - Atrial Appendage|8.75:Whole Blood|7.58:Heart - Left Ventricle|5.97:Liver|5.47:Pancreas,"20.54:occipital neocortex|18.90:caudal ganglionic eminence|16.50:parietal neocortex|15.64:medial ganglionic eminence|15.38:lateral ganglionic eminence|14.27:temporal neocortex|10.64:amygdaloid complex|9.91:hippocampus (hippocampal formation)|9.54:primary visual cortex (striate cortex, area V1/17)|9.35:striatum|9.11:primary somatosensory cortex (area S1, areas 3,1,2)|9.03:orbital frontal cortex|9.00:cerebellar cortex|8.98:posterior (caudal) superior temporal cortex (area 22c)|8.84:dorsal thalamus|8.81:ventrolateral prefrontal cortex|8.76:primary motor cortex (area M1, area 4)|8.73:anterior (rostral) cingulate (medial prefrontal) cortex|8.71:inferolateral temporal cortex (area TEv, area 20)|8.71:posteroventral (inferior) parietal cortex|8.66:dorsolateral prefrontal cortex|8.48:cerebellum|8.14:upper (rostral) rhombic lip|8.00:primary auditory cortex (core)|7.01:mediodorsal nucleus of thalamus|6.57:primary motor-sensory cortex (samples)",1,SNP,1.59,"18|0.13;0-17,19-46|0.00",34890208,NA,C|P,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|63,65|C:G|P:A;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^",0.0007,0.0004,B,T
90,HAUS5,Homo sapiens HAUS augmin-like complex subunit 5 (HAUS5) mRNA.,,NM_015302,chr19,4.09,3e-01,0.30,2e-01,+,HAUS5,35612735,35625355,HAUS augmin like complex subunit 5,protein_coding,"dgt5,KIAA0841",0.00,0,0,1.63:Ciliopathy,0.65:Carcinoma,NA,NA,NA,37.06:Ovary|31.68:Testis|30.94:Brain - Cerebellum|28.74:Brain - Cerebellar Hemisphere|28.61:Uterus|26.93:Cervix - Ectocervix|24.98:Cervix - Endocervix|24.50:Fallopian Tube|23.35:Cells - EBV-transformed lymphocytes|18.57:Nerve - Tibial|18.31:Thyroid|18.13:Spleen|17.63:Vagina|16.46:Pituitary|15.60:Prostate|14.00:Breast - Mammary Tissue|13.59:Skin - Not Sun Exposed (Suprapubic)|13.35:Skin - Sun Exposed (Lower leg)|13.17:Bladder|12.55:Lung|11.73:Esophagus - Mucosa|11.52:Adipose - Subcutaneous|11.42:Small Intestine - Terminal Ileum|11.10:Artery - Aorta|10.68:Minor Salivary Gland|10.06:Colon - Sigmoid|9.64:Artery - Tibial|9.56:Artery - Coronary|9.19:Adipose - Visceral (Omentum)|8.90:Adrenal Gland|8.90:Esophagus - Gastroesophageal Junction|8.69:Brain - Spinal cord (cervical c-1)|8.19:Colon - Transverse|8.13:Esophagus - Muscularis|8.05:Cells - Cultured fibroblasts|7.69:Stomach|7.27:Kidney - Medulla|6.17:Brain - Cortex|5.01:Pancreas|5.01:Brain - Hypothalamus|4.96:Kidney - Cortex|4.82:Brain - Substantia nigra|4.69:Brain - Frontal Cortex (BA9)|4.52:Brain - Caudate (basal ganglia)|4.37:Brain - Nucleus accumbens (basal ganglia)|4.22:Liver|3.92:Brain - Hippocampus|3.83:Brain - Amygdala|3.74:Brain - Putamen (basal ganglia)|3.72:Heart - Atrial Appendage|3.45:Brain - Anterior cingulate cortex (BA24)|3.33:Muscle - Skeletal|2.68:Whole Blood|2.35:Heart - Left Ventricle,"5.94:caudal ganglionic eminence|5.78:lateral ganglionic eminence|5.64:occipital neocortex|5.13:medial ganglionic eminence|4.69:parietal neocortex|4.26:temporal neocortex|3.04:upper (rostral) rhombic lip|2.93:cerebellar cortex|2.91:cerebellum|2.78:primary motor-sensory cortex (samples)|1.92:primary visual cortex (striate cortex, area V1/17)|1.84:amygdaloid complex|1.83:dorsal thalamus|1.83:striatum|1.77:hippocampus (hippocampal formation)|1.66:ventrolateral prefrontal cortex|1.50:orbital frontal cortex|1.44:mediodorsal nucleus of thalamus|1.32:anterior (rostral) cingulate (medial prefrontal) cortex|1.32:dorsolateral prefrontal cortex|1.29:posterior (caudal) superior temporal cortex (area 22c)|1.25:primary auditory cortex (core)|1.16:primary somatosensory cortex (area S1, areas 3,1,2)|1.13:primary motor cortex (area M1, area 4)|1.13:posteroventral (inferior) parietal cortex|1.09:inferolateral temporal cortex (area TEv, area 20)",1,SNP,2.65,"36|0.30;0-35,37-46|0.00",36110587,NA,C|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|43|^:^|^:^;N|83|^:^|^:^;N|86|^:^|^:^;N|104,107|^:^|^:^;N|108|^:^|^:^;N|126|C:T|R:C;N|124|^:^|^:^;N|128|^:^|^:^;N|137,141|^:^|^:^;N|162|^:^|^:^;N|165,169|^:^|^:^",0.0004,0.0004,D,D
91,LIPE,Homo sapiens lipase hormone-sensitive (LIPE) mRNA.,,NM_005357,chr19,18.46,3e-01,0.30,5e-01,-,LIPE,42401512,42427421,"lipase E, hormone sensitive type",protein_coding,"AOMS4,FPLD6,HSL,LHS",0.00,0,0,3.14:Obesity|2.77:Diabetes mellitus|2.61:Lipid metabolism disorder|2.51:Hyperglycemia|2.42:Hyperinsulinism|2.40:Neutral lipid storage disease|2.39:Nonalcoholic fatty liver disease|2.33:Lipodystrophy|2.20:Hypertension|2.19:Atherosclerosis|2.02:Coronary artery disease|1.96:Cancer|1.90:Liver disease|1.83:Cerebrovascular disease|1.80:Heart disease|1.80:Polycystic ovary syndrome|1.78:Myopathy|1.77:Bruck syndrome|1.75:Hypoglycemia|1.64:Kidney disease|1.60:Primary hyperaldosteronism|1.58:Intestinal disease|1.56:Lung disease,0.82:Carcinoma,5.00:Familial partial lipodystrophy|4.00:Obesity|4.00:Diabetes mellitus,Infinity:enlarged heart|Infinity:abnormal heart morphology|10.00:male infertility|4.40:increased lean body mass|4.06:increased bone mineral density,0.91:lipodystrophy|0.72:nervous system|0.72:brain|0.65:central nervous system|0.55:testis|0.55:pancreas|0.54:heart|0.53:liver|0.47:autism spectrum disorder|0.47:placenta|0.46:fetus|0.45:cerebellum|0.41:kidney|0.38:prostate gland|0.38:ovary|0.35:intestine|0.35:skeletal muscle|0.35:mammary gland|0.35:adrenal gland|0.34:gastrointestinal tract|0.31:glucose metabolism disease|0.31:carbohydrate metabolism disease|0.29:diabetes mellitus|0.28:lung|0.26:small intestine|0.26:overnutrition|0.26:telencephalon|0.25:cerebral cortex|0.25:colon|0.24:hypophysis|0.24:thyroid gland|0.23:large intestine|0.22:forebrain|0.22:blood|0.21:nutrition disease|0.21:obesity|0.20:uterus|0.20:temporal lobe|0.19:amygdala|0.19:leukocyte|0.18:spleen|0.17:frontal lobe|0.16:regulation of lipid metabolic process|0.15:hippocampus|0.15:spinal cord|0.14:muscle|0.14:regulation of protein serine/threonine kinase activity|0.14:lymph node|0.13:subthalamic nucleus|0.13:positive regulation of protein kinase activity|0.13:corpus striatum|0.12:positive regulation of MAPK cascade|0.12:regulation of lipid catabolic process|0.12:bone marrow|0.11:regulation of lipid localization|0.11:medulla oblongata|0.11:basal ganglion|0.11:negative regulation of protein modification process|0.10:lymphocyte|0.10:stomach|0.10:skin,342.75:Adipose - Subcutaneous|231.30:Adipose - Visceral (Omentum)|146.14:Breast - Mammary Tissue|74.51:Testis|57.05:Brain - Spinal cord (cervical c-1)|17.56:Adrenal Gland|17.18:Brain - Substantia nigra|11.28:Nerve - Tibial|10.82:Brain - Hippocampus|10.30:Artery - Coronary|10.26:Brain - Cerebellum|9.70:Brain - Putamen (basal ganglia)|9.67:Spleen|9.41:Brain - Cerebellar Hemisphere|8.66:Brain - Hypothalamus|8.62:Small Intestine - Terminal Ileum|7.97:Brain - Caudate (basal ganglia)|7.32:Uterus|7.02:Skin - Sun Exposed (Lower leg)|6.90:Heart - Left Ventricle|6.80:Brain - Nucleus accumbens (basal ganglia)|6.45:Thyroid|5.92:Brain - Cortex|5.80:Bladder|5.47:Minor Salivary Gland|5.46:Cells - EBV-transformed lymphocytes|5.39:Brain - Amygdala|5.27:Pituitary|5.20:Vagina|5.14:Fallopian Tube|5.12:Prostate|4.84:Brain - Frontal Cortex (BA9)|4.35:Esophagus - Mucosa|4.26:Cervix - Endocervix|4.11:Ovary|3.93:Skin - Not Sun Exposed (Suprapubic)|3.90:Muscle - Skeletal|3.76:Kidney - Medulla|3.74:Heart - Atrial Appendage|3.73:Esophagus - Muscularis|3.71:Colon - Sigmoid|3.58:Colon - Transverse|3.50:Cervix - Ectocervix|3.49:Brain - Anterior cingulate cortex (BA24)|3.48:Esophagus - Gastroesophageal Junction|2.84:Stomach|2.68:Lung|2.36:Cells - Cultured fibroblasts|2.01:Kidney - Cortex|1.71:Artery - Aorta|1.65:Whole Blood|1.30:Artery - Tibial|1.07:Pancreas|0.35:Liver,"5.34:striatum|5.18:caudal ganglionic eminence|5.15:upper (rostral) rhombic lip|4.96:occipital neocortex|4.45:mediodorsal nucleus of thalamus|4.44:parietal neocortex|4.34:cerebellum|4.14:lateral ganglionic eminence|4.10:amygdaloid complex|3.94:cerebellar cortex|3.81:hippocampus (hippocampal formation)|3.68:medial ganglionic eminence|3.56:primary visual cortex (striate cortex, area V1/17)|3.39:primary motor cortex (area M1, area 4)|3.38:ventrolateral prefrontal cortex|3.29:temporal neocortex|3.25:orbital frontal cortex|3.23:primary motor-sensory cortex (samples)|3.07:posterior (caudal) superior temporal cortex (area 22c)|3.02:dorsolateral prefrontal cortex|2.91:primary somatosensory cortex (area S1, areas 3,1,2)|2.85:primary auditory cortex (core)|2.81:anterior (rostral) cingulate (medial prefrontal) cortex|2.80:posteroventral (inferior) parietal cortex|2.70:dorsal thalamus|2.50:inferolateral temporal cortex (area TEv, area 20)",4,SNP,3.69,0-46|0.00,42911769,3,G|R,"N|30|^:^|^:^;N|34|^:^|^:^;N|36|^:^|^:^;N|41|^:^|^:^;N|67|^:^|^:^;N|83|^:^|^:^;B|105,107|A:G|C:R;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.98,0-46|0.00,42914772,1,G|P,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|101|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|144|A:G|L:P,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.89,0-46|0.00,42931022,4,C|A,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;B|122-123|C:T|A:T;N|128|^:^|^:^;B|163,165,168,171|C:T|A:T",0.0024,0.0028,P,D
,,,,,,,,,,,,,,,,,,,,,,,,,,,,del,9.79,"16|0.30;0-15,17-46|0.00",42905974,NA,CCCCCGCAGCCCCCGTCTA|VDGGCGG,"0-1|^:^|^:^;5|^:^|^:^;8-10|^:^|^:^;20-21|^:^|^:^;24-25|^:^|^:^;30|^:^|^:^;34|^:^|^:^;35-37|^:^|^:^;40|^:^|^:^;41|^:^|^:^;42-44|^:^|^:^;50|^:^|^:^;59|-:CCCCCGCAGCCCCCGTCTA|-:VDGGCGG;58|^:^|^:^;73-74|^:^|^:^;79-81|^:^|^:^;83|^:^|^:^;86-88|^:^|^:^;92-93|^:^|^:^;97|^:^|^:^;100-101|^:^|^:^;104,107|^:^|^:^;108|^:^|^:^;124|^:^|^:^;128|^:^|^:^;136|^:^|^:^;137-141|^:^|^:^;142-145|^:^|^:^;146-149|^:^|^:^;150-153|^:^|^:^;154-158|^:^|^:^;159-162|^:^|^:^;163-171|^:^|^:^",NA,NA,NA,NA
92,ANKRD27,Homo sapiens ankyrin repeat domain 27 (VPS9 domain) (ANKRD27) mRNA.,,NM_032139,chr19,7.90,3e-01,0.19,4e-01,-,ANKRD27,32597005,32675215,ankyrin repeat domain 27,protein_coding,"PP12899,VARP",0.00,0,0,2.04:Hermansky-Pudlak syndrome|1.56:Oculocutaneous albinism|1.52:Eosinophilic esophagitis|1.51:Tetanus,1.85:Mental depression|0.84:Carcinoma,NA,7.76:decreased total retina thickness|5.53:short tibia|4.82:abnormal motor capabilities/coordination/movement|4.51:increased neutrophil cell number,NA,26.08:Cells - EBV-transformed lymphocytes|23.57:Colon - Sigmoid|22.83:Bladder|22.30:Esophagus - Muscularis|20.86:Testis|20.42:Esophagus - Gastroesophageal Junction|19.14:Cells - Cultured fibroblasts|18.95:Artery - Tibial|17.36:Uterus|17.13:Vagina|16.55:Brain - Cerebellar Hemisphere|16.54:Thyroid|16.31:Cervix - Endocervix|15.86:Lung|15.73:Cervix - Ectocervix|15.58:Prostate|15.54:Artery - Aorta|14.82:Artery - Coronary|14.78:Skin - Sun Exposed (Lower leg)|14.33:Colon - Transverse|14.08:Fallopian Tube|14.06:Brain - Cerebellum|13.89:Esophagus - Mucosa|13.70:Skin - Not Sun Exposed (Suprapubic)|13.64:Nerve - Tibial|13.00:Ovary|12.68:Adipose - Subcutaneous|12.52:Small Intestine - Terminal Ileum|11.81:Minor Salivary Gland|11.66:Breast - Mammary Tissue|11.38:Spleen|11.26:Adipose - Visceral (Omentum)|10.68:Muscle - Skeletal|10.61:Brain - Spinal cord (cervical c-1)|10.27:Brain - Frontal Cortex (BA9)|10.06:Pituitary|9.80:Stomach|8.80:Brain - Cortex|7.64:Adrenal Gland|7.35:Brain - Hypothalamus|7.25:Brain - Anterior cingulate cortex (BA24)|7.18:Brain - Caudate (basal ganglia)|7.07:Kidney - Medulla|6.94:Brain - Substantia nigra|6.67:Brain - Nucleus accumbens (basal ganglia)|6.10:Brain - Hippocampus|5.76:Kidney - Cortex|5.68:Brain - Putamen (basal ganglia)|5.68:Brain - Amygdala|5.39:Heart - Atrial Appendage|5.22:Whole Blood|4.20:Heart - Left Ventricle|3.43:Pancreas|2.27:Liver,"7.40:occipital neocortex|7.11:temporal neocortex|7.11:parietal neocortex|7.02:primary motor-sensory cortex (samples)|6.67:primary motor cortex (area M1, area 4)|6.66:caudal ganglionic eminence|6.58:anterior (rostral) cingulate (medial prefrontal) cortex|6.58:posteroventral (inferior) parietal cortex|6.50:hippocampus (hippocampal formation)|6.38:posterior (caudal) superior temporal cortex (area 22c)|6.35:mediodorsal nucleus of thalamus|6.34:primary somatosensory cortex (area S1, areas 3,1,2)|6.29:orbital frontal cortex|6.24:medial ganglionic eminence|6.20:lateral ganglionic eminence|6.14:primary visual cortex (striate cortex, area V1/17)|6.12:amygdaloid complex|5.89:dorsolateral prefrontal cortex|5.81:primary auditory cortex (core)|5.80:ventrolateral prefrontal cortex|5.76:cerebellum|5.68:inferolateral temporal cortex (area TEv, area 20)|5.59:cerebellar cortex|5.36:upper (rostral) rhombic lip|5.15:striatum|5.03:dorsal thalamus",2,SNP,3.73,"40|0.19;0-39,41-46|0.00",33095290,NA,G|T,"N|2|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|138,141|A:G|I:T;N|142|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.18,0-46|0.00,33119742,2,C|G,"B|0-2,4|C:T|G:D;N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^",0.0014,0.0012,D,D
93,PLEKHG2,Homo sapiens pleckstrin homology domain containing family G (with RhoGef domain) member 2 (PLEKHG2) mRNA.,MAPKKK cascade;Calcium-mediated Signaling;NF-KappaB Cascade;Neurological system process,NM_022835,chr19,14.77,4e-01,0.60,2e-01,+,PLEKHG2,39412582,39428415,pleckstrin homology and RhoGEF domain containing G2,protein_coding,"ARHGEF42,CLG,CTB-60E11.4,LDAMD",0.00,0,0,NA,0.88:Carcinoma,4.00:Intellectual disability|4.00:Leukodystrophy,NA,0.78:spleen|0.76:heart|0.75:lung|0.75:ovary|0.74:placenta|0.74:testis|0.73:pancreas|0.72:liver|0.68:fetus|0.68:blood|0.68:kidney|0.67:lymph node|0.64:leukocyte|0.64:brain|0.64:central nervous system|0.63:nervous system|0.59:skeletal muscle|0.57:prostate gland|0.55:forebrain|0.54:caudate nucleus|0.54:spinal cord|0.52:hippocampus|0.51:diencephalon|0.50:telencephalon|0.50:corpus striatum|0.50:amygdala|0.50:cerebral cortex|0.49:temporal lobe|0.47:autism spectrum disorder|0.47:basal ganglion|0.47:corpus callosum|0.46:cerebellum|0.44:gastrointestinal tract|0.43:substantia nigra|0.43:midbrain|0.43:intestine|0.43:subthalamic nucleus|0.38:lymphocyte|0.37:large intestine|0.37:colon|0.36:mammary gland|0.36:thalamus|0.35:uterus|0.31:mononuclear phagocyte|0.31:small intestine|0.30:monocyte|0.23:bone marrow|0.23:thyroid gland|0.21:adrenal gland|0.20:blood vessel|0.19:stomach|0.18:T-lymphocyte|0.17:muscle|0.17:B-lymphocyte|0.17:umbilical vein endothelial cell|0.16:tonsil|0.14:hypophysis|0.14:artery|0.14:umbilical cord|0.13:dendritic cell|0.13:skin|0.12:uterine endometrium|0.11:vascular endothelial cell|0.11:epilepsy|0.11:aorta|0.11:peripheral nervous system disease|0.11:blood plasma|0.11:trachea|0.10:neuropathy,46.26:Nerve - Tibial|40.44:Artery - Aorta|38.83:Lung|38.14:Cervix - Ectocervix|36.16:Uterus|32.75:Artery - Coronary|30.00:Cervix - Endocervix|29.23:Fallopian Tube|29.21:Artery - Tibial|29.17:Spleen|26.61:Adipose - Visceral (Omentum)|24.43:Cells - EBV-transformed lymphocytes|23.78:Colon - Sigmoid|22.76:Esophagus - Gastroesophageal Junction|21.85:Cells - Cultured fibroblasts|21.49:Adipose - Subcutaneous|21.43:Esophagus - Muscularis|21.35:Ovary|20.35:Prostate|18.80:Small Intestine - Terminal Ileum|18.47:Thyroid|18.32:Breast - Mammary Tissue|18.03:Bladder|17.25:Vagina|15.15:Kidney - Medulla|14.46:Colon - Transverse|13.98:Testis|9.86:Pituitary|9.79:Heart - Atrial Appendage|8.51:Stomach|7.26:Skin - Not Sun Exposed (Suprapubic)|7.12:Skin - Sun Exposed (Lower leg)|6.81:Adrenal Gland|6.80:Esophagus - Mucosa|6.48:Minor Salivary Gland|6.37:Kidney - Cortex|5.88:Heart - Left Ventricle|5.50:Whole Blood|4.33:Brain - Cerebellum|3.44:Brain - Cerebellar Hemisphere|2.56:Brain - Spinal cord (cervical c-1)|2.34:Pancreas|2.26:Brain - Cortex|2.24:Muscle - Skeletal|2.20:Brain - Substantia nigra|2.13:Liver|1.88:Brain - Hypothalamus|1.78:Brain - Amygdala|1.78:Brain - Putamen (basal ganglia)|1.71:Brain - Hippocampus|1.69:Brain - Anterior cingulate cortex (BA24)|1.65:Brain - Caudate (basal ganglia)|1.57:Brain - Frontal Cortex (BA9)|1.27:Brain - Nucleus accumbens (basal ganglia),"9.12:upper (rostral) rhombic lip|8.82:temporal neocortex|8.38:lateral ganglionic eminence|7.98:parietal neocortex|7.16:medial ganglionic eminence|6.96:caudal ganglionic eminence|6.94:cerebellum|6.28:occipital neocortex|6.14:primary motor-sensory cortex (samples)|3.46:dorsal thalamus|1.96:dorsolateral prefrontal cortex|1.92:striatum|1.72:hippocampus (hippocampal formation)|1.66:ventrolateral prefrontal cortex|1.60:anterior (rostral) cingulate (medial prefrontal) cortex|1.51:primary auditory cortex (core)|1.34:primary visual cortex (striate cortex, area V1/17)|1.24:amygdaloid complex|1.21:orbital frontal cortex|1.08:posteroventral (inferior) parietal cortex|1.07:primary somatosensory cortex (area S1, areas 3,1,2)|0.99:primary motor cortex (area M1, area 4)|0.90:cerebellar cortex|0.84:posterior (caudal) superior temporal cortex (area 22c)|0.83:inferolateral temporal cortex (area TEv, area 20)|0.82:mediodorsal nucleus of thalamus",3,SNP,1.83,"44|0.60;0-43,45-46|0.00",39904776,NA,T|L,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|73|^:^|^:^;N|83|^:^|^:^;N|87|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|137|^:^|^:^;N|155-158|C:T|P:L,NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,1.68,0-46|0.00,39908657,10,G|G,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;B|47-48|G:T|G:V;N|83|^:^|^:^;N|108|^:^|^:^;B|129|G:T|G:V;N|128|^:^|^:^;N|146,148|^:^|^:^",0.0084,0.0187,D,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,8.59,0-46|0.00,39911451,31,C|P,"B|0-1,3|C:G|P:R;B|11-12|C:G|P:R;B|14-15|C:G|P:R;B|18-19|C:G|P:R;N|30|^:^|^:^;N|34|^:^|^:^;B|37,39|C:G|P:R;N|41|^:^|^:^;B|47-48|C:G|P:R;B|64|C:G|P:R;N|83|^:^|^:^;B|92,95|C:G|P:R;N|108|^:^|^:^;N|128|^:^|^:^;B|131-133|C:G|P:R;N|130|G:G|R:R;B|135|C:G|P:R;B|144|C:G|P:R;B|155|C:G|P:R",0.0296,0.0277,D,T
94,SPTBN4,Homo sapiens spectrin beta non-erythrocytic 4 (SPTBN4) transcript variant sigma5 mRNA.,Nervous  System Development;Schizophrenia Associated;Neurological system process,NM_020971,chr19,17.93,4e-01,0.01,6e-01,+,SPTBN4,40467001,40576464,"spectrin beta, non-erythrocytic 4",protein_coding,"CMND,NEDHND,QV,SPNB4,SPTBN3",NA,0,0,1.58:Neuropathy|1.51:Hyperkalemic periodic paralysis,1.10:Carcinoma|0.54:Kidney cancer|0.50:Melanoma,4.00:Neuropathy,NA,"0.94:insulin secretion|0.92:positive regulation of epithelial cell proliferation|0.91:regulation of epithelial cell proliferation|0.91:brain|0.88:central nervous system|0.88:nervous system|0.80:cerebellum|0.79:peptide hormone secretion|0.74:hormone secretion|0.73:substantia nigra|0.73:midbrain|0.72:temporal lobe|0.72:basal ganglion|0.72:amygdala|0.71:corpus striatum|0.70:diencephalon|0.70:thalamus|0.70:telencephalon|0.69:forebrain|0.69:cerebral cortex|0.69:hippocampus|0.69:caudate nucleus|0.68:spinal cord|0.68:cell surface receptor signaling pathway involved in cell-cell signaling|0.66:corpus callosum|0.65:subthalamic nucleus|0.64:Wnt signaling pathway|0.62:Wnt signaling pathway involved in dorsal/ventral axis specification|0.62:autism spectrum disorder|0.61:pancreas|0.60:heart|0.59:response to reactive oxygen species|0.58:testis|0.56:positive regulation of cell differentiation|0.54:caudate putamen|0.53:signal release|0.52:fetus|0.51:liver|0.49:regulation of nervous system development|0.49:ovary|0.49:response to oxidative stress|0.47:prostate gland|0.47:regulation of neurogenesis|0.46:hypophysis|0.44:occipital lobe|0.41:placenta|0.40:kidney|0.40:lung|0.36:gastrointestinal tract|0.36:frontal lobe|0.35:positive regulation of nervous system development|0.35:regulation of Wnt signaling pathway|0.33:intestine|0.32:spleen|0.31:positive regulation of neurogenesis|0.31:regulation of cell development|0.30:regulation of ion transmembrane transport|0.29:adrenal gland|0.27:small intestine|0.26:medulla oblongata|0.26:hormone transport|0.26:endomembrane system organization|0.26:nucleus accumbens|0.26:uterus|0.26:positive regulation of cell development|0.25:positive regulation of Wnt signaling pathway|0.25:vesicle organization|0.25:cell-cell signaling by wnt|0.25:regulation of ion transport|0.23:regulation of hormone levels|0.22:hypothalamus|0.22:regulation of cytoskeleton organization|0.21:regulation of transmembrane transport|0.21:G-protein coupled receptor signaling pathway|0.21:retinal degeneration|0.21:skeletal muscle|0.20:retinal disease|0.20:blood|0.20:large intestine|0.20:leukocyte|0.20:thyroid gland|0.19:colon|0.19:positive regulation of cellular protein localization|0.18:cerebellar cortex|0.18:regulation of intracellular protein transport|0.18:mammary gland|0.18:intellectual disability|0.18:regulation of microtubule-based process|0.18:protein secretion|0.17:movement disease|0.17:retinitis pigmentosa|0.17:canonical Wnt signaling pathway|0.17:peptide secretion|0.16:fundus dystrophy|0.16:lymph node|0.16:epilepsy|0.16:hereditary retinal dystrophy|0.15:epithelial cell proliferation|0.15:occipital pole|0.14:cognitive disorder|0.14:positive regulation of MAPK cascade|0.14:cilium organization|0.14:regulation of cation transmembrane transport|0.14:regulation of mRNA metabolic process|0.14:cilium assembly|0.13:stomach|0.12:positive regulation of protein transport|0.12:cerebellar Purkinje cell|0.12:positive regulation of intracellular transport|0.12:dentate gyrus|0.12:negative regulation of protein modification process|0.12:negative regulation of protein phosphorylation|0.12:neuron|0.12:regulation of microtubule cytoskeleton organization|0.11:negative regulation of cell proliferation|0.11:regulation of protein complex assembly|0.11:pons|0.11:trachea|0.11:negative regulation of cell cycle|0.10:negative regulation of phosphorylation|0.10:auditory system disease|0.10:regulation of mitochondrion organization|0.10:parietal lobe|0.10:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|0.10:regulation of neuron differentiation|0.10:peripheral nervous system disease|0.10:regulation of autophagy",89.84:Brain - Cerebellar Hemisphere|88.73:Brain - Cerebellum|31.24:Brain - Cortex|29.11:Brain - Frontal Cortex (BA9)|20.18:Pituitary|17.43:Brain - Anterior cingulate cortex (BA24)|16.70:Brain - Nucleus accumbens (basal ganglia)|14.28:Brain - Hypothalamus|12.59:Brain - Caudate (basal ganglia)|10.47:Brain - Hippocampus|9.94:Brain - Putamen (basal ganglia)|8.62:Brain - Amygdala|7.45:Nerve - Tibial|7.25:Brain - Substantia nigra|6.32:Ovary|5.56:Testis|4.29:Brain - Spinal cord (cervical c-1)|3.99:Uterus|3.55:Fallopian Tube|2.99:Esophagus - Gastroesophageal Junction|2.96:Cervix - Endocervix|2.84:Esophagus - Muscularis|2.80:Prostate|2.68:Colon - Sigmoid|2.54:Cervix - Ectocervix|1.73:Bladder|1.65:Heart - Atrial Appendage|1.61:Adipose - Visceral (Omentum)|1.54:Vagina|1.45:Muscle - Skeletal|1.36:Artery - Aorta|1.36:Artery - Coronary|1.27:Thyroid|1.15:Adrenal Gland|1.10:Adipose - Subcutaneous|1.09:Heart - Left Ventricle|1.08:Breast - Mammary Tissue|1.05:Stomach|1.05:Artery - Tibial|0.96:Colon - Transverse|0.92:Skin - Sun Exposed (Lower leg)|0.76:Skin - Not Sun Exposed (Suprapubic)|0.67:Kidney - Cortex|0.61:Lung|0.59:Minor Salivary Gland|0.52:Kidney - Medulla|0.50:Esophagus - Mucosa|0.45:Small Intestine - Terminal Ileum|0.42:Pancreas|0.32:Cells - EBV-transformed lymphocytes|0.29:Spleen|0.24:Liver|0.21:Cells - Cultured fibroblasts|0.07:Whole Blood,"10.36:cerebellar cortex|7.81:primary visual cortex (striate cortex, area V1/17)|7.78:posteroventral (inferior) parietal cortex|7.56:mediodorsal nucleus of thalamus|6.93:primary auditory cortex (core)|6.61:orbital frontal cortex|6.56:inferolateral temporal cortex (area TEv, area 20)|6.46:primary somatosensory cortex (area S1, areas 3,1,2)|6.33:posterior (caudal) superior temporal cortex (area 22c)|6.25:ventrolateral prefrontal cortex|5.92:primary motor cortex (area M1, area 4)|5.81:primary motor-sensory cortex (samples)|5.79:cerebellum|5.72:anterior (rostral) cingulate (medial prefrontal) cortex|5.61:striatum|5.60:dorsolateral prefrontal cortex|5.39:upper (rostral) rhombic lip|4.84:amygdaloid complex|4.40:hippocampus (hippocampal formation)|2.14:dorsal thalamus|1.89:parietal neocortex|1.59:temporal neocortex|1.40:occipital neocortex|1.33:lateral ganglionic eminence|1.05:medial ganglionic eminence|0.35:caudal ganglionic eminence",4,SNP,7.87,0-46|0.00,41025415,NA,G|R,N|6|G:T|R:L;N|14|^:^|^:^;N|30|^:^|^:^;N|34|^:^|^:^;N|36|^:^|^:^;N|41|^:^|^:^;N|45|^:^|^:^;N|67|^:^|^:^;N|72|^:^|^:^;N|83|^:^|^:^;N|102|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|144|^:^|^:^;N|168|^:^|^:^,NA,NA,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,3.84,0-46|0.00,41025981,1,G|E,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|102|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;B|124-125,127|A:G|K:E;N|128|^:^|^:^",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,0.63,"42|0.01;0-41,43-46|0.00",41029399,12,C|A,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|65|^:^|^:^;N|69|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;B|146,148|A:C|D:A",NA,NA,NA,NA
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,5.59,0-46|0.00,41063263,NA,G|R,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|107|^:^|^:^;N|108|^:^|^:^;N|119-120|A:G|Q:R;N|128|^:^|^:^;N|141|^:^|^:^,NA,NA,NA,NA
97,CEACAM5,Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) mRNA.,,NM_004363,chr19,1.85,4e-01,0.32,2e-01,+,CEACAM5,41708626,41730433,CEA cell adhesion molecule 5,protein_coding,"CD66e,CEA",0.00,0,0,3.76:Cancer|3.59:Gastrointestinal system disease|3.05:Lung disease|2.91:Breast disease|2.74:Adenoma|2.73:Ovarian disease|2.52:Uterine disease|2.47:Pancreatitis|2.40:Prostate disease|2.38:Skin disease|2.38:Hepatitis B|2.33:Kidney disease|2.28:Anemia|2.25:Connective tissue disease|2.24:Endometriosis|2.16:Lymphatic system disease|2.16:Bladder disease|2.11:Tuberculosis|2.06:Adenocarcinoma in situ|2.05:Hypertension|2.01:Multiple endocrine neoplasia type 2A|2.00:Diabetes mellitus|1.99:Pheochromocytoma|1.97:Familial adenomatous polyposis|1.97:Central nervous system disease|1.96:Hydronephrosis|1.92:Lymphangioma|1.91:Autoimmune hypersensitivity disease|1.91:Hemangioma|1.89:Vaccinia|1.86:Neutropenia|1.86:Thrombocytopenia|1.83:Muscular disease|1.83:Thrombosis|1.81:Multiple endocrine neoplasia type 2B|1.81:Lynch syndrome|1.81:Pericardial effusion|1.80:Lipoma|1.79:Bone marrow disease|1.78:Angiomyolipoma|1.78:Leiomyoma|1.75:Pneumothorax|1.72:Heart disease|1.72:Papilloma|1.71:Eye disease|1.69:Neuropathy|1.64:Neurilemmoma|1.63:Vulvar disease|1.62:Goiter|1.61:Testicular disease|1.56:Vaginal discharge|1.56:Allergic hypersensitivity disease|1.55:Hydrocele|1.55:Upper respiratory tract disease|1.55:Bilirubin metabolic disorder|1.54:Cavernous hemangioma|1.54:Hypothyroidism|1.54:Sarcoidosis|1.52:Varicose veins|1.50:Syphilis,0.78:Carcinoma,4.00:Cancer,NA,"1.00:negative regulation of T cell mediated immunity|1.00:negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|1.00:negative regulation of adaptive immune response|0.98:regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|0.96:negative regulation of cell killing|0.92:regulation of adaptive immune response|0.85:regulation of natural killer cell mediated immune response to tumor cell|0.85:regulation of natural killer cell mediated cytotoxicity directed against tumor cell target|0.85:negative regulation of cell adhesion|0.83:positive regulation of cell migration|0.83:regulation of T cell mediated immunity|0.83:positive regulation of cell motility|0.82:negative regulation of leukocyte mediated cytotoxicity|0.81:positive regulation of cellular component movement|0.81:regulation of exocytosis|0.77:positive regulation of locomotion|0.77:regulation of lymphocyte activation|0.76:immune response-regulating cell surface receptor signaling pathway|0.76:negative regulation of natural killer cell mediated cytotoxicity|0.76:negative regulation of natural killer cell mediated immunity|0.76:antigen receptor-mediated signaling pathway|0.76:immune response-regulating signaling pathway|0.75:regulation of leukocyte mediated cytotoxicity|0.75:negative regulation of immune system process|0.75:regulation of leukocyte cell-cell adhesion|0.74:regulation of cell-cell adhesion|0.74:immune response-activating cell surface receptor signaling pathway|0.74:T cell receptor signaling pathway|0.73:activation of immune response|0.73:immune response-activating signal transduction|0.72:regulation of lymphocyte mediated immunity|0.72:adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|0.69:regulation of leukocyte activation|0.68:regulation of leukocyte mediated immunity|0.68:regulation of cell activation|0.66:regulation of defense response|0.65:regulation of T cell activation|0.63:negative regulation of lymphocyte mediated immunity|0.63:regulation of immune response|0.62:positive regulation of immune response|0.61:regulation of cell killing|0.61:regulation of natural killer cell mediated cytotoxicity|0.61:regulation of natural killer cell mediated immunity|0.60:regulation of innate immune response|0.59:regulation of leukocyte degranulation|0.58:regulation of response to biotic stimulus|0.58:regulation of cell adhesion|0.57:negative regulation of response to biotic stimulus|0.56:prostate gland|0.56:negative regulation of immune response|0.56:regulation of secretion|0.55:epiboly involved in wound healing|0.55:wound healing, spreading of cells|0.55:negative regulation of defense response|0.55:negative regulation of cell activation|0.55:regulation of secretion by cell|0.55:regulation of vesicle-mediated transport|0.54:negative regulation of lymphocyte activation|0.53:placenta|0.53:negative regulation of secretion|0.51:negative regulation of leukocyte mediated immunity|0.51:testis|0.50:regulation of immune effector process|0.49:negative regulation of immune effector process|0.49:adaptive immune response|0.49:fetus|0.47:negative regulation of cell-cell adhesion|0.42:negative regulation of secretion by cell|0.42:negative regulation of leukocyte activation|0.40:negative regulation of transport|0.38:pancreas|0.38:gastrointestinal tract|0.37:innate immune response|0.37:kidney|0.36:intestine|0.36:T cell mediated immunity|0.35:autism spectrum disorder|0.34:natural killer cell mediated immunity|0.34:liver|0.34:large intestine|0.33:mammary gland|0.33:wound healing|0.33:nervous system|0.32:response to wounding|0.32:negative regulation of leukocyte cell-cell adhesion|0.32:ovary|0.31:negative regulation of exocytosis|0.30:exocytosis|0.29:epithelium development|0.28:natural killer cell mediated cytotoxicity|0.27:lung|0.26:leukocyte activation involved in immune response|0.26:regulation of immune response to tumor cell|0.26:regulation of response to tumor cell|0.26:colon|0.25:cell activation involved in immune response|0.25:central nervous system|0.25:blood|0.24:brain|0.24:regulation of regulated secretory pathway|0.23:adrenal gland|0.23:regulation of antigen receptor-mediated signaling pathway|0.23:skin|0.23:T cell activation involved in immune response|0.23:uterus|0.23:small intestine|0.22:regulation of nucleotide metabolic process|0.22:regulation of purine nucleotide metabolic process|0.20:heart|0.18:regulation of T cell mediated cytotoxicity|0.18:negative regulation of antigen receptor-mediated signaling pathway|0.17:thyroid gland|0.17:negative regulation of innate immune response|0.17:regulation of protein catabolic process|0.17:leukocyte|0.16:leukocyte degranulation|0.16:negative regulation of T cell activation|0.16:stomach|0.15:negative regulation of T cell receptor signaling pathway|0.15:positive regulation of protein catabolic process|0.15:regulation of T cell receptor signaling pathway|0.15:positive regulation of catabolic process|0.14:epidermis|0.14:eye|0.14:spleen|0.13:regulation of cellular protein catabolic process|0.13:positive regulation of MAPK cascade|0.13:hypophysis|0.13:blood plasma|0.13:positive regulation of cellular catabolic process|0.12:regulation of response to external stimulus|0.12:positive regulation of cellular protein catabolic process|0.12:regulation of peptidase activity|0.12:negative regulation of regulated secretory pathway|0.12:regulation of cellular amide metabolic process|0.12:regulated exocytosis|0.11:regulation of translation|0.11:negative regulation of proteolysis|0.11:serum|0.11:regulation of endopeptidase activity|0.10:lymphocyte activation involved in immune response",293.42:Esophagus - Mucosa|249.49:Colon - Transverse|78.92:Vagina|30.68:Small Intestine - Terminal Ileum|17.24:Minor Salivary Gland|4.39:Lung|3.95:Skin - Sun Exposed (Lower leg)|2.51:Skin - Not Sun Exposed (Suprapubic)|0.74:Colon - Sigmoid|0.62:Testis|0.58:Stomach|0.45:Cervix - Ectocervix|0.37:Fallopian Tube|0.24:Prostate|0.23:Bladder|0.16:Esophagus - Muscularis|0.14:Pituitary|0.13:Thyroid|0.13:Uterus|0.13:Esophagus - Gastroesophageal Junction|0.12:Breast - Mammary Tissue|0.11:Spleen|0.10:Ovary|0.10:Cervix - Endocervix|0.09:Adrenal Gland|0.08:Brain - Cerebellum|0.07:Pancreas|0.07:Cells - Cultured fibroblasts|0.06:Liver|0.06:Artery - Coronary|0.06:Whole Blood|0.04:Artery - Aorta|0.04:Cells - EBV-transformed lymphocytes|0.04:Adipose - Visceral (Omentum)|0.04:Brain - Cerebellar Hemisphere|0.04:Kidney - Cortex|0.04:Nerve - Tibial|0.03:Adipose - Subcutaneous|0.03:Artery - Tibial|0.02:Heart - Atrial Appendage|0.02:Muscle - Skeletal|0.02:Brain - Cortex|0.02:Heart - Left Ventricle|0.02:Brain - Amygdala|0.02:Brain - Frontal Cortex (BA9)|0.02:Brain - Hippocampus|0.01:Brain - Anterior cingulate cortex (BA24)|0.01:Brain - Hypothalamus|0.01:Brain - Nucleus accumbens (basal ganglia)|0.01:Brain - Caudate (basal ganglia)|0.01:Brain - Putamen (basal ganglia)|0.01:Brain - Substantia nigra|0.00:Kidney - Medulla|0.00:Brain - Spinal cord (cervical c-1),"0.00:ventrolateral prefrontal cortex|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:striatum|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:parietal neocortex|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:medial ganglionic eminence|0.00:lateral ganglionic eminence|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:hippocampus (hippocampal formation)|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",1,SNP,0.39,"40|0.19;0-39,41-46|0.00",42213866,NA,A|N,N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;N|108|^:^|^:^;N|128|^:^|^:^;N|140-141|A:G|N:S,NA,NA,P,D
98,CEACAM6,Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6) mRNA.,,NM_002483,chr19,1.55,4e-01,0.01,4e-01,+,CEACAM6,41755529,41772211,CEA cell adhesion molecule 6,protein_coding,"CD66c,CEAL,NCA",0.19,0,0,2.44:Cancer|2.14:Crohn's disease|1.98:Colonic disease|1.81:Breast disease|1.80:Colitis|1.79:Lung disease|1.77:Hematopoietic system disease|1.76:Stomach disease|1.67:Gonorrhea|1.57:Adenoma,0.61:Carcinoma,4.00:Cancer,NA,"1.00:negative regulation of T cell mediated immunity|1.00:negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|1.00:regulation of myotube differentiation|1.00:negative regulation of adaptive immune response|1.00:regulation of striated muscle cell differentiation|1.00:negative regulation of myotube differentiation|1.00:negative regulation of anoikis|1.00:negative regulation of striated muscle cell differentiation|1.00:regulation of anoikis|1.00:negative regulation of muscle cell differentiation|1.00:regulation of muscle cell differentiation|1.00:regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|0.99:negative regulation of cell killing|0.98:regulation of adaptive immune response|0.98:regulation of natural killer cell mediated immune response to tumor cell|0.98:regulation of natural killer cell mediated cytotoxicity directed against tumor cell target|0.96:negative regulation of leukocyte mediated cytotoxicity|0.96:regulation of T cell mediated immunity|0.96:negative regulation of cell adhesion|0.95:regulation of exocytosis|0.94:negative regulation of natural killer cell mediated cytotoxicity|0.94:negative regulation of natural killer cell mediated immunity|0.93:negative regulation of cell differentiation|0.92:regulation of leukocyte mediated cytotoxicity|0.92:antigen receptor-mediated signaling pathway|0.92:T cell receptor signaling pathway|0.92:immune response-regulating cell surface receptor signaling pathway|0.91:immune response-activating cell surface receptor signaling pathway|0.91:immune response-regulating signaling pathway|0.90:activation of immune response|0.90:immune response-activating signal transduction|0.90:adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|0.89:negative regulation of immune system process|0.89:regulation of lymphocyte mediated immunity|0.89:negative regulation of developmental process|0.89:regulation of lymphocyte activation|0.89:regulation of cell-cell adhesion|0.87:regulation of leukocyte cell-cell adhesion|0.87:negative regulation of lymphocyte mediated immunity|0.87:regulation of leukocyte mediated immunity|0.86:regulation of defense response|0.86:regulation of leukocyte degranulation|0.85:regulation of leukocyte activation|0.85:regulation of cell activation|0.84:regulation of secretion by cell|0.84:regulation of secretion|0.83:positive regulation of immune response|0.83:regulation of natural killer cell mediated cytotoxicity|0.83:regulation of natural killer cell mediated immunity|0.83:regulation of immune response|0.82:regulation of response to biotic stimulus|0.82:negative regulation of response to biotic stimulus|0.82:regulation of T cell activation|0.81:regulation of innate immune response|0.81:regulation of cell killing|0.81:negative regulation of cell activation|0.79:negative regulation of immune response|0.79:regulation of cell adhesion|0.78:negative regulation of lymphocyte activation|0.78:epiboly involved in wound healing|0.78:wound healing, spreading of cells|0.78:negative regulation of leukocyte mediated immunity|0.76:regulation of vesicle-mediated transport|0.75:negative regulation of defense response|0.75:negative regulation of secretion|0.73:adaptive immune response|0.72:negative regulation of cell-cell adhesion|0.71:negative regulation of immune effector process|0.71:prostate gland|0.69:gastrointestinal tract|0.69:regulation of immune effector process|0.69:negative regulation of leukocyte activation|0.68:blood|0.68:leukocyte|0.68:large intestine|0.65:mammary gland|0.65:negative regulation of secretion by cell|0.64:tear gland|0.64:colon|0.61:T cell mediated immunity|0.61:positive regulation of hormone secretion|0.60:intestine|0.59:innate immune response|0.57:negative regulation of exocytosis|0.56:natural killer cell mediated immunity|0.54:negative regulation of transport|0.54:wound healing|0.54:regulation of hormone secretion|0.54:lung|0.53:negative regulation of leukocyte cell-cell adhesion|0.51:regulation of immune response to tumor cell|0.51:regulation of response to tumor cell|0.51:exocytosis|0.51:response to wounding|0.51:testis|0.51:lymph node|0.48:ovary|0.47:blood plasma|0.46:spleen|0.46:natural killer cell mediated cytotoxicity|0.46:morbid obesity|0.45:pancreas|0.45:fetus|0.44:leukocyte activation involved in immune response|0.44:cell activation involved in immune response|0.44:eye|0.44:regulation of regulated secretory pathway|0.43:regulation of antigen receptor-mediated signaling pathway|0.43:epithelium development|0.43:liver|0.41:T cell activation involved in immune response|0.41:regulation of bone remodeling|0.40:autism spectrum disorder|0.40:kidney|0.39:small intestine|0.37:serum|0.37:neutrophil|0.37:regulation of T cell mediated cytotoxicity|0.37:placenta|0.35:leukocyte degranulation|0.35:negative regulation of antigen receptor-mediated signaling pathway|0.33:skin|0.32:thyroid gland|0.32:uterus|0.32:negative regulation of T cell receptor signaling pathway|0.31:granulocyte|0.30:negative regulation of innate immune response|0.30:regulation of system process|0.29:regulation of T cell receptor signaling pathway|0.29:bone marrow|0.28:negative regulation of T cell activation|0.28:stomach|0.27:negative regulation of regulated secretory pathway|0.27:positive regulation of secretion by cell|0.25:hypophysis|0.25:positive regulation of secretion|0.23:regulation of response to external stimulus|0.23:cornea|0.23:mammary epithelium|0.22:regulated exocytosis|0.20:positive regulation of MAPK cascade|0.20:epidermis|0.20:natural killer cell mediated cytotoxicity directed against tumor cell target|0.20:natural killer cell mediated immune response to tumor cell|0.19:adrenal gland|0.18:hormone secretion|0.18:tonsil|0.17:lymphocyte activation involved in immune response|0.17:cecum|0.16:lymphocyte|0.16:macrophage|0.16:vermiform appendix|0.16:monocyte|0.16:regulation of peptidase activity|0.16:mononuclear phagocyte|0.15:trachea|0.15:nervous system|0.15:nervous system process|0.15:regulation of endopeptidase activity|0.14:regulation of kidney development|0.14:signal release|0.14:keratinocyte|0.14:brain|0.13:uterine endometrium|0.13:pancreatic islet|0.13:intestinal epithelium|0.12:negative regulation of proteolysis|0.12:esophagus|0.12:uterine cervix|0.12:nutrition disease|0.12:heart|0.11:erythrocyte|0.11:rectum|0.11:central nervous system|0.11:regulation of protein serine/threonine kinase activity|0.11:hematopoietic stem cell|0.11:regulation of MAP kinase activity|0.10:stress-activated MAPK cascade",258.63:Lung|249.73:Esophagus - Mucosa|236.13:Minor Salivary Gland|87.66:Vagina|23.68:Colon - Transverse|8.58:Skin - Sun Exposed (Lower leg)|8.18:Small Intestine - Terminal Ileum|6.80:Whole Blood|6.22:Skin - Not Sun Exposed (Suprapubic)|2.16:Pancreas|1.33:Prostate|1.29:Spleen|1.14:Fallopian Tube|0.45:Colon - Sigmoid|0.40:Stomach|0.34:Breast - Mammary Tissue|0.33:Testis|0.32:Cervix - Ectocervix|0.21:Thyroid|0.21:Pituitary|0.17:Uterus|0.16:Brain - Nucleus accumbens (basal ganglia)|0.15:Liver|0.14:Esophagus - Muscularis|0.13:Esophagus - Gastroesophageal Junction|0.12:Adipose - Visceral (Omentum)|0.12:Bladder|0.12:Cervix - Endocervix|0.12:Ovary|0.10:Adipose - Subcutaneous|0.10:Cells - Cultured fibroblasts|0.10:Artery - Coronary|0.09:Brain - Cerebellum|0.08:Artery - Aorta|0.07:Adrenal Gland|0.06:Heart - Atrial Appendage|0.06:Nerve - Tibial|0.06:Artery - Tibial|0.06:Heart - Left Ventricle|0.06:Brain - Caudate (basal ganglia)|0.06:Kidney - Cortex|0.05:Brain - Cerebellar Hemisphere|0.05:Brain - Cortex|0.05:Muscle - Skeletal|0.05:Cells - EBV-transformed lymphocytes|0.05:Brain - Frontal Cortex (BA9)|0.04:Brain - Hypothalamus|0.04:Brain - Putamen (basal ganglia)|0.04:Brain - Substantia nigra|0.03:Brain - Anterior cingulate cortex (BA24)|0.03:Brain - Hippocampus|0.03:Brain - Amygdala|0.03:Brain - Spinal cord (cervical c-1)|0.01:Kidney - Medulla,"0.02:striatum|0.01:lateral ganglionic eminence|0.01:parietal neocortex|0.01:medial ganglionic eminence|0.00:ventrolateral prefrontal cortex|0.00:upper (rostral) rhombic lip|0.00:temporal neocortex|0.00:primary visual cortex (striate cortex, area V1/17)|0.00:primary somatosensory cortex (area S1, areas 3,1,2)|0.00:primary motor-sensory cortex (samples)|0.00:primary motor cortex (area M1, area 4)|0.00:primary auditory cortex (core)|0.00:posteroventral (inferior) parietal cortex|0.00:posterior (caudal) superior temporal cortex (area 22c)|0.00:orbital frontal cortex|0.00:occipital neocortex|0.00:mediodorsal nucleus of thalamus|0.00:inferolateral temporal cortex (area TEv, area 20)|0.00:hippocampus (hippocampal formation)|0.00:dorsolateral prefrontal cortex|0.00:dorsal thalamus|0.00:cerebellum|0.00:cerebellar cortex|0.00:caudal ganglionic eminence|0.00:anterior (rostral) cingulate (medial prefrontal) cortex|0.00:amygdaloid complex",1,SNP,1.31,"28|0.01;0-27,29-46|0.00",42265357,1,G|D,"N|30|^:^|^:^;N|34|^:^|^:^;N|41|^:^|^:^;N|83|^:^|^:^;B|100,103|A:G|N:D;N|108|^:^|^:^;N|128|^:^|^:^",NA,NA,NA,NA
99,ATP2A3,Homo sapiens ATPase Ca++ transporting ubiquitous (ATP2A3) transcript variant 7 mRNA.,Ion channel activity,NM_174958,chr17,17.74,4e-01,0.17,2e-01,-,ATP2A3,3923869,3964464,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3,protein_coding,SERCA3,0.06,0,0,2.05:Keratosis follicularis|1.79:Acrokeratosis verruciformis|1.75:Hailey-Hailey disease|1.57:Cancer|1.50:Diabetes mellitus,1.03:Carcinoma|0.54:Kidney cancer,NA,NA,0.94:blood|0.93:leukocyte|0.89:mononuclear phagocyte|0.87:lymph node|0.82:monocyte|0.81:spleen|0.67:testis|0.64:prostate gland|0.63:pancreas|0.63:ovary|0.63:liver|0.62:lymphocyte|0.60:B-lymphocyte|0.59:placenta|0.58:blood platelet|0.57:fetus|0.52:blood plasma|0.51:granulocyte|0.48:gastrointestinal tract|0.46:intestine|0.46:small intestine|0.46:T-lymphocyte|0.46:lung|0.42:bone marrow|0.42:kidney|0.41:hematopoietic stem cell|0.41:heart|0.41:central nervous system|0.40:autism spectrum disorder|0.40:uterus|0.38:nervous system|0.38:brain|0.37:skeletal muscle|0.37:large intestine|0.36:neutrophil|0.34:colon|0.33:mammary gland|0.31:adrenal gland|0.30:serum|0.30:thyroid gland|0.24:tonsil|0.21:spinal cord|0.20:cerebellum|0.19:stomach|0.19:cerebral cortex|0.18:thalamus|0.18:dendritic cell|0.17:corpus striatum|0.15:caudate nucleus|0.14:telencephalon|0.14:skin|0.14:hypophysis|0.13:basal ganglion|0.13:subthalamic nucleus|0.12:macrophage|0.12:forebrain|0.12:amygdala|0.11:plasma cell|0.11:bronchoalveolar lavage fluid|0.10:megakaryocyte|0.10:blood vessel,176.84:Spleen|124.38:Whole Blood|114.38:Minor Salivary Gland|103.39:Small Intestine - Terminal Ileum|88.78:Cells - EBV-transformed lymphocytes|83.65:Colon - Transverse|55.48:Brain - Cerebellum|50.64:Lung|44.09:Skin - Sun Exposed (Lower leg)|39.23:Esophagus - Muscularis|38.54:Artery - Aorta|36.84:Prostate|35.34:Stomach|34.06:Bladder|31.63:Artery - Coronary|30.59:Esophagus - Gastroesophageal Junction|29.64:Skin - Not Sun Exposed (Suprapubic)|25.37:Pancreas|23.59:Thyroid|21.14:Uterus|18.82:Artery - Tibial|17.59:Adrenal Gland|17.47:Colon - Sigmoid|16.13:Fallopian Tube|15.36:Kidney - Medulla|15.32:Brain - Cerebellar Hemisphere|15.00:Cervix - Endocervix|14.78:Cervix - Ectocervix|14.53:Vagina|13.63:Breast - Mammary Tissue|11.55:Esophagus - Mucosa|10.79:Adipose - Visceral (Omentum)|10.26:Adipose - Subcutaneous|8.99:Nerve - Tibial|7.39:Kidney - Cortex|6.68:Heart - Atrial Appendage|5.71:Brain - Substantia nigra|5.30:Testis|4.99:Ovary|4.01:Pituitary|3.92:Heart - Left Ventricle|3.06:Liver|2.70:Brain - Spinal cord (cervical c-1)|2.51:Brain - Putamen (basal ganglia)|2.18:Brain - Hypothalamus|1.78:Brain - Cortex|1.66:Brain - Caudate (basal ganglia)|1.60:Brain - Nucleus accumbens (basal ganglia)|1.53:Brain - Amygdala|1.37:Brain - Hippocampus|1.37:Cells - Cultured fibroblasts|1.28:Brain - Frontal Cortex (BA9)|1.25:Brain - Anterior cingulate cortex (BA24)|1.08:Muscle - Skeletal,"24.69:cerebellar cortex|3.49:mediodorsal nucleus of thalamus|1.44:striatum|1.04:hippocampus (hippocampal formation)|1.02:primary motor-sensory cortex (samples)|1.01:dorsal thalamus|0.95:ventrolateral prefrontal cortex|0.94:primary motor cortex (area M1, area 4)|0.90:posterior (caudal) superior temporal cortex (area 22c)|0.90:posteroventral (inferior) parietal cortex|0.87:upper (rostral) rhombic lip|0.86:anterior (rostral) cingulate (medial prefrontal) cortex|0.86:cerebellum|0.86:amygdaloid complex|0.83:primary auditory cortex (core)|0.82:orbital frontal cortex|0.81:inferolateral temporal cortex (area TEv, area 20)|0.80:primary visual cortex (striate cortex, area V1/17)|0.79:primary somatosensory cortex (area S1, areas 3,1,2)|0.78:dorsolateral prefrontal cortex|0.55:parietal neocortex|0.52:lateral ganglionic eminence|0.48:medial ganglionic eminence|0.47:temporal neocortex|0.43:occipital neocortex|0.38:caudal ganglionic eminence",3,SNP,6.78,0-46|0.00,3833680,NA,C|D,N|36|^:^|^:^;N|40|C:T|D:N;N|42|^:^|^:^;N|69|^:^|^:^;N|104|^:^|^:^;N|146|^:^|^:^;N|165|^:^|^:^,0.0152,0.0273,B,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,7.02,"9|0.29;0-8,10-46|0.00",3844344,NA,C|R,"N|35-36,39|C:T|R:H;N|87|^:^|^:^;N|101-102|^:^|^:^;N|137,140|C:T|R:H",0.0051,0.0033,P,T
,,,,,,,,,,,,,,,,,,,,,,,,,,,,SNP,17.96,0-46|0.00,3844345,NA,G|R,"N|35-36,38|A:G|C:R;N|67|^:^|^:^;N|69,71|A:G|C:R;N|100-102|A:G|C:R;N|109-111|A:G|C:R;N|124,127|A:G|C:R;N|128|A:G|C:R",NA,NA,NA,NA
